Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.8212308366458247,1.9591533775288323,0.0,0.06726130143928644,0.07,3/12,5.29%,LMOD1;CSRP2;OBSCN
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.9124782876328801,1.8920290358304366,0.0,0.12010946685586862,0.22,4/8,4.52%,CTNNA3;RYR2;CACNA1C;BIN1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.9011952668777743,1.8684053770054656,0.0,0.1377255219947294,0.32,2/11,1.09%,JPH2;RYR2
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.6919900641055525,1.8489211099828933,0.0,0.12010946685586862,0.34,13/57,5.39%,JPH2;TAGLN;ACTA2;TWIST2;LMOD1;ADGRA2;SERPINH1;TPM2;ITGA8;COL5A2;MYL9;IGFBP7;MSRB3
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.5828685565812164,1.8456522561288222,0.0,0.10185282789377662,0.37,26/95,8.18%,JPH2;TAGLN;MYH11;NOX4;ACTA2;SLIT3;LMOD1;PRKG1;NOTCH3;COL14A1;TPM2;SYNPO2;ITGA8;COL5A2;SLC38A11;MYL9;RASL12;OBSCN;MSRB3;IRAG1;TNS2;MYLK;PRRX1;GJC1;RBPMS2;GJA4
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.6918185053114596,1.8189674187982303,0.0,0.14413136022704237,0.57,10/44,7.46%,MYH11;ACTA2;LMOD1;MYOM1;TPM2;DTNA;MYL9;MYLK;GJC1;ITGB5
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.8596565485578131,1.8173132316544436,0.0,0.12765920477252324,0.58,3/9,7.17%,SPRY3;DSTYK;SMOC2
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.8323090837902518,1.8129442858582057,0.037037037037037035,0.11770727751875126,0.61,2/8,5.36%,MPP7;ACTB
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.6329136544845625,1.7851944334875747,0.0,0.15053719845935537,0.7,9/41,4.68%,JPH2;MYH11;CAV2;ACTA2;FKBP9;ITGA3;TINAGL1;NTN4;MYL9
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.8297590991847101,1.7592646090933688,0.0,0.20754915872694102,0.8,1/10,0.02%,JPH2
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.6645421833312212,1.7500234139543014,0.0,0.21226618506164419,0.81,14/30,8.13%,CTNNA3;FILIP1;GALNT16;RYR2;LDB3;ATP1B2;SLC35F1;FGF13;CACNB2;DTNA;ANO5;HFM1;LRP1B;PREX2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.7719190365440609,1.7251009810718543,0.0,0.26904520575714574,0.91,1/15,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.9203798738699809,1.7122760849143877,0.0,0.3082193703316752,0.97,4/12,3.50%,JPH2;RYR2;MCU;CACNA1C
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.5667516946253957,1.7111313875681893,0.0,0.29306709912831946,0.97,15/76,7.30%,TAGLN;MYH11;ACTA2;LMOD1;COL14A1;TPM2;FKBP9;SYNPO2;COL5A2;MYL9;RASL12;TNS2;MYLK;SMOC2;PRRX1
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.8578890142540715,1.7068890103315204,0.0,0.29402797486316645,0.97,5/9,3.50%,JPH2;ATP2B4;RYR2;GRIN2A;CACNA1C
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.8819907390880763,1.6998832849807093,0.06666666666666667,0.30147476180823024,0.98,2/5,5.20%,ERBB4;VPS35
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.5578402874419436,1.6874887708498818,0.0,0.33461084413493764,0.99,16/80,8.82%,JPH2;LMOD1;CSPG4;NOTCH3;FKBP9;HEYL;PLS3;NTN4;ITGA7;COL5A2;ARHGEF17;TNS2;ADCY6;CAP2;CHST3;PTPN21
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.6340737567770052,1.684130924865909,0.0,0.3309683086695047,0.99,12/55,7.17%,TAGLN;MYH11;ACTA2;SLIT3;LMOD1;COL14A1;SYNPO2;MYL9;RASL12;TNS2;MYLK;SMOC2
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.9321025048998601,1.6799850467225699,0.0,0.32568630170601853,0.99,3/5,3.55%,MCAM;MYO1E;ITGA3
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.8542966684960059,1.6713793065795306,0.038461538461538464,0.3363065071964322,0.99,2/8,5.60%,CAV2;SKI
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.9019342200140898,1.6590263914654586,0.0,0.37382641684283685,1.0,1/7,0.10%,HSPA1A
prerank,PanglaoDB_Augmented_2021__Pericytes,0.5282309291245284,1.6554949311835134,0.0,0.37692534507859865,1.0,18/94,6.13%,TAGLN;MCAM;ACTA2;SLIT3;INPP4B;LMOD1;ADGRA2;CSPG4;NOTCH3;COL14A1;HEYL;KCNJ8;SYNPO2;COL5A2;SLC38A11;RASL12;TNS2;GNB4
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.7181844943206817,1.6509957597545653,0.0,0.37933702923523027,1.0,2/15,2.97%,RYR2;NOTCH1
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.8629683170317866,1.6434348497356082,0.02857142857142857,0.3923575917291709,1.0,1/5,2.86%,ERBB4
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.7828999495073867,1.6426729066829755,0.0,0.3805067909993919,1.0,1/13,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.8291311557324827,1.6318145040916288,0.0,0.41687224188744565,1.0,4/8,10.35%,ADCY9;GUCY1B1;ADCY6;GUCY1A1
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.8562644292690076,1.624097147215107,0.0,0.43310584048471745,1.0,3/7,10.72%,RNF185;ATXN3;TMEM259
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.6926759986182836,1.6154274388479235,0.047619047619047616,0.45710231386290573,1.0,1/13,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.8084262300390621,1.6144255731193295,0.08333333333333333,0.43271437259274276,1.0,2/9,2.20%,HSPA1A;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.8084262300390621,1.6144255731193295,0.08333333333333333,0.43271437259274276,1.0,2/9,2.20%,HSPA1A;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.8332896967882077,1.6116775472394143,0.07692307692307693,0.4330140005100606,1.0,3/6,9.24%,NOTCH1;SOX6;HDAC1
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.5496045619609289,1.6086768768404809,0.0,0.4341957226839651,1.0,13/68,8.82%,JPH2;LMOD1;CSPG4;PRKG1;TPM2;FKBP9;LMCD1;COL5A2;TNS2;CAP2;PRRX1;CHST3;PTPN21
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.8353841659509804,1.6060900723681235,0.04,0.4332676040764425,1.0,2/8,3.95%,HSPA1A;PTGES3
prerank,PanglaoDB_Augmented_2021__Myocytes,0.6109875001980047,1.6028140281338568,0.0,0.4329593017016253,1.0,11/41,4.89%,JPH2;LMOD1;LDB3;PRKG1;MEF2D;NOTCH3;TPM2;ITGA3;ITGA7;SYNPO2;RASL12
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.8516832873962898,1.6010772837219465,0.027777777777777776,0.42717789812052936,1.0,3/7,2.97%,RYR2;HEY2;NOTCH1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.8363696069606347,1.60084278898737,0.0,0.4155787553213055,1.0,3/7,9.11%,CDC42;RHOA;OPHN1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.5768783125668511,1.600346282844606,0.0,0.40590507393669767,1.0,16/49,5.29%,JPH2;CTNNA3;RBM20;FILIP1;RYR2;LMOD1;LDB3;PRKG1;SORBS2;HEY2;MYOM1;NOTCH1;ITGA7;SYNPO2;RASL12;OBSCN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.9071587904871383,1.598112020230241,0.0,0.40356780863571867,1.0,1/5,0.29%,ATP2B4
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.9207168676895198,1.597447043107786,0.0,0.39691559200985516,1.0,1/6,0.08%,ATP10A
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.9128441621400457,1.5915064416018592,0.027777777777777776,0.41125481451449425,1.0,1/5,0.27%,CAV2
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),0.9692955187303836,1.5785660386433475,0.0,0.45770495369660774,1.0,1/5,0.27%,CAV2
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.763023196344692,1.5783119031660078,0.0,0.44840867626190956,1.0,5/12,9.88%,MYO1E;SYNE2;MYO1D;ACTN4;MYO1B
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.8567713898429501,1.5759997736111724,0.0,0.44490781118145944,1.0,2/8,2.97%,ATP2B4;NOTCH1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.6001769490999711,1.5740534777376254,0.0,0.4433131231225697,1.0,5/24,3.42%,RCAN2;RYR2;GUCY1B1;EDN3;MCU
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.8607045920274914,1.5723263346721914,0.045454545454545456,0.4398675586188256,1.0,2/5,8.81%,PPARD;SLC27A1
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.9538784718323319,-1.5710387509102863,0.0,1.0,0.68,1/8,0.24%,TEFM
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.9118571679836265,1.570901881551839,0.0,0.4340651689156435,1.0,1/5,1.91%,JADE3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.6759896600876533,1.5693388241614612,0.09090909090909091,0.4313718724525665,1.0,4/15,3.50%,CTNNA3;RYR2;FGF13;CACNA1C
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.8568677156227424,-1.569230288869758,0.0,0.7778600518326545,0.69,6/24,6.87%,SRGN;NELL1;TWIST1;ANKH;TGFB1;ADGRV1
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.7438659117843233,1.5649022307584086,0.0,0.4422030204743564,1.0,4/10,9.88%,MYO1E;MYO1D;ACTN4;MYO1B
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.9112093547586935,1.5530554176972264,0.047619047619047616,0.4820066441334288,1.0,3/5,6.27%,NSUN3;TFB1M;MTERF4
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.7811417620752106,1.5497247042796083,0.07142857142857142,0.4757276922526562,1.0,2/6,6.14%,MCU;DAPK2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.7811417620752106,1.5497247042796083,0.07142857142857142,0.4757276922526562,1.0,2/6,6.14%,MCU;DAPK2
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.9336056605965177,-1.5491234177412612,0.0,0.9260238712293506,0.9,3/10,3.35%,SLC2A3;SLC23A2;SLC2A1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.7929531801739425,1.5491076371941783,0.0,0.46972040730402786,1.0,1/8,1.30%,LEMD3
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.8310116716870573,1.5431869850357507,0.06451612903225806,0.4844264082096317,1.0,3/8,9.11%,CDC42;RHOA;OPHN1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.7851440057697943,-1.5399773213190817,0.011904761904761904,0.9192891521658645,0.92,10/31,9.02%,CSE1L;SEC13;TSC2;IPO5;IPO9;NUP153;NUP133;NUP88;BACH2;STAT3
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.8819763827893378,1.538659402580087,0.047619047619047616,0.49663040295515465,1.0,1/6,0.98%,SPRY3
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.9231514850639443,1.5384826147060329,0.043478260869565216,0.487950168623187,1.0,1/6,0.51%,SNAP29
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.8270599734063603,1.5365332172606323,0.041666666666666664,0.4862717558136167,1.0,3/8,3.72%,HCN2;CACNA1C;CACNB2
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.8511086403213733,1.5332935400542884,0.07407407407407407,0.48819230317837975,1.0,4/6,13.89%,ABCA3;PGS1;SLC27A1;CDS2
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.9600610456867287,-1.5332502299836404,0.0,0.8748400063468557,0.95,3/6,3.35%,SLC2A3;SLC23A2;SLC2A1
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.7525334187723933,-1.5313948562885247,0.0,0.7627069339398105,0.97,8/55,3.75%,STC1;COL4A6;MID1;GJA1;GPR161;NXN;TENM3;EFNB2
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.8634296112364848,1.5285786393836482,0.02631578947368421,0.502968746723334,1.0,1/5,0.87%,ST3GAL2
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.8066877738929626,1.5265584726817323,0.0,0.5034011688833763,1.0,1/12,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.7373775081887979,1.5246602481054696,0.037037037037037035,0.5025380093249544,1.0,2/7,6.14%,MCU;DAPK2
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.5156496436675408,1.5228496394989437,0.0,0.5024907531412734,1.0,12/64,7.30%,TAGLN;ACTA2;LMOD1;ADGRA2;PRKG1;COL14A1;COL5A2;MYL9;IGFBP7;MSRB3;MYLK;PRRX1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.8814434208519764,1.5209832173328879,0.0,0.49965538212041355,1.0,2/7,2.20%,HSPA1A;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.9102893236109932,-1.5191304731381523,0.0,0.9380501552712902,0.98,2/10,4.94%,SRSF12;SRSF10
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.7495309117901684,-1.5174407150320015,0.0,0.8586766805944887,0.98,8/39,11.12%,GNPAT;SOD1;SLC23A2;CADM1;DHRS3;SOD2;ESR2;PABPC1
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.8431590417807943,-1.5157128772399369,0.02564102564102564,0.8081662876183424,1.0,2/18,3.45%,MID1;TENM3
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.6440601784972858,1.5145454342948612,0.09523809523809523,0.5202455764385625,1.0,1/12,0.29%,ATP2B4
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.8284560990640578,-1.5070489330557273,0.0,0.9011054106944517,1.0,9/22,9.66%,SLC2A3;BTD;SLC23A2;SLC2A1;MMUT;ALDH1L1;PANK2;MCCC2;MTHFD2L
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.9082991303871312,1.503991119128854,0.0,0.5547556000405433,1.0,1/6,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.7314567157252383,1.4990068334395652,0.1,0.566473202451309,1.0,3/15,2.18%,ATP2B4;RYR2;GRIN2A
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.9200804094950561,-1.4989567206768235,0.0,0.9881669607697005,1.0,3/11,2.45%,TBC1D20;SEC24A;SEC13
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.8208482609814379,1.4985785145603703,0.10714285714285714,0.5593461474669664,1.0,2/6,6.58%,ADCY9;ADCY6
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.8674964497656821,-1.4930357999249895,0.0375,1.0,1.0,3/11,4.94%,SRSF12;STRAP;SRSF10
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.8076674451996388,-1.4929308323433241,0.0,0.9534808027958713,1.0,6/14,15.58%,TGFB2;TGFB1;STAT3;HIF1A;JUN;TEAD1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.9280414258700755,1.4919194561541778,0.03571428571428571,0.5809712838604464,1.0,3/5,3.56%,HEY2;NOTCH1;HEYL
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.8166038232613864,1.4902938603173355,0.09090909090909091,0.5806232933067815,1.0,3/9,12.13%,ATM;UBE2N;UBE2V2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.8684450765716629,1.486399310606101,0.045454545454545456,0.5890586026670428,1.0,1/9,1.09%,RYR2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.6619580483945529,1.486114234849551,0.05263157894736842,0.5818788914308882,1.0,1/23,0.10%,HSPA1A
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.725658561951778,-1.4842867709557654,0.010526315789473684,1.0,1.0,16/55,12.05%,CSF1;F3;SLC7A2;CD55;PDE4B;SELENOS;NFKBIA;SLC1A2;ADM;ITGA5;PTPRE;EIF2AK2;HIF1A;CMKLR1;IL18;ADORA2B
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.9057288098691096,-1.4842662891380762,0.0,0.9825955113626346,1.0,6/8,9.16%,TAF7;SELENOS;HDAC2;TGFB1;TMEFF2;AP2A1
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.8289920250395777,-1.4822502899896706,0.013157894736842105,0.9552778071613688,1.0,3/13,3.88%,ENO1;CRY1;PGK1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.7745661808687073,1.4822257604920321,0.06451612903225806,0.5906002404045191,1.0,3/8,9.11%,CDC42;RHOA;OPHN1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.8487802147306449,-1.4812630117701018,0.024390243902439025,0.9133467529922001,1.0,8/19,6.90%,EPN1;ADAMTS9;KLF2;CEMIP2;VEGFA;RHOJ;GLUL;ITGA5
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.9668448765036617,-1.4810757050511365,0.0,0.8642889464807273,1.0,2/5,2.58%,TAF7;TAF1B
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.8577423933352167,1.4805363375332175,0.10714285714285714,0.5892036624096223,1.0,1/5,4.06%,SNAPC3
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.6734442516350053,1.4800460533479967,0.09090909090909091,0.5820537670538642,1.0,2/14,3.95%,HSPA1A;PTGES3
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.8427463487353034,1.4764377730048612,0.08695652173913043,0.5889908558467245,1.0,1/9,1.09%,RYR2
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.785481330439396,1.4750186873920208,0.10714285714285714,0.5872872491384553,1.0,3/5,17.23%,TRIM25;IRF3;ANXA11
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.8972122644778088,-1.472696173097956,0.0,0.9841551305141788,1.0,1/8,0.08%,STC1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.7244774366411042,-1.4719669523400682,0.0,0.9511106997408367,1.0,11/44,9.02%,CSE1L;SEC13;TSC2;IPO5;IPO9;NUP153;NUP133;NUP88;ALDH3A2;PEX3;STAT3
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.9135307285894438,-1.4714587555956822,0.0,0.9144786385490886,1.0,2/9,4.94%,SRSF12;SRSF10
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.9071707487571613,-1.4691089374610151,0.0,0.916534039821711,1.0,2/6,5.63%,TWIST1;AKAP8
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.9436651234436032,-1.4681686651788786,0.0,0.8951320076990119,1.0,2/6,2.61%,CD55;CADM1
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.7487922605794343,-1.466835732078376,0.0,0.8822481973166904,1.0,5/33,5.68%,GNPAT;SOD1;SLC23A2;SLCO1A2;FADS2
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.6312307668115507,1.465278448666039,0.0,0.6219141762779135,1.0,3/13,3.72%,MCU;CACNA1C;CACNB2
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.7718829778905157,-1.463704975562564,0.0125,0.9051462421325436,1.0,10/26,11.50%,SOD1;NDUFB9;HOMER2;SPTBN4;COL11A1;DCDC2;ADGRV1;CEMIP;KCNQ1;GRM7
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.8914555928582051,-1.463078368104293,0.0273972602739726,0.8800464622382429,1.0,3/7,8.97%,ADAMTS9;CTSL;MANBA
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.9593976480550339,-1.4613453243859915,0.0,0.8814998951985253,1.0,1/6,0.16%,COL4A6
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.8079859636172768,-1.4604240131935518,0.011904761904761904,0.8698611247534926,1.0,3/15,3.48%,OS9;SEC13;SELENOS
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.7115514461946433,1.456443149405053,0.07692307692307693,0.6505253513970319,1.0,2/10,2.97%,IL34;NOTCH1
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.8191273549003706,-1.4558114627606962,0.0125,0.920334194779164,1.0,1/12,0.08%,STC1
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.7916094435556366,-1.4555000595369345,0.0,0.8963911073500114,1.0,4/20,9.93%,SOD1;NRG1;FGFR2;TGFBR1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.8917455499022534,-1.4551049633307458,0.025974025974025976,0.8749703557480845,1.0,1/9,1.27%,NRG1
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.9282563190561602,-1.4533971128860181,0.0,0.8731984185751308,1.0,2/7,0.85%,TAF7;TWIST1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.7282542416912263,-1.4530082718914878,0.011235955056179775,0.8531664559061819,1.0,9/39,9.02%,CSE1L;SEC13;TSC2;IPO5;IPO9;NUP153;NUP133;NUP88;STAT3
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.6846905789360176,1.4527528107212837,0.06666666666666667,0.6575839323862839,1.0,4/11,6.42%,HSPA1A;BCL2L1;BCL2L11;NCK1
prerank,PanglaoDB_Augmented_2021__Platelets,-0.7610777808058897,-1.4522206767498478,0.0,0.8447120425363778,1.0,8/37,9.61%,SLC2A3;SRGN;FHL1;VEGFA;WIPF1;PDLIM1;CA2;RAP1B
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.7655033967925741,-1.4513598433926875,0.0,0.8306794913448534,1.0,10/27,11.50%,SOD1;NDUFB9;HOMER2;SPTBN4;COL11A1;DCDC2;ADGRV1;CEMIP;KCNQ1;GRM7
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.8741465050428667,-1.4505026082034747,0.0,0.8230387922168744,1.0,3/15,2.94%,STC1;ADAMTS9;MCC
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.6770827436534164,-1.4498096484326077,0.0,0.8114426374330114,1.0,36/74,24.41%,PELI1;IFITM3;IFIT3;PDE4B;CFH;NFKBIA;HERC6;MT2A;SOD2;PTPN1;EIF2AK2;LATS2;CD38;STAT3;C1R;HIF1A;CMKLR1;PTPN2;PSMB2;EPSTI1;C1S;SP110;CMTR1;VAMP5;NAMPT;RNF213;DDX60;WARS1;HLA-B;IFI44;BTG1;IRF1;STAT1;MARCHF1;PSMA3;IFI44L
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.9077319405819366,-1.4488445526160656,0.0,0.8039127808414037,1.0,3/10,5.31%,ADAMTS9;ROBO2;ROBO1
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.8628261345917885,1.4455550296720896,0.07692307692307693,0.6841678491789985,1.0,2/7,7.88%,PPIP5K2;IPPK
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.798437419584357,-1.4454758703632091,0.025,0.8374364127788785,1.0,3/14,3.88%,ENO1;CRY1;PGK1
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.8988720381212539,-1.4444863858417443,0.014285714285714285,0.8329163801766541,1.0,3/8,2.13%,TWIST1;KDM1A;CD44
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.8125224988236397,-1.4443565135050112,0.04938271604938271,0.8138333073181052,1.0,3/12,3.69%,FHL1;DPP6;ANK3
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.9169910318146424,-1.4419340777416614,0.0,0.8394346261273854,1.0,1/6,1.35%,RPS21
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.8763144523719628,-1.441076138015708,0.013513513513513514,0.8340088142573011,1.0,3/8,8.20%,GJA1;KDM1A;EIF2AK2
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.8481666655992106,-1.4401862705687858,0.013333333333333334,0.8311255571529544,1.0,3/12,7.83%,WWC1;MLPH;SHROOM3
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.8469787977470936,-1.4397032882310967,0.02564102564102564,0.820513272568067,1.0,1/10,0.74%,SOD1
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.7589760981915177,-1.4387351209177441,0.03333333333333333,0.8182683662135717,1.0,7/21,14.63%,NRCAM;DIP2B;OLFM1;MT3;SIN3A;GOLGA4;ZFYVE27
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.8227436534597137,-1.4373325297625785,0.036585365853658534,0.8208476203229919,1.0,4/16,4.33%,RHEB;GPR137C;SEC13;SLC38A9
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.8985426613291411,-1.4338256240274974,0.02666666666666667,0.8555197810334796,1.0,3/7,5.71%,EFNB2;TGFB2;TGFB1
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.841654295247571,-1.4327950492422752,0.03896103896103896,0.8533163939929386,1.0,2/12,3.88%,ENO1;PGK1
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.92242328244508,-1.4304396669423936,0.014285714285714285,0.8683746760459089,1.0,3/6,4.44%,CD55;TGFB2;CFH
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.9045253253119452,-1.430137078606222,0.012987012987012988,0.8557054810076566,1.0,2/8,5.63%,VEGFA;AKAP8
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.8323496366752917,1.4289750063125854,0.1724137931034483,0.7552483275897021,1.0,2/6,2.44%,PRKG1;PDGFA
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.8150605025094566,-1.4268662307232758,0.012987012987012988,0.8885943748957447,1.0,3/15,2.13%,TWIST1;KDM1A;CD44
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.811239801612621,-1.4266082831966227,0.0,0.8762123641937547,1.0,1/11,0.38%,NELL1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.8531233485211114,-1.4253412046088572,0.013157894736842105,0.8816869707280667,1.0,3/11,2.13%,TWIST1;KDM1A;CD44
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.7743023799565871,-1.424843025711192,0.011363636363636364,0.8726359164715329,1.0,9/28,11.55%,RHEB;EPM2A;SEC13;TSC2;SLC38A9;DDIT4;NPRL3;UBR1;C9ORF72
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.6263482746838156,1.4248201570356545,0.05263157894736842,0.7669211883685835,1.0,1/13,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.7133975256748022,1.42335959792587,0.034482758620689655,0.7653023688152957,1.0,2/8,2.20%,HSPA1A;BCL2L1
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.8533061908872133,1.4223963819836853,0.12,0.760481048458989,1.0,2/6,5.29%,CSRP2;OBSCN
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.836255478183863,-1.4218479254736662,0.07894736842105263,0.9010693318423258,1.0,2/10,4.25%,EPHA7;TGFB2
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.9132641948673568,-1.4202371732483368,0.0,0.9106049091629481,1.0,3/5,3.69%,KCNE4;NOS1AP;ANK3
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.9550417450996587,-1.4194296405813258,0.0,0.9095354211084017,1.0,1/5,0.69%,PRKACA
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.9197969945971267,-1.4184219207682078,0.028169014084507043,0.9086734085573185,1.0,1/5,1.80%,KDM1A
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.7973602979792848,-1.4182040469619652,0.0,0.8962227393734242,1.0,5/18,9.83%,ZFP36L2;ZFPM1;TGFB1;ZFPM2;ANKRD26
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.8528648242183535,-1.4181387888364116,0.02631578947368421,0.8681270121835742,1.0,2/11,3.88%,ENO1;PGK1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.8528648242183535,-1.4181387888364116,0.02631578947368421,0.8681270121835742,1.0,2/11,3.88%,ENO1;PGK1
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8893364642642679,-1.4171285832077667,0.0,0.8671752546507928,1.0,3/7,9.96%,ENO1;PGK1;RPS27A
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.7579594704938886,-1.4167242099252582,0.01098901098901099,0.8605708203310942,1.0,6/26,10.17%,TGFB2;PDCD4;TGFB1;SMAD6;USP15;HIVEP1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.7323018009784243,-1.41572216448396,0.011627906976744186,0.8599200133446709,1.0,7/27,7.52%,PRAG1;CRMP1;EFNB2;OMG;HDAC2;SPOCK1;CBFA2T2
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.7848338622899325,1.4151403840347545,0.1875,0.7755962843276374,1.0,2/7,5.15%,ZDHHC15;ZDHHC21
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.7848338622899325,1.4151403840347545,0.1875,0.7755962843276374,1.0,2/7,5.15%,ZDHHC15;ZDHHC21
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.7795106671472395,-1.4139855871530782,0.037037037037037035,0.8701563153617948,1.0,9/23,12.14%,STC1;NKAIN3;SYT1;SPTBN4;ANK3;SNX6;CA2;NEDD4L;TF
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.48474687212124357,1.413904321455963,0.0,0.7722759394490829,1.0,13/67,7.30%,TAGLN;ACTA2;SLIT3;LMOD1;PRKG1;COL14A1;TPM2;COL5A2;MYL9;RASL12;TNS2;MYLK;PRRX1
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.6484405065909677,-1.413779797641007,0.010526315789473684,0.8600336762266838,1.0,31/91,15.99%,SLC2A3;STC1;ENO1;GLRX;PDK1;SLC2A1;PGK1;RPA1;FADS2;DDIT4;GMPS;PSMD14;MTHFD2L;ACTR3;USO1;SSR1;GBE1;SEC11A;PSMA4;PPA1;SCD;ETF1;EIF2S2;TXNRD1;TBK1;ATP6V1D;HSPA5;UCHL5;LDHA;GSR;IGFBP5
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.7987963000406934,-1.4131838197107038,0.0379746835443038,0.8551112410902902,1.0,4/14,2.13%,TWIST1;TPT1;KDM1A;CD44
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.896035706754809,-1.4119794288486631,0.027777777777777776,0.8589694944668145,1.0,2/6,7.57%,LIMA1;PLEKHH2
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.9063379651657772,-1.4109052884747526,0.0,0.8634390890750969,1.0,1/5,0.08%,STC1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.8682337650416997,-1.41079474521652,0.05194805194805195,0.8527008031156208,1.0,2/6,8.97%,ADAMTS9;MANBA
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.7427506867651733,-1.410414428151533,0.05128205128205128,0.8456281624089843,1.0,4/22,5.71%,KDM1A;HABP4;NFKBIA;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.9187804733012235,-1.410255978943417,0.013888888888888888,0.8357048306382139,1.0,2/7,5.71%,TWIST1;TGFB1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.6361275339046836,1.4100351033096763,0.1111111111111111,0.779966027527489,1.0,4/9,12.03%,HDAC9;NOTCH1;HDAC1;MAPK14
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.7001178657096147,-1.4098362159016442,0.0,0.8305546780185803,1.0,13/62,10.35%,STC1;ADAMTS4;GJA1;ANKH;CD44;CREB3L2;TGFB2;SUFU;SLC10A7;FGFR2;FBN1;TGFBR1;CMKLR1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.9116635133505923,-1.4088730919600878,0.024691358024691357,0.8205280416888203,1.0,1/7,3.48%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.9116635133505923,-1.4088730919600878,0.024691358024691357,0.8205280416888203,1.0,1/7,3.48%,SELENOS
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.9708903578593214,-1.4087201779957756,0.0,0.8119709665697924,1.0,1/5,0.16%,COL4A6
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.8396285455483126,1.4082176878377832,0.15151515151515152,0.7799472015922452,1.0,1/5,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.7278337374637509,1.407867714711962,0.14285714285714285,0.7735589483346506,1.0,4/10,15.77%,PPIP5K2;IPPK;CYP27A1;ISYNA1
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.9257122074341867,-1.4075510013223096,0.0547945205479452,0.8160666311351243,1.0,3/5,6.21%,SOD1;KLF2;SOD2
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.9091991961603058,-1.40585535133169,0.05333333333333334,0.8282425703962032,1.0,2/5,3.40%,SOD1;VEGFA
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.8897082935461168,-1.4053478746738155,0.039473684210526314,0.8253398212302322,1.0,3/7,5.81%,NFKBIA;TMSB4X;SUFU
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.9064086579829195,-1.4048552836876418,0.013513513513513514,0.8216357257453148,1.0,4/7,8.45%,WWC1;SOD1;WWC2;LATS2
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.7842021163514715,-1.404705250618219,0.024096385542168676,0.8137101112376756,1.0,4/19,6.87%,NELL1;TGFB2;TGFB1;ADGRV1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.7048842659661694,1.4040606564853886,0.13043478260869565,0.7838610716940333,1.0,4/7,10.86%,ATM;HMBOX1;FEM1B;LDB2
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.9071031998177588,-1.4025921129884389,0.014084507042253521,0.8327520692597438,1.0,3/7,5.28%,VEGFA;TSC2;LGALS3
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.752659765831623,-1.4003953719238058,0.01098901098901099,0.849897493243873,1.0,6/27,10.17%,TGFB2;PDCD4;TGFB1;SMAD6;USP15;HIVEP1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.6632889672885611,-1.3998771432065003,0.021505376344086023,0.8452468584620075,1.0,17/52,20.40%,CSE1L;SEC13;TSC2;IPO5;TOR1AIP2;IPO9;NUP153;NUP133;NUP88;TBRG1;STAT3;GBP2;WRN;MDM2;SKP1;APPL2;XPA
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.5427012371338251,1.3989024501995135,0.0,0.8013281265663182,1.0,9/23,18.80%,MYO1E;MYO1D;ACTN4;MYO1B;NDE1;TRAK1;DYNC1I1;MYO5A;WASL
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.8782098857958096,1.3976680131491994,0.037037037037037035,0.7974224169083104,1.0,1/5,0.63%,OAZ2
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.8383687185833368,1.397552983826233,0.14814814814814814,0.789467902146832,1.0,2/5,3.99%,SOX5;SOX6
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.8347215847164775,-1.397265410606886,0.03896103896103896,0.8715979439139682,1.0,3/12,11.73%,SRSF12;SRSF10;PTBP2
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.9017210614038993,-1.3970252874314257,0.02857142857142857,0.8657597471957416,1.0,2/6,8.21%,TWIST1;FGFR2
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.721883468075441,1.3966417098217492,0.11428571428571428,0.7843403737745361,1.0,1/6,1.09%,RYR2
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.8176956849803098,1.396277423549388,0.1,0.7772978970840847,1.0,3/5,10.47%,ITGA3;ITGA8;ITGB1
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,-0.8110521525846832,-1.3961357843160334,0.012987012987012988,0.8662532395409108,1.0,5/18,8.21%,PLEKHG4B;EPHA7;CRMP1;UNC5D;FGFR2
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.7167882399396954,-1.3961001299740994,0.04878048780487805,0.8568605765773689,1.0,9/31,9.50%,CADM1;TGFB2;TGFB1;PRKCI;NECTIN2;CDH20;CDH18;AFDN;CDH12
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.8723150992351034,1.3957599982967233,0.058823529411764705,0.7635495014639468,1.0,2/5,3.37%,ACTA2;EDN3
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.8723150992351034,1.3957599982967233,0.058823529411764705,0.7635495014639468,1.0,2/5,3.37%,ACTA2;EDN3
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.6573414186734833,-1.3951174400425495,0.010416666666666666,0.8597991337717366,1.0,12/83,9.46%,SLC2A3;CSF1;IFITM3;CD44;EMP1;DHRS3;PTRH2;RHOB;ALCAM;CA2;MAP3K8;PHTF2
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.7293796311115587,-1.3943382660044437,0.05555555555555555,0.8434692504511329,1.0,11/32,18.91%,TBC1D20;SEC24A;CSNK1D;SEC13;CNIH3;ANKRD28;USO1;GOLGA2;COL7A1;NSF;MCFD2
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.7293796311115587,-1.3943382660044437,0.05555555555555555,0.8434692504511329,1.0,11/32,18.91%,TBC1D20;SEC24A;CSNK1D;SEC13;CNIH3;ANKRD28;USO1;GOLGA2;COL7A1;NSF;MCFD2
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.7293796311115587,-1.3943382660044437,0.05555555555555555,0.8434692504511329,1.0,11/32,18.91%,TBC1D20;SEC24A;CSNK1D;SEC13;CNIH3;ANKRD28;USO1;GOLGA2;COL7A1;NSF;MCFD2
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),-0.902181043772712,-1.3934157180951392,0.0,0.8451355965200326,1.0,1/7,1.48%,NRCAM
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.7201831119844878,-1.3925707317955662,0.023809523809523808,0.8475112253050248,1.0,9/35,11.36%,SRGN;CTSL;F3;CPD;SPG7;C1R;PITRM1;C1RL;SEC11A
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.4657949691406477,1.3923403163809611,0.0,0.7697791218656529,1.0,16/70,7.97%,MYH11;ACTA2;SLIT3;LMOD1;ADGRA2;PRKG1;COL14A1;KCNJ8;SYNPO2;ITGA8;COL5A2;MSRB3;DLC1;MYLK;PRRX1;SLIT2
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.8998158888431572,-1.3905673915186836,0.02631578947368421,0.8666741594823786,1.0,2/8,5.28%,STC1;LGALS3
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.7054431705611696,-1.3855384766482115,0.053763440860215055,0.9257461508555987,1.0,11/37,18.91%,TBC1D20;SEC24A;CSNK1D;SEC13;CNIH3;ANKRD28;USO1;GOLGA2;COL7A1;NSF;MCFD2
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.8301240500560283,1.3848477322888686,0.13333333333333333,0.7971386273028276,1.0,3/5,8.33%,HMBOX1;ZNF618;PARP9
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.7050121950888719,-1.3847260012405156,0.03614457831325301,0.928463488849287,1.0,7/29,11.53%,NR4A3;MCC;VEGFA;TGFB2;TGFB1;FGFR2;PRKDC
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.7767436017879387,-1.3840022755187324,0.011904761904761904,0.9292891895631622,1.0,9/19,13.36%,SLC23A2;SLC16A12;SLC16A7;SLC6A17;SLC16A6;SLC3A2;SLC36A4;SLC13A3;SLC1A1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.6640593422728496,1.3796317200080337,0.058823529411764705,0.8126126089600649,1.0,3/10,15.05%,SNAPC3;GTF3C2;GTF3C3
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),-0.9035113706037321,-1.3770866397709156,0.0273972602739726,1.0,1.0,1/6,1.48%,NRCAM
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.523204753756932,1.3770435610950678,0.0,0.8176957367336166,1.0,8/40,7.97%,ATP2B4;SPRY3;LEMD3;EPN2;NOTCH1;SKI;RBPMS2;SLIT2
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.802771343368377,-1.3768029166698181,0.0759493670886076,1.0,1.0,4/15,11.07%,CSNK1D;TTC8;IFT122;IFT57
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.8751436861824593,-1.3766420521510645,0.03896103896103896,1.0,1.0,2/8,2.25%,BASP1;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.8542675597419563,1.376278626736772,0.038461538461538464,0.8129762344832521,1.0,5/6,10.72%,BCL2L11;NCK1;RNF185;ATXN3;TMEM259
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.8633438572837449,-1.3745004433944703,0.0821917808219178,1.0,1.0,3/6,9.93%,TWIST1;FGFR2;TGFBR1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.7009578345428686,1.3741137726658852,0.14285714285714285,0.8169309524324984,1.0,2/11,2.20%,HSPA1A;BCL2L1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.7633517106835017,-1.3731870255254104,0.023255813953488372,1.0,1.0,4/19,7.94%,TWIST1;ANKH;TGFB2;SMAD6
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.8622717867118532,-1.373059335403236,0.09333333333333334,1.0,1.0,2/7,4.94%,SRSF12;SRSF10
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.84754843015788,-1.3728979803295067,0.0410958904109589,1.0,1.0,2/6,3.40%,GJA1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.6952783617599358,1.3720084273954982,0.1,0.818499820673954,1.0,3/11,8.36%,PDGFA;CDK6;CDKN1A
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.9139514631507897,-1.3715682175051107,0.01639344262295082,1.0,1.0,3/5,8.21%,TGFB2;TGFB1;FGFR2
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.8199947210733777,-1.370710209552115,0.05128205128205128,1.0,1.0,4/13,9.93%,ROBO2;VEGFA;ROBO1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.7984654130126061,1.3702466926746042,0.2,0.8185746141148533,1.0,2/5,15.27%,CDC27;TPR
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.7150036879689441,-1.370110515080305,0.06451612903225806,1.0,1.0,15/31,24.13%,TWIST1;VEGFA;KCND2;PGK1;HIF1A;MT3;RGCC;FMN2;MDM4;P4HB;MDM2;CPEB4;CPEB2;AK4;RORA
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.7697557246953077,1.369933631712695,0.15625,0.8126651851795187,1.0,2/5,7.96%,BCL2L11;RHOT1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.8284897807836309,-1.3689643709177515,0.05263157894736842,1.0,1.0,2/9,6.38%,HS3ST5;NECTIN2
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),-0.8079250637144082,-1.3684069711014892,0.02564102564102564,1.0,1.0,5/10,13.36%,SLC22A6;GJA1;SLC1A2;SLC13A3;SLC1A1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8792968507299007,-1.366277821087623,0.039473684210526314,1.0,1.0,3/7,1.83%,EPN1;ADAMTS9;KLF2
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.8812064848304828,-1.3659736666993902,0.05194805194805195,1.0,1.0,1/5,1.81%,HABP4
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.7737892512257365,-1.3658636345245136,0.0963855421686747,1.0,1.0,7/13,9.72%,VEGFA;TENM3;NKD1;AGTPBP1;IFT122;STAT3;FBN1
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.8870937331626266,-1.3647341697244764,0.029850746268656716,1.0,1.0,1/6,0.74%,SOD1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.7296905920001852,-1.3642337496230108,0.03896103896103896,1.0,1.0,3/19,3.88%,ENO1;CRY1;PGK1
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.8277008903666467,-1.3642121237949605,0.0379746835443038,1.0,1.0,2/10,6.38%,HS3ST5;NECTIN2
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.7116014290766861,-1.3638957536125083,0.08139534883720931,1.0,1.0,9/22,18.78%,SYT1;PLAA;RIMS2;NEDD4L;GOLGA4;ZFYVE27;RIMS1;SEMA4D;PPIB
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.9153077188884389,-1.3635259367865131,0.030303030303030304,1.0,1.0,2/5,5.39%,VEGFA;NCAM1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.852237196662605,-1.3633433126138834,0.06329113924050633,1.0,1.0,4/7,10.86%,CD55;BACH2;STAT3;IL18
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.6661830179181863,-1.3632825553431613,0.031914893617021274,1.0,1.0,22/76,18.17%,STC1;SOD1;ENO1;COG2;CD44;GLRX;VEGFA;PGK1;HDLBP;DDIT4;RARS1;STMN1;PDK3;ADORA2B;GLCE;HSPA5;LDHA;PAM;VCAN;PYGB;DLD;GPC4
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6402484891751138,1.3619228777007604,0.21428571428571427,0.8377579187277746,1.0,2/10,4.96%,ATP2B4;PKIA
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),-0.7589866592434893,-1.361698449375412,0.03614457831325301,1.0,1.0,3/17,9.13%,WWC1;LATS2;STK4
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.6147588293751592,1.3616186613281267,0.05,0.8324920602743429,1.0,2/23,1.14%,PPIP5K2;INPP4B
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.761159704398503,1.3598678905740953,0.15625,0.8338461996254395,1.0,3/5,16.01%,NOTCH1;P2RX4;MLIP
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.7412791367953475,-1.3595836536728967,0.03488372093023256,1.0,1.0,8/25,12.99%,SLC22A6;SLC23A2;SLCO1A2;SLC7A2;SLC38A4;SLC7A14;SLC3A2;SLC13A3
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),-0.8362780599193821,-1.3588719415754624,0.08823529411764706,1.0,1.0,2/8,1.25%,TWIST1;NR4A3
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.9268907899546835,-1.3580493717674804,0.0410958904109589,1.0,1.0,2/5,3.48%,TMCO1;SELENOS
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.8344380884768882,-1.3577941567674867,0.08955223880597014,1.0,1.0,2/7,3.61%,KLF2;DHRS3
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.7989458562896826,-1.3560741471060154,0.04477611940298507,1.0,1.0,3/10,8.20%,MID1;TGFB2;EIF2AK2
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.8007193548047585,-1.3560140215041276,0.05333333333333334,1.0,1.0,7/11,17.66%,SYT1;RIMS2;LRRK2;RAB27A;RIMS1;DTNBP1;PREPL
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.7103520064065504,-1.3559507867745628,0.06896551724137931,1.0,1.0,7/22,14.20%,TRAF3IP1;IFT122;IFT52;IFT57;IFT140;DYNC2LI1;WDR19
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.6831928706783261,-1.355938034125383,0.020833333333333332,1.0,1.0,21/41,24.41%,CSF1;IFITM3;IFIT3;HERC6;EIF2AK2;PROCR;ELF1;EPSTI1;GBP2;NCOA7;C1S;SP110;CMTR1;TRIM5;LPAR6;DDX60;WARS1;IFI44;IRF1;PSMA3;IFI44L
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.7883270999282325,1.3557349967518735,0.25,0.8429500764793689,1.0,1/5,0.69%,IL34
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.9059046853855102,-1.3553040073969889,0.09333333333333334,1.0,1.0,2/5,3.50%,SELENOS;NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.9343864431825714,-1.3543456129476887,0.012658227848101266,1.0,1.0,1/5,3.48%,SELENOS
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.9272209931996209,-1.3541297449999137,0.02857142857142857,1.0,1.0,1/5,1.25%,NR4A3
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.7561353630211325,-1.3538977845383222,0.08536585365853659,1.0,1.0,6/14,14.16%,MDGA2;SPOCK1;AGTPBP1;ZC4H2;SIN3A;NR4A2
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.8513667672925449,-1.3527740611760073,0.06493506493506493,1.0,1.0,4/6,13.88%,OS9;ANKRD13C;TAPT1;HSPA5
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.7782217882507355,-1.3521464594215704,0.0375,1.0,1.0,4/19,2.52%,ZFP36L2;IFITM3;CD44;IFIT3
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.6477882106859852,-1.3509743644050403,0.02040816326530612,1.0,1.0,19/85,18.91%,TBC1D20;SEC24A;COG2;CD55;SEC13;SPTBN4;ANK3;CNIH3;PROS1;COG7;ARF4;USO1;NRBP1;GOLGA2;COL7A1;GOSR1;TMED4;NSF;MCFD2
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.6735689982448619,1.3502525638784122,0.13043478260869565,0.8588151500375298,1.0,2/12,3.95%,HSPA1A;PTGES3
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.9101594845462487,-1.3496695384662143,0.045454545454545456,1.0,1.0,1/5,0.93%,TBC1D20
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.7727092836930418,1.3488213300220413,0.13793103448275862,0.8565520836349947,1.0,1/6,0.98%,SPRY3
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.8525884022665965,-1.3485371949795784,0.05405405405405406,1.0,1.0,3/7,9.56%,KCNE4;NOS1AP;KCNQ1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.783367082119323,-1.3485327013258284,0.08974358974358974,1.0,1.0,3/11,13.38%,KDM1A;CTR9;DNMT1
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.6798296473145244,-1.348279111651265,0.05952380952380952,1.0,1.0,11/37,19.25%,KDM1A;HABP4;ZFPM1;NFKBIA;GOLGA2;JUN;SYMPK;LRRK2;LRPAP1;MITD1;ARHGAP28
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.8760077919088476,-1.3475661960844438,0.07246376811594203,1.0,1.0,2/6,3.40%,KDM1A;VEGFA
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.8265818002917384,-1.3472206496161834,0.07142857142857142,1.0,1.0,3/10,10.73%,SOD1;LPCAT3;SREBF1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.8400621944603359,-1.3470936662087316,0.05063291139240506,1.0,1.0,2/8,9.96%,TUT7;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.8557296088813676,-1.3469446852489408,0.09090909090909091,1.0,1.0,2/7,5.28%,CD55;LGALS3
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.9035638758140678,-1.3468100426776313,0.027777777777777776,1.0,1.0,4/6,9.02%,VEGFA;NKD1;AGTPBP1;STAT3
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.7879762625649371,1.3465333947392377,0.18181818181818182,0.8587508005503839,1.0,1/5,2.78%,RBL1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.4984265675967355,1.3458745880540712,0.0,0.8546736799428126,1.0,19/62,13.06%,FAT1;LMOD1;TPM2;MCU;MYO1E;PLS3;DSTN;CDC42;MYO1D;EVL;RHOA;CARMIL1;FLNA;MYO1B;ACTN1;HIP1;CORO1C;MPRIP;PPP1R9A
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.6343220242651916,-1.3458595855587088,0.021505376344086023,1.0,1.0,29/90,16.12%,SLC2A3;STC1;ENO1;F3;GLRX;PDK1;SLC2A1;VEGFA;PGK1;MT2A;CCN2;ADM;HDLBP;DDIT4;PDK3;NEDD4L;GBE1;ERRFI1;ADORA2B;JUN;WSB1;HSPA5;CDKN1B;PPARGC1A;CP;LDHA;DUSP1;AKAP12;PAM
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.6372340399870214,-1.3458308928626062,0.021739130434782608,1.0,1.0,12/76,7.94%,STC1;SRGN;HS3ST5;WWC1;GJA1;RHEB;MCC;WWC2;ROBO1;TGFB1;ADM;SMAD6
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.8495161191340468,-1.3455114002811621,0.05128205128205128,1.0,1.0,1/8,4.09%,PLAA
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.8379620176068483,-1.3453676373583119,0.07407407407407407,1.0,1.0,4/8,9.93%,TGFB2;TGFB1;USP15;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.854128897680096,-1.3446608888578022,0.1,1.0,1.0,1/5,10.96%,PTPN2
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.7738062315713551,1.3442998503832682,0.125,0.8533412069558166,1.0,2/7,10.23%,HEY2;MRTFB
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.7445105776530285,-1.3434606346040794,0.060240963855421686,1.0,1.0,2/12,8.66%,PELI1;SDCBP
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.5635670140053655,1.3422826637172671,0.10526315789473684,0.8538540581726166,1.0,4/19,3.87%,ATP2B4;HCN2;ATP1B2;KCNJ8
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.6510543651717526,1.3419867708186786,0.09523809523809523,0.8475416738137194,1.0,3/15,3.50%,SCN1A;HCN2;CACNA1C
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.842817524084424,-1.3417751696780094,0.0945945945945946,1.0,1.0,3/6,13.36%,SLC23A2;SLC1A2;SLC1A1
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.7076045442276173,-1.341758881211902,0.07692307692307693,1.0,1.0,8/23,18.88%,SOD1;PDCD4;SOD2;RAP1B;CFL1;PITPNA;P4HB;HNRNPF
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.8055287989607645,1.341643422996984,0.2608695652173913,0.8418248599023526,1.0,1/6,0.29%,ATP2B4
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.6145696249758292,1.341098192911623,0.10526315789473684,0.8375768065182693,1.0,2/24,1.14%,PPIP5K2;INPP4B
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.8056379898228175,-1.3406266027897824,0.025974025974025976,1.0,1.0,6/17,8.21%,ROBO2;TGFB2;ROBO1;ZFPM2;SMAD6;FGFR2
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.7672097152642948,-1.3405095691796736,0.05063291139240506,1.0,1.0,4/16,8.21%,STC1;GJA1;SLC10A7;FGFR2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.7871887338307358,-1.3402349623065288,0.047058823529411764,1.0,1.0,3/15,3.06%,STC1;PRKACA;PDE4B
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.7556419891203527,-1.3401887910898942,0.10666666666666667,1.0,1.0,3/12,11.55%,ENO1;NPRL3;C9ORF72
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.6183682606650036,1.3397089523014003,0.0,0.8372430569633084,1.0,1/19,0.08%,ATP10A
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.9093620447724993,-1.339705270232043,0.043478260869565216,1.0,1.0,1/5,0.38%,NELL1
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.6111708918553451,1.3396139130839728,0.15,0.8304031040739296,1.0,1/14,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.6221850933968394,-1.3394203223477765,0.04081632653061224,1.0,1.0,32/78,24.43%,RHEB;SEC13;RIPOR1;WIPI1;ATP6V1E1;ATP6V1G1;SLC38A9;SZT2;EIF2AK2;SIK2;ATP6V1H;NPRL3;SREBF1;ATP6V1D;HSPA5;STK24;LRRK2;LAMP2;ITFG2;SESN1;PRKAG2;WRN;GABARAPL1;EIF2AK4;LARS1;CPEB4;MAPK1;PPARA;ATP6V0D1;RRAGB;MAP1LC3B;SREBF2
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.8144246665809176,1.3385635793925164,0.058823529411764705,0.8272982556419961,1.0,2/6,6.66%,BCL2L1;DLC1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.7325049798370848,-1.3379326035986212,0.04597701149425287,1.0,1.0,5/23,6.38%,ROBO2;CADM1;TENM3;ROBO1;NECTIN2
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.6796392058864805,-1.3377470032121597,0.011494252873563218,1.0,1.0,6/44,6.51%,STC1;ADAMTS9;VEGFA;RHOJ;RHOB;GLUL
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.7903019661955921,-1.3373915996350545,0.024096385542168676,1.0,1.0,4/16,12.67%,PRKACA;RAP1B;RUNX1;ROCK2
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.7214480139328108,-1.3368779287804535,0.08641975308641975,1.0,1.0,4/20,3.88%,ENO1;NR4A3;PDHX;PGK1
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.7590359445989822,-1.335815379833684,0.1038961038961039,1.0,1.0,4/9,13.78%,PSMB1;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.7770965929645889,-1.3354235611534653,0.02564102564102564,1.0,1.0,3/16,6.87%,NELL1;TGFB1;ADGRV1
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.8678466571659033,-1.3348274357191996,0.015151515151515152,1.0,1.0,2/7,1.80%,GJA1;KDM1A
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.7954797559239569,-1.3335308946920668,0.0958904109589041,1.0,1.0,2/8,3.50%,PDE4B;NOS1AP
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.7173076859787417,-1.3334254754151065,0.07142857142857142,1.0,1.0,7/25,10.86%,PDE4B;SELENOS;PLAA;PDCD4;TGFB1;CTR9;IL18
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.7279314993751685,1.3333228307864196,0.14285714285714285,0.839789768260545,1.0,2/8,2.97%,ERBB4;NOTCH1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.7673747419145411,-1.332689553674161,0.06896551724137931,1.0,1.0,5/18,12.90%,SOD1;NRCAM;OLFM1;LATS2;SIN3A
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.8219344366176174,-1.3322845767804257,0.013513513513513514,1.0,1.0,3/9,5.31%,VEGFA;EFNB2;ROBO1
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.868112900593264,-1.3320390513111289,0.028985507246376812,1.0,1.0,2/7,5.71%,VEGFA;TGFB1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.5245955838501641,1.3316640278471992,0.15789473684210525,0.8395264283332134,1.0,4/35,6.37%,CAV2;BCL2L1;CDC42;TTL
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.7887059828238927,-1.329018659982704,0.09210526315789473,1.0,1.0,3/9,9.56%,KCNE4;NOS1AP;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.6579731606617505,1.3287496026193166,0.25,0.8464162173119806,1.0,3/16,4.20%,NOX4;IL34;GPRC5B
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.763366756341229,-1.3284066256442055,0.12,1.0,1.0,7/12,21.09%,RAP1B;RIMS2;LRRK2;RIMS1;DTNBP1;PREPL;NLGN1
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.6158262655178067,-1.3268465552743787,0.020618556701030927,1.0,1.0,37/126,19.46%,TBC1D20;SEC24A;CSNK1D;SEC13;WASF3;SLC2A1;WIPF1;CSNK1A1;WASF1;ELOB;CNIH3;NAPG;SPG7;AFDN;DARS1;ANKRD28;RBX1;USO1;CDC123;GOLGA2;WDR19;FANCC;PPARGC1A;TEAD1;LRRK2;COL7A1;TLE4;MDM4;RIMS1;LIN7A;FARP2;NSF;MDM2;MCFD2;ST13;SKP1;TSPAN4
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.688992535503554,-1.3268218798293905,0.043478260869565216,1.0,1.0,12/39,19.43%,GJA1;KDM1A;LPIN1;VEGFA;CMKLR1;IL18;SCD;PRLR;PPARGC1A;KDM3A;APPL2;ACADL
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.669401300606013,-1.3268031285165416,0.03125,1.0,1.0,12/43,19.43%,GJA1;KDM1A;LPIN1;VEGFA;CMKLR1;IL18;SCD;PRLR;PPARGC1A;KDM3A;APPL2;ACADL
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.7031056337061617,-1.3263769032603536,0.05,1.0,1.0,7/25,9.50%,CADM1;JAM3;NECTIN2;CDH20;CDH18;AFDN;CDH12
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.6420881673538508,-1.325117933456978,0.05319148936170213,1.0,1.0,33/67,27.37%,RPS21;RPS4X;RPL28;RPL34;RPL21;RPLP2;RPS27A;RPL19;SSR1;RPLP1;RPS14;TRAM1;SRP14;RPL13A;RPL18;RPL27;RPL35A;RPL31;RPS12;RPL5;RPS18;RPL27A;RPL36;RPL41;RPL32;RPL37;RPL24;RPL9;RPS20;RPS2;RPL37A;SEC62;RPL3
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.8089489733729494,-1.324137909345948,0.1,1.0,1.0,3/7,9.88%,NR4A3;SLC2A1;PRKCB
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.8606267811475217,-1.3236259887416406,0.0641025641025641,1.0,1.0,4/7,9.35%,CD44;CEMIP2;TGFB1;CEMIP
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.894800203464666,-1.3234311461969086,0.027777777777777776,1.0,1.0,2/5,10.09%,TGFB2;HIF1A
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.8158217146951261,1.323353119048256,0.041666666666666664,0.8614327222881855,1.0,1/5,4.68%,MYL9
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.8861189054552625,-1.3232752415092508,0.06944444444444445,1.0,1.0,1/5,0.85%,TWIST1
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),-0.8274459470934166,-1.3232438690972554,0.04054054054054054,1.0,1.0,2/9,4.76%,WASF3;WASF1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.8582013625812741,-1.3228075437148266,0.1111111111111111,1.0,1.0,1/7,1.83%,KLF2
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.7622724063450852,-1.3228027137177405,0.12345679012345678,1.0,1.0,3/12,7.15%,OS9;SELENOS;RHBDD1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.6877782344423269,-1.322693619901337,0.09302325581395349,1.0,1.0,7/30,12.29%,NELL1;RUBCN;MTMR9;CST3;STAT3;GOLGA2;MT3
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.8325176601884303,-1.3226570818555763,0.11594202898550725,1.0,1.0,3/8,7.48%,TWIST1;TGFB1;NIBAN2
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.7888058104494847,-1.322590368206391,0.09523809523809523,1.0,1.0,3/11,8.21%,TGFB2;HDAC2;FGFR2
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.6377530389217193,-1.3218935093325548,0.07777777777777778,1.0,1.0,19/61,18.32%,PRKACA;RHEB;EPM2A;ATP6V1E1;ATP6V1G1;TSC2;SLC38A9;SNX6;ATP6V1H;LZTS1;C9ORF72;EXOC1;TBK1;WAC;ATP6V1D;TRIM13;LRRK2;SESN1;PRKAG2
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.864878061865603,-1.3218777336531347,0.1111111111111111,1.0,1.0,1/6,4.22%,CSNK1A1
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.8076404610565423,-1.3217212406177006,0.03529411764705882,1.0,1.0,6/10,14.71%,CD55;CFH;PROS1;C1R;C1S;CLU
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.8076404610565423,-1.3217212406177006,0.03529411764705882,1.0,1.0,6/10,14.71%,CD55;CFH;PROS1;C1R;C1S;CLU
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.8076404610565423,-1.3217212406177006,0.03529411764705882,1.0,1.0,6/10,14.71%,CD55;CFH;PROS1;C1R;C1S;CLU
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),-0.8493853867910298,-1.3216087056968737,0.12121212121212122,1.0,1.0,1/6,0.85%,TWIST1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.8164748163705033,-1.3208061240711948,0.08333333333333333,1.0,1.0,1/7,1.19%,ZFP36L2
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.6510258379517032,1.320406271712928,0.25,0.8670579465626801,1.0,2/21,0.35%,HSPA1A;RBM20
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.7368161767911284,1.3201843725212623,0.21428571428571427,0.8612599457733631,1.0,3/5,9.91%,PLS3;CARMIL1;ACTN1
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.8077199340349995,-1.3201797320576112,0.05128205128205128,1.0,1.0,2/11,4.73%,TWIST1;HDAC2
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.7997253922804031,1.319863198212095,0.16,0.8559987554155922,1.0,2/5,4.88%,NFU1;YAE1
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.8257260358908964,-1.3195351059175344,0.11267605633802817,1.0,1.0,2/6,8.57%,CD44;ENPP2
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.8299433073257014,-1.3192451189746284,0.12162162162162163,1.0,1.0,2/6,9.56%,PDE4B;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.8532597889387155,-1.3192156766097176,0.10526315789473684,1.0,1.0,2/6,12.90%,TAF7;SIN3A
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.7918055912190008,-1.318924578692169,0.11363636363636363,1.0,1.0,3/11,8.21%,TGFB2;RARB;FGFR2
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.8331889512858891,-1.318681186276889,0.0945945945945946,1.0,1.0,2/5,8.05%,UBA5;AGTPBP1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.8168282444969834,-1.3185928427312914,0.1,1.0,1.0,1/6,0.74%,SOD1
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.8284338796125367,-1.3182920126686204,0.05333333333333334,1.0,1.0,2/10,4.76%,WASF3;WASF1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.7355876850409983,-1.318197910445073,0.11904761904761904,1.0,1.0,6/13,13.36%,SLC7A2;SLC1A2;SLC3A2;SLC36A4;SLC47A1;SLC1A1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.7404033892976674,-1.3181105027142828,0.17857142857142858,1.0,1.0,2/16,9.06%,PRKACA;PDK3
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),-0.8522125263987548,-1.3173293716250627,0.18461538461538463,1.0,1.0,1/5,0.85%,TWIST1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.7451526202452927,-1.3171259943090916,0.1,1.0,1.0,3/15,6.46%,STC1;LGALS3;GRIN1
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.8146366070505161,-1.3169071691867948,0.05952380952380952,1.0,1.0,4/11,4.33%,KLF2;VEGFA;IPO5;SLC38A9
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.4763383164943008,1.316479681796542,0.0,0.8625707558202996,1.0,8/62,4.81%,TAGLN;ACTA2;LMOD1;ADGRA2;COL14A1;COL5A2;MYL9;IGFBP7
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.8893385832614813,-1.3162313414676945,0.027777777777777776,1.0,1.0,2/7,4.76%,WASF3;WASF1
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.85464534359845,-1.316107582634848,0.0273972602739726,1.0,1.0,2/7,8.89%,CRY1;STMN1
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.761026386068874,1.3161051814771183,0.17857142857142858,0.8572331842104042,1.0,4/6,15.08%,ATM;MAP2K2;DYRK1A;PIKFYVE
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.7215989520139336,1.3159161350342536,0.16666666666666666,0.851685310432523,1.0,1/7,1.11%,NFU1
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.6683459836586186,-1.3153422068993617,0.12941176470588237,1.0,1.0,5/29,3.40%,WWC1;SLC22A6;CRMP1;SPTBN4;VEGFA
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.7174378437400803,-1.315257745985315,0.13333333333333333,1.0,1.0,3/16,5.81%,IPO5;TGFB1;SUFU
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.7309796759459715,-1.3148939614887183,0.06976744186046512,1.0,1.0,5/24,5.71%,CSF1;SSH1;NFKBIA;RBM4B;TGFB1
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.8681022666160191,-1.3148082433212074,0.0547945205479452,1.0,1.0,3/5,12.86%,NRG1;KCNQ1;SGK1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.8938990943791288,-1.3147483299148617,0.0547945205479452,1.0,1.0,2/5,9.22%,TAF7;KLF15
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.664132892506731,1.3146109737368206,0.13043478260869565,0.8504833947833297,1.0,1/9,0.02%,JPH2
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.7576842754937516,-1.313714883670821,0.15,1.0,1.0,4/14,7.41%,CADM1;TENM3;ALCAM;PTPRD
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.5546993636429077,1.3135884508827886,0.10526315789473684,0.8489408824517187,1.0,3/18,5.20%,INF2;MCU;VPS35
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.7157354940593252,-1.313437907398369,0.0625,1.0,1.0,8/17,21.72%,ZFP36L2;TGFB1;ANGEL2;RGCC;CDKN1B;BTG2;HECA;BTG1
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.6472931915480173,1.3123995112975269,0.14814814814814814,0.847278870193932,1.0,3/6,6.27%,NSUN3;TFB1M;MTERF4
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6364558209900479,-1.3118169227746235,0.05434782608695652,1.0,1.0,30/63,27.37%,RPS21;RPS4X;RPL28;RPL34;RPL21;RPLP2;RPS27A;RPL19;RPLP1;RPS14;SRP14;RPL13A;RPL18;RPL27;RPL35A;RPL31;RPS12;RPL5;RPS18;RPL27A;RPL36;RPL41;RPL32;RPL37;RPL24;RPL9;RPS20;RPS2;RPL37A;RPL3
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.6758536588735569,-1.311665923378641,0.10344827586206896,1.0,1.0,10/28,22.60%,SOD1;ATP6V1G1;ACO1;FTH1;TF;CP;SKP1;NDFIP1;SLC40A1;ATP6V0D1
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.8007107691778226,-1.3101743647372983,0.12941176470588237,1.0,1.0,2/9,12.53%,RPS21;RPS14
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.6449723501473853,-1.3092008482766286,0.056179775280898875,1.0,1.0,30/64,27.37%,RPS21;RPS4X;RPL28;RPL34;RPL21;RPS27A;RPL19;RPLP1;RPS14;ETF1;RPL13A;RPL18;ZC3H15;RPL27;RPL35A;RPL31;RPS12;RPL5;RPS18;RPL27A;RPL36;RPL41;RPL32;RPL37;RPL24;RPL9;RPS20;RPS2;RPL37A;RPL3
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.769477730683584,-1.3073998949744379,0.14457831325301204,1.0,1.0,6/14,8.21%,EMP1;HDAC2;CCN2;ALDH3A2;SVEP1;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.8436842158355127,-1.307099220963975,0.08450704225352113,1.0,1.0,2/6,14.74%,SDCBP;RAB7A
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.8254391762647917,-1.3070313469345256,0.15384615384615385,1.0,1.0,1/5,4.12%,SSH1
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.7600413140741242,-1.3070099245637024,0.0759493670886076,1.0,1.0,3/17,6.87%,NELL1;TGFB1;ADGRV1
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.6963769809214483,-1.3067062063319728,0.08974358974358974,1.0,1.0,8/24,18.88%,SOD1;PDCD4;SOD2;RAP1B;CFL1;PITPNA;P4HB;HNRNPF
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),-0.7324185106020733,-1.3065707709363423,0.08791208791208792,1.0,1.0,6/18,19.12%,SMOC1;TGFB2;SMCHD1;ATF6;RAB18;CPAMD8
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),-0.8184459612501023,-1.3065024056115704,0.08641975308641975,1.0,1.0,3/10,12.67%,PRKACA;RUNX1;ROCK2
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.7489875124361497,-1.3061818579661018,0.1,1.0,1.0,3/16,5.94%,ZC3H7A;TUT7;ZC3H7B
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.7817753366997805,-1.3058873047944366,0.14285714285714285,1.0,1.0,2/10,3.88%,ENO1;PGK1
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),-0.6942278516478486,-1.3058400079785308,0.09195402298850575,1.0,1.0,5/21,19.91%,NELL1;TP63;ZHX3;CCN4;CCN1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.7686375365253176,-1.3057578410755488,0.07692307692307693,1.0,1.0,4/14,9.93%,TGFB2;TGFB1;SDCBP;TGFBR1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.7715118879651349,-1.305423955744064,0.09210526315789473,1.0,1.0,2/10,3.48%,OS9;SELENOS
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.7839330765637658,-1.3053485806166285,0.1267605633802817,1.0,1.0,3/10,11.93%,SH3BP5;SNX6;ERRFI1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.8051997356804462,-1.3050782016098612,0.1388888888888889,1.0,1.0,3/9,8.44%,PIGL;DPM1;PIGG
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),-0.7720592252887909,-1.304902337118551,0.07407407407407407,1.0,1.0,3/15,9.06%,PDK1;SELENOS;PDK3
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.7839263671648394,-1.3040788205535647,0.1566265060240964,1.0,1.0,3/10,7.38%,SSH1;TMSB4X;TMSB10
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.8313941686100007,-1.3037332169680276,0.14925373134328357,1.0,1.0,1/6,0.85%,TWIST1
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.8222878800289883,-1.303665080429005,0.11392405063291139,1.0,1.0,4/8,9.35%,CD44;CEMIP2;TGFB1;CEMIP
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.7897467775496243,-1.3032486587383545,0.09523809523809523,1.0,1.0,3/8,9.72%,CSF1;PRXL2A;FBN1
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.7349945279464206,-1.3031333880302467,0.125,1.0,1.0,1/15,1.19%,ZFP36L2
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.6375878352539593,-1.3028962287334358,0.05813953488372093,1.0,1.0,19/52,19.46%,WASF3;SLC2A1;WIPF1;WASF1;ELOB;NAPG;NUP133;SPG7;DARS1;WDR19;FANCC;PPARGC1A;TEAD1;MDM4;RIMS1;LIN7A;MDM2;ST13;TSPAN4
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.6234279439009258,-1.3028422422889274,0.050505050505050504,1.0,1.0,34/121,22.62%,SOD1;ENO1;TWIST1;GJA1;KDM1A;CADM1;LPIN1;VEGFA;TGFB2;TGFB1;OLFM1;NIBAN2;EIF2AK2;SDCBP;TGFBR1;CMKLR1;IL18;CFL1;SCD;RGCC;TAPT1;PRLR;PPARGC1A;LRPAP1;AGO2;PPIB;KDM3A;APPL2;ACADL;NLGN1;SMURF2;STAT6;TP53BP1;NR2C2
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.8038345464423715,-1.302531595253463,0.0547945205479452,1.0,1.0,2/9,6.90%,VEGFA;ITGA5
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.6345767116104986,1.3023196443341296,0.09090909090909091,0.8788480342471472,1.0,1/16,0.08%,ATP10A
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.6842183752976085,-1.301271674073483,0.08433734939759036,1.0,1.0,10/25,22.60%,SOD1;ATP6V1G1;ACO1;FTH1;TF;CP;SKP1;NDFIP1;SLC40A1;ATP6V0D1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.8564687944279259,-1.301144999886465,0.043478260869565216,1.0,1.0,4/8,10.57%,ADAMTS9;TGFB1;FGFR2;MYL3
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.717750198502534,-1.3008349697353403,0.10588235294117647,1.0,1.0,4/20,8.98%,SLC22A6;SLCO1A2;MGST1;CA2
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.8377273819083988,-1.3004971135481505,0.056338028169014086,1.0,1.0,2/6,14.45%,AKAP8;CAMK2D
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.806095673239313,-1.3003397071629206,0.06493506493506493,1.0,1.0,3/9,14.05%,NAA11;AGTPBP1;PARP1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.6702500545162497,-1.3001221723369258,0.060240963855421686,1.0,1.0,8/35,11.50%,NRCAM;SPTBN4;ATL1;ANK3;FGFR2;CCK;PLP1;GRM7
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.47669985885613525,1.3000906744577578,0.07142857142857142,0.8804286933966242,1.0,11/51,8.82%,BCAM;GPRC5C;ARHGEF10L;FKBP9;CDC42BPB;ARHGEF17;MYO1D;ADCY6;PLXNB2;NFE2L1;PTPN21
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.7522247857202942,-1.2997708668485946,0.1375,1.0,1.0,6/10,22.33%,CD55;ERAP1;TRIM5;APPL2;BIRC2;IRF1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.7111615925856628,-1.299550602801412,0.1038961038961039,1.0,1.0,8/18,21.11%,CYP3A5;LIPA;AKR1C2;PRLR;NPC1;HSD17B4;LSS;AKR1C1
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.631322525047401,-1.299218166866886,0.05813953488372093,1.0,1.0,8/48,17.97%,PRKACA;CSNK1D;TUBA1A;CCP110;CEP57;NINL;SCLT1;YWHAG
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.617763301527129,-1.2987977992378772,0.09782608695652174,1.0,1.0,37/76,28.34%,RPS21;RPS4X;RPL28;RPL34;UPF3A;RPL21;RPLP2;RPS27A;RPL19;PABPC1;RPLP1;RPS14;ETF1;PPP2R2A;RPL13A;RPL18;RPL27;SMG7;RPL35A;RPL31;RPS12;RPL5;RPS18;RPL27A;RPL36;RPL41;RPL32;RPL37;RPL24;RPL9;RPS20;RPS2;RPL37A;RPL3;NCBP1;UPF2;EIF4G1
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.7489212595478781,-1.298364579001877,0.0945945945945946,1.0,1.0,3/12,10.62%,SPTLC3;SPTLC1;AGK
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.7928017436435228,-1.298155046425254,0.09859154929577464,1.0,1.0,3/7,16.23%,MCTP2;SNCAIP;RIMS1
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.7338162968208802,-1.2973339161464275,0.15789473684210525,1.0,1.0,4/14,15.29%,ENO1;PGK1;MANBA;LDHA
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.8170164445995509,-1.297302273337486,0.1625,1.0,1.0,3/6,17.71%,MTCH2;LRRK2;DNAJA1
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.8350251594363498,1.2972479389283142,0.17857142857142858,0.8854678782643951,1.0,1/5,6.16%,CHMP4B
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.8079639466968838,-1.296886489550217,0.05194805194805195,1.0,1.0,2/9,9.93%,TGFB1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.9055985026540284,-1.296277473811318,0.043478260869565216,1.0,1.0,2/5,2.13%,KDM1A;CD44
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.9055985026540284,-1.296277473811318,0.043478260869565216,1.0,1.0,2/5,2.13%,KDM1A;CD44
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.7270660716093478,-1.2961652001329695,0.14102564102564102,1.0,1.0,5/22,8.39%,PDE4B;SELENOS;PLAA;PDCD4;CTR9
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.6861595156273659,-1.2954372625352326,0.056179775280898875,1.0,1.0,8/25,17.84%,GNPAT;AGPAT4;SREBF1;PDSS2;SCD;PRLR;PAM;LSS
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.7200432144246465,-1.2953051244770388,0.1111111111111111,1.0,1.0,4/19,1.96%,ADAMTS9;GJA1;NRG1;ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.8133331588051003,-1.2951602227426642,0.06493506493506493,1.0,1.0,2/8,9.93%,TGFB1;TGFBR1
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.7151579121830277,-1.2951451233998972,0.10227272727272728,1.0,1.0,10/23,14.47%,SLC23A2;SLC7A2;SLC16A12;SLC1A2;SLC16A7;SLC3A2;SLC36A4;SLC13A3;SLC1A1;LRRC8B
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.76037069295252,-1.2949140689673226,0.04225352112676056,1.0,1.0,4/13,12.67%,CTSL;RUNX1;ERRFI1;ROCK2
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.672084576994951,-1.294783267398426,0.10227272727272728,1.0,1.0,2/23,8.97%,ADAMTS9;MANBA
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.7455794205182854,-1.2945494632959877,0.0641025641025641,1.0,1.0,4/14,8.07%,PDE10A;CREM;MCF2L2;SLC7A14
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.7590151171476975,-1.293427048018363,0.11688311688311688,1.0,1.0,1/11,4.25%,TGFB2
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.7357963434105554,-1.2923733976829745,0.16049382716049382,1.0,1.0,5/12,13.36%,SLC7A2;SLC1A2;SLC3A2;SLC36A4;SLC1A1
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.7520878465596783,-1.2922112078016605,0.10810810810810811,1.0,1.0,1/9,1.88%,BASP1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.7455685267527407,-1.291536983124228,0.14666666666666667,1.0,1.0,4/15,13.62%,SSH1;LIMA1;PLEKHH2;IQCJ-SCHIP1
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.8332066409998999,-1.2914992199387223,0.1095890410958904,1.0,1.0,2/5,8.87%,CTCF;RAD21
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.8048080376384507,-1.2911709252625163,0.14285714285714285,1.0,1.0,4/9,7.48%,NRG1;EFNB2;TGFB1;NIBAN2
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.7231629808676687,1.290294864366217,0.23076923076923078,0.9072326002972202,1.0,3/5,8.53%,ZDHHC21;TRAF6;RHOA
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.8215953546001281,-1.2887816524146185,0.05405405405405406,1.0,1.0,1/6,5.63%,AKAP8
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.7662388748167108,-1.288397135960712,0.1566265060240964,1.0,1.0,2/13,5.65%,CSNK1D;NUDCD3
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.6331692769332905,1.2883484228910593,0.21428571428571427,0.9081648373924879,1.0,1/9,0.29%,ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.5780773224291232,1.2879523044215018,0.11764705882352941,0.9034957796170817,1.0,1/14,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.8650070166211283,-1.287240048695279,0.0945945945945946,1.0,1.0,1/5,0.24%,TEFM
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.7802154127352394,-1.2871182682714386,0.19444444444444445,1.0,1.0,3/10,9.19%,CD44;NCAM1;MAP3K8
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.7911300047661926,1.286469793593108,0.20689655172413793,0.9024111830928813,1.0,1/5,4.06%,SNAPC3
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.7690848584905795,-1.286326801672642,0.09876543209876543,1.0,1.0,5/13,13.94%,OS9;MARCHF6;RPS27A;AMFR;TRIM13
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),-0.8227297521877922,-1.2863265941600168,0.16666666666666666,1.0,1.0,2/5,12.77%,RHEB;CLOCK
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.8058059967840021,-1.285991799180657,0.08823529411764706,1.0,1.0,4/10,14.77%,CRY1;SELENOS;PTPN2;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.7090909788989415,1.2856986257118586,0.16666666666666666,0.8995275148528746,1.0,1/6,4.59%,BCL2L11
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.6547602650370046,-1.284594758643189,0.08235294117647059,1.0,1.0,13/34,24.11%,SOD1;ATP6V1G1;MT2A;ACO1;FTH1;TF;MT3;CP;SKP1;NDFIP1;SLC40A1;ATP6V0D1;APP
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.670170150881723,-1.2843253245793855,0.14634146341463414,1.0,1.0,4/19,6.50%,SEC13;NUP153;NUP133;NUP88
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.5892112654930091,-1.2841520169413498,0.033707865168539325,1.0,1.0,19/81,19.33%,PRKACA;ZFP36L2;CSNK1D;TUBA1A;PSMB1;PSMD14;CCP110;RPS27A;CEP57;PSMA4;PSMB2;NINL;RGCC;PSMA7;ANAPC4;YWHAG;BTRC;SKP1;APPL2
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.7089396047578973,1.283744819093297,0.23076923076923078,0.9000869991215622,1.0,3/9,3.56%,HEY2;NOTCH1;HEYL
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.7765650178146977,-1.2834475166945474,0.2073170731707317,1.0,1.0,4/12,6.46%,GLRB;IPO5;SLC38A9;GRIN1
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.7918758078731282,-1.2831813603766786,0.125,1.0,1.0,3/10,8.44%,PIGL;DPM1;PIGG
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.7463157418039398,-1.2829649109905175,0.12162162162162163,1.0,1.0,3/12,7.48%,TWIST1;TGFB1;NIBAN2
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.6472928077339364,-1.2826073432677756,0.13095238095238096,1.0,1.0,9/33,14.16%,NRCAM;VEGFA;DNER;SPOCK1;GPM6A;DCDC2;DDIT4;CCK;NR4A2
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.7173861306254455,-1.2824283759257544,0.10843373493975904,1.0,1.0,7/22,7.09%,SOD1;GLRX;MGST1;SELENOS;PDLIM1;SOD2;OXSR1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.8054462887648355,-1.2823976205841954,0.08333333333333333,1.0,1.0,5/8,16.23%,SYT1;PLAA;RIMS2;NEDD4L;RIMS1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.8054462887648355,-1.2823976205841954,0.08333333333333333,1.0,1.0,5/8,16.23%,SYT1;PLAA;RIMS2;NEDD4L;RIMS1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.8371498940364328,1.2823611567483346,0.16666666666666666,0.8934828065946699,1.0,1/5,3.48%,MYO1E
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.8371498940364328,1.2823611567483346,0.16666666666666666,0.8934828065946699,1.0,1/5,3.48%,MYO1E
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.6636794871025402,1.2822584941511093,0.18181818181818182,0.8883198120115673,1.0,2/11,2.12%,A2M;CNOT7
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.8156471098834501,-1.2821771569889586,0.125,1.0,1.0,2/6,7.88%,BTD;MCCC2
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.7005435344755683,-1.2821416143122162,0.1511627906976744,1.0,1.0,3/21,4.73%,TWIST1;TGFB2;HDAC2
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.6939218802077401,-1.282022953431756,0.11538461538461539,1.0,1.0,5/20,11.93%,EPHA7;VEGFA;DDX3X;PDGFD;ERRFI1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.7237198381572816,-1.281654372271691,0.13333333333333333,1.0,1.0,7/15,17.66%,MCTP2;SNCAIP;RIMS2;LRRK2;RIMS1;DTNBP1;PREPL
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.841996610486711,-1.2815264512622675,0.10526315789473684,1.0,1.0,3/5,15.70%,RBX1;SASH1;LRRK2
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.7585048749013914,-1.2812395360827018,0.1518987341772152,1.0,1.0,1/8,0.80%,SRSF12
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.6134375102126313,-1.2803641527554797,0.0967741935483871,1.0,1.0,28/72,21.83%,PRKACA;SYT1;GLRB;KCND2;PDE7B;SLC1A2;KCNQ3;GRIN1;GABRE;SNAP25;SDCBP;GRIA3;PRKAR1A;PLP1;GRIK1;DLGAP1;GRM7;PMP22;SLC1A1;SLC12A6;NOVA1;CAMKK2;GRIK2;GABBR2;NLGN1;MAPK1;PRKAR2A;MINK1
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.6582706738152928,-1.2798175111237988,0.16470588235294117,1.0,1.0,8/34,12.90%,NR4A3;ZFPM1;PURB;LGALS3;CTR9;PRKCB;RUNX1;SIN3A
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.6809899335705781,-1.2791209262618293,0.14942528735632185,1.0,1.0,6/20,15.58%,TGFB2;TGFB1;STAT3;HIF1A;JUN;TEAD1
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.623042670734652,-1.2791107351059468,0.052083333333333336,1.0,1.0,22/71,19.71%,SOD1;ANKH;IFITM3;CD44;EMP1;TGFB2;RHOB;LGALS3;PDCD4;SOD2;CD38;IL18;SAT1;JUN;ETF1;CDKN1B;CLU;GSR;DNAJA1;GPX4;BTG2;PAK1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.7960627466260166,-1.2788481627344717,0.10810810810810811,1.0,1.0,3/7,16.35%,NR4A3;CA2;AZIN1
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.6711915020082211,1.2780979510499184,0.1724137931034483,0.8962763188893332,1.0,2/7,6.58%,ADCY9;ADCY6
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.5427715262782774,1.2779556503378537,0.2631578947368421,0.8907769480161684,1.0,5/23,5.61%,TAGLN;MEF2D;ITGA7;SOX6;LARGE1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.70156836043009,-1.2776138976539702,0.13157894736842105,1.0,1.0,6/19,14.20%,FSIP2;CSNK1D;IFT122;IFT140;ATP6V1D;WDR19
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.7453772804417724,-1.2772191953806475,0.11235955056179775,1.0,1.0,5/14,19.12%,SMOC1;TGFB2;ATF6;RAB18;CPAMD8
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.8265154663258525,-1.2770989038196991,0.10144927536231885,1.0,1.0,1/6,5.68%,FADS2
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.809143440759672,-1.2768264088288055,0.1095890410958904,1.0,1.0,3/8,12.90%,NRCAM;OLFM1;SIN3A
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.6576530277251396,-1.2766504873698907,0.0875,1.0,1.0,8/35,18.54%,PRKACA;CSNK1D;TUBA1A;CCP110;CEP57;NINL;YWHAG;ATAD5
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.7679723606270119,-1.2764054708283765,0.14102564102564102,1.0,1.0,5/10,13.36%,SLC7A2;SLC1A2;SLC3A2;SLC47A1;SLC1A1
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.8424458466475394,-1.276259956805733,0.1527777777777778,1.0,1.0,2/6,3.40%,F3;VEGFA
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.6533391263187899,-1.2755568788842557,0.042105263157894736,1.0,1.0,13/53,9.50%,ROBO2;CADM1;TENM3;TGFB2;ROBO1;NECTIN2;CDH20;CDH18;UNC5D;ALCAM;PTPRD;LRFN5;CDH12
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.7827758553099188,-1.275365243061223,0.11688311688311688,1.0,1.0,3/8,10.86%,ZFPM1;PDE4B;IL18
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.7030225201173963,-1.2753165244501115,0.07865168539325842,1.0,1.0,10/26,22.89%,MID1;CD44;NCAM1;MT2A;GBP2;CAMK2D;TRIM5;HLA-B;IRF1;STAT1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.7903504094983347,1.2750842099209865,0.24,0.8966892357591728,1.0,2/7,5.60%,LEMD3;SKI
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.5672904232907855,1.2748086234151494,0.17647058823529413,0.8917054087688938,1.0,4/15,4.52%,CTNNA3;CACNA1C;CACNB2;BIN1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.6626464182778752,-1.2741869232816776,0.10227272727272728,1.0,1.0,4/36,9.16%,SEC24A;CTSL;SEC13;AP2A1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.8053060706219898,-1.2738536373773668,0.12195121951219512,1.0,1.0,2/9,2.13%,NR4A3;CD44
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),-0.8280139484407318,-1.273242027279344,0.09722222222222222,1.0,1.0,1/6,1.75%,GLRB
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.7706956104220988,-1.27271665580904,0.1506849315068493,1.0,1.0,4/7,21.88%,MT3;PLAAT3;ACADL;LPL
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.7610361292020059,1.2726599878216147,0.20833333333333334,0.8940569419697632,1.0,2/9,0.64%,MYH11;ACTA2
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.6953356092802567,-1.2725269417267049,0.13253012048192772,1.0,1.0,7/26,12.67%,RIPOR1;RHOJ;RHOB;CFL1;CDC42EP4;ARHGAP5;ROCK2
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),-0.8351267711112043,-1.27252061588742,0.0958904109589041,1.0,1.0,1/5,3.35%,SLC2A1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.8463891583234338,-1.2723122023955613,0.18055555555555555,1.0,1.0,2/5,13.96%,VEGFA;JCAD
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.7626044984458591,-1.272266412078758,0.18072289156626506,1.0,1.0,1/11,1.86%,CSNK1D
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.7098277725314802,-1.2715612323563044,0.12941176470588237,1.0,1.0,3/21,9.06%,PRKACA;SELENOS;PDK3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5067616453528431,1.2714551904936946,0.07692307692307693,0.8918559680105571,1.0,2/29,2.20%,HSPA1A;BCL2L1
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.6141446219196872,-1.2712465532813322,0.0967741935483871,1.0,1.0,31/68,27.37%,RPS21;RPS4X;RPL28;RPL34;RPL21;RPLP2;RPS27A;RPL19;RPLP1;RPS14;SRP14;RPL13A;RPL18;RPL27;RPL35A;RPL31;RPS12;RPL5;RPS18;RPL27A;RPL36;RPL41;RPL32;RPL37;RPL24;RPL9;RPS20;RPS2;RPL37A;SEC62;RPL3
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.8418451887452674,-1.2706969654073663,0.2,1.0,1.0,3/6,9.93%,TGFB2;TGFB1;TGFBR1
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.7529646197214526,-1.2706473646490692,0.11842105263157894,1.0,1.0,3/11,5.31%,VEGFA;EFNB2;ROBO1
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.709911764451507,-1.2703229824846467,0.058823529411764705,1.0,1.0,2/21,2.63%,STC1;HOMER2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.7237025214950359,-1.270204801056724,0.22093023255813954,1.0,1.0,4/13,16.99%,PLAA;ARF4;FGFR2;FLT1
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.6301106511590184,1.2701425826055757,0.13636363636363635,0.8917425975605582,1.0,2/10,6.77%,CD4;BCL2
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.6357419908616693,-1.2701025550724314,0.11764705882352941,1.0,1.0,7/35,10.35%,ZFP36L2;ZFPM1;TGFB1;PTPRQ;ZFPM2;ANKRD26;CMKLR1
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.5792854004291041,1.2699576743688645,0.2,0.8865473473578206,1.0,2/13,2.20%,HSPA1A;BCL2L1
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.6200143539028249,-1.269803570327675,0.0989010989010989,1.0,1.0,18/44,23.31%,GNPAT;BTD;CYP3A5;PDHX;PANK2;MCCC2;PTGR1;ACOT11;ALDH1A2;NPC1;LDHA;ACSL4;DLD;GLO1;AKR1C1;LPL;PPARA;MTHFD1L
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.5855260674723236,-1.2693854532928341,0.0,1.0,1.0,39/205,14.45%,MID1;PRKACA;SOD1;TWIST1;CSF1;PELI1;IFITM3;F3;CD44;IFIT3;VEGFA;NFKBIA;TMSB4X;PSMB1;PDCD4;NCAM1;TGFB1;MT2A;SOD2;CEBPD;CTR9;PSMD14;STAT3;MAP3K8;RBX1;RAP1B;RPS27A;HIF1A;IL18;PSMA4;PSMB2;CFL1;MT3;GBP2;PSMA7;PITPNA;CDKN1B;PRLR;CAMK2D
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.7649288274331374,-1.269307764885898,0.12345679012345678,1.0,1.0,5/9,21.93%,USP15;ANKRD17;NPLOC4;DDX60;BIRC2
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.6616744642448885,-1.269233626077878,0.08045977011494253,1.0,1.0,11/37,16.83%,SOD1;EPHA7;TGFB2;SOD2;PRKCI;SNX6;MT3;PPARGC1A;NAE1;NAIP;UNC5B
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.7928556489113316,-1.2686557429494383,0.06756756756756757,1.0,1.0,2/9,2.13%,KDM1A;CD44
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.7978431269608752,-1.2686517861233657,0.16901408450704225,1.0,1.0,2/7,3.40%,KDM1A;VEGFA
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),-0.8308771950987195,-1.268381718791265,0.14084507042253522,1.0,1.0,2/6,8.21%,ROBO2;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.6867592235359448,-1.2679559149750392,0.12643678160919541,1.0,1.0,7/25,13.49%,TWIST1;TGFB2;TGFB1;OLFM1;SDCBP;TGFBR1;RGCC
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.6022698254789597,-1.2677318123212133,0.06382978723404255,1.0,1.0,7/66,9.21%,STC1;GJA1;MCC;RHOB;ROBO1;TMEFF2;AFDN
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),-0.8229798012568073,-1.2675302444300893,0.13333333333333333,1.0,1.0,2/8,9.22%,DIP2B;KLF15
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.6102083382283083,-1.2670466343922238,0.13043478260869565,1.0,1.0,14/39,19.57%,SYT1;PLAA;TGFB2;DDX3X;SDCBP;RIMS2;TGFBR1;NEDD4L;GOLGA4;ZFYVE27;RIMS1;SEMA4D;ADAM17;ADNP2
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.7761701575892969,-1.2662845745770195,0.10666666666666667,1.0,1.0,3/8,12.70%,DIP2B;DDX3X;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.7094798874320581,-1.2661521528538773,0.11494252873563218,1.0,1.0,6/17,14.13%,WWC1;WWC2;DIP2B;NKD1;MT3;CDKN1B
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.8464425557144197,-1.2660096376470567,0.13846153846153847,1.0,1.0,1/5,1.22%,CTSL
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.8464425557144197,-1.2660096376470567,0.13846153846153847,1.0,1.0,1/5,1.22%,CTSL
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.7959657632924568,-1.2656894599307844,0.1111111111111111,1.0,1.0,3/10,14.13%,IPO5;LATS2;CDKN1B
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),-0.6261193902841716,-1.2655531175806816,0.1839080459770115,1.0,1.0,9/34,16.30%,TBC1D20;CDKL1;DCDC2;CCP110;TBC1D8;IFT140;DYNC2LI1;TAPT1;USP6NL
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.7893185786421368,-1.2651352631178105,0.18309859154929578,1.0,1.0,3/6,12.29%,NR4A3;STAT3;MT3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.6421910694638684,-1.264636503479601,0.08791208791208792,1.0,1.0,4/39,9.16%,SEC24A;CTSL;SEC13;AP2A1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.8730465335665714,1.2640764386480345,0.07407407407407407,0.9037159475432331,1.0,1/5,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.5289322081693524,1.264040433169818,0.058823529411764705,0.8980821995633205,1.0,5/20,10.47%,HDAC9;CD4;PIK3CD;GPR89B;ITGB1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.6400480173532976,-1.263768671429116,0.13793103448275862,1.0,1.0,14/37,26.87%,HSPA4L;LPIN1;NAA11;PIAS2;JAM3;SNAP91;TLE4;PEBP1;NF2;PRKAR2A;SPATA6;STRBP;MAP7;DCC
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.6704264997860436,-1.2633527928165416,0.16455696202531644,1.0,1.0,4/18,6.50%,SEC13;NUP153;NUP133;NUP88
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.6704264997860436,-1.2633527928165416,0.16455696202531644,1.0,1.0,4/18,6.50%,SEC13;NUP153;NUP133;NUP88
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.5876862688956324,1.2615910166300788,0.26666666666666666,0.9009122237989053,1.0,5/22,11.10%,PKN1;ADGRA2;RHOA;ZEB2;PTP4A3
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.6668777875028868,-1.2612724934185884,0.19480519480519481,1.0,1.0,8/22,18.40%,ANK3;AFDN;GGA3;GOLGA4;RAB7A;VAMP5;PREPL;NSF
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.655487178226948,-1.2610839941751644,0.13414634146341464,1.0,1.0,7/22,18.32%,SEC13;NUP153;NUP133;NUP88;HIF1A;RANBP2;PRKAG2
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.7435877159030824,-1.2607545135695957,0.14473684210526316,1.0,1.0,5/14,12.43%,ETV5;SOAT1;CEBPD;SAT1;SCD
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.8249574305739703,-1.2607401540436118,0.16883116883116883,1.0,1.0,3/6,9.93%,TWIST1;FGFR2;TGFBR1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.814338954547194,-1.2607205478657335,0.189873417721519,1.0,1.0,1/5,9.61%,RAP1B
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.8296233361569505,-1.2607117668680783,0.140625,1.0,1.0,2/6,8.44%,PIGL;PIGG
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.7044619232206206,-1.2607108516664611,0.15714285714285714,1.0,1.0,2/16,6.29%,NR4A3;PRKCI
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.7322310720873102,-1.2605627749963317,0.14814814814814814,1.0,1.0,8/15,14.97%,SLC7A2;SLC38A4;SLC38A9;SLC7A14;SLC6A17;SLC3A2;SLC36A4;SLC38A10
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.7422420124000871,-1.2600694187132353,0.16666666666666666,1.0,1.0,3/9,8.52%,VEGFA;TENM3;IFT122
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.7072743210443346,-1.2597415780696013,0.10975609756097561,1.0,1.0,6/16,16.67%,KDM1A;HABP4;NFKBIA;JUN;SIN3A;TNKS
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.7287326594848255,-1.259522015654852,0.13924050632911392,1.0,1.0,5/17,13.94%,OS9;MARCHF6;RPS27A;AMFR;TRIM13
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.6538895259569133,1.259421554105443,0.2727272727272727,0.9014706501076692,1.0,3/7,8.53%,LRCH1;DOCK8;RHOA
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.6440680773471632,-1.259071328705469,0.12048192771084337,1.0,1.0,7/26,19.43%,LPIN1;MMUT;ALDH3A2;HADHA;HSD17B4;ECHDC1;ACADL
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.8031479496340017,-1.2588746784239486,0.2,1.0,1.0,4/6,17.79%,OS9;UBAC2;UBE2J1;ERLEC1
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.8031479496340017,-1.2588746784239486,0.2,1.0,1.0,4/6,17.79%,OS9;UBAC2;UBE2J1;ERLEC1
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.8031479496340017,-1.2588746784239486,0.2,1.0,1.0,4/6,17.79%,OS9;UBAC2;UBE2J1;ERLEC1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.6297486128750527,-1.2588086535520333,0.04819277108433735,1.0,1.0,18/52,26.72%,GLUL;ALDH3A2;BCKDHB;HSPH1;CA2;LDHA;ACSL4;HSD17B4;DLD;ACADL;GABARAPL1;METAP1;XIST;PPARA;PTS;ACO2;SERINC1;ACADVL
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.8189537807462699,-1.2587988184719199,0.08,1.0,1.0,1/8,2.04%,UBA5
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.8430505736611881,-1.258359512738008,0.14666666666666667,1.0,1.0,1/5,2.10%,F3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.8244936197609924,-1.2581224504672675,0.2,1.0,1.0,2/5,13.49%,ZFP36L2;RGCC
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.6558485166169815,1.2580733366077947,0.24,0.9011212750861545,1.0,4/10,15.50%,RYR2;SLC9A1;SLC8A1;PTK2
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.7341436900349112,-1.2578884290352368,0.20270270270270271,1.0,1.0,2/12,9.29%,TAF7;TBPL1
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.7074296552579563,-1.2571280570711332,0.2073170731707317,1.0,1.0,4/13,8.77%,BASP1;VEGFA;FGFR2;SMCHD1
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.6454469976112142,-1.2570606282735,0.11904761904761904,1.0,1.0,8/23,19.97%,SEC13;NUP153;NUP133;NUP88;HIF1A;RANBP2;PRKAG2;SCARB2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.6606380515454235,1.2568395145771707,0.2,0.8991648336151637,1.0,2/10,0.55%,HSPA1A;CD58
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.6076446545899599,-1.2558612911485303,0.11827956989247312,1.0,1.0,17/75,17.77%,RIPOR1;RRAS2;WASF1;RHOB;SHC2;RAP1B;KRAS;PLD1;CFL1;CDC42EP4;ARHGAP5;ROCK2;JUN;DNMT1;GPSM2;BRAP;FARP2
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.6177930765852248,-1.2556752979550647,0.05263157894736842,1.0,1.0,20/78,13.59%,WWC1;GJA1;PRSS23;KAZN;CD44;SLC7A2;SLC2A1;DHRS3;TMEM164;MLPH;OLFM1;THSD4;SH3BP5;FHL2;SEMA3B;ELF1;AMFR;SLC1A1;RHOBTB3;PLAAT3
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.7187408891103039,-1.2555487159875587,0.19047619047619047,1.0,1.0,1/14,0.50%,TAF7
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.6504028716498294,-1.2554576419699277,0.10975609756097561,1.0,1.0,7/23,18.32%,SEC13;NUP153;NUP133;NUP88;HIF1A;RANBP2;PRKAG2
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.8640866863414501,-1.255302352466176,0.14285714285714285,1.0,1.0,1/5,0.93%,TBC1D20
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.6504375542656862,-1.2545740420155695,0.10843373493975904,1.0,1.0,13/29,28.84%,SOD1;SOD2;HIF1A;JUN;STK24;CAMKK2;MAPK1;FYN;APOD;APTX;EGFR;MAPK9;ADAM9
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.6997499673920134,-1.2542892087675692,0.14285714285714285,1.0,1.0,5/18,12.53%,ZFPM1;UBA5;VEGFA;PTPN2;RPS14
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.7357300097534768,-1.254216724130648,0.14634146341463414,1.0,1.0,3/13,6.38%,HS3ST5;IFITM3;NECTIN2
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.8454227691898211,-1.2539342498258395,0.16176470588235295,1.0,1.0,1/5,0.50%,TAF7
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.6464617632051991,-1.253681620799043,0.13636363636363635,1.0,1.0,8/32,17.07%,OS9;SELENOS;MARCHF6;AMFR;HSPA5;TRIM13;UBE2J1;NPLOC4
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.6563563780894502,1.2534337447444466,0.2222222222222222,0.9074937495776743,1.0,2/12,3.37%,CAV2;EDN3
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.7356962635829041,-1.253360104355063,0.16455696202531644,1.0,1.0,2/10,3.37%,WWC1;WWC2
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.6179800230124,-1.2531521080062813,0.0851063829787234,1.0,1.0,5/53,3.45%,MID1;GLRB;GPR161;NXN;TENM3
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.710421840596522,-1.2527111823707333,0.2714285714285714,1.0,1.0,2/12,5.71%,IPO5;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.710421840596522,-1.2527111823707333,0.2714285714285714,1.0,1.0,2/12,5.71%,IPO5;TGFB1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.5952765009313689,-1.2524825655633556,0.07954545454545454,1.0,1.0,13/63,13.78%,PRKACA;CSNK1D;FHL1;TUBA1A;PSMB1;PSMD14;CCP110;RBX1;CEP57;PSMA4;PSMB2;NINL;PSMA7
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),-0.7838098784530666,-1.2520046153422018,0.15384615384615385,1.0,1.0,4/8,11.89%,TGFB1;CST3;IL18;RUNX1
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.6067158841959145,1.2516990071169292,0.10526315789473684,0.907408600398717,1.0,1/12,0.02%,JPH2
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.8128806659945041,-1.2510217474858891,0.1875,1.0,1.0,1/5,8.21%,FGFR2
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.7937979625495218,-1.250818865427188,0.14084507042253522,1.0,1.0,2/8,14.74%,SDCBP;RAB7A
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.7811324048790349,-1.2507841023398818,0.14084507042253522,1.0,1.0,3/9,10.96%,LGALS3;NECTIN2;PTPN2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.6323349490120543,-1.2506610224204717,0.15,1.0,1.0,7/40,10.30%,NRCAM;SPTBN4;ATL1;ANK3;DCDC2;FGFR2;CCK
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.8133270912789835,-1.250632492943619,0.10294117647058823,1.0,1.0,2/7,7.75%,TGFB1;CST3
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.7277790647166072,-1.250609420625856,0.16470588235294117,1.0,1.0,3/13,8.21%,TGFB2;GPM6A;FGFR2
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.7189133826370301,-1.2502456958842105,0.19736842105263158,1.0,1.0,2/10,5.71%,TGFB2;TGFB1
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.6043127573712269,-1.2500987834153918,0.08235294117647059,1.0,1.0,10/48,15.70%,SYT1;ANK3;MT2A;ADGRV1;TF;MT3;JUN;CDKN1B;CAMK2D;LRRK2
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.6432966734885168,-1.250075569080316,0.07777777777777778,1.0,1.0,7/37,13.49%,TWIST1;TGFB2;TGFB1;OLFM1;SDCBP;TGFBR1;RGCC
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.8518173831116375,-1.249999542023195,0.1,1.0,1.0,2/6,8.39%,TET3;CTR9
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.7755791732211978,-1.2497564218282178,0.2465753424657534,1.0,1.0,5/8,22.12%,NEDD4L;CAMK2D;NEDD4;HECW1;STK39
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.6712084313429064,-1.2495443892907434,0.19230769230769232,1.0,1.0,6/19,18.40%,ANK3;GGA3;GOLGA4;VAMP5;PREPL;NSF
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.6169315306966795,-1.249542857335074,0.05319148936170213,1.0,1.0,25/77,15.61%,SLC2A3;CSF1;NR4A3;KLF2;F3;CD44;PDE4B;VEGFA;NFKBIA;RHOB;SOD2;PTPRE;SLC16A6;CEBPD;MAP3K8;TANK;IL18;SAT1;JUN;SGK1;GEM;NR4A2;PLPP3;DUSP1;PHLDA1
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.6721363255206414,-1.2490854253715058,0.1625,1.0,1.0,5/18,21.27%,MAP3K8;RPS27A;BTRC;SKP1;MAPK1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.7967470977183237,-1.2490830360928256,0.12,1.0,1.0,1/8,1.80%,KDM1A
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.7164735739706138,-1.2489254409831845,0.20512820512820512,1.0,1.0,3/12,14.63%,VEGFA;GOLGA4;ZFYVE27
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.7750051436393699,-1.2488925823166395,0.17567567567567569,1.0,1.0,2/9,10.57%,ENO1;MYL3
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.6537651090792003,-1.2486804459058687,0.13253012048192772,1.0,1.0,10/34,15.24%,BTD;CPD;ALDH1L1;PANK2;MCCC2;MTHFD2L;ACOT11;PLAAT3;PLPP3;ACBD6
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.6120022836933351,-1.2485889648633455,0.10344827586206896,1.0,1.0,8/42,11.65%,TBC1D20;CDKL1;DCDC2;TBC1D8;NPRL3;IFT140;C9ORF72;DYNC2LI1
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.8175983075429938,-1.2484601230312764,0.21428571428571427,1.0,1.0,2/5,10.96%,LGALS3;PTPN2
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.8175983075429938,-1.2484601230312764,0.21428571428571427,1.0,1.0,2/5,10.96%,LGALS3;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.804805907403423,-1.2480556256026596,0.18571428571428572,1.0,1.0,3/6,8.82%,ENO1;RHBDD1;LPCAT3
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.7477465715827625,-1.247882333031721,0.13157894736842105,1.0,1.0,4/13,8.08%,CD44;ARHGAP24;ITGA5;TMEFF2
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.6979060111045188,-1.2475521888358023,0.15476190476190477,1.0,1.0,2/13,8.66%,PELI1;SDCBP
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.8225221879334282,-1.247029489249867,0.17857142857142858,1.0,1.0,1/5,2.10%,F3
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.745243033968825,-1.2463133796899388,0.1794871794871795,1.0,1.0,2/13,9.06%,PRKACA;PDK3
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.6986062545489703,-1.2460298393974811,0.14864864864864866,1.0,1.0,5/14,21.58%,COG2;NAPG;GOSR1;NSF;COG6
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.7598415123470132,-1.2459232057711027,0.19753086419753085,1.0,1.0,3/8,15.16%,RPA1;RPS27A;POLK
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.666307184763806,-1.2454342274146628,0.11904761904761904,1.0,1.0,7/35,8.39%,PELI1;PDE4B;SELENOS;PLAA;PDCD4;SMAD6;CTR9
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.7600300644760699,-1.2452592944533865,0.1375,1.0,1.0,4/11,14.45%,NR4A3;ROCK2;PARP1;CAMK2D
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.7103897141138393,1.244933654990733,0.23076923076923078,0.926834954240481,1.0,1/5,1.64%,NT5C3A
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.7803258770516963,-1.2441407522262036,0.17567567567567569,1.0,1.0,2/9,5.81%,NUP153;SUFU
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.4385236094661505,1.2439438613701637,0.1,0.9249448058529753,1.0,5/35,3.50%,CAV2;ATP2B4;RYR2;TRPC6;CACNA1C
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.7885286430881675,-1.2439386224211226,0.1527777777777778,1.0,1.0,3/7,10.86%,LGALS3;CEBPD;IL18
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.8358956576657184,-1.2438955436481784,0.10606060606060606,1.0,1.0,1/5,2.58%,TAF1B
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.7905552673069267,1.2438657668559585,0.3684210526315789,0.9197201536736852,1.0,2/5,6.62%,ACTA2;WNT5B
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.7047770410891319,-1.2438121725903966,0.14457831325301204,1.0,1.0,4/16,9.21%,EPHA7;TENM3;TGFB1;AFDN
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),-0.6647754422127368,-1.2435368573244756,0.10714285714285714,1.0,1.0,8/24,18.67%,WWC1;KDM1A;PARP1;CAMK2D;LRRK2;GOSR1;ADGRE2;REEP5
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.7227887794107469,1.2430395909443268,0.13636363636363635,0.9173198706984976,1.0,2/9,2.84%,TIPRL;MFHAS1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.6736569102519642,-1.242995920558068,0.21951219512195122,1.0,1.0,7/18,20.98%,RPA1;CTCF;XRCC4;RAD21;TERF2IP;TNKS;SLF1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.5666176683148533,-1.2428949071717366,0.05102040816326531,1.0,1.0,33/155,19.33%,STX6;CSE1L;SEC13;RAB28;TSC2;IPO5;ARL5A;IPO9;NUP153;TGFB1;COG7;NAPG;NUP133;NUP88;XPO4;ARF4;SYNDIG1;SNX6;STAT3;AP2A1;TBC1D8;USO1;GGA3;RAB7A;STRADB;USP6NL;KIF13B;LAMP2;AP4E1;TMED4;NSF;RAB18;APPL2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.6827207782061602,-1.2427590178572123,0.12987012987012986,1.0,1.0,8/18,23.02%,NR4A3;OGN;IL18;PRKDC;IGFBP5;CCN4;STAT1;APOD
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),-0.8220257999792757,-1.242743716084356,0.19736842105263158,1.0,1.0,1/6,0.93%,TBC1D20
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.8050003699119388,-1.2427165450386413,0.10144927536231885,1.0,1.0,2/6,10.07%,SPTLC3;SPTLC1
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.5976279127184783,-1.2423279287115883,0.19148936170212766,1.0,1.0,14/70,18.33%,STX6;TBC1D20;COG2;CSNK1D;CSNK1A1;GOLGA8A;COG7;GOLGA8B;GOLGA2;FAM174B;LRRK2;USP6NL;NPLOC4;TMED4
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.6838905306416053,-1.2420122302120937,0.13157894736842105,1.0,1.0,8/23,24.16%,SYT1;MCTP2;SNCAIP;RIMS2;RIMS1;NSF;RAB8B;RAB12
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.7304170515190598,-1.2418361488639862,0.15476190476190477,1.0,1.0,3/12,15.86%,RNMT;CCNH;CMTR1
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.7304170515190598,-1.2418361488639862,0.15476190476190477,1.0,1.0,3/12,15.86%,RNMT;CCNH;CMTR1
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.6776846693848588,-1.2415768207437365,0.16455696202531644,1.0,1.0,4/19,7.12%,EPHA7;EFNB2;TGFB2;DDIT4
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.7660106425797778,-1.241367136245519,0.14666666666666667,1.0,1.0,2/8,7.94%,SRGN;SMAD6
prerank,GO_Biological_Process_2021__limb development (GO:0060173),-0.7234174871995456,-1.2413428833262516,0.1951219512195122,1.0,1.0,2/15,8.52%,SMOC1;IFT122
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.7925450028143279,1.2413351949434301,0.1724137931034483,0.9126045218951704,1.0,1/5,0.58%,AP3M1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.7925450028143279,1.2413351949434301,0.1724137931034483,0.9126045218951704,1.0,1/5,0.58%,AP3M1
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.8098054174231393,-1.2408882304789297,0.18181818181818182,1.0,1.0,1/7,1.72%,SYT1
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.7274397807611428,-1.240552188523898,0.16216216216216217,1.0,1.0,6/10,22.25%,NR4A3;PPARGC1A;PRKAG2;APPL2;ACADL;PPARA
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.6223168075119667,-1.2404091111995765,0.15730337078651685,1.0,1.0,6/34,7.64%,STC1;TPT1;TMCO1;SLC10A7;MT2A;TMEM165
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.7102874082016934,-1.2403157360131454,0.225,1.0,1.0,1/12,3.13%,NCKAP5
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.622073282054787,1.2402346604446062,0.15384615384615385,0.9116449839615554,1.0,2/10,3.50%,SCN1A;CACNA1C
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.7614412427485353,-1.2395963019565543,0.12987012987012986,1.0,1.0,2/8,14.82%,HABP4;AFF2
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.5952411361666142,-1.2394625619727724,0.10989010989010989,1.0,1.0,23/70,20.92%,FSIP2;MTCH2;CSNK1D;RIPOR1;RPA1;COG7;ALDH3A2;DDX3X;IFT122;IFT140;UBAC2;GBP2;TRAM1;ATP6V1D;WASHC2C;LRRK2;LAMP2;DNAJA1;MDM2;SERP1;XPA;SSB;GAK
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.6100079682511326,-1.2391565126356612,0.12222222222222222,1.0,1.0,17/38,23.68%,RHEB;SEC13;ATP6V1E1;ATP6V1G1;SLC38A9;SZT2;EIF2AK2;ATP6V1H;NPRL3;ATP6V1D;ITFG2;SESN1;EIF2AK4;LARS1;MAPK1;ATP6V0D1;RRAGB
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.7969605336851138,-1.238857526014275,0.16,1.0,1.0,4/9,6.10%,CSF1;VEGFA;LGALS3;JAM3
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.7148344650465407,-1.238805205600013,0.16216216216216217,1.0,1.0,4/8,21.09%,GRIN1;RIMS2;RIMS1;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.607361059419946,-1.2387973026820773,0.13333333333333333,0.9997886753215706,1.0,9/53,15.99%,STC1;RHOB;ROBO1;TMEFF2;AFDN;FRMD5;NAV3;STK24;IGFBP5
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.5705614899798737,1.238756724561832,0.15789473684210525,0.9110338180744787,1.0,2/17,0.55%,HSPA1A;CD58
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.7610897557163611,-1.2385195955917983,0.14285714285714285,0.9995633874460756,1.0,1/6,1.25%,NR4A3
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.7001276183921833,-1.2381034847394534,0.13953488372093023,1.0,1.0,8/16,26.72%,PDK1;PANK2;PDK3;ACADL;NCOR2;PPARA;RORA;ACADVL
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.8419186501321612,-1.2372220689630369,0.17142857142857143,1.0,1.0,2/5,9.56%,KCNE4;KCNQ1
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.7811655082210307,-1.2357148047702458,0.18072289156626506,1.0,1.0,5/8,16.97%,PURB;LGALS3;PRKCB;RUNX1;MYSM1
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.6243963636721498,-1.2354239740669035,0.11235955056179775,1.0,1.0,22/54,22.75%,PRKACA;GRINA;IGFBP2;NFKBIA;RHOB;SOD2;OLFM1;PTPRD;CDC5L;CA2;CCK;MGAT1;RAB27A;DNAJA1;AGO2;BTG2;EIF2S3;DDX21;BTG1;IRF1;CHKA;JUNB
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.7168257199538907,-1.235145691541976,0.14814814814814814,1.0,1.0,3/17,10.03%,SEC24A;SEC13;ERAP1
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.8160532697605154,-1.2350418813632236,0.13636363636363635,1.0,1.0,2/5,10.07%,SPTLC3;SPTLC1
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.8160532697605154,-1.2350418813632236,0.13636363636363635,1.0,1.0,2/5,10.07%,SPTLC3;SPTLC1
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.7328303534065588,1.234926173627472,0.2413793103448276,0.9184742998034122,1.0,3/5,10.72%,RNF185;ATXN3;TMEM259
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.6971424454441343,1.23480593449913,0.26666666666666666,0.9133873676045132,1.0,1/6,0.27%,CAV2
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.7902685626566873,-1.2344565497457398,0.15492957746478872,1.0,1.0,2/5,4.84%,TGFB2;SNCAIP
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.6084481554219517,-1.233939658128946,0.12359550561797752,1.0,1.0,17/39,23.68%,RHEB;SEC13;ATP6V1E1;ATP6V1G1;SLC38A9;SZT2;EIF2AK2;ATP6V1H;NPRL3;ATP6V1D;ITFG2;SESN1;EIF2AK4;LARS1;MAPK1;ATP6V0D1;RRAGB
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.6464725696342726,-1.2338583176880618,0.10588235294117647,1.0,1.0,3/40,2.78%,ARHGAP15;SOD1;VAV3
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.6901699589912094,-1.2332737088894778,0.1111111111111111,1.0,1.0,8/22,24.17%,RARS1;FARSB;DARS1;YARS1;PPA1;WARS1;LARS1;EPRS1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.775305356916731,-1.2328895722926079,0.19736842105263158,1.0,1.0,3/9,2.13%,TPT1;KDM1A;CD44
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.6755239479896704,-1.232443192286604,0.11392405063291139,1.0,1.0,8/25,24.17%,RARS1;FARSB;DARS1;YARS1;PPA1;WARS1;LARS1;EPRS1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.6091068627183551,-1.2321601835645017,0.08695652173913043,1.0,1.0,15/67,11.89%,PRKACA;CSF1;SMOC1;PURB;LGALS3;TGFB1;PTPRQ;ST7;CCN2;EIF2AK2;FGFR2;CEBPD;PRKCB;TGFBR1;RUNX1
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.6372487430090243,-1.2315788680456619,0.15789473684210525,1.0,1.0,8/25,22.51%,MID1;TGFB2;EIF2AK2;ULK4;PER1;MAPK1;TAOK3;ARL6IP5
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.7838070404858349,-1.2314495214965757,0.14814814814814814,1.0,1.0,2/9,3.69%,GLRX;ANK3
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.5821008376182972,1.2313639777659156,0.16666666666666666,0.9192930090802965,1.0,2/15,3.56%,HEY2;HEYL
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.702009346289273,-1.2312139049152704,0.1686746987951807,1.0,1.0,8/16,25.26%,ENO1;TMSB4X;HIF1A;PPARGC1A;PID1;PPARA;APP;INSR
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.6282191287485495,-1.2311297194746762,0.09411764705882353,1.0,1.0,6/34,9.53%,WWC1;SLC7A2;EFNB2;SHROOM3;ARFGEF3;SHC2
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.6193661532076158,-1.2308815752499709,0.15384615384615385,1.0,1.0,13/55,17.07%,SRGN;ZFPM1;HOMER2;SELENOS;TMSB4X;PDCD4;TRAF3IP1;CMKLR1;RGCC;TBK1;NAV3;LGR4;NPLOC4
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),-0.7997016728713535,-1.230735262003737,0.19230769230769232,1.0,1.0,3/8,8.21%,TGFB2;RARB;FGFR2
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.7849140295250228,-1.229977677381199,0.19047619047619047,1.0,1.0,1/7,2.90%,SPTBN4
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.5720081137456614,1.2296814549483204,0.25,0.9186521096985317,1.0,1/16,0.27%,CAV2
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.6563265879808331,-1.2296280037308884,0.1839080459770115,1.0,1.0,5/31,7.41%,KDM1A;ROBO2;VEGFA;ROBO1;PTPRD
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.7273947374338876,-1.2292943832850511,0.22784810126582278,1.0,1.0,6/12,13.88%,KLF2;VEGFA;HIF1A;MT3;ATF6;HSPA5
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.7755669296728532,-1.2287811810938403,0.20253164556962025,1.0,1.0,1/9,0.77%,CHST11
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.7998228743527244,-1.2281320880615398,0.1625,1.0,1.0,2/6,9.88%,NECTIN2;PRKCB
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),-0.6130930843944121,-1.2281162788099977,0.14583333333333334,1.0,1.0,8/41,9.91%,NELL1;PRKACA;TWIST1;SMOC1;SUFU;SMAD6;FGFR2;TP63
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.6367511528873723,-1.228055149917733,0.19101123595505617,1.0,1.0,10/35,16.83%,SOD1;CSF1;SOD2;PRKCI;SNX6;MT3;PPARGC1A;LRRK2;NAIP;UNC5B
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.6100821484454111,-1.2280181660759542,0.07865168539325842,1.0,1.0,20/60,18.70%,TWIST1;VEGFA;KCND2;PGK1;ELOB;PSMB1;PSMD14;RBX1;RPS27A;HIF1A;PSMA4;PSMB2;MT3;RGCC;PSMA7;FMN2;HIF3A;MDM4;P4HB;MDM2
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.6388458391279097,-1.2279164130144529,0.1590909090909091,1.0,1.0,15/35,28.59%,RIPOR1;WIPI1;SREBF1;STK24;LRRK2;LAMP2;WRN;LPL;PPARA;RRAGB;MAP1LC3B;SREBF2;WDR45B;EIF4G1;FOXO1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.7094638210558065,-1.2277860158690093,0.20270270270270271,1.0,1.0,3/12,12.80%,TWIST1;MED14;JUN
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.6918552173771051,-1.2272808521454823,0.16666666666666666,1.0,1.0,5/22,18.94%,PRKACA;PDK3;HIF1A;PPARGC1A;TRA2B
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.835607380548987,-1.227198925286058,0.16176470588235295,1.0,1.0,2/6,6.75%,DHRS3;ALDH3A2
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.7493064039498166,-1.2270587153645782,0.16666666666666666,1.0,1.0,2/10,8.39%,TET3;CTR9
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.5933989397970362,1.2269502546207813,0.24,0.9212942059967196,1.0,1/11,1.28%,ADGRA2
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),-0.8119433469473132,-1.2266443438044883,0.21333333333333335,1.0,1.0,2/6,8.21%,ROBO2;FGFR2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.6035176783189935,-1.2262866913986443,0.13095238095238096,1.0,1.0,10/38,20.29%,TAF7;TSC2;PTPRQ;PTPN1;SH3BP5;CDKN1B;DTNBP1;YWHAG;PRKAG2;WARS1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.6572474542907446,-1.2260838433733035,0.20454545454545456,1.0,1.0,5/23,9.93%,ROBO2;VEGFA;TGFB2;TRAF3IP1;TGFBR1
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.6126226012377054,-1.2258102360572238,0.08421052631578947,1.0,1.0,17/55,18.94%,CSE1L;DUT;NUP153;RPA1;CTCF;MELK;RAD21;STMN1;CCP110;DONSON;PRKDC;RBBP7;DNMT1;CDKN1B;NAP1L1;SMC3;TRA2B
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.80408118583232,-1.2255669519894152,0.17105263157894737,1.0,1.0,2/7,9.11%,SOD1;PXDN
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.8071180976676827,-1.2254089702677353,0.15584415584415584,1.0,1.0,2/8,5.07%,SPTBN4;SZT2
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.5796721305221295,-1.2253875983512479,0.13333333333333333,1.0,1.0,19/79,19.44%,SRGN;ADAMTS9;CTSL;F3;CPD;SUFU;ADGRV1;SPG7;UFSP2;PITRM1;ERAP1;SENP1;APH1B;ENPEP;LNPEP;ATG4B;MDM2;MIPEP;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.6366111846379501,-1.2249701113360905,0.20930232558139536,1.0,1.0,6/24,7.52%,PRAG1;CRMP1;EFNB2;HDAC2;SPOCK1;CBFA2T2
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.4346757235182615,1.2245061241415207,0.07692307692307693,0.9229292863351967,1.0,7/59,4.68%,TAGLN;ACTA2;LMOD1;CSPG4;COL14A1;COL5A2;MYL9
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5561716307161818,-1.2243917422982624,0.14432989690721648,1.0,1.0,45/109,28.75%,RPS21;RPS4X;RPL28;TUT7;RPL34;UPF3A;RPL21;RPLP2;RPS27A;RPL19;PABPC1;RPLP1;CNOT8;RPS14;ETF1;PPP2R2A;RPL13A;RPL18;DCP2;PATL1;CSDE1;RPL27;SMG7;RPL35A;RPL31;RPS12;RPL5;RPS18;RPL27A;RPL36;NBDY;RPL41;RPL32;RPL37;RPL24;RPL9;CNOT1;RPS20;RPS2;RPL37A;RPL3;NCBP1;UPF2;EIF4G1;RC3H2
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.7533088064857036,1.2243228156950345,0.3,0.9131540293565056,1.0,3/6,19.14%,ADCY6;ADCY2;ADCY3
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.7533088064857036,1.2243228156950345,0.3,0.9131540293565056,1.0,3/6,19.14%,ADCY6;ADCY2;ADCY3
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.6454855457392203,-1.2241973881512958,0.21052631578947367,1.0,1.0,5/24,14.74%,EPN1;SNX6;PTPN2;ERRFI1;RAB7A
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.7554795630097901,-1.2239322615336925,0.21686746987951808,1.0,1.0,4/8,13.36%,SLC6A17;SLC3A2;SLC36A4;SLC1A1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.5750550696317006,1.2235180668677843,0.16666666666666666,0.9105365227380228,1.0,2/9,13.27%,MCU;RAP1GDS1
prerank,MSigDB_Hallmark_2020__Myogenesis,0.48034407634957926,1.2233143578321877,0.0,0.9061429789006946,1.0,19/83,7.46%,TAGLN;MYH11;LDB3;MEF2D;ADCY9;MYOM1;NOTCH1;TPM2;ITGA7;DTNA;BIN1;IGFBP7;PKIA;MYH9;LARGE1;DAPK2;MYLK;PLXNB2;ITGB5
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.6592155269377772,1.2232463211521454,0.19047619047619047,0.9014809435445964,1.0,2/8,4.62%,GLB1;GPC6
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.6445263213765269,-1.2231284390470807,0.22093023255813954,1.0,1.0,5/31,10.04%,TSC2;RUBCN;LGALS3;PTPN1;NEDD4L
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.6759147425986215,-1.2228484161629358,0.2,1.0,1.0,3/15,9.90%,PRKACA;CRY1;PRKAR1A
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.6738787799499085,-1.2222838566410033,0.1935483870967742,1.0,1.0,6/18,14.95%,GNPAT;AGPAT4;PLAA;ENPP2;PLAAT3;PLPP3
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.5999071985740302,1.2221784277916992,0.16666666666666666,0.9002302991230022,1.0,3/11,3.77%,MYH11;LTBP3;NTN4
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.748815567025577,-1.2218586176078456,0.2,1.0,1.0,3/8,13.49%,TGFB1;RUNX1;RGCC
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.8078925996721503,-1.2215166124392929,0.18181818181818182,1.0,1.0,2/6,3.40%,GJA1;VEGFA
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.7955148292899836,-1.2212448640943205,0.20833333333333334,1.0,1.0,1/5,0.74%,SOD1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.7452255283463691,-1.2211670745122394,0.18421052631578946,1.0,1.0,3/8,5.79%,GLRX;ANK3;ATP1B3
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.5584835630702656,1.2210481436273792,0.29411764705882354,0.8988888056478551,1.0,1/14,0.06%,ZBTB7C
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.6142560983530317,1.221019238793706,0.21875,0.8942377041545904,1.0,1/7,0.77%,GPRC5C
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.749729912465889,1.2209226277828438,0.28,0.8850847343710533,1.0,1/5,0.87%,ST3GAL2
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.749729912465889,1.2209226277828438,0.28,0.8850847343710533,1.0,1/5,0.87%,ST3GAL2
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.6964257507896592,1.2208630813308483,0.22727272727272727,0.8805301680820871,1.0,3/9,3.50%,SCN1A;HCN2;CACNA1C
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.696094121774894,-1.2207109301575962,0.21686746987951808,1.0,1.0,3/15,11.92%,SRSF12;SRSF10;SRSF5
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.7343669872045784,-1.2205117883497607,0.21951219512195122,1.0,1.0,2/11,3.95%,NDUFB9;NDUFV1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.8110380343606328,-1.220210109213488,0.18055555555555555,1.0,1.0,4/6,12.29%,ITGA5;PRKCB;HIF1A;MT3
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.7234622124345671,-1.2200634642413442,0.21794871794871795,1.0,1.0,9/15,24.11%,TWIST1;DDX3X;EIF2AK2;HIF1A;IL18;ADAM17;LPL;MBP;APP
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.6533127037886584,-1.2199475854066872,0.19047619047619047,1.0,1.0,10/24,28.22%,SNCAIP;CST3;RPS27A;GGA3;APH1B;TSPAN5;MDM2;APP;SIAH1;GSN
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.7345901172443337,-1.2199303881101211,0.19480519480519481,1.0,1.0,4/10,19.06%,HABP4;DDX3X;CDC123;UHMK1
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.8224318358669689,-1.2197567132695917,0.15492957746478872,1.0,1.0,1/5,9.96%,RPS27A
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.8224318358669689,-1.2197567132695917,0.15492957746478872,1.0,1.0,1/5,9.96%,RPS27A
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.6295514221689809,-1.2197356989244355,0.18888888888888888,1.0,1.0,10/39,17.79%,OS9;SELENOS;MARCHF6;RHBDD1;AMFR;HSPA5;TRIM13;UBE2J1;NPLOC4;ERLEC1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.7001589075534749,-1.21944018781529,0.13414634146341464,1.0,1.0,7/17,20.40%,RPA1;RBX1;RPS27A;PARP1;FAN1;POLK;XPA
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.6599990756939247,-1.2189514545700244,0.18604651162790697,1.0,1.0,8/26,20.40%,RPA1;RBX1;RPS27A;PARP1;FAN1;POLK;IHO1;XPA
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.8042971406491946,-1.2186294291298043,0.16216216216216217,1.0,1.0,3/5,17.20%,VEGFA;ADGRV1;ULK4
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.6547835565788136,-1.218233572465735,0.20689655172413793,1.0,1.0,11/27,21.24%,SOD1;SOD2;PRKCI;SNX6;HIF1A;MT3;PPARGC1A;NAIP;UNC5B;NONO;CPEB4
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.6311342831310521,-1.2180730136591738,0.10465116279069768,1.0,1.0,4/38,9.16%,SEC24A;CTSL;SEC13;AP2A1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.732409737871293,-1.2179437135682236,0.16455696202531644,1.0,1.0,6/11,15.45%,GLRX;DUT;CMPK1;TXNRD1;GUK1;GSR
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.8258998583935534,-1.2177185376322668,0.2,1.0,1.0,2/6,6.18%,CSNK1D;NKD1
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.7966122673071439,-1.217301781727845,0.15384615384615385,1.0,1.0,1/5,11.28%,POMP
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.6520979518061737,-1.2171457051387775,0.189873417721519,1.0,1.0,6/23,16.01%,DHRS3;COL11A1;ADGRV1;ATF6;PITPNA;COL18A1
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.693752749493656,1.217047764753439,0.2962962962962963,0.8879203549789402,1.0,1/8,1.11%,NFU1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.5764094163271632,-1.2166256836572542,0.11235955056179775,1.0,1.0,23/74,24.11%,NRCAM;SPTBN4;ATL1;ANK3;DCLK1;GPM6A;DCDC2;ALCAM;FGFR2;CCK;MYO16;SGK1;LRRK2;DTNBP1;PAK1;EIF2AK4;NLGN1;TAOK3;MINK1;FARP1;EPB41L3;APBB1;APP
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.8372446744874165,-1.2163431917152077,0.19402985074626866,1.0,1.0,3/5,8.21%,NELL1;EIF2AK2;FGFR2
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.5693679289283429,-1.216207920829044,0.08602150537634409,1.0,1.0,14/78,9.93%,TWIST1;ZFP36L2;ZFPM1;SRA1;NFKBIA;PDCD4;TGFB1;SUFU;ADGRV1;ZFPM2;SMAD6;CTR9;ANKRD26;TGFBR1
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.6949159596818765,-1.2160460769920112,0.14814814814814814,1.0,1.0,5/20,9.93%,TGFB2;TGFB1;SMAD6;SDCBP;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.6905573423396554,-1.215359434625551,0.23376623376623376,1.0,1.0,3/13,8.52%,GPR161;SUFU;IFT122
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.6335851897950273,1.2153421796260286,0.25,0.8884054754766504,1.0,2/6,4.80%,CSPG4;ARSB
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.5817030120081929,-1.2152292706098753,0.18181818181818182,1.0,1.0,18/68,16.96%,SRGN;SOD1;SYT1;HABP4;VEGFA;TGFB2;TMSB4X;TGFB1;PROS1;SNAP25;SCCPDH;RIMS2;TF;ANXA5;CLU;SYTL4;RIMS1;LAMP2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.7772427269947952,-1.214741612927889,0.15714285714285714,1.0,1.0,1/8,2.73%,WIPI1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.6487610927165002,-1.2144714978025752,0.15384615384615385,1.0,1.0,7/28,13.89%,MCC;RHOJ;TGFB2;GLUL;ENPP2;HIF1A;SASH1
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.6701975968108753,-1.2140324244946759,0.2894736842105263,1.0,1.0,4/17,15.70%,TSC2;RUBCN;LZTS1;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.6172969873487711,-1.2138772053435531,0.2261904761904762,1.0,1.0,7/28,20.29%,TAF7;TSC2;CDKN1B;DTNBP1;YWHAG;PRKAG2;WARS1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.5925614975252643,1.213602328636772,0.2608695652173913,0.8898413611504103,1.0,2/10,4.59%,BCL2L1;BCL2L11
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),-0.780640588033102,-1.213516308592469,0.18421052631578946,1.0,1.0,2/6,8.82%,ATL1;LPCAT3
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.8099441790947551,-1.2128049420202953,0.16666666666666666,1.0,1.0,1/5,3.40%,VEGFA
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.652385196588728,-1.212679117265001,0.17333333333333334,1.0,1.0,4/20,6.50%,SEC13;NUP153;NUP133;NUP88
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.8293604323032736,-1.212535780402533,0.18840579710144928,1.0,1.0,2/6,6.38%,CADM1;NECTIN2
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.841158395848906,-1.2123437031559308,0.2028985507246377,1.0,1.0,4/5,15.70%,FHL1;NEDD4L;CAMK2D;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.756174980388177,-1.2120278670010176,0.21518987341772153,1.0,1.0,5/6,22.25%,ENO1;TMSB4X;PPARGC1A;PID1;PPARA
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.756174980388177,-1.2120278670010176,0.21518987341772153,1.0,1.0,5/6,22.25%,ENO1;TMSB4X;PPARGC1A;PID1;PPARA
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.781870323130741,-1.2119067813986133,0.22666666666666666,1.0,1.0,2/7,4.25%,VEGFA;TGFB2
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.8285983547420674,-1.211715882644994,0.23809523809523808,1.0,1.0,2/5,14.16%,VEGFA;NR4A2
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.771563922781321,-1.2116740774502233,0.25,1.0,1.0,3/6,16.51%,PCBP3;IGF2BP2;NOVA1
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.6175008864543607,-1.2111114926183968,0.13636363636363635,1.0,1.0,7/24,18.32%,SEC13;NUP153;NUP133;NUP88;HIF1A;RANBP2;PRKAG2
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.758227761557616,-1.2110346268495444,0.18518518518518517,1.0,1.0,7/8,22.35%,ENO1;TMSB4X;PARP1;PPARGC1A;PID1;PPARA;AK4
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5387004478300946,1.210980367317052,0.2727272727272727,0.8927636580174337,1.0,4/18,9.35%,ATP2B4;NOTCH1;RHOA;HMGB1
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.7954149859999833,-1.210664763233528,0.1,1.0,1.0,2/5,10.86%,TGFB1;IL18
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.6385817322371687,-1.2105519327491345,0.15294117647058825,1.0,1.0,7/31,16.14%,CD44;EPHA7;VEGFA;DDX3X;DELE1;MT3;NAIP
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.8060693611328316,-1.209899503670002,0.17333333333333334,1.0,1.0,2/7,13.38%,KDM1A;DNMT1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.664734337552674,-1.208719970771531,0.23076923076923078,1.0,1.0,4/15,14.21%,WASF3;WASF1;DIAPH1;MICALL2
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.6787123062659309,-1.2082638853911067,0.21428571428571427,1.0,1.0,2/19,3.40%,STC1;VEGFA
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.7345353228333129,-1.2082204273075896,0.1875,1.0,1.0,6/10,24.11%,EIF2AK2;HIF1A;IL18;ADAM17;LPL;APP
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.7227673089396893,-1.2078673402268514,0.22077922077922077,1.0,1.0,2/12,5.28%,RUBCN;LGALS3
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.686431426585953,-1.2078410289390278,0.22784810126582278,1.0,1.0,4/18,9.93%,ADAMTS9;VEGFA;TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.7755627663535658,-1.2073860653083772,0.19718309859154928,1.0,1.0,3/6,17.74%,SOAT1;NECAB1;AGO2
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.8102322080929658,-1.2070426512821932,0.2602739726027397,1.0,1.0,2/5,11.53%,XRCC4;PRKDC
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.6970467858312162,-1.2070008945238804,0.2345679012345679,1.0,1.0,3/13,5.71%,TWIST1;ANKH;TGFB1
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.7647078885308932,-1.206684387634062,0.20270270270270271,1.0,1.0,2/7,3.55%,GNPAT;NCEH1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.6388279731754791,-1.205660330134502,0.14814814814814814,1.0,1.0,7/27,17.92%,KDM1A;ZFPM1;GOLGA2;SYMPK;LRRK2;LRPAP1;MITD1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.7400320318451523,-1.2054615952349266,0.19047619047619047,1.0,1.0,4/11,14.47%,SLC22A6;SLCO1A2;SLC13A3;LRRC8B
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.7401072402040921,1.2052927786368477,0.3548387096774194,0.907006950126514,1.0,2/5,5.45%,HSPA1A;SACS
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.7026246643454004,-1.205183222480727,0.1686746987951807,1.0,1.0,5/16,19.84%,PELI1;SMAD6;ADAM17;MAPKAPK2;ERBIN
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.8242153177789255,-1.205139505213427,0.23076923076923078,1.0,1.0,1/6,2.07%,SLCO1A2
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.5566156028309178,1.2049888620238476,0.14285714285714285,0.9034213094643481,1.0,1/17,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.5104731967847346,1.204980458452221,0.14285714285714285,0.8987883796722231,1.0,2/30,2.20%,HSPA1A;BCL2L1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.6945762997717839,1.2046686943971971,0.35,0.8948890644845006,1.0,3/7,19.94%,PLA2G4C;ABHD2;MGLL
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.7922485668919076,-1.2045914228841879,0.18421052631578946,1.0,1.0,3/5,19.44%,GALNT11;APH1B;ADAM17
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.41809849647523306,1.204562309145976,0.0,0.8905903574908856,1.0,15/123,4.81%,TAGLN;NOX4;ACTA2;IL34;TWIST2;SLIT3;LMOD1;SERPINH1;COL14A1;ADAMTS10;EDN3;SYNPO2;COL5A2;MYL9;IGFBP7
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.5799234723750986,-1.204346675791049,0.18478260869565216,1.0,1.0,9/44,15.99%,NELL1;DDX3X;CST3;EIF2AK2;GIGYF2;CNOT8;IGF2BP2;RPL13A;IGFBP5
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.7477865078356309,1.2039165335720472,0.2857142857142857,0.8880335894931476,1.0,3/8,2.23%,MYH11;SORBS2;HEY2
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.8040607608740247,-1.2036166141138513,0.15789473684210525,1.0,1.0,1/5,1.30%,PELI1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.8040607608740247,-1.2036166141138513,0.15789473684210525,1.0,1.0,1/5,1.30%,PELI1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.6505965258646156,-1.2031513628176242,0.2235294117647059,1.0,1.0,2/30,1.07%,SRSF12;HNRNPL
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.6680439546861032,-1.2030818864933084,0.16883116883116883,1.0,1.0,6/18,16.73%,CYP3A5;ENPP2;ERAP1;PDXDC1;ENPEP;LNPEP
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.600817299024479,-1.2027519229493717,0.19767441860465115,1.0,1.0,13/40,20.76%,SRGN;SOD1;CADM1;EIF2AK2;IGF2BP2;RGCC;TBK1;LGR4;POLA1;CCN4;PER1;MAPKAPK2;HLA-B
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.7400588995211256,-1.2024177213676892,0.19117647058823528,1.0,1.0,3/9,12.29%,TSC2;TGFB1;MT3
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.7255288945962929,-1.2023779597306412,0.2597402597402597,1.0,1.0,4/11,10.57%,ZFPM1;TGFB1;FGFR2;MYL3
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.6586858485175143,1.2021745696458261,0.19230769230769232,0.8887376269142184,1.0,3/11,3.88%,CTNNA3;CD58;ITGA7
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.6690948000331767,1.2019518709502173,0.3793103448275862,0.8849185080072979,1.0,4/6,13.28%,CDKN1A;DEK;EP300;PML
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.7464993860570697,-1.2017028527394786,0.22972972972972974,1.0,1.0,3/11,9.93%,TWIST1;VEGFA;TGFBR1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.7688260215394072,-1.201437988248336,0.2463768115942029,1.0,1.0,1/5,3.21%,MGST1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.7688260215394072,-1.201437988248336,0.2463768115942029,1.0,1.0,1/5,3.21%,MGST1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.5919385310120426,-1.2013638549759174,0.1590909090909091,1.0,1.0,10/43,15.21%,WIPI1;VEGFA;DDIT4;SSR1;SEC11A;RPS14;ATF6;HSPA5;TSPYL2;DCP2
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.806700528068012,-1.2011697953686011,0.1794871794871795,1.0,1.0,2/5,12.90%,CRY1;SIN3A
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.6724946331337862,-1.2011522670685615,0.2558139534883721,1.0,1.0,8/16,23.87%,SOAT1;LIMA1;CLU;NPC1;SCARB1;ABCA8;AKR1C1;STX12
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.5699002197391854,-1.2009868464736868,0.0989010989010989,1.0,1.0,40/104,27.37%,RPS21;RPS4X;RPL28;RPL34;RARS1;RPL21;FARSB;RPLP2;DARS1;RPS27A;RPL19;YARS1;PPA1;RPLP1;RPS14;ETF1;RPL13A;RPL18;ZC3H15;AGO2;RPL27;RPL35A;RPL31;RPS12;WARS1;LARS1;RPL5;RPS18;RPL27A;RPL36;RPL41;RPL32;RPL37;RPL24;EPRS1;RPL9;RPS20;RPS2;RPL37A;RPL3
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.6974208948719666,1.2003373243134685,0.30303030303030304,0.8866349380202172,1.0,1/5,4.01%,CDC42
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),-0.799515117628855,-1.2003353657947724,0.22857142857142856,1.0,1.0,4/6,13.49%,HDAC2;TGFB1;RUNX1;RGCC
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),-0.799515117628855,-1.2003353657947724,0.22857142857142856,1.0,1.0,4/6,13.49%,HDAC2;TGFB1;RUNX1;RGCC
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.799515117628855,-1.2003353657947724,0.22857142857142856,1.0,1.0,4/6,13.49%,HDAC2;TGFB1;RUNX1;RGCC
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.5795372518203854,-1.2001968519324657,0.16666666666666666,1.0,1.0,30/81,27.37%,DDX52;RPL28;DHX29;WDR43;GLUL;RPL34;RPL21;RPLP2;RPL19;NOP58;RPLP1;RPS14;RPL13A;RPL18;RPL27;RPL35A;RPL31;RPL5;RPL27A;RPL36;RPL41;RPL32;RPL37;RPL24;RPL9;RCL1;EIF2A;RPS2;RPL37A;RPL3
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.7426180251541148,1.2001340828250606,0.2916666666666667,0.8830067458397979,1.0,3/6,18.58%,TRIM44;DHX9;IL7
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.6044174985506787,1.1999005830983043,0.25,0.8793196318350628,1.0,2/15,5.61%,GLB1;LARGE1
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.7540650107188219,-1.1995858252648572,0.25,1.0,1.0,3/8,13.07%,CAMKMT;PCMT1;ETF1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.7674307780978731,-1.1992727628670994,0.1951219512195122,1.0,1.0,2/9,6.21%,SOD1;SOD2
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.6862845846203018,-1.1991749740893587,0.189873417721519,1.0,1.0,2/13,7.60%,ALDH3A2;PEX3
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.5373478878680971,-1.1989216423401088,0.12121212121212122,1.0,1.0,71/181,28.34%,CSF1;RPS21;PRSS23;IGFBP2;PCMT1;RPS4X;RPL28;PAPPA;RPL34;GALNT11;CST3;RPL21;FARSB;SPG7;MANBA;RPLP2;DARS1;FBN1;RPS27A;RPL19;SEC11A;PRKDC;ADORA2B;RPLP1;TF;RPS14;MGAT4A;RPL13A;RPL18;CP;APH1B;UBE2L3;IGFBP5;VCAN;AGO2;P4HB;RPL27;FBXO22;RPL35A;RPL31;ADAM17;RPS12;CCN1;WARS1;SERP1;RPL5;RPS18;RPL27A;FSTL1;RPL36;ITIH2;RPL41;RPL32;RPL37;RPL24;APP;RAB12;TGOLN2;RPL9;CHRM3;ABL1;PARP4;RPS20;RPS2;RPL37A;RPL3;FN1;ST3GAL6;LAMB1;YME1L1;EIF4G1
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.7564193122062988,-1.1985655651003457,0.14864864864864866,1.0,1.0,3/7,16.67%,PARP6;PARP1;TNKS
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.7836191184456865,-1.1984847913877656,0.14705882352941177,1.0,1.0,1/8,2.07%,SLCO1A2
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.6371927344300903,-1.1982554125918248,0.21621621621621623,1.0,1.0,3/22,11.93%,EPN1;PTPN2;ERRFI1
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.5767976572901983,-1.1982253285233497,0.17894736842105263,1.0,1.0,27/73,27.37%,DDX52;RPL28;WDR43;RPL34;RPL21;RPLP2;RPL19;NOP58;RPLP1;RPS14;RPL13A;RPL18;RPL27;RPL35A;RPL31;RPL5;RPL27A;RPL36;RPL41;RPL32;RPL37;RPL24;RPL9;RCL1;RPS2;RPL37A;RPL3
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.7040475583474992,-1.1980840987358274,0.2236842105263158,1.0,1.0,4/14,15.94%,SDCBP;RAB7A;SYTL4;RAB27A
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.6196285487840681,-1.1980715551797585,0.27586206896551724,1.0,1.0,10/38,15.50%,NELL1;NKAIN3;ELAVL3;CRMP1;DNER;SNAP25;PURG;NXPH1;SNAP91;CDK14
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.7424390335907257,-1.197774880042914,0.2702702702702703,1.0,1.0,2/6,10.09%,NR4A3;HIF1A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.6886850551674312,-1.1976928107438913,0.2073170731707317,1.0,1.0,6/16,20.40%,RPA1;RBX1;RPS27A;PARP1;POLK;XPA
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.5911464930192486,-1.1976464368277735,0.1951219512195122,1.0,1.0,7/31,15.38%,CTSL;NR4A3;ROBO2;SRA1;STAT3;AKR1C2;UBE2L3
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.6335244624331061,-1.1974441623963938,0.24096385542168675,1.0,1.0,6/22,13.55%,NFKBIA;AZI2;RPS27A;TANK;ROCK2;TBK1
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.7818972247370846,-1.1964101625176897,0.1780821917808219,1.0,1.0,3/7,10.86%,IGFBP2;PRKAR1A;IL18
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),-0.6979668297109554,-1.196238855808557,0.28,1.0,1.0,2/9,16.68%,NAA11;NAA15
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.6926699768311533,-1.1954935201129162,0.19230769230769232,1.0,1.0,5/18,16.35%,NELL1;CST3;FMN2;MDM4;AZIN1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.569708950792179,1.1950433822387967,0.19047619047619047,0.8897049880158835,1.0,5/13,12.45%,DERL1;RNF185;FBXL17;ATXN3;VCP
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,-0.5899144984968485,-1.1949400962266816,0.17582417582417584,1.0,1.0,15/55,14.55%,FAT3;PCDH17;ELAVL3;ROBO2;CRMP1;DCLK1;UNC5D;PTPRD;SNAP25;PLP1;TRPM3;PURG;DENND2A;FMN2;SNAP91
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.7283300499076396,-1.1946794812607187,0.2222222222222222,1.0,1.0,2/9,3.40%,NRG1;VEGFA
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.6663255387001633,-1.1935209488071312,0.2073170731707317,1.0,1.0,9/22,25.97%,SYT1;RIMS2;STXBP6;SYTL4;RAB27A;NSF;RAB8B;RAB12;CLASP2
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.5450535859490039,1.193026305646101,0.23529411764705882,0.8912239620673118,1.0,3/25,2.37%,HSPA1A;RBM20;WDR75
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.6815181268978676,-1.192718977464326,0.2345679012345679,1.0,1.0,7/12,24.11%,GRIN1;RIMS2;LRRK2;RIMS1;MTMR2;NLGN1;APP
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.7881183711114695,-1.1927060187404255,0.32432432432432434,1.0,1.0,1/6,2.13%,CD44
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.6999059923697893,-1.1926807496221543,0.22058823529411764,1.0,1.0,3/10,19.14%,NR4A3;IGFBP5;CCN4
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.6336658366484751,-1.1925854609565645,0.24691358024691357,1.0,1.0,3/23,6.53%,IPO5;TGFB1;XPO4
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.617123091747928,-1.1924401255933768,0.22727272727272727,1.0,1.0,13/42,20.40%,UVSSA;HMGN1;RPA1;RBX1;RPS27A;RNF111;CCNH;PARP1;FAN1;FANCC;POLK;POLA1;XPA
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.8477943527675398,-1.1924094297785326,0.22857142857142856,1.0,1.0,2/5,9.05%,MLPH;PTGR1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.7111129971604124,-1.1918660029489438,0.24050632911392406,1.0,1.0,4/13,14.45%,NR4A3;ROCK2;PARP1;CAMK2D
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.6593772624711391,-1.1912361828766864,0.24705882352941178,1.0,1.0,7/20,20.40%,RPA1;RPS27A;FAN1;FANCC;WDR48;RNF168;XPA
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.7534499207648598,-1.1907284746719402,0.24675324675324675,1.0,1.0,4/9,18.16%,TTC8;ADGRV1;GNAL;TRPA1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.5835074104984777,1.190521831737406,0.2631578947368421,0.8951070559083959,1.0,3/10,6.95%,PGF;NUS1;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.6562556580607005,-1.1902303258441609,0.20238095238095238,1.0,1.0,2/21,3.40%,CSF1;VEGFA
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.706884021936818,-1.190109463105167,0.2894736842105263,1.0,1.0,2/10,6.10%,TGFB2;JAM3
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.5433586488315693,-1.1899264913400884,0.0707070707070707,1.0,1.0,40/197,16.04%,PRAG1;PRKACA;CSNK1D;EPHA7;CSNK1G2;PDK1;PGK1;DCLK1;CSNK1A1;TGFB2;CDKL1;FGGY;TGFB1;PRKCI;PANK2;OXSR1;MAPK6;EIF2AK2;SIK2;LATS2;DGKI;MELK;STAT3;PDK3;STK4;PRKCB;TGFBR1;AGK;GK5;NRBP1;PRKDC;ROCK2;SGK1;TBK1;MAK;CAMK2D;CDK14;STK24;LRRK2;STRADB
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.659672699760849,-1.189892328648753,0.2631578947368421,1.0,1.0,9/17,29.03%,TGFB1;DDIT4;CEMIP;PRKAG2;UBE2K;MAPK1;APP;EIF4G1;SPRED1
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.6548207456619495,-1.1895042961860642,0.2976190476190476,1.0,1.0,4/14,21.93%,RPS27A;TANK;TBK1;BIRC2
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.6548207456619495,-1.1895042961860642,0.2976190476190476,1.0,1.0,4/14,21.93%,RPS27A;TANK;TBK1;BIRC2
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.7718442965229066,-1.189248458118437,0.23684210526315788,1.0,1.0,1/7,0.74%,SOD1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.6864646871270605,-1.188978067610479,0.25,1.0,1.0,4/16,19.30%,TAF1B;NR4A2;PWP1;FUBP3
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.7619302130714247,-1.188595227176356,0.2318840579710145,1.0,1.0,2/5,11.76%,PTPN2;FRMD5
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.705512873864205,-1.1881594046162047,0.18292682926829268,1.0,1.0,3/13,9.56%,FHL1;NOS1AP;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.8020996439804273,-1.1880683897774675,0.2857142857142857,1.0,1.0,1/5,9.88%,PRKCB
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.8314823685288344,-1.1876834357633084,0.26153846153846155,1.0,1.0,2/5,6.38%,CADM1;NECTIN2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.8314823685288344,-1.1876834357633084,0.26153846153846155,1.0,1.0,2/5,6.38%,CADM1;NECTIN2
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.7386722796683582,-1.1874060784708669,0.2465753424657534,1.0,1.0,2/8,15.11%,SLC3A2;COLEC12
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.6923321868746949,-1.1873422144513868,0.1794871794871795,1.0,1.0,8/18,18.27%,EPM2A;TSC2;SZT2;DDIT4;NPRL3;UBR1;ITFG2;SESN1
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.5693342515457106,-1.1872594867814645,0.16304347826086957,1.0,1.0,14/92,14.16%,TEFM;RNMT;TAF7;TAF1B;ELOB;CEBPD;GLIS3;CTR9;TBPL1;CCNH;RTF1;POLR1C;PARP1;NR4A2
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.7479683982014035,-1.187057340218799,0.24675324675324675,1.0,1.0,2/6,12.29%,MT2A;MT3
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.6815322067826344,-1.1869870073011541,0.25,1.0,1.0,4/13,14.95%,CYP3A5;DGKI;LPCAT3;PLPP3
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.7394364106084366,-1.1868940785165765,0.1891891891891892,1.0,1.0,2/10,8.39%,TET3;CTR9
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.706433698052086,1.1867973406692072,0.3448275862068966,0.9023412275212485,1.0,1/5,3.42%,MCU
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.792231056527149,-1.186557996393955,0.19117647058823528,1.0,1.0,3/5,19.20%,CRY1;CLOCK;PER1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.6619381299191232,-1.1862880787110468,0.2558139534883721,1.0,1.0,7/21,22.49%,CD44;VEGFA;DDX3X;MT3;NAIP;RAF1;RNF34
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.6918401839352896,-1.1862486963697534,0.2375,1.0,1.0,2/13,5.71%,VEGFA;TGFB1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.6511574855788677,-1.1860731939839617,0.2948717948717949,1.0,1.0,5/22,12.53%,ZFPM1;UBA5;PTPN2;RUNX1;RPS14
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.7464150858798129,-1.1858642568246058,0.27848101265822783,1.0,1.0,1/7,4.73%,HDAC2
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.7272131196221991,-1.1858595738177935,0.2465753424657534,1.0,1.0,3/7,21.67%,MORF4L1;EP400;MORF4L2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.6549514332312462,-1.1856401202651057,0.2,1.0,1.0,6/22,19.79%,CD44;VEGFA;DDX3X;MT3;NAIP;RAF1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.675365213254017,-1.1855207025118673,0.2345679012345679,1.0,1.0,7/17,23.34%,SOD1;TGFB1;GRIN1;RAB27A;PID1;AKR1C1;GRB2
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.7512105428581342,-1.1849680430371858,0.24285714285714285,1.0,1.0,4/7,21.11%,PLAA;PTGR1;AKR1C2;AKR1C1
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.6529411633372316,1.1849679559706972,0.2222222222222222,0.9041933056807373,1.0,2/5,3.32%,RYR2;CASP7
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6311994292857414,-1.1849424409620442,0.2441860465116279,1.0,1.0,11/26,31.10%,RPA1;RBX1;RPS27A;PARP1;WRN;XPA;PURA;RAD23B;GTF2H1;POT1;ASCC3
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.5760228388033017,-1.1844946662538711,0.0967741935483871,1.0,1.0,20/102,13.49%,NELL1;TWIST1;CSF1;GJA1;NRCAM;TGFB2;AKIRIN1;TGFB1;OLFM1;CCN2;SDCBP;TP63;TGFBR1;CMKLR1;IL18;ZC4H2;SIN3A;ZHX3;TCF4;RGCC
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.7288419618990607,-1.184418268447774,0.26582278481012656,1.0,1.0,2/7,9.22%,BASP1;KLF15
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.7715208905791879,-1.1840493542310786,0.19736842105263158,1.0,1.0,2/5,6.29%,SLC22A6;PRKCI
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.7489269867974939,-1.183683416982714,0.30666666666666664,1.0,1.0,1/8,1.83%,KLF2
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.7709199827651503,-1.1835095067652726,0.20987654320987653,1.0,1.0,3/6,18.37%,CD55;SASH1;TRIM5
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.5942638912803911,-1.183481893322671,0.2,1.0,1.0,10/53,12.34%,SRGN;CSF1;TGFB2;TGFB1;RARS1;DARS1;PRKCB;HIF1A;IL18;GBP2
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.640607094601822,-1.1834172166271826,0.35294117647058826,1.0,1.0,6/17,22.54%,WWC1;LRRK2;DNAJA1;REEP5;ARL6IP5;RAB11A
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.5089529416401077,1.1833729648613884,0.08333333333333333,0.9036829399115613,1.0,1/22,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.6612508617551258,-1.1832391983470611,0.2619047619047619,1.0,1.0,4/21,5.71%,F3;VEGFA;TMSB4X;TGFB1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.41841648435552925,1.1831478665182564,0.1,0.9002948075642176,1.0,10/61,5.77%,TAGLN;RCAN2;LMOD1;OPCML;FAM13C;ITGA7;GPRC5B;NFASC;RASL12;TNS2
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),-0.8163377917193865,-1.182803384434372,0.19672131147540983,1.0,1.0,2/5,14.77%,PTPN2;PPARGC1A
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.5555029620686824,-1.182750619909068,0.2,1.0,1.0,16/66,19.10%,PRKACA;PPME1;CSNK1D;TUBA1A;AKAP8;MELK;CCP110;CEP57;CCNH;NINL;PPP2R2A;CDK14;PHLDA1;YWHAG;BTRC;SKP1
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.7572989032049599,-1.1824663004053024,0.18666666666666668,1.0,1.0,2/8,3.38%,CYP3A5;SPTLC3
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),-0.5714180131330048,-1.1823082684962714,0.1956521739130435,1.0,1.0,9/69,18.88%,HNRNPL;PCBP3;RBMS2;DDX3X;HNRNPC;RBM39;NOVA1;AGO2;HNRNPF
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.6775626756935306,-1.1822970400802852,0.25925925925925924,1.0,1.0,5/17,17.44%,CRY1;UVSSA;CLOCK;ZRANB3;UBE2B
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.43518260097557687,1.182061660422067,0.0,0.899762216545309,1.0,14/65,8.82%,TWIST2;LMOD1;CSPG4;TRABD2B;SERPINH1;NOTCH3;COL14A1;FKBP9;PLS3;COL5A2;PRRX1;CHST3;SLIT2;PTPN21
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.7217856235523559,-1.1818207386682125,0.2692307692307692,1.0,1.0,4/11,16.03%,TMEM232;DNAH7;MYO16;GFAP
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.7151212373330186,-1.1818082413600635,0.2876712328767123,1.0,1.0,6/10,24.11%,TGFB1;CEMIP;PRKAG2;UBE2K;MAPK1;APP
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.681520486085242,-1.1816369150663086,0.21052631578947367,1.0,1.0,6/16,15.94%,HDAC2;TGFB1;GRIN1;RUNX1;RGCC;RAB27A
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.5797428493737818,-1.1815815595426313,0.19540229885057472,1.0,1.0,14/39,23.50%,APIP;ATL1;SLC1A2;SOD2;GOLGA2;ALDH1A2;ELAVL1;TRPA1;APPL2;RNF213;KCNC2;TP53BP1;STEAP4;ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.7002274489787099,-1.181452764395746,0.23684210526315788,1.0,1.0,5/10,15.99%,GJA1;NR4A3;JUN;DNMT1;IGFBP5
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.7673182465445118,-1.180981581725372,0.2804878048780488,1.0,1.0,1/7,4.25%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.6351025866728363,-1.1809459441458252,0.18072289156626506,1.0,1.0,12/30,21.72%,IPO5;RHOB;PDCD4;TGFB1;LATS2;ANGEL2;CDKN1B;TSPYL2;DUSP1;BTG2;HECA;BTG1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.6880107044036501,-1.1809450959324248,0.21518987341772153,1.0,1.0,3/14,7.15%,GLRB;MARCHF6;RHBDD1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.5983168114780618,1.1804908862136267,0.17391304347826086,0.8997332175682448,1.0,2/16,1.54%,ST3GAL2;GLB1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.7054883966058533,-1.1804604951866153,0.22972972972972974,1.0,1.0,7/10,27.69%,ADGRV1;PRKAR1A;AKAP12;LRRK2;PRKAR2A;AKAP6;AKAP7
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.5962634941158814,-1.1802692087146565,0.24719101123595505,1.0,1.0,14/42,20.89%,VEGFA;TENM3;TGFB2;SPOCK1;DDIT4;PTPRD;TGFBR1;RUNX1;WNT2B;NR4A2;ACSL4;SMARCA1;ADNP2;ATP8A2
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.5598745183080401,-1.1801949231834137,0.17894736842105263,1.0,1.0,20/74,22.83%,NELL1;PRDM6;PCBP3;MTMR9;CTCF;HIF1A;IGF2BP2;ROCK2;AFF2;NOVA1;CGGBP1;PRDM10;AFF4;TRIM5;FUBP3;ADNP2;SCARB2;MTMR2;TARDBP;FUBP1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.6994903058565092,-1.1800960355612262,0.2261904761904762,1.0,1.0,4/15,14.52%,KDM1A;SPIDR;TERF2IP;ZRANB3
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.4218599263723754,1.1800505108323507,0.25,0.8968624640606664,1.0,14/76,7.30%,TAGLN;ACTA2;SLIT3;LMOD1;COL14A1;TPM2;KCNJ8;COL5A2;MYL9;IGFBP7;RASL12;TNS2;MEG3;PRRX1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.6737208555881484,-1.1799026075591437,0.25316455696202533,1.0,1.0,4/18,17.36%,KDM1A;AKAP8;PPARGC1A;TET1
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.7310860498574081,-1.179718368053292,0.2465753424657534,1.0,1.0,2/5,23.48%,SLC1A2;STEAP4
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.7310860498574081,-1.179718368053292,0.2465753424657534,1.0,1.0,2/5,23.48%,SLC1A2;STEAP4
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.58038506247739,-1.1796486279846272,0.2808988764044944,1.0,1.0,10/56,17.92%,PRKACA;KDM1A;ZFPM1;STK4;AMFR;GOLGA2;SYMPK;LRRK2;LRPAP1;MITD1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.6929242184461083,-1.1784608129903802,0.2857142857142857,1.0,1.0,5/12,15.48%,SLC7A2;SLC3A2;SLC36A4;TRPM3;ABCC9
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.7804316060415853,-1.1783182504250658,0.26666666666666666,1.0,1.0,2/5,8.74%,CD55;HSPH1
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.5815273533624845,-1.17830268835541,0.18888888888888888,1.0,1.0,8/37,12.29%,STC1;TPT1;TMCO1;ATP1B3;SLC10A7;TMEM165;NEDD4L;MT3
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),0.7445238537344336,1.1782306611996123,0.26666666666666666,0.8983290106113511,1.0,1/5,17.02%,MEF2C
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.6803065252581852,-1.1782157965989715,0.22857142857142856,1.0,1.0,2/15,7.44%,WWC1;PTPN1
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),-0.765021546638619,-1.178154148407467,0.25316455696202533,1.0,1.0,3/7,9.93%,NRG1;TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.5401248872829605,1.178143344874593,0.3333333333333333,0.8943295037219674,1.0,1/19,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.6482855278148845,-1.1778351625703698,0.3157894736842105,1.0,1.0,3/15,13.36%,GJA1;JAM3;SLC1A1
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.7286439702098858,-1.1777643538192217,0.23376623376623376,1.0,1.0,2/9,7.60%,ALDH3A2;PEX3
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.5490636553077208,1.1773628854989437,0.16666666666666666,0.8920574588373088,1.0,3/19,3.56%,HEY2;NOTCH1;HEYL
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.5730956667640738,-1.177135547209473,0.23863636363636365,1.0,1.0,11/58,14.13%,VAV3;PDK1;SLC2A1;TSC2;GNA14;PPP2R1B;PRKCB;ACTR3;CFL1;TBK1;CDKN1B
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.6375818443311002,-1.1769842268658366,0.24390243902439024,1.0,1.0,7/28,15.16%,UVSSA;HMGN1;RPA1;RBX1;RPS27A;CCNH;POLK
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.6684008301025267,-1.17690433252652,0.2962962962962963,1.0,1.0,4/11,19.43%,LPIN1;ENPP2;MT3;ACADL
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.7105576118463928,-1.176894418014804,0.23376623376623376,1.0,1.0,3/10,12.67%,S1PR3;VEGFA;ROCK2
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.5423110913833111,1.1766671780958053,0.25,0.8903819942996523,1.0,6/16,12.66%,BCL9;BCL9L;HDAC1;EP300;PYGO1;TCF7L1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.7067437426786077,-1.1765655491331797,0.27848101265822783,1.0,1.0,3/8,12.75%,TAF1B;CCNH;POLR1C
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.7067437426786077,-1.1765655491331797,0.27848101265822783,1.0,1.0,3/8,12.75%,TAF1B;CCNH;POLR1C
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.6136232759782942,-1.1761086608724132,0.21839080459770116,1.0,1.0,7/29,16.76%,SYT1;SLC1A2;GLUL;SNAP25;SLC1A1;RIMS1;LIN7A
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.7091914994749555,-1.1760549458147984,0.24675324675324675,1.0,1.0,4/9,17.26%,BASP1;TGFB2;WNT2B;CSDE1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.457057496022968,1.1757616595069589,0.14285714285714285,0.8889863622077118,1.0,4/38,4.89%,ZBTB7C;RALGPS1;EDN3;RASL12
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),-0.7638250500337072,-1.1755983652545583,0.21739130434782608,1.0,1.0,1/6,9.02%,STAT3
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.8161805025694799,-1.1753382035264284,0.22666666666666666,1.0,1.0,2/5,17.71%,PDCD4;DNAJA1
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.570132368239737,-1.1752600038121213,0.2127659574468085,1.0,1.0,12/46,16.51%,PCDH17;ELAVL3;ROBO2;DPP6;PHYHIPL;UNC5D;SNAP25;UNC79;SNAP91;EZH1;RIMS1;NOVA1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.7095157691636481,-1.1746658082261423,0.19480519480519481,1.0,1.0,3/13,10.86%,ZFPM1;PDE4B;IL18
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.6376729185199904,1.1744052156918872,0.25,0.8897095046222117,1.0,1/11,0.02%,JPH2
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.7448484091370787,-1.174279967126997,0.18840579710144928,1.0,1.0,2/10,11.98%,STX6;GOLGA2
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.768229208000196,-1.1741748168293658,0.29577464788732394,1.0,1.0,2/6,12.70%,DDX3X;TERF2IP
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.7023269755388846,-1.17406615161904,0.27710843373493976,1.0,1.0,7/10,23.02%,PDCD4;STAT3;HIF1A;PER1;APPL2;PPARA;APOD
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.7346814356949354,-1.174032723742155,0.29411764705882354,1.0,1.0,2/7,11.89%,SOD1;RUNX1
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.8109079755679597,-1.1739110129062456,0.25,1.0,1.0,2/5,4.65%,MGST1;SLC16A12
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.5752526868703842,-1.1735848373825006,0.3103448275862069,1.0,1.0,4/27,6.50%,SEC13;NUP153;NUP133;NUP88
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.5752526868703842,-1.1735848373825006,0.3103448275862069,1.0,1.0,4/27,6.50%,SEC13;NUP153;NUP133;NUP88
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.6432611636896556,-1.1735089876502374,0.2987012987012987,1.0,1.0,7/19,21.24%,SZT2;SIK2;HSPA5;ITFG2;SESN1;PRKAG2;CPEB4
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.6409958862024114,-1.172900217224047,0.25316455696202533,1.0,1.0,1/15,0.30%,HS3ST5
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.7997984680416441,-1.1726335138505082,0.3055555555555556,1.0,1.0,1/5,3.48%,SELENOS
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.5387403598637472,-1.172560516035806,0.1717171717171717,1.0,1.0,6/93,3.45%,COL4A6;MID1;GJA1;NXN;WWC2;TENM3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.7420425194723723,-1.1724536069658187,0.29850746268656714,1.0,1.0,2/9,6.38%,CADM1;NECTIN2
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.7225382482119846,-1.1724520210404419,0.32,1.0,1.0,4/8,19.96%,DHX29;EIF2S2;MCTS1;EIF2S3
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.8125826741363499,-1.1723370945040972,0.2916666666666667,1.0,1.0,2/5,9.93%,TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.7121965024652983,-1.1719802644446806,0.22666666666666666,1.0,1.0,3/11,23.02%,SUFU;LRRK2;APOD
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.781870223802229,-1.1719237574167989,0.20833333333333334,1.0,1.0,3/5,17.77%,JAM3;RAP1B;FARP2
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.7763879327992256,-1.1719150510123528,0.1917808219178082,1.0,1.0,2/7,8.49%,GLUL;SNAP25
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.7746477760352318,-1.1713747444325662,0.22857142857142856,1.0,1.0,1/5,1.25%,NR4A3
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.5695167337350447,-1.171301218267165,0.1595744680851064,1.0,1.0,33/97,27.37%,DDX52;RPL28;WDR43;TUT7;RPL34;INTS8;RPL21;RPLP2;RPL19;NOP58;RPLP1;RPS14;RPL13A;RPL18;INTS4;AGO2;RPL27;RPL35A;RPL31;INTS2;SSB;RPL5;RPL27A;RPL36;RPL41;RPL32;RPL37;RPL24;RPL9;RCL1;RPS2;RPL37A;RPL3
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.6105517956277888,-1.171232576823142,0.18888888888888888,1.0,1.0,3/29,8.97%,ADAMTS9;MARCHF6;MANBA
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.7339965420975707,-1.171117658653549,0.30666666666666664,1.0,1.0,5/8,22.12%,NEDD4L;CAMK2D;NEDD4;HECW1;STK39
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.7381189091896329,-1.1709498539902197,0.32432432432432434,1.0,1.0,2/8,8.93%,MIGA1;SPG7
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),-0.7140963428475403,-1.1707855088321533,0.325,1.0,1.0,4/10,24.13%,PDK1;PDK3;SCARB2;RORA
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.5481104974490275,-1.1702317132634394,0.25555555555555554,1.0,1.0,10/54,14.16%,PRKACA;NR4A3;LPIN1;SELENOS;PRKCI;PRKAR1A;PRKDC;DENND4C;PARP1;NR4A2
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.692625428402813,-1.1700001085917373,0.20930232558139536,1.0,1.0,4/17,8.69%,NDUFB9;NDUFV1;COX4I1;COX6C
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.692625428402813,-1.1700001085917373,0.20930232558139536,1.0,1.0,4/17,8.69%,NDUFB9;NDUFV1;COX4I1;COX6C
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.6100238116377474,-1.1699747382860874,0.2823529411764706,1.0,1.0,7/21,23.50%,KDM1A;RHBDD1;PARP1;POLK;NEDD4;EIF2AK4;ZBTB1
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.6412979260035998,-1.1696965956438048,0.26506024096385544,1.0,1.0,4/18,12.67%,KLF2;SSH1;NEDD4L;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.780035629301851,-1.1694770748461147,0.2328767123287671,1.0,1.0,2/7,10.86%,CSF1;IL18
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.7897164222029043,-1.169013082566181,0.25675675675675674,1.0,1.0,2/5,9.88%,LPIN1;PRKCB
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.6477294644104242,-1.1679346186099069,0.24050632911392406,1.0,1.0,5/20,13.97%,TWIST1;KDM1A;SPIDR;TERF2IP;FMN2
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.4967689265479296,1.1677364158641608,0.2222222222222222,0.9043150950002764,1.0,1/22,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.6312617509058728,-1.1673419850442692,0.3373493975903614,1.0,1.0,10/25,24.06%,FHL1;DPP6;NOS1AP;KCNQ1;NEDD4L;GABBR2;NEDD4;DPP10;STK39;AKAP6
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),-0.7642613113409682,-1.1673071121165952,0.2857142857142857,1.0,1.0,2/5,7.27%,ROBO2;ALCAM
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.47152951259082826,1.1668887918693316,0.0,0.9027449268157106,1.0,3/29,3.50%,JPH2;RYR2;CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6713979233287596,1.166882392131229,0.22857142857142856,0.8986785082264507,1.0,1/5,1.46%,PRKG1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.718041711594765,-1.1665800991740602,0.2857142857142857,1.0,1.0,2/7,12.29%,MT2A;MT3
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.6653957738845118,-1.166556077876223,0.25301204819277107,1.0,1.0,4/15,8.13%,SLCO1A2;SLC16A12;SLC16A7;SLC16A6
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),-0.7444567469590474,-1.1657352665461984,0.2878787878787879,1.0,1.0,1/5,2.60%,RIPOR1
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.6551845219866431,-1.1655627788804828,0.2289156626506024,1.0,1.0,10/24,24.53%,NRG1;PIP4P2;RUBCN;LGALS3;RAB7A;NDFIP2;NDFIP1;MTMR2;ARL6IP5;RACK1
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.7815811438942286,-1.1651391059665708,0.23684210526315788,1.0,1.0,3/5,19.78%,USP15;ANKRD17;DDX60
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.6790799457256609,-1.164715139830261,0.22784810126582278,1.0,1.0,4/10,21.30%,NOS1AP;DIAPH1;CAMK2D;FYN
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.5952136768356873,-1.1646260148657284,0.24705882352941178,1.0,1.0,4/26,6.50%,PIAS2;NUP153;NUP133;NUP88
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.6555128703542721,-1.1646233036219718,0.23376623376623376,1.0,1.0,1/17,1.80%,KDM1A
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.5008585630822264,1.1645780491312394,0.2857142857142857,0.9009394950634465,1.0,5/21,7.76%,NSUN3;TFB1M;MTERF4;TRDMT1;TARBP1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.6704321457549383,-1.1645207008865512,0.3058823529411765,1.0,1.0,6/18,22.89%,IFITM3;IFIT3;GBP2;HLA-B;IRF1;STAT1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.6704321457549383,-1.1645207008865512,0.3058823529411765,1.0,1.0,6/18,22.89%,IFITM3;IFIT3;GBP2;HLA-B;IRF1;STAT1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.6584386960207465,-1.1641976382826995,0.2619047619047619,1.0,1.0,4/15,6.00%,CSNK1D;RIPOR1;ARL5A;COG7
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.6715803434628025,-1.163969432547719,0.2289156626506024,1.0,1.0,2/16,1.92%,GNPAT;AGPAT4
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.6260416943564533,-1.163842629470897,0.2619047619047619,1.0,1.0,4/25,12.90%,NR4A3;ZFPM1;RUNX1;SIN3A
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),-0.7617020670878709,-1.163836460909395,0.2318840579710145,1.0,1.0,1/5,2.87%,LPIN1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.7278541758740271,-1.1635527258655711,0.2602739726027397,1.0,1.0,1/10,0.30%,HS3ST5
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.617257091591373,-1.1630610226263667,0.3253012048192771,1.0,1.0,5/21,18.17%,KDM1A;PTPN1;SPIDR;PARP1;GPC4
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.6746115420336491,-1.1630017786149687,0.26506024096385544,1.0,1.0,7/17,14.97%,SLC23A2;SLC38A4;SLC38A9;SLC16A7;SLC36A4;SLC13A3;SLC38A10
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.7383347378350258,-1.1629237441724185,0.3125,1.0,1.0,2/7,8.63%,VAV3;CD38
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.6697259481397275,-1.1629040816275065,0.26582278481012656,1.0,1.0,5/11,24.82%,PTPN1;STAT3;PRLR;STAT6;LYN
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.568479701002072,1.1627023835116241,0.2692307692307692,0.9021507848020619,1.0,1/7,4.09%,ATM
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.6175603587267031,1.1626909369808753,0.3888888888888889,0.8981412257584972,1.0,3/16,4.20%,NOX4;IL34;GPRC5B
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.7335547198542072,-1.1623080164858894,0.24691358024691357,1.0,1.0,2/8,5.81%,NFKBIA;SUFU
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.7387674444952561,-1.1621419762691232,0.2857142857142857,1.0,1.0,2/6,11.93%,SNX6;ERRFI1
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.6714935168324859,-1.161693307388438,0.2823529411764706,1.0,1.0,3/15,10.06%,GNPAT;AGPAT4;PLD1
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.6714935168324859,-1.161693307388438,0.2823529411764706,1.0,1.0,3/15,10.06%,GNPAT;AGPAT4;PLD1
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.46897046158314887,1.16149366678179,0.11764705882352941,0.8968456969407762,1.0,3/28,1.99%,A2M;SORBS2;C2ORF72
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.706868575239987,-1.1612336540502013,0.3026315789473684,1.0,1.0,1/10,0.90%,ADAMTS9
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.6036355533307219,-1.160907320754116,0.26136363636363635,1.0,1.0,6/31,11.13%,RARRES1;EMP1;LGALS3;TP63;GYPC;SLC25A37
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.6598355495555217,-1.1605945798023674,0.32051282051282054,1.0,1.0,1/11,9.70%,PITRM1
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.7193499542589129,-1.1604408355416798,0.2777777777777778,1.0,1.0,3/9,13.36%,GJA1;SLC1A2;SLC1A1
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.5517399797470978,-1.1602909020326542,0.1595744680851064,1.0,1.0,31/93,21.83%,PRKACA;SYT1;GLRB;KCND2;PDE7B;SLC1A2;KCNQ3;GRIN1;GABRE;SNAP25;SDCBP;GRIA3;PRKAR1A;PLP1;GRIK1;DLGAP1;GRM7;PMP22;SLC1A1;SLC12A6;RIMS1;NOVA1;LIN7A;CAMKK2;GRIK2;GABBR2;NLGN1;MAPK1;PRKAR2A;SYN3;MINK1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.7697690998716519,-1.1600944630823657,0.3,1.0,1.0,1/5,1.83%,KLF2
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.6977493907902896,-1.1590244562347292,0.3484848484848485,1.0,1.0,2/6,18.32%,LSS;PRKAG2
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.7399574239192866,-1.1590166018502763,0.3466666666666667,1.0,1.0,1/7,0.74%,SOD1
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.5310435645539318,1.1588777099305128,0.25,0.8997098565714494,1.0,3/19,2.97%,PGF;NUS1;NOTCH1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.6753219223692285,-1.158845638673909,0.25301204819277107,1.0,1.0,7/17,10.57%,NRG1;TGFB2;TGFB1;ZFPM2;FGFR2;TGFBR1;MYL3
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.6835207571885588,-1.1587797315097927,0.3048780487804878,1.0,1.0,2/11,3.50%,KLF2;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.6835207571885588,-1.1587797315097927,0.3048780487804878,1.0,1.0,2/11,3.50%,KLF2;NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.6981011934519183,-1.1587183668919439,0.3246753246753247,1.0,1.0,6/10,27.78%,NEDD4L;CAMK2D;NEDD4;HECW1;STK39;GOPC
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.5304201387155665,-1.1587067891680571,0.16494845360824742,1.0,1.0,37/163,17.42%,NELL1;BTD;NRG1;NRCAM;GLRB;ROBO2;CRMP1;SLC2A1;VEGFA;DCLK1;DNER;SZT2;ROBO1;TGFB1;SPOCK1;GPM6A;ALDH3A2;ADGRV1;SPG7;STAT3;TGFBR1;DPYSL2;GRIK1;IGF2BP2;ZC4H2;PMP22;ARNT2;ALDH1A2;ZIC4;NOTCH2;NAV3;TEAD1;NAIP;WWP1;KIRREL3;VCAN;MTR
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.7108115082791125,-1.1581405980810044,0.32894736842105265,1.0,1.0,1/8,2.26%,CD55
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.5874372542675432,-1.1578884302727435,0.27906976744186046,1.0,1.0,8/31,22.25%,GNPAT;LPIN1;ACOT11;PPARGC1A;ACSL4;GPX4;LPL;PPARA
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.7310762135004651,-1.1575731543326304,0.35135135135135137,1.0,1.0,2/6,22.54%,ATAD5;RAB11A
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.7842619874287663,-1.1573519206227783,0.25757575757575757,1.0,1.0,2/5,11.53%,ZFP36L2;PRKDC
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.41042539145212786,1.1572176058331525,0.125,0.9020431679238639,1.0,2/27,3.55%,ATP2B4;ITGA3
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.6327348361059539,-1.1570607384883116,0.3026315789473684,1.0,1.0,3/20,12.29%,SOD1;XRCC4;MT3
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.6881857343072864,-1.1568387846165251,0.2926829268292683,1.0,1.0,3/11,13.59%,LPIN1;SELENOI;PLAAT3
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.5326901188641203,1.1567332378557031,0.23076923076923078,0.8994048636001901,1.0,4/10,12.45%,DERL1;RNF185;ATXN3;VCP
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.5692270757092783,-1.1564027234001315,0.2235294117647059,1.0,1.0,13/55,13.78%,PELI1;NFKBIA;PSMB1;PSMD14;MAP3K8;RBX1;RPS27A;TANK;HIF1A;PSMA4;PSMB2;GBP2;PSMA7
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.574885384237523,-1.1561074111475766,0.2441860465116279,1.0,1.0,10/34,25.26%,SEC13;NUP153;NUP133;NUP88;HIF1A;RANBP2;PRKAG2;PPARA;APP;INSR
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.6262146873070044,1.1559790227701607,0.2857142857142857,0.8970819414942842,1.0,4/6,12.56%,HCN2;SLC6A1;SLC9A1;SLC8A1
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.5999707207729057,1.1558889438997988,0.2962962962962963,0.8933648552947155,1.0,2/8,4.28%,NUS1;OSBPL6
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.7404661025600787,-1.1557664204252802,0.21951219512195122,1.0,1.0,3/8,14.95%,SPTLC3;SPTLC1;PLPP3
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.7203968653798283,-1.1556527664420948,0.3055555555555556,1.0,1.0,2/7,17.10%,FADS2;HSD17B4
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.5782307362023369,-1.155589928179611,0.22093023255813954,1.0,1.0,13/52,15.14%,SRGN;SOD1;HABP4;VEGFA;TGFB2;TMSB4X;TGFB1;PROS1;SCCPDH;TF;ANXA5;CLU;SYTL4
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.5889897640883639,-1.15554208563234,0.22988505747126436,1.0,1.0,13/38,17.15%,ZFP36L2;ZFPM1;TGFB2;TGFB1;ARIH2;FGFR2;MELK;RUNX1;WNT2B;NOTCH2;KIRREL3;FLT1;PGM3
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.7801032799694259,-1.1551410941238927,0.23880597014925373,1.0,1.0,2/5,6.38%,CTSL;NECTIN2
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.7801032799694259,-1.1551410941238927,0.23880597014925373,1.0,1.0,2/5,6.38%,CTSL;NECTIN2
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.7358478845338897,-1.1551370249066528,0.2916666666666667,1.0,1.0,4/8,10.70%,CTSL;PGK1;C1R;C1RL
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.6274572950970956,-1.1550549837443886,0.32142857142857145,1.0,1.0,8/19,15.99%,GJA1;NR4A3;PDCD4;SOD2;JUN;DNMT1;CDKN1B;IGFBP5
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.6452419537903286,-1.154707050505207,0.25,1.0,1.0,4/16,19.31%,PITRM1;AGK;PMPCB;MIPEP
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.6798397157812821,1.154189920927522,0.2894736842105263,0.894856945133758,1.0,2/5,9.66%,FGF13;ULK2
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.7495956105138141,-1.1541886216056298,0.32,1.0,1.0,2/6,13.94%,IFITM3;TRIM13
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.6927629385404022,-1.1539894880906274,0.25316455696202533,1.0,1.0,2/10,7.60%,ALDH3A2;PEX3
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.6537015438698173,-1.153295000816882,0.2962962962962963,1.0,1.0,3/16,12.29%,NRG1;IL18;MT3
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.6999338505735623,-1.1530818069330169,0.3108108108108108,1.0,1.0,8/10,24.83%,GRIN1;STAT3;ROCK2;APH1B;FYN;MBP;LYN;GRIN2B
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.6224169638043934,-1.1530687012762237,0.23684210526315788,1.0,1.0,5/18,18.58%,FADS2;PTGR1;SCD;HSD17B4;GPX4
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.6855987413879472,-1.1530425032593696,0.2857142857142857,1.0,1.0,3/13,10.86%,CSF1;NFKBIA;IL18
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.6150542282580739,-1.1529462771107883,0.34065934065934067,1.0,1.0,10/25,27.32%,DPM1;TMEM165;MGAT1;MGAT4A;UBE2J1;PGM3;MCFD2;FUT8;MAGT1;UGGT2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.6868982173571023,-1.152754915267942,0.1951219512195122,1.0,1.0,4/15,14.95%,CD44;ANK3;AFDN;PLPP3
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.6480786813922228,1.152554507525993,0.35294117647058826,0.896336227334697,1.0,3/6,13.65%,CACNA1C;MAPK14;CACNA1D
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.6364995148173549,-1.1524914348535915,0.29411764705882354,1.0,1.0,9/22,24.40%,KDM1A;HDAC2;GMPS;PARP1;NAP1L1;ATAD5;FUBP1;SUPT16H;NASP
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.7068696763247406,-1.1523706449341125,0.32,1.0,1.0,3/7,12.75%,TAF1B;CCNH;POLR1C
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.7555324221275586,-1.1523189767225002,0.3157894736842105,1.0,1.0,3/5,22.35%,CMPK1;ENTPD4;AK4
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.6985710189292225,1.15181849109323,0.38235294117647056,0.8948052623098235,1.0,1/5,1.41%,LRCH1
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.6829673274050471,-1.1518018979366722,0.2777777777777778,1.0,1.0,2/9,13.59%,PEX3;PLAAT3
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.6028916510935326,-1.15139048388456,0.21686746987951808,1.0,1.0,13/35,25.67%,EPM2A;TSC2;SPTLC1;C9ORF72;FYCO1;TBK1;WAC;TRIM13;SESN1;DCN;VPS13D;KDR;VDAC1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.6968075741907391,-1.1506909508141132,0.2839506172839506,1.0,1.0,3/12,9.56%,NOS1AP;ANK3;KCNQ1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.5660577494565618,-1.1505333399991,0.24705882352941178,1.0,1.0,11/36,22.55%,TBC1D20;CDKL1;DCDC2;TBC1D8;PLD1;IFT140;DYNC2LI1;USP6NL;MYO10;TBC1D15;CAPZB
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.6759465901196917,-1.150071527485973,0.35135135135135137,1.0,1.0,3/11,11.44%,NR4A3;PTPN1;PDGFD
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.6977820186685314,-1.150007336989952,0.32051282051282054,1.0,1.0,3/13,14.31%,PRKACA;PSMD14;UCHL5
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.4894440153200948,1.1499346038089229,0.16666666666666666,0.8967219464224868,1.0,3/16,5.15%,ATP2B4;NUS1;ZDHHC21
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.7563564444608462,-1.1497070128903348,0.2878787878787879,1.0,1.0,1/7,0.66%,GNPAT
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.5797947110854402,-1.149662868564708,0.21348314606741572,1.0,1.0,17/52,21.22%,CSF1;KLF2;NFKBIA;TGFB1;NKD1;NEDD4L;IL18;SLC25A37;ROCK2;CDKN1B;CLU;RAB7A;WWP1;NSF;NEDD4;HECW1;SMURF2
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.7105134275741024,-1.1496399134435462,0.2727272727272727,1.0,1.0,3/11,13.09%,MTMR9;TGFB1;SYMPK
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.684082342563668,-1.1495576773904963,0.2911392405063291,1.0,1.0,3/11,18.03%,VEGFA;SEMA3B;SEMA4D
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.7039872476417718,-1.14915049044986,0.32142857142857145,1.0,1.0,2/11,12.53%,DDX52;RPS14
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.640763810534994,-1.148828244471187,0.23076923076923078,1.0,1.0,3/20,5.71%,STC1;ADAMTS9;TGFB1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.6944063790029797,-1.148801229763525,0.273972602739726,1.0,1.0,2/10,6.32%,NUP153;NUP133
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),-0.7517629278892075,-1.148683472394841,0.3235294117647059,1.0,1.0,2/6,13.12%,RUBCN;FYCO1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),-0.7779664302110597,-1.1481600415760949,0.2876712328767123,1.0,1.0,1/5,1.72%,SYT1
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.7447912011113471,-1.1480752855377385,0.2894736842105263,1.0,1.0,1/5,10.92%,BRD1
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.5511141212334129,-1.1478925845465744,0.26881720430107525,1.0,1.0,35/78,28.34%,RPS21;RPS4X;RPL28;RPL34;RPL21;FARSB;RPLP2;DARS1;RPS27A;RPL19;RPLP1;RPS14;RPL13A;RPL18;AGO2;RPL27;RPL35A;RPL31;RPS12;WARS1;RPL5;RPS18;RPL27A;RPL36;RPL41;RPL32;RPL37;RPL24;RPL9;RPS20;RPS2;RPL37A;RPL3;GGT7;EIF4G1
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.5896400663066345,-1.1474402613735744,0.24096385542168675,1.0,1.0,7/26,18.08%,ASPA;GLUL;BLMH;MCCC2;BCKDHB;BCAT2;DLD
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.672936623218486,-1.1474366847470896,0.25925925925925924,1.0,1.0,3/15,6.53%,CSE1L;TGFB1;XPO4
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.7478262859566216,-1.1473603748758652,0.21052631578947367,1.0,1.0,3/8,13.49%,PDCD4;PRKCI;RGCC
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.5690931741270064,-1.1472579291231781,0.20652173913043478,1.0,1.0,9/55,20.13%,SRSF12;HNRNPL;SRSF10;KHDRBS2;RBM39;NOVA1;TRA2B;METTL16;KHDRBS3
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.6257724154742408,-1.147222874582759,0.31521739130434784,1.0,1.0,8/22,24.11%,TWIST1;SELENOS;STAT3;MAPKAPK2;HLA-B;LPL;MBP;APP
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.7158674491054288,-1.1471910776399803,0.33783783783783783,1.0,1.0,4/8,19.33%,KDM1A;LRRK2;NAP1L1;APPL2
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),-0.5992263460462728,-1.147182360917718,0.25925925925925924,1.0,1.0,6/26,9.91%,ROBO2;TGFB2;ROBO1;PRKCI;STAT3;TP63
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.6629706279321399,-1.1470895464293598,0.34615384615384615,1.0,1.0,6/14,9.56%,KCNE4;KCND2;ANK3;GNA14;SCN3A;KCNQ1
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.725272572073445,-1.1469713449430565,0.2535211267605634,1.0,1.0,2/10,3.40%,KDM1A;VEGFA
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.599117295550996,-1.1469623217097138,0.28888888888888886,1.0,1.0,4/29,14.05%,STX6;KDM1A;AFDN;PARP1
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.5282970541301838,-1.1468239615071891,0.20408163265306123,1.0,1.0,48/140,31.26%,RNMT;PRKACA;SRSF12;HNRNPL;SRSF10;RBM4B;RBM17;CDC5L;CCAR1;RAVER2;PABPC1;CCNH;SRSF5;HNRNPC;DDX42;SYMPK;PPARGC1A;CMTR1;DDX46;ALKBH5;CSTF3;NOVA1;ELAVL1;HNRNPF;TRA2B;CPSF2;NONO;RSRC1;PRMT9;THOC2;TCERG1;SF3B1;TRA2A;KIN;PRPF3;NCBP1;GTF2H1;CWC22;WBP4;YBX1;RNPC3;RALY;SFPQ;POLR2F;UBL5;SPEN;SRSF2;DHX15
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.6269796295418314,-1.146728936901242,0.24390243902439024,1.0,1.0,12/31,23.95%,DCLK1;WASF1;GPM6A;MYO16;SGK1;LRRK2;DTNBP1;PAK1;TAOK3;MINK1;SNX2;EPB41L3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.6804605686165529,-1.146175702300593,0.24050632911392406,1.0,1.0,9/18,29.13%,RPA1;RBX1;RPS27A;CCNH;PARP1;XPA;RAD23B;GTF2H1;RPA3
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.7633260155600683,-1.1459337861719059,0.29850746268656714,1.0,1.0,1/5,2.36%,CRY1
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.7510647479924936,-1.1458252463736411,0.2916666666666667,1.0,1.0,2/7,10.76%,NECTIN2;CEP57
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.6070225871289435,-1.1456985659128305,0.2716049382716049,1.0,1.0,6/23,16.01%,DHRS3;COL11A1;ADGRV1;ATF6;PITPNA;COL18A1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.7410238711879857,-1.1454924167211367,0.27848101265822783,1.0,1.0,2/5,15.08%,HOMER2;NAV3
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.6525391209912346,-1.145369799290735,0.30952380952380953,1.0,1.0,8/15,23.68%,IPO5;SLC38A9;UBR1;SESN1;LARS1;CPEB4;FYN;RRAGB
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.7375841008085322,-1.1453694446479432,0.34328358208955223,1.0,1.0,3/7,12.14%,ACO1;HIF1A;TF
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.6761441713771438,-1.1453013783053914,0.2948717948717949,1.0,1.0,7/16,27.56%,RBX1;RPS27A;RNF111;PARP1;XPA;RAD23B;GTF2H1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.7513357507364284,-1.1452534827776186,0.30434782608695654,1.0,1.0,2/6,5.71%,EFNB2;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.5852852497614036,-1.1450486004020506,0.32142857142857145,1.0,1.0,9/26,28.34%,DDX3X;ANKRD17;RGCC;ANAPC4;ADAM17;RAB11A;EGFR;RDX;EIF4G1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.6383934190633722,1.1448044483737685,0.34615384615384615,0.9081904297244089,1.0,2/6,5.71%,GUCY1B1;IRAG1
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.58097079787172,-1.1446409837285554,0.23863636363636365,1.0,1.0,4/51,3.63%,TAF7;SOD1;CSF1;TSC2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.6256025560638925,-1.1445842085785327,0.27710843373493976,1.0,1.0,7/18,19.14%,GJA1;NR4A3;IL18;JUN;DNMT1;IGFBP5;CCN4
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.7658831332666525,-1.144341184021403,0.3013698630136986,1.0,1.0,1/5,5.07%,SZT2
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.5938186660434359,-1.1442827794393944,0.2976190476190476,1.0,1.0,7/29,15.70%,RUBCN;MTMR9;STAT3;LZTS1;GOLGA2;MT3;LRRK2
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.7113135758367884,-1.1441325246133964,0.3717948717948718,1.0,1.0,5/8,24.82%,PTPN1;STAT3;PRLR;STAT6;LYN
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.7143658992673538,-1.144036091010281,0.3333333333333333,1.0,1.0,3/8,16.23%,SYT1;RIMS2;RIMS1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.6994485097785836,-1.1434486470546865,0.3150684931506849,1.0,1.0,5/11,24.51%,LPIN1;GK5;PLAAT3;LPL;LMF1
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.5824967055041119,1.1429573774642958,0.32142857142857145,0.9105209811473748,1.0,3/10,4.52%,IL34;NOTCH1;BIN1
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.739720341254079,-1.14260759747997,0.296875,1.0,1.0,1/6,1.96%,ZFPM1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.6479951368945917,-1.1425384742399438,0.34523809523809523,1.0,1.0,3/14,2.13%,ADAMTS4;CTSL;CD44
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.6479951368945917,-1.1425384742399438,0.34523809523809523,1.0,1.0,3/14,2.13%,ADAMTS4;CTSL;CD44
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.7321310619936807,-1.1423195225335425,0.3125,1.0,1.0,1/7,1.19%,ZFP36L2
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.5149437004016018,-1.1422463355727461,0.2,1.0,1.0,43/188,21.22%,OS9;UBA5;SELENOS;UVSSA;PIAS2;MARCHF6;ELOB;NUP153;NUP133;NUP88;ARIH2;CTR9;RBX1;RPS27A;NEDD4L;HIF1A;RNF111;UBR1;KLHL7;PRKDC;AMFR;RTF1;KLHL2;WAC;TRIM13;HIF3A;UBE2L3;RANBP2;NAE1;WWP1;BRAP;UBE2B;TRIM5;BTRC;MDM2;SKP1;DCUN1D4;RNF213;RNF168;NEDD4;UBE2K;HECW1;SMURF2
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.6594047940457993,1.1421073664285808,0.3055555555555556,0.909763605421897,1.0,1/5,0.51%,SNAP29
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.6188107785022188,-1.1418022234784446,0.29347826086956524,1.0,1.0,7/28,24.11%,TWIST1;SELENOS;STAT3;CLU;MAPKAPK2;LPL;APP
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.49731640257818793,1.141712403588584,0.23809523809523808,0.9073239993316297,1.0,1/15,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.49923815532192417,1.1414347136351017,0.21739130434782608,0.9045844313804987,1.0,1/6,1.09%,RYR2
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.7156521444361649,1.1413703479960124,0.4117647058823529,0.9009505800969506,1.0,1/5,1.04%,ZDHHC15
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.7295530881320856,-1.1412529342574638,0.2911392405063291,1.0,1.0,1/8,1.40%,CYP3A5
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),-0.6506368279688031,-1.1412214889574679,0.2682926829268293,1.0,1.0,3/16,18.45%,HDAC2;CST3;BTRC
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.7333497413618464,-1.1409266983546198,0.3037974683544304,1.0,1.0,1/7,3.56%,ARHGAP24
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.6303309546950648,-1.140924002341723,0.3194444444444444,1.0,1.0,3/13,9.74%,PDE7B;PDE7A;RIMS2
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.7701449736791168,-1.1406377397527092,0.3484848484848485,1.0,1.0,2/5,11.50%,HOMER2;GRM7
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.7059809771086534,-1.1405120571619318,0.23529411764705882,1.0,1.0,4/10,12.67%,CTSL;RUNX1;ERRFI1;ROCK2
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.6516656009720999,1.139996048913441,0.34375,0.9009202654412097,1.0,1/6,10.15%,EP300
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.6014683876659883,-1.1399864233069865,0.3333333333333333,1.0,1.0,14/29,30.11%,PELI1;TGFB1;SMAD6;STAT3;SCD;ADAM17;MAPKAPK2;ERBIN;PPARA;GPX3;GGT7;FOXO1;STRN3;TAB2
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.7226225614668366,-1.1399240421066905,0.2716049382716049,1.0,1.0,3/10,17.74%,ZC3H7A;ZC3H7B;AGO2
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.6701822072164508,-1.1398648280090062,0.31645569620253167,1.0,1.0,4/13,18.03%,DIP2B;SEMA3B;MT3;SEMA4D
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),-0.6986179789122665,-1.1398392534451212,0.3287671232876712,1.0,1.0,3/10,18.75%,ATL1;ZFYVE27;RAB18
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),0.6416228722761649,1.1394345474244971,0.2692307692307692,0.8990712585685219,1.0,2/7,5.60%,COL5A2;SKI
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.59610313504987,-1.139317716859535,0.29213483146067415,1.0,1.0,7/32,15.08%,SSH1;LIMA1;PLEKHH2;STMN1;HDGFL3;CLU;NAV3
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5852180591120222,-1.1392726412562126,0.26373626373626374,1.0,1.0,7/38,8.10%,SLC2A3;SLC7A2;SLC2A1;SLC16A12;SLC1A2;SLC16A7;SLC6A17
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.5852180591120222,-1.1392726412562126,0.26373626373626374,1.0,1.0,7/38,8.10%,SLC2A3;SLC7A2;SLC2A1;SLC16A12;SLC1A2;SLC16A7;SLC6A17
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.6595507141449594,-1.1390148979740913,0.2948717948717949,1.0,1.0,5/14,14.55%,ELAVL3;DNER;GRIN1;NXPH1;SNAP91
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.5709847440721835,-1.138979826060198,0.3103448275862069,1.0,1.0,9/43,18.43%,S1PR3;GPR161;GNA14;ADM;ADGRG2;GNAL;AKAP12;LGR4;ADGRE2
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.5882912587443411,-1.1388471464758094,0.2682926829268293,1.0,1.0,9/32,16.07%,CSF1;EFNB2;RRAS2;DDIT4;TBK1;CLU;PPARGC1A;LRRK2;NAE1
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.7157008229484836,-1.1386859063576302,0.3055555555555556,1.0,1.0,1/6,2.95%,ASPA
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.6845207761636046,-1.1383907717442483,0.34210526315789475,1.0,1.0,4/10,12.90%,TWIST1;TGFB1;NIBAN2;SIN3A
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.6996361150569392,-1.1383211246648897,0.3076923076923077,1.0,1.0,2/9,8.20%,IFITM3;EIF2AK2
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.656461291408687,-1.1377392166293334,0.3291139240506329,1.0,1.0,4/13,14.55%,CRMP1;STMN1;PURG;SNAP91
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.7318971561875721,-1.1373073260845084,0.2976190476190476,1.0,1.0,4/8,22.67%,CSF1;FARP2;GLO1;GAB2
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.6486114466762857,-1.1372437292646858,0.32051282051282054,1.0,1.0,2/12,9.21%,NUP153;AFDN
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.5420035389518753,-1.1372169269813708,0.22105263157894736,1.0,1.0,24/91,18.37%,PRAG1;CD55;IGFBP2;DHRS3;TSC2;NCAM1;TGFB1;DCDC2;GALNT11;PTPN1;FGFR2;SIK2;PTPN2;ELF1;AMFR;RUNX1;TSPYL2;CLU;LRRK2;IGFBP5;BRAP;DTNBP1;YWHAG;TRIM5
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.5410275186795894,-1.1371786915649158,0.28888888888888886,1.0,1.0,15/65,19.10%,PRKACA;PPME1;CSNK1D;TUBA1A;MELK;CCP110;CEP57;CCNH;NINL;PPP2R2A;CDK14;PHLDA1;YWHAG;BTRC;SKP1
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.6200541050943082,-1.136952984841312,0.35714285714285715,1.0,1.0,6/25,8.52%,ZFPM1;TGFB2;TGFB1;RARB;FGFR2;IFT122
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.5612987910532317,1.1368670154727962,0.4,0.9031050502969297,1.0,3/11,13.80%,AFAP1L2;HIP1;ARAP1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.6839885211743952,-1.1365186052374638,0.34146341463414637,1.0,1.0,3/12,14.13%,IPO5;LATS2;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.7027470071726927,-1.1363887928600869,0.375,1.0,1.0,2/8,13.49%,TGFB1;RGCC
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.6633405366816055,1.136228758823358,0.3793103448275862,0.9010269033621963,1.0,1/5,8.69%,NEK4
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.6525024381828117,-1.1360699469463478,0.3448275862068966,1.0,1.0,2/17,3.95%,NDUFB9;NDUFV1
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.6525024381828117,-1.1360699469463478,0.3448275862068966,1.0,1.0,2/17,3.95%,NDUFB9;NDUFV1
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.7021554635360168,-1.136049580208661,0.38571428571428573,1.0,1.0,4/7,26.72%,PANK2;ACADL;RORA;ACADVL
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),-0.6966861196684108,-1.1359973508059615,0.3188405797101449,1.0,1.0,4/9,21.64%,NRXN3;NCAM2;NLGN1;ASTN2
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.6408980940989739,1.135859016154424,0.43478260869565216,0.8984969320603403,1.0,3/5,27.46%,MEF2C;COL13A1;BMPR1B
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.6566653887530012,1.1357700491521252,0.39285714285714285,0.8950149000657392,1.0,1/5,2.44%,PDGFA
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.633235904072963,-1.1352010747983932,0.2976190476190476,1.0,1.0,8/20,22.49%,SSH1;PANK2;ARF4;PDK3;PID1;NCOR2;PPARA;RNF34
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.7376168755777345,-1.1347309216395818,0.3333333333333333,1.0,1.0,2/8,7.94%,KLF2;SMAD6
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.7382726909916953,-1.134603196226171,0.35064935064935066,1.0,1.0,1/7,8.36%,TRAF3IP1
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),-0.697830107048711,-1.1340187372644528,0.3333333333333333,1.0,1.0,6/8,25.91%,PDK3;AKR1C2;PID1;AKR1C1;LPL;IRS1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.612868256688197,-1.1339313306151937,0.26744186046511625,1.0,1.0,7/24,14.93%,ATP6V1E1;ATP6V1G1;FTH1;ATP6V1H;TF;ATP6V1D;CP
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.6797308335174261,-1.1334295824745027,0.2976190476190476,1.0,1.0,4/11,21.22%,VEGFA;POMZP3;AGO2;SMURF2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.6784425753300996,-1.1333620018965227,0.2839506172839506,1.0,1.0,5/14,25.01%,RBX1;RPS27A;PARP1;XPA;RAD23B
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.7575903847907297,-1.1329242284133876,0.2361111111111111,1.0,1.0,2/5,10.86%,TGFB1;IL18
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.649970761981678,-1.132892999402531,0.345679012345679,1.0,1.0,4/12,19.44%,TGFB1;RHBDD1;APH1B;ADAM17
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.5256297072585624,-1.1327973300283452,0.21739130434782608,1.0,1.0,28/90,31.26%,PRKACA;HNRNPL;RBMS2;TUT7;SRSF5;HNRNPC;RBM39;PPARGC1A;ALKBH5;CSTF3;NOVA1;HNRNPF;NONO;RSRC1;TARDBP;PRMT9;TCERG1;SF3B1;SETX;CELF2;KIN;PRPF3;NCBP1;WBP4;RNPC3;SFPQ;SRSF2;DHX15
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.432996356183271,1.1325823017752403,0.21739130434782608,0.9017121361731066,1.0,2/23,1.44%,SPRY3;TNIP1
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.5335592313161833,-1.1323725968261138,0.2736842105263158,1.0,1.0,30/74,24.53%,HSPA4L;PITPNC1;TGFB1;DDIT4;PTPRE;SLC35D1;CCP110;TP63;PROCR;SLC3A2;SAT1;ELP1;JUN;RPL18;TSPYL2;WWP1;KIF13B;SESN1;MDM2;DRAM1;BTG2;SLC7A11;RPS12;HINT1;BTG1;CCNK;RPL36;RCHY1;APP;RACK1
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.7087798513953136,1.1322801897030215,0.45161290322580644,0.8988625900317264,1.0,2/6,2.97%,MYH11;NOTCH1
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.7336722735334789,-1.1320996046035927,0.3037974683544304,1.0,1.0,2/7,15.48%,SSH1;ABCC9
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.5715957107526117,-1.1314421342973588,0.32941176470588235,1.0,1.0,4/34,10.76%,ZFP36L2;CD44;FGFR2;CEP57
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5696065444275257,1.1305597893801462,0.26666666666666666,0.8994949929049261,1.0,2/10,3.72%,JPH2;CACNB2
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.7947854018824445,-1.1302981929298062,0.31343283582089554,1.0,1.0,2/5,14.45%,VEGFA;CAMK2D
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.5773656842683691,-1.1300433047999894,0.3,1.0,1.0,12/39,20.55%,KDM1A;UVSSA;RHBDD1;PARP1;ZRANB3;POLK;MAP3K4;UBE2B;WRN;XPA;NEDD4;EIF2AK4
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),-0.7136216804404466,-1.1300378689804933,0.3333333333333333,1.0,1.0,2/7,14.74%,STXBP6;RAB7A
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.5640696838172027,-1.1298966735928684,0.3176470588235294,1.0,1.0,10/36,22.65%,SLC22A6;SLCO1A2;PEX3;SLC47A1;ARRDC2;RAB7A;ABCA8;ABCA4;ARL6IP5;CHKA
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.6674715584674455,-1.1297426735600635,0.32926829268292684,1.0,1.0,4/12,23.07%,DDX3X;TBK1;IRF1;RIOK3
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.7454238159829437,-1.1292933123248416,0.36486486486486486,1.0,1.0,3/6,21.83%,CNIH3;NLGN1;MINK1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.739140292251832,-1.1292834715613258,0.3770491803278688,1.0,1.0,1/5,9.21%,AFDN
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.4464965525618879,1.1285722421778002,0.21052631578947367,0.9010028404525018,1.0,3/17,4.36%,BTBD2;CDK6;ERCC6
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.7082184708748507,-1.1284814622348447,0.33766233766233766,1.0,1.0,3/9,9.93%,NRG1;TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),-0.7539618379539206,-1.1282672376572664,0.2777777777777778,1.0,1.0,1/6,1.72%,SYT1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.6227794496742292,-1.128037586657637,0.3614457831325301,1.0,1.0,4/18,14.95%,SPTLC3;SPTLC1;AGK;PLPP3
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),-0.755373252404522,-1.1279606141038905,0.34782608695652173,1.0,1.0,3/5,24.13%,BTRC;NLGN1;RORA
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.6641168445422119,-1.1273337177265137,0.3291139240506329,1.0,1.0,4/10,21.80%,TBC1D20;PPIB;EIF2AK4;CCNK
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.6652603664202161,-1.1269603803782635,0.38372093023255816,1.0,1.0,2/14,12.53%,DDX52;RPS14
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.6235204485330338,-1.1266908806347757,0.36,1.0,1.0,4/19,9.93%,NR4A3;NCEH1;LGALS3;TGFBR1
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.505033192304068,1.1266537353768036,0.28,0.9025368509455273,1.0,4/16,4.56%,NOTCH3;NOTCH1;HEYL;PPARD
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.6111964211455146,-1.126407560431273,0.3448275862068966,1.0,1.0,7/18,19.67%,SLC38A4;SLC38A9;SLC3A2;SLC36A4;SLC47A1;SLC38A10;SLC7A11
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),-0.7610087144956962,-1.1263700329548172,0.25,1.0,1.0,1/6,3.40%,VEGFA
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.5430737582449991,-1.1262165794627426,0.24210526315789474,1.0,1.0,29/78,27.37%,DDX52;RPL28;WDR43;RPL34;RPL21;RPLP2;RPL19;PRKDC;NOP58;RPLP1;RPS14;RPL13A;RPL18;RPL27;RPL35A;RPL31;RPL5;RPL27A;RPL36;RPL41;RPL32;RIOK3;RPL37;RPL24;RPL9;RCL1;RPS2;RPL37A;RPL3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.6769130321839252,-1.1253591296079881,0.345679012345679,1.0,1.0,6/14,27.56%,RBX1;RPS27A;PARP1;XPA;RAD23B;GTF2H1
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.5571870848734393,-1.124598019758225,0.29213483146067415,1.0,1.0,16/50,25.59%,EPM2A;TSC2;C9ORF72;ATF6;TBK1;WAC;TRIM13;LRRK2;CAMKK2;SESN1;TRIM5;EIF2AK4;DCN;TMEM59;PIK3CB;KDR
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.6305749902761681,-1.1243444710432118,0.30952380952380953,1.0,1.0,4/16,23.07%,DDX3X;TBK1;IRF1;RIOK3
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.5930260575778893,-1.1242690147402434,0.3291139240506329,1.0,1.0,8/22,22.10%,RHEB;ACOT11;NOVA1;LGR4;LNPEP;ADAM17;LAMA4;MAP2K6
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),-0.7391284652633902,-1.1240428853631819,0.3026315789473684,1.0,1.0,2/8,8.41%,LPIN1;SELENOI
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.7737667413212946,-1.1239045382789417,0.3783783783783784,1.0,1.0,2/5,5.71%,TGFB2;TGFB1
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),-0.7445711154160684,-1.123559497313233,0.3333333333333333,1.0,1.0,2/6,13.67%,NRG1;TAPT1
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.6072665450903709,1.1235495901794978,0.32142857142857145,0.9081225176255099,1.0,2/8,5.00%,ATP2B4;DDI2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.689236817387382,-1.1232651455331462,0.3611111111111111,1.0,1.0,1/11,0.30%,HS3ST5
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.7091729175203775,-1.122392554550489,0.35526315789473684,1.0,1.0,2/8,14.55%,SMAP1;SNAP91
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.7577720637154793,-1.122167479050856,0.29333333333333333,1.0,1.0,3/5,22.12%,OXSR1;ADAM17;STK39
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.7577720637154793,-1.122167479050856,0.29333333333333333,1.0,1.0,3/5,22.12%,OXSR1;ADAM17;STK39
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.5817865469462699,-1.122113286229219,0.2976190476190476,1.0,1.0,12/35,21.51%,ELAVL3;SPTBN4;PHYHIPL;SNAP25;LRFN5;NXPH1;MT3;SNAP91;GFAP;GABBR2;KCNC2;CADM2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.6326559413071258,1.1218352926571566,0.28,0.9089354835105373,1.0,2/7,6.77%,BCL2L1;BCL2
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.6143806994216829,-1.1218093142840386,0.3291139240506329,1.0,1.0,6/22,10.96%,TSC2;PTPRE;PTPN1;SIK2;PRKCB;PTPN2
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.6693372341094173,-1.1213666251683183,0.4027777777777778,1.0,1.0,1/9,1.19%,ZFP36L2
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.6459381851133877,-1.1211193972553268,0.34177215189873417,1.0,1.0,4/12,27.49%,AFDN;RAP1B;PDE4D;RDX
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.6411365627066208,-1.120568745856972,0.3157894736842105,1.0,1.0,1/14,0.98%,GJA1
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.5750917818674244,-1.120128418888336,0.3,1.0,1.0,7/36,9.91%,PRAG1;TGFB2;PRKCI;GALNT11;NIBAN2;STAT3;TP63
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.7006704039566952,-1.119981632797748,0.3157894736842105,1.0,1.0,4/8,22.33%,LGR4;APPL2;BIRC2;IRF1
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.5354574511797378,-1.1199339640598818,0.25806451612903225,1.0,1.0,14/96,9.93%,COL4A6;ADAMTS4;ADAMTS9;SMOC1;CD44;COL11A1;JAM3;ST7;ITGA5;THSD4;COL6A3;PXDN;FBN1;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.44733303953381676,1.1194283693883464,0.23076923076923078,0.9124174526895696,1.0,2/17,2.12%,SLIT3;CNOT7
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),-0.725065910655778,-1.1187505143795624,0.3246753246753247,1.0,1.0,2/8,8.28%,GRIN1;FARSB
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.698584628797841,-1.1183804181133221,0.3333333333333333,1.0,1.0,1/7,2.73%,WIPI1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.5132005993987262,-1.1178710126183526,0.2604166666666667,1.0,1.0,26/143,14.20%,PRKACA;CSNK1D;TUBA1A;TTC8;PTPDC1;NUDCD3;DCDC2;GALNT11;ARF4;LZTFL1;TRAF3IP1;IFT122;ARMC9;CCP110;ACTR3;IFT52;CEP57;IFT57;IFT140;EXOC1;DYNC2LI1;NINL;ATP6V1D;MAK;BBOF1;WDR19
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.5134071790122884,-1.1177768526832883,0.26804123711340205,1.0,1.0,23/125,21.29%,SRSF12;HNRNPL;STRAP;SRSF10;RBM4B;RBM17;CDC5L;CCAR1;RAVER2;PABPC1;SRSF5;HNRNPC;DDX42;SYMPK;DDX46;CSTF3;NOVA1;ELAVL1;HNRNPF;TRA2B;CPSF2;NONO;RSRC1
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.6582075235021458,-1.1169948418192779,0.35714285714285715,1.0,1.0,2/12,9.35%,ANK3;CEMIP
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.4812311191633009,1.1169565303363689,0.3,0.9156470137340361,1.0,3/16,9.11%,PSMF1;QRICH2;OPHN1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.5503636200085561,-1.1167898025058973,0.2391304347826087,1.0,1.0,14/57,21.83%,PRKACA;NRG1;VEGFA;TGFB2;STK4;PRKAR1A;IL18;MT3;PRLR;STRADB;PAK1;TAOK3;PRKAR2A;MINK1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.5863495380913348,-1.116558432639279,0.3717948717948718,1.0,1.0,13/27,27.61%,SUFU;DCDC2;FGFR2;IFT122;ARMC9;UCHL5;TTC23;BTRC;EVC;RORA;RACK1;INTU;PTCH1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.694471318912871,-1.1165061629961128,0.3157894736842105,1.0,1.0,3/8,9.88%,VAV3;CD38;PRKCB
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.6311284120204823,-1.116399669294796,0.3253012048192771,1.0,1.0,3/17,8.81%,GJA1;GRIN1;SNX6
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.6242520312349961,1.1163260676906204,0.34615384615384615,0.9135423231614924,1.0,2/7,7.97%,PRKG1;SLIT2
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.5319654501089425,-1.116062026744813,0.30851063829787234,1.0,1.0,10/62,12.80%,TGFB2;PDCD4;TGFB1;SMAD6;USP15;TGFBR1;RPS27A;HIVEP1;RNF111;JUN
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6033610581588651,1.116039319997391,0.32142857142857145,0.9106718398634729,1.0,2/8,8.53%,NOTCH1;RHOA
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.7701182878148266,-1.115922541811619,0.30120481927710846,1.0,1.0,2/5,14.95%,SPTLC3;PLPP3
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.6726925892550571,1.115910737025958,0.375,0.9076751246627589,1.0,3/6,14.40%,MFHAS1;YWHAB;URI1
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.7052724424190503,-1.1159073776087474,0.38271604938271603,1.0,1.0,2/8,3.40%,CSF1;VEGFA
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.6428424338587004,-1.115900457578547,0.32142857142857145,1.0,1.0,4/12,23.72%,PRKAR1A;UBE2B;PRKAR2A;PDE4D
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.6875244201096872,-1.1158580957256965,0.33783783783783783,1.0,1.0,2/9,5.71%,SRGN;TGFB1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.6904075915923691,-1.115717398422809,0.35,1.0,1.0,6/10,29.13%,RPA1;RBX1;PARP1;XPA;GTF2H1;RPA3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.6904075915923691,-1.115717398422809,0.35,1.0,1.0,6/10,29.13%,RPA1;RBX1;PARP1;XPA;GTF2H1;RPA3
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.7413148614285441,-1.1152400158162326,0.3333333333333333,1.0,1.0,2/5,16.41%,PTPN1;BRAP
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.7256789820835917,-1.1147393035019402,0.3333333333333333,1.0,1.0,2/5,21.93%,DDX3X;BIRC2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.7169002117659948,-1.114503307965419,0.37333333333333335,1.0,1.0,1/7,5.71%,TGFB1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.6644157407040447,-1.1141661217364465,0.3333333333333333,1.0,1.0,2/10,15.83%,IPO5;RANBP2
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.6648385733890174,-1.113319783047277,0.35064935064935066,1.0,1.0,4/10,14.20%,IFT122;IFT140;DYNC2LI1;WDR19
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.657496920585016,1.1132330984832735,0.38461538461538464,0.9121667264420152,1.0,2/6,3.75%,NOTCH1;LIN7C
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),-0.7014589003110718,-1.113211726517544,0.3783783783783784,1.0,1.0,6/9,28.59%,PDK3;SCD;PID1;LPL;IRS1;FOXO1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.6813171811636771,-1.1129926570103308,0.4057971014492754,1.0,1.0,8/11,26.84%,EPHA7;GRIN1;DELE1;MT3;FYN;BIRC2;GRIN2B;BEX3
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.6986675271122706,-1.1123586110459571,0.4,1.0,1.0,3/7,17.15%,SLC35D1;UAP1;PGM3
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.7440894604469952,-1.1123557485601363,0.38461538461538464,1.0,1.0,2/6,17.74%,DDX3X;AGO2
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.6498042223783237,-1.111775710422166,0.37333333333333335,1.0,1.0,3/10,19.84%,PRKCI;LRRC7;ERBIN
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.6315675598722791,1.1116109278324178,0.3,0.9127215026178377,1.0,3/6,12.45%,DERL1;RNF185;VCP
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.7493990243466675,-1.1114588954008877,0.2876712328767123,1.0,1.0,2/6,3.50%,PDE4B;NOS1AP
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.5609003311562425,-1.1111084939931102,0.3626373626373626,1.0,1.0,8/41,17.32%,SRGN;F3;NAA11;CPD;PITRM1;APH1B;NAA15;TSPAN5
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.6738370163745943,-1.1108973755662805,0.32857142857142857,1.0,1.0,1/8,3.72%,SRA1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.6174363019098363,-1.1108135771477778,0.35526315789473684,1.0,1.0,3/14,16.99%,RUBCN;TGFB1;FLT1
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.6206059590708202,-1.110417031182097,0.2987012987012987,1.0,1.0,2/12,11.98%,CSNK1D;GOLGA2
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.7165873608726478,-1.1103776322367982,0.3333333333333333,1.0,1.0,2/7,7.35%,TMSB4X;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.6996263091300313,-1.1103333740518586,0.3055555555555556,1.0,1.0,5/7,22.70%,DCDC2;ARMC9;UCHL5;TTC23;EVC
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.6339051439029977,-1.1100842025709003,0.4230769230769231,1.0,1.0,6/17,15.99%,TGFB1;STAT3;IL18;SLC1A1;LRRK2;IGFBP5
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.53035627371069,-1.1097939532946697,0.26881720430107525,1.0,1.0,13/95,9.72%,COL4A6;ADAMTS4;ADAMTS9;SMOC1;CD44;COL11A1;JAM3;ST7;ITGA5;THSD4;COL6A3;PXDN;FBN1
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.6282302475272658,-1.1094228434049493,0.3855421686746988,1.0,1.0,4/12,19.96%,DHX29;EIF2S2;MCTS1;EIF2S3
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.631555936789626,-1.1094159933197512,0.2857142857142857,1.0,1.0,8/17,22.12%,GLRX;ANK3;NEDD4L;CAMK2D;FGF14;NEDD4;HECW1;STK39
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.6207198392384473,-1.1091029538635786,0.35714285714285715,1.0,1.0,6/19,20.71%,PTPRD;NEDD4L;LZTS1;SEMA4D;NEDD4;HECW1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.6124090195661155,1.1090651572857564,0.25925925925925924,0.9166461113268948,1.0,2/6,6.64%,SMYD3;SETD7
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.5448829088417998,-1.108924550213978,0.3225806451612903,1.0,1.0,12/55,20.44%,TSC2;SNCAIP;SPOCK1;PTPN1;RAP1B;NRG3;ROCK2;SGK1;CAMK2D;GFAP;SEMA4D;NEDD4
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.6301538608787055,-1.1085799364222608,0.3950617283950617,1.0,1.0,2/13,9.02%,CTR9;STAT3
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.5723881690818734,-1.1083999920768433,0.32954545454545453,1.0,1.0,11/35,28.14%,COG7;ARF4;ATP9B;PLPP3;NSF;ERGIC2;ARFGAP3;GOLPH3;RAB6A;UVRAG;COG4
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.6094130372416785,-1.1082717522157408,0.37349397590361444,1.0,1.0,7/21,26.88%,SMAP1;TF;SNAP91;CLU;LRPAP1;PIK3CB;SGIP1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.6246155289892162,1.1080950406192889,0.29411764705882354,0.9161566512175702,1.0,1/6,3.13%,INPP5F
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.7105231985154574,-1.1079867678542175,0.3333333333333333,1.0,1.0,4/7,27.80%,FYCO1;SETX;INSR;UVRAG
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.5639504041426542,-1.107848023910585,0.345679012345679,1.0,1.0,5/34,9.50%,GJA1;JAM3;CDH20;CDH18;CDH12
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.6196007494537755,-1.1076746398041362,0.37349397590361444,1.0,1.0,4/12,18.70%,KDM1A;TRIM13;WRN;MDM2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.7078538253205346,-1.1075568373553146,0.3835616438356164,1.0,1.0,3/6,19.10%,GOLGA2;BTRC;SKP1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.37865516735833454,1.1073662467073218,0.0,0.9147973757440612,1.0,12/71,8.18%,ARHGEF10L;LMOD1;SORBS2;HEY2;CDH6;DACH1;MYL9;IGFBP7;RASL12;TNS2;SMARCD3;GJA4
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.7159921697106449,-1.1073613949568033,0.4,1.0,1.0,3/6,19.78%,USP15;ANKRD17;DDX60
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.6876630749517477,-1.1073305040563068,0.35135135135135137,1.0,1.0,3/9,16.91%,RIMS2;RIMS1;RNF10
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.7091538966713596,-1.1071014202623195,0.3287671232876712,1.0,1.0,2/9,8.08%,CD44;TMEFF2
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.5638567078894803,1.1070732958084923,0.25,0.9119979804856778,1.0,1/8,1.12%,WTIP
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.7628635759321534,-1.1063457341886658,0.35294117647058826,1.0,1.0,2/5,16.99%,LGALS3;FLT1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.55240940687315,-1.105721110020609,0.32926829268292684,1.0,1.0,8/45,13.78%,TEFM;PSMB1;RPA1;PSMD14;RPS27A;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.6115771383293104,1.1055539560359695,0.3939393939393939,0.9124707166253359,1.0,1/6,1.46%,PRKG1
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.7275229712305545,-1.1052996923397396,0.39473684210526316,1.0,1.0,3/5,22.25%,PARP1;PID1;PPARA
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.6273562420838922,1.1052290559642084,0.30434782608695654,0.9098809439751091,1.0,1/8,0.72%,HDAC9
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.6875255171448502,-1.1050601240513294,0.40540540540540543,1.0,1.0,6/7,26.26%,ANGEL2;HNRNPC;ELAVL1;MAPKAPK2;TARDBP;YBX3
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.6582509865134724,-1.1046421430519748,0.4142857142857143,1.0,1.0,2/11,9.35%,ANK3;CEMIP
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.6499361904300905,-1.1042843217954914,0.34210526315789475,1.0,1.0,6/10,28.78%,MT2A;MT3;JUN;MAPK1;EGFR;MAPK9
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.6499361904300905,-1.1042843217954914,0.34210526315789475,1.0,1.0,6/10,28.78%,MT2A;MT3;JUN;MAPK1;EGFR;MAPK9
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.5434951036870987,-1.1042011978015605,0.2857142857142857,1.0,1.0,10/54,18.75%,RHEB;ARHGAP31;RRAS2;SHC2;KRAS;PLD1;JUN;DNMT1;BRAP;RAB18
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.5306072695700094,-1.1041000680047108,0.2978723404255319,1.0,1.0,27/81,24.82%,DCLK1;OMG;GPM6A;ADGRV1;STMN1;PLP1;HDGFL3;GRM7;MYO16;SGK1;MICALL2;ZFYVE27;LRRK2;DTNBP1;UHMK1;BTG2;PAK1;NEDD4;NLGN1;TAOK3;MINK1;RAB11A;GPM6B;PTPRM;EPB41L3;APP;LYN
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.7138819240620957,-1.1040294570862277,0.39285714285714285,1.0,1.0,2/6,10.86%,CD55;IL18
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.6040657977019148,-1.1034401901860156,0.34177215189873417,1.0,1.0,4/22,12.67%,ZFP36L2;TUT7;GIGYF2;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.6754030367665189,-1.1032776890335338,0.3698630136986301,1.0,1.0,2/12,8.89%,SSH1;STMN1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.6734025004450128,-1.1027839859766444,0.3670886075949367,1.0,1.0,2/10,5.20%,VEGFA;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),-0.7006327173283395,-1.1021906156818448,0.3181818181818182,1.0,1.0,3/8,25.91%,PTPN2;PPARGC1A;IRS1
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.5764406668331369,-1.1021372270385228,0.3170731707317073,1.0,1.0,9/28,28.10%,CTSL;AP2A1;RAB7A;MDM2;RAB12;MALT1;AP2B1;AFG1L;YME1L1
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.7067003250219264,-1.1020876690759327,0.4027777777777778,1.0,1.0,4/7,27.61%,TGFB2;TGFBR1;BMP5;PTCH1
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.5957160270896878,-1.1018990159178736,0.3783783783783784,1.0,1.0,8/20,22.10%,RHEB;ACOT11;NOVA1;LGR4;LNPEP;ADAM17;LAMA4;MAP2K6
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),-0.5833756237329095,-1.101800467396184,0.36585365853658536,1.0,1.0,8/27,23.50%,KDM1A;RHBDD1;PARP1;POLK;XPA;NEDD4;EIF2AK4;ZBTB1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.6400672079443693,-1.1017528130921066,0.37037037037037035,1.0,1.0,6/12,12.29%,ITGA5;PTPN1;NIBAN2;PRKCB;HIF1A;MT3
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),-0.7783325134759892,-1.1017422939601946,0.3076923076923077,1.0,1.0,1/5,5.45%,AKIRIN1
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.4938556397597752,-1.1013030307671832,0.17,1.0,1.0,58/391,14.16%,WWC1;PRDM6;TAF7;SCML1;ENO1;TWIST1;ETV5;NR4A3;NRG1;KDM1A;KLF2;BASP1;ZFPM1;CRY1;CREM;JDP2;WWC2;VEGFA;HDAC2;PDCD4;TGFB1;SUFU;ZMYM5;HCFC2;RARB;NIBAN2;CBFA2T2;ZFPM2;ESR2;FGFR2;CTCF;GLIS3;CTR9;ZNF608;CD38;SDCBP;SNX6;SAP130;STAT3;FHL2;TP63;RPS27A;NEDD4L;HIVEP1;RCOR1;RUNX1;MT3;MAFK;RTF1;RPS14;CLOCK;JUN;SIN3A;ZHX3;EID1;PARP1;CDKN1B;NR4A2
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.565350979271436,-1.1011759500079568,0.37777777777777777,1.0,1.0,9/45,15.59%,HDAC2;HMGN1;NUP133;RBX1;RPS27A;FAM50A;GEM;PARP1;EZH1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.5767960576093126,-1.1006588899948517,0.3614457831325301,1.0,1.0,10/36,22.49%,PELI1;MARCHF6;ARIH2;RBX1;NEDD4L;AMFR;ZNRF1;UBE2B;UBE2K;RNF34
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.5620513036542013,-1.10059847063609,0.39080459770114945,1.0,1.0,7/30,18.43%,S1PR3;GPR161;ADM;ADGRG2;GNAL;LGR4;ADGRE2
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.651148131647069,-1.1005714788033623,0.3466666666666667,1.0,1.0,1/11,3.40%,VEGFA
prerank,PanglaoDB_Augmented_2021__B Cells,-0.6108614284305689,-1.1003076414133846,0.2857142857142857,1.0,1.0,5/22,12.43%,CD55;IFIT3;BACH2;CD38;SCD
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.5056248802348354,-1.1002645548480872,0.3163265306122449,1.0,1.0,37/115,31.26%,SRSF12;HNRNPL;SRSF10;RBM4B;RBM17;CDC5L;CCAR1;RAVER2;PABPC1;SRSF5;HNRNPC;DDX42;SYMPK;DDX46;CSTF3;NOVA1;ELAVL1;HNRNPF;TRA2B;CPSF2;NONO;RSRC1;SF3B1;TRA2A;PRPF3;NCBP1;CWC22;WBP4;YBX1;RNPC3;RALY;SFPQ;POLR2F;UBL5;SPEN;SRSF2;DHX15
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.6368169387696804,-1.1000577819028308,0.36,1.0,1.0,7/18,21.09%,SYT1;DGKI;GRIK1;GRM7;LRRK2;TSHZ3;NLGN1
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.6854200105194643,-1.0997042548943083,0.40540540540540543,1.0,1.0,2/7,10.04%,KCNQ1;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.65992285378521,-1.0990472241016573,0.3974358974358974,1.0,1.0,2/11,5.31%,PRAG1;ROBO1
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.6956117440159792,-1.099045644680319,0.32857142857142857,1.0,1.0,1/8,3.40%,VEGFA
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.6787677896965028,-1.09890603148119,0.3561643835616438,1.0,1.0,3/7,9.56%,KCNE4;ATP1B3;KCNQ1
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.6467971186015923,-1.0987761461017467,0.3924050632911392,1.0,1.0,3/12,9.53%,SYT1;PHYHIPL;SHC2
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.750342951205262,-1.098743824858508,0.3380281690140845,1.0,1.0,2/5,24.11%,CLU;APP
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.5114481776225926,-1.0985474988204995,0.25773195876288657,1.0,1.0,33/159,18.75%,STX6;SEC13;ATP6V1E1;RAB28;ATP6V1G1;ANK3;ARL5A;OLFM2;SLC10A7;COG7;NAPG;ARF4;SYNDIG1;SNX6;AP2A1;TBC1D8;PRKCB;ATP6V1H;USO1;GGA3;TF;ARRDC2;ATP6V1D;GOLGA4;CLU;RAB7A;USP6NL;VAMP5;LAMP2;PREPL;TMED4;NSF;RAB18
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.6989419255297505,-1.0984772423041547,0.41333333333333333,1.0,1.0,3/6,16.12%,MT2A;MT3;PAM
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.7325371374576024,-1.0984354128746616,0.2833333333333333,1.0,1.0,2/5,23.02%,PTPN2;APOD
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.7261887395922135,-1.0983127553947256,0.40789473684210525,1.0,1.0,2/6,7.94%,ZFPM1;SMAD6
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.6119153730915874,-1.0981969318177263,0.3974358974358974,1.0,1.0,8/16,29.85%,DDX3X;ANKRD17;RGCC;ADAM17;EGFR;RDX;EIF4G1;STXBP4
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.6584961479876161,-1.0980436963943574,0.3614457831325301,1.0,1.0,5/16,16.54%,CD44;CD55;GYPC;SLC25A37;VAMP5
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.5092843758545971,-1.0978624768687861,0.3263157894736842,1.0,1.0,13/76,11.69%,FAT3;NRG1;ELAVL3;SYT1;EPHA7;CRMP1;HOMER2;DCLK1;LZTFL1;SNAP25;SLC25A36;PURG;LINGO2
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.6410228749607487,-1.0975259112550766,0.35443037974683544,1.0,1.0,2/11,0.98%,PRKACA;GJA1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.66869424320898,-1.097468622631009,0.37662337662337664,1.0,1.0,3/11,14.45%,FHL1;NEDD4L;CAMK2D
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.6626651170055613,-1.0974125365631937,0.3835616438356164,1.0,1.0,4/10,21.41%,PDK1;CD38;PPIB;CD9
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.6615530031396075,-1.0973965267604282,0.36363636363636365,1.0,1.0,2/8,10.09%,TGFB2;HIF1A
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.5039819061460534,-1.097132288297912,0.2755102040816326,1.0,1.0,61/175,27.72%,HNRNPL;RPS21;SEC13;TAF1B;RPS4X;RPL28;RBMS2;NUP153;NUP133;FYTTD1;NUP88;RPL34;RPL21;FARSB;RPLP2;DARS1;RPS27A;RPL19;SRSF5;RPLP1;RPS14;RBM39;SYMPK;RPL13A;NR4A2;RPL18;RANBP2;PWP1;ALKBH5;NOVA1;TSPAN5;AGO2;RPL27;HNRNPF;SMG7;RPL35A;RPL31;FUBP3;RPS12;WARS1;CPSF2;RPL5;RPS18;RPL27A;RPL36;RPL41;RPL32;THOC2;RPL37;RPL24;LMF1;SETX;RPL9;CELF2;RPS20;GOLPH3;RPS2;RPL37A;RPL3;NCBP1;UPF2
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.5873147377222969,-1.0969949568187036,0.3375,1.0,1.0,8/25,18.21%,VEGFA;EFNB2;TGFB1;ADM;TGFBR1;SLC1A1;FLT1;LAMA1
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.67532437177491,-1.0969889141740683,0.3380281690140845,1.0,1.0,4/7,16.17%,ZFPM1;TGFB2;NOTCH2;MDM4
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),-0.6579505216643101,-1.0969635129239634,0.375,1.0,1.0,2/14,5.05%,NRG1;OLFM2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.6538918917423708,-1.0967728629592661,0.3875,1.0,1.0,2/13,9.02%,TWIST1;STAT3
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.5464354663512317,-1.0966606275145054,0.34782608695652173,1.0,1.0,15/46,19.86%,CSNK1G2;NXN;CSNK1A1;DDX3X;RBX1;RPS27A;WNT2B;NR4A2;PLPP3;LRRK2;GPC4;BTRC;SKP1;DIXDC1;SFRP4
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.7524595389227688,-1.096656519556881,0.25757575757575757,1.0,1.0,3/6,22.51%,PDK1;STK24;ARL6IP5
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.6620210380988574,1.0966185236789254,0.52,0.9293962984590528,1.0,2/7,12.46%,CHMP4B;CORO1C
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.6562266445144402,-1.0965346096705526,0.35802469135802467,1.0,1.0,3/14,13.49%,PDCD4;PRKCI;RGCC
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.7100470505966612,-1.096053175034749,0.373134328358209,1.0,1.0,4/7,27.62%,MTMR9;SMG7;MTMR2;MTMR1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.5547293007314684,-1.095950579337788,0.32558139534883723,1.0,1.0,9/39,9.02%,CSE1L;SEC13;TSC2;IPO5;IPO9;NUP153;NUP133;NUP88;STAT3
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.6930242629016121,-1.0954556532843736,0.37333333333333335,1.0,1.0,4/8,19.23%,RARRES1;STAT3;PRLR;KDM3A
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.49864531756855995,1.0954232422344465,0.3333333333333333,0.9293704412359821,1.0,6/19,12.48%,PDGFA;CDK6;SKI;CDKN1A;MORC3;DAB2IP
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.5767285150299041,1.0954022059380875,0.38095238095238093,0.9259639164808433,1.0,1/8,0.02%,JPH2
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.6439043677630483,-1.0953803370510495,0.34177215189873417,1.0,1.0,3/16,8.81%,GJA1;GRIN1;SNX6
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.6534067812787555,-1.094947246112848,0.39285714285714285,1.0,1.0,5/12,23.07%,USP15;ANKRD17;SASH1;DDX60;RIOK3
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.5309570685958411,-1.0948470654417874,0.3626373626373626,1.0,1.0,9/34,17.74%,SEC13;NUP153;TGFB1;NUP133;NUP88;STAT3;RANBP2;ELAVL1;AGO2
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.5656072775395617,-1.0947879203285313,0.3488372093023256,1.0,1.0,6/26,18.77%,NR4A3;SMAD6;ERAP1;NR4A2;PPARGC1A;PID1
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.6116713143752108,1.0947545619933654,0.3157894736842105,0.9210629792156069,1.0,1/5,1.84%,C2ORF49
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.6116713143752108,1.0947545619933654,0.3157894736842105,0.9210629792156069,1.0,1/5,1.84%,C2ORF49
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.5527815721540708,-1.0947307052670578,0.3132530120481928,1.0,1.0,3/33,11.93%,EPN1;PTPN2;ERRFI1
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.557590570339988,-1.0946122951220236,0.3409090909090909,1.0,1.0,8/27,19.79%,NRG1;TGFB2;TGFBR1;PPP3CA;SYTL4;SCARB1;PAK1;RAF1
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.7220346213911653,-1.0945475886190457,0.29333333333333333,1.0,1.0,1/7,8.87%,RAD21
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.5870681072807405,-1.094477442721704,0.32142857142857145,1.0,1.0,8/28,19.31%,SOD1;CPD;ERAP1;SEC11A;ENPEP;GSR;LNPEP;MIPEP
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.6334588294203505,-1.0942946058553888,0.4057971014492754,1.0,1.0,3/14,5.71%,SRA1;AKIRIN1;TGFB1
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.401400823318312,1.0938721770306583,0.25,0.9201177091710236,1.0,6/43,9.35%,SH3RF3;MECOM;MFHAS1;TRAF6;MTURN;HMGB1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),-0.5412157702065666,-1.0929280301323863,0.3695652173913043,1.0,1.0,6/54,9.53%,CSF1;MPZL1;EPHA7;PTPRD;FGFR2;SHC2
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.5750724876923111,-1.0928554261509968,0.4,1.0,1.0,7/29,13.89%,NFKBIA;TMSB4X;PDCD4;DDX3X;EIF2AK2;TERF2IP;SASH1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.6430690932098988,-1.0928096065175175,0.2988505747126437,1.0,1.0,4/12,9.72%,VEGFA;TENM3;IFT122;FBN1
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.5445781192904594,-1.092560619732268,0.3902439024390244,1.0,1.0,16/42,24.82%,PRKACA;MUCL1;PSMB1;PSMD14;KRAS;PSMA4;PSMB2;PSMA7;BTRC;SKP1;PAK1;RAF1;FYN;PSMA3;MALT1;LYN
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.5445781192904594,-1.092560619732268,0.3902439024390244,1.0,1.0,16/42,24.82%,PRKACA;MUCL1;PSMB1;PSMD14;KRAS;PSMA4;PSMB2;PSMA7;BTRC;SKP1;PAK1;RAF1;FYN;PSMA3;MALT1;LYN
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.5445781192904594,-1.092560619732268,0.3902439024390244,1.0,1.0,16/42,24.82%,PRKACA;MUCL1;PSMB1;PSMD14;KRAS;PSMA4;PSMB2;PSMA7;BTRC;SKP1;PAK1;RAF1;FYN;PSMA3;MALT1;LYN
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.6232660242040483,-1.0921284596811116,0.3783783783783784,1.0,1.0,2/13,9.90%,PRKACA;PRKAR1A
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.7503074815766635,-1.0920768270948515,0.3939393939393939,1.0,1.0,1/5,11.93%,ERRFI1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.5208977378315445,-1.0919327912570111,0.34375,1.0,1.0,24/103,18.75%,BTD;NRCAM;EPHA7;ROBO2;SLC2A1;DCLK1;DNER;SZT2;SPOCK1;GRIN1;ALDH3A2;DDIT4;SLC6A17;STAT3;GRIK1;ARNT2;NR4A2;ZIC4;AFF2;WWP1;VCAN;SMARCA1;SH3GL3;RAB18
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.649318389960644,-1.0918225664969918,0.40963855421686746,1.0,1.0,2/11,14.77%,DIP2B;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.6787538127234283,-1.0916703037726359,0.36,1.0,1.0,2/10,9.35%,GRIN1;CEMIP
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.6613655853010545,-1.0915989111498392,0.40540540540540543,1.0,1.0,5/11,28.30%,PLAA;UBAP1;NEDD4;TOM1L1;MVB12B
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.6548264982296674,-1.0915157542408047,0.41333333333333333,1.0,1.0,2/10,13.38%,CTR9;DNMT1
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.6641791321892667,-1.0906400671101504,0.41333333333333333,1.0,1.0,3/7,21.27%,MAP3K4;TNKS;MAPK1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.4963026644267764,-1.090337148441427,0.25252525252525254,1.0,1.0,51/230,22.12%,PRAG1;PRKACA;CSNK1D;CRY1;CSNK1G2;PDK1;DCLK1;CSNK1A1;TGFB2;CDKL1;TGFB1;PRKCI;OXSR1;MAPK6;EIF2AK2;FGFR2;SIK2;LATS2;MELK;PDK3;STK4;USP15;STK33;PRKCB;TGFBR1;NRBP1;PRKDC;CCNH;ROCK2;SGK1;TBK1;MAK;CAMK2D;CDK14;STK24;LRRK2;STRADB;TNKS;FLT1;CAMKK2;PRKAG2;UHMK1;PAK1;MAPKAPK2;EIF2AK4;MAPK1;FYN;TAOK3;MINK1;MAP2K6;STK39
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.6668779496794528,-1.089981589615136,0.3880597014925373,1.0,1.0,1/8,2.60%,RIPOR1
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.5361459558686905,-1.0899229854151788,0.32941176470588235,1.0,1.0,9/39,13.78%,ZFP36L2;PSMB1;EIF2AK2;PSMD14;PSMA4;PRKDC;PSMB2;RUNX1;PSMA7
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.6130723861691815,-1.0896327123607665,0.3902439024390244,1.0,1.0,6/16,30.78%,CTR9;STAT3;PID1;STAT1;ST3GAL6;ST18
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.7288060907272585,-1.0895973742884633,0.391304347826087,1.0,1.0,1/5,1.25%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.7176231546277144,-1.089512172167976,0.33766233766233766,1.0,1.0,1/7,6.53%,XPO4
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.7208067139620533,-1.0893273726018702,0.352112676056338,1.0,1.0,2/5,12.95%,EMP1;PMP22
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.5154056696422824,-1.089169763670544,0.4065934065934066,1.0,1.0,12/52,12.86%,PRAG1;TWIST1;NRG1;RHOB;TMSB4X;TGFB1;DIAPH1;TMSB10;ENPP2;FRMD5;ROCK2;SGK1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.546208932366255,-1.0890289004534903,0.3493975903614458,1.0,1.0,10/46,13.78%,PELI1;NFKBIA;PSMB1;PSMD14;MAP3K8;RBX1;RPS27A;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),-0.7209678238686423,-1.0890230446209432,0.3333333333333333,1.0,1.0,3/5,27.62%,MTMR9;MTMR2;MTMR1
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.6106194201256363,-1.0890197618300508,0.4342105263157895,1.0,1.0,3/12,21.09%,JAM3;HEG1;NLGN1
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.616787332348023,-1.088417892457219,0.4177215189873418,1.0,1.0,4/15,20.77%,CTSL;RPS27A;MAPKAPK2;ALPK1
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.6460914410230537,-1.0884113351851357,0.41333333333333333,1.0,1.0,5/12,28.18%,SCD;ACSS3;PAM;FAR2;GGT7
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.569338695201296,-1.0876310697847866,0.3488372093023256,1.0,1.0,11/30,23.08%,MCC;RHOB;GLUL;SCD;CP;PHLDA1;KIF13B;ASS1;AKR1C1;ITIH2;SAMD5
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.5976074272131128,-1.0873160565114255,0.4225352112676056,1.0,1.0,4/15,15.32%,PTPRQ;PTPN1;PTPN2;DUSP1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),-0.6361317945214197,-1.0872286961104518,0.3835616438356164,1.0,1.0,3/16,16.68%,NAA11;CLOCK;NAA15
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.4838485527449303,-1.087180296425443,0.28,1.0,1.0,43/285,14.16%,WWC1;PRDM6;TAF7;ENO1;TWIST1;ETV5;NR4A3;KDM1A;KLF2;ZFPM1;CRY1;CREM;JDP2;WWC2;VEGFA;HDAC2;SUFU;ZMYM5;HCFC2;RARB;ZFPM2;ESR2;FGFR2;CTCF;GLIS3;CTR9;ZNF608;SDCBP;SAP130;STAT3;FHL2;RPS27A;NEDD4L;HIVEP1;RUNX1;MAFK;RTF1;RPS14;JUN;SIN3A;EID1;PARP1;NR4A2
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.6547516829957843,-1.0871723837949192,0.3783783783783784,1.0,1.0,1/8,5.21%,NUP153
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.6647556654051856,-1.08694570146486,0.40540540540540543,1.0,1.0,5/9,30.65%,MIGA1;SPG7;EEA1;CHCHD3;AFG3L2
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.6129708461922908,-1.0869251365604071,0.345679012345679,1.0,1.0,5/16,14.74%,ATP6V1E1;ATP6V1G1;ATP6V1H;ATP6V1D;RAB7A
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.7092918056530235,-1.0868530013784288,0.4375,1.0,1.0,1/5,1.78%,IFITM3
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,-0.5481755975687084,-1.0867340164082147,0.36046511627906974,1.0,1.0,11/38,16.03%,ELAVL3;KCND2;KCNQ3;CDH20;SNAP25;GRIA3;CCK;NXPH1;NR4A2;SNAP91;GFAP
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.5842610300458921,-1.0863977891915895,0.3707865168539326,1.0,1.0,10/25,19.92%,KCND2;ATP1B3;KCNQ3;KCNQ1;SLC9A9;ABCC9;KCNH7;NALCN;KCNQ5;KCNC2
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.6439055550870139,-1.0862504574051044,0.42105263157894735,1.0,1.0,6/10,30.94%,ROCK2;CLU;LYN;SP1;RANBP9;EPHA4
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.6422073369131884,-1.0859615228545636,0.42857142857142855,1.0,1.0,3/14,11.89%,UBA5;UFSP2;RUNX1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.3323035983332388,1.085774000114519,0.0,0.9400450711061066,1.0,12/100,7.30%,TAGLN;ACTA2;LMOD1;COL14A1;TPM2;ITGA8;COL5A2;MYL9;TNS2;DLC1;MYLK;PRRX1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.5127785453253296,-1.0855630378369474,0.3707865168539326,1.0,1.0,20/57,24.91%,NR4A3;VAV3;PSMB1;PSMD14;PSMA4;PSMB2;JUN;PSMA7;PPP3CA;BTRC;SKP1;PAK1;MAPK1;GAB2;GRB2;PPP3CB;PSMA3;MALT1;LYN;PIK3CB
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.666329777268482,-1.0854701763468808,0.44,1.0,1.0,3/7,20.81%,NAA11;NAA15;METAP1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.5770070019141906,-1.0852984596037984,0.43373493975903615,1.0,1.0,2/20,8.36%,DIAPH1;TRAF3IP1
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),0.7475877114565356,1.0852899957888917,0.38461538461538464,0.9380593037613106,1.0,3/5,17.84%,ITGB5;KIFC3;PLEKHA7
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.6000187324162692,-1.0848903023155783,0.35714285714285715,1.0,1.0,9/27,26.21%,ZC3H7A;RBM4B;ZC3H7B;PUM3;PER1;METTL16;METAP1;APP;EIF2A
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.6945844603057219,-1.084741179932327,0.43902439024390244,1.0,1.0,2/7,14.05%,RPA1;PARP1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.5126579856564835,-1.0844390443168552,0.38144329896907214,1.0,1.0,17/120,11.55%,DOK6;NRCAM;EPHA7;ROBO2;NRXN3;SPTBN4;ATL1;ANK3;EFNB2;ROBO1;NCAM1;UNC5D;NIBAN2;FGFR2;SEMA3B;CCK;C9ORF72
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),-0.7094557991387971,-1.0836962847439195,0.375,1.0,1.0,1/5,7.22%,GABRE
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.6095155442049563,-1.083558141754484,0.3670886075949367,1.0,1.0,3/18,17.87%,UBA5;GOLGA2;MCTS1
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.6459749961216944,-1.0835026295001904,0.3235294117647059,1.0,1.0,3/14,13.07%,CAMKMT;PCMT1;ETF1
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.6255903570011011,-1.0831935711451586,0.4189189189189189,1.0,1.0,2/13,9.90%,PRKACA;PRKAR1A
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.5174703862223575,-1.083066961402915,0.37755102040816324,1.0,1.0,17/89,16.67%,PRKACA;CSNK1D;CSNK1G2;CSNK1A1;PRKCI;LATS2;PDK3;STK4;PRKCB;TGFBR1;PRKDC;ROCK2;SGK1;TBK1;CAMK2D;LRRK2;TNKS
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.6509583671342496,-1.0821303367306658,0.42105263157894735,1.0,1.0,7/11,28.71%,NMNAT2;CMPK1;GUK1;NUDT5;AK4;FHIT;NMNAT3
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.6128836268236264,-1.0818518273631106,0.4634146341463415,1.0,1.0,10/19,26.72%,WIPI1;MYDGF;SSR1;HSPA5;TSPYL2;SERP1;ATP6V0D1;EXTL2;VAPB;ACADVL
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.6253473188747525,-1.0818099249375495,0.4074074074074074,1.0,1.0,5/13,14.74%,ATP6V1E1;ATP6V1G1;ATP6V1H;ATP6V1D;RAB7A
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.6840164168965244,-1.0816393949252374,0.4264705882352941,1.0,1.0,2/6,15.24%,ACOT11;ACBD6
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.6840164168965244,-1.0816393949252374,0.4264705882352941,1.0,1.0,2/6,15.24%,ACOT11;ACBD6
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.7419248196207721,-1.0816341569782892,0.37681159420289856,1.0,1.0,2/5,9.02%,NR4A3;STAT3
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.6377827204669073,-1.0816105534995348,0.41975308641975306,1.0,1.0,8/16,30.98%,SMCHD1;TERF2IP;ZRANB3;TP53BP1;POT1;TERF1;POLR2F;SHLD2
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.5193230054164899,-1.0811226887281493,0.32653061224489793,1.0,1.0,10/101,6.00%,SRGN;TBC1D20;COG2;CSNK1D;ATL1;ANK3;CSNK1A1;TOR1AIP2;GOLGA8A;COG7
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.6455392109797752,-1.0808712664138902,0.43037974683544306,1.0,1.0,3/11,18.61%,RPA1;RAD21;WRN
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.5092891314982014,-1.0803067853851274,0.30303030303030304,1.0,1.0,29/105,26.10%,OS9;RNF19A;ARIH2;PSMD14;RBX1;RPS27A;NEDD4L;RNF111;AMFR;NDFIP2;UBE2L3;NPLOC4;UBE2B;ANAPC4;FBXO22;BTRC;MDM2;RNF213;RNF168;NEDD4;UBE2K;NDFIP1;SMURF2;RNF34;RCHY1;FBXL4;UBA1;SIAH1;FBXL7
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.6818593707667673,1.0802501752997584,0.391304347826087,0.9497003322786205,1.0,2/6,16.51%,NSFL1C;APC
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.5310316116863985,-1.0801884355590643,0.3409090909090909,1.0,1.0,7/47,16.67%,SEC13;PPP1CC;NUP133;STMN1;GPSM2;RANBP2;TNKS
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.609962148568966,-1.0801419532131973,0.379746835443038,1.0,1.0,4/15,10.96%,ROBO2;ROBO1;SEMA3B;PTPN2
prerank,PanglaoDB_Augmented_2021__Neuroblasts,-0.5508459269166114,-1.0796209161203127,0.4,1.0,1.0,7/33,7.23%,ELAVL3;EPHA7;CRMP1;NCAM1;PROS1;UNC5D;TSHZ1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.6365479601638875,-1.0795347944635236,0.41025641025641024,1.0,1.0,6/14,21.33%,PDCD4;SASH1;MAP3K4;DNAJA1;PAK1;TAOK3
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.6280998576678256,-1.0789789862039207,0.43037974683544306,1.0,1.0,4/12,23.15%,RPA1;RPS27A;NPLOC4;RCHY1
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.4612555450246846,1.0789340315129894,0.4,0.9503650724766017,1.0,5/27,6.71%,SPRY3;HEY2;CDK6;NOTCH1;KLF7
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.6225278111932421,-1.0787404593545442,0.3972602739726027,1.0,1.0,7/15,28.34%,DDX3X;ANKRD17;RGCC;ADAM17;EGFR;RDX;EIF4G1
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.5219310706473241,-1.0786698416255585,0.3076923076923077,1.0,1.0,10/51,15.01%,EPHA7;VAV3;EFNB2;GRIN1;SDCBP;AP2A1;ACTR3;ROCK2;ANKS1B;APH1B
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.7083093984914285,-1.0782787702737135,0.49295774647887325,1.0,1.0,1/5,5.58%,FGGY
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.6082017308098037,1.0779011225049824,0.4117647058823529,0.949642475356832,1.0,1/8,0.13%,MYH11
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.681401030268197,-1.0778260603129086,0.4605263157894737,1.0,1.0,3/6,11.18%,NCKAP5;STMN1;HDGFL3
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.6966626141767145,-1.0777921386010123,0.4,1.0,1.0,2/8,12.53%,PRKDC;RPS14
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.6670067648983664,-1.077468075583071,0.375,1.0,1.0,2/9,10.07%,SPTLC3;SPTLC1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.6363415272482457,-1.07702576971045,0.3902439024390244,1.0,1.0,7/15,27.32%,DPM1;MGAT1;UBE2J1;MCFD2;FUT8;MAGT1;UGGT2
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.6363415272482457,-1.07702576971045,0.3902439024390244,1.0,1.0,7/15,27.32%,DPM1;MGAT1;UBE2J1;MCFD2;FUT8;MAGT1;UGGT2
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.6814853929133247,-1.0767707861429037,0.37333333333333335,1.0,1.0,1/8,3.48%,SELENOS
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.6138220041436423,-1.0767697215085004,0.48717948717948717,1.0,1.0,5/11,31.46%,PRKAG2;ACADL;WDTC1;ACADVL;NR1H3
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),-0.6864106695049588,-1.0760777703751778,0.38571428571428573,1.0,1.0,1/8,3.48%,SELENOS
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),-0.6642342301937421,-1.07606351169108,0.4,1.0,1.0,2/9,17.74%,TUT7;AGO2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.674275155886947,-1.0755181506575342,0.3902439024390244,1.0,1.0,2/10,8.77%,TWIST1;SMCHD1
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.6750528144675004,-1.075460263123003,0.4027777777777778,1.0,1.0,3/7,27.13%,DNM3;ARHGEF4;FGD6
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.6517863777195265,-1.0751078766890152,0.4864864864864865,1.0,1.0,4/9,27.46%,SCD;ACSL4;HSD17B4;FAR2
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.7115581198201844,-1.074496495335508,0.38571428571428573,1.0,1.0,2/5,13.70%,CTR9;WAC
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.6901082028754764,-1.0743186196654633,0.42857142857142855,1.0,1.0,3/5,25.04%,ACO1;ASS1;ACO2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.7443895021109723,-1.0740549276611853,0.3246753246753247,1.0,1.0,3/5,25.59%,SELENOS;NAMPT;KDR
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.4922312317990119,-1.0740507861455328,0.3978494623655914,1.0,1.0,19/75,18.77%,TAF7;TWIST1;TSC2;TGFB1;DDIT4;SMAD6;TRAF3IP1;PRKDC;C9ORF72;ERRFI1;TERF2IP;PLPP3;PRR5L;LRRK2;DTNBP1;YWHAG;SEMA4D;PRKAG2;PID1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.6052947289628714,-1.0737852366327973,0.42045454545454547,1.0,1.0,2/21,3.95%,NDUFB9;NDUFV1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.6184249937222364,-1.0737231272405774,0.3764705882352941,1.0,1.0,6/18,16.57%,KDM1A;SMCHD1;SPIDR;TERF2IP;PARP1;WDR48
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.6740174194732825,-1.073712820129443,0.42857142857142855,1.0,1.0,3/10,18.42%,GNA14;CMKLR1;LPAR6
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.5497090192272069,-1.0733305624973926,0.3707865168539326,1.0,1.0,8/31,21.19%,MT2A;NEDD4L;HIF1A;MT3;PPP3CA;PAM;NEDD4;AHCYL1
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.7404551668616185,-1.0733009955854091,0.43373493975903615,1.0,1.0,4/5,19.33%,SELENOS;PRKCB;PID1;APPL2
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),-0.6626246785895498,-1.073272716200112,0.4305555555555556,1.0,1.0,4/6,29.52%,STAT3;MT3;UGCG;LEPR
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.6901868241863021,-1.0732519887791068,0.4166666666666667,1.0,1.0,4/7,30.21%,TERF2IP;POT1;TERF1;POLR2F
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.6901868241863021,-1.0732519887791068,0.4166666666666667,1.0,1.0,4/7,30.21%,TERF2IP;POT1;TERF1;POLR2F
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.5534580419796419,-1.0731328291987576,0.39325842696629215,1.0,1.0,11/29,14.55%,ELAVL3;PHYHIPL;VEGFA;UNC5D;ALCAM;SCN3A;SNAP25;ENPP2;CCK;UNC79;SNAP91
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.6909727698658792,-1.072773138610702,0.4057971014492754,1.0,1.0,1/8,1.27%,NRG1
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.6800836123379577,-1.072756030780492,0.4057971014492754,1.0,1.0,1/7,3.40%,VEGFA
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.6377389660226687,-1.072514991762706,0.4084507042253521,1.0,1.0,3/12,5.28%,PDE4B;TGFB2;LGALS3
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.6377389660226687,-1.072514991762706,0.4084507042253521,1.0,1.0,3/12,5.28%,PDE4B;TGFB2;LGALS3
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.7267279579720725,-1.071248621746687,0.46153846153846156,1.0,1.0,2/5,9.66%,ALDH1L1;MTHFD2L
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.7267279579720725,-1.071248621746687,0.46153846153846156,1.0,1.0,2/5,9.66%,ALDH1L1;MTHFD2L
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.4406700738156654,1.0712062349033487,0.38461538461538464,0.9633898541531796,1.0,3/23,2.09%,ATP2B4;RYR2;ATP1B2
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),-0.7114352979645614,-1.070745736506749,0.42105263157894735,1.0,1.0,4/6,23.55%,RHBDD1;RUNX1;LRRK2;TMEM59
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.5309121973025871,-1.0706885070474819,0.391304347826087,1.0,1.0,11/44,23.64%,STX6;SNX6;DENND2A;RHOBTB3;RAB7A;WASHC2C;GOSR1;PREPL;VPS50;VPS51;SNX2
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.7006225141468131,-1.0706647776912013,0.47297297297297297,1.0,1.0,3/6,23.72%,ANK3;CAMK2D;PDE4D
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.6137823122663781,-1.0705851761969927,0.42168674698795183,1.0,1.0,2/13,3.37%,WWC1;WWC2
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.6308706580844303,-1.0703156369271905,0.2948717948717949,1.0,1.0,5/17,13.80%,ATP6V1E1;ATP6V1G1;ATP6V1H;TF;ATP6V1D
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.586841300620143,-1.0701186077469182,0.379746835443038,1.0,1.0,10/19,27.56%,TAF1B;CCNH;POLR1C;SYMPK;CSTF3;CPSF2;TAF1D;SETX;NCBP1;GTF2H1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.6852292132828358,-1.0700038578322135,0.47435897435897434,1.0,1.0,1/6,1.78%,IFITM3
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),-0.7041938173207578,-1.0697234636266677,0.38235294117647056,1.0,1.0,3/6,22.51%,SLC1A2;SLC1A1;ARL6IP5
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.5623598943033512,-1.0695736266954174,0.3875,1.0,1.0,4/37,9.96%,CTSL;MARCHF6;RHBDD1;RPS27A
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.6043003152356224,-1.0686539370389896,0.37662337662337664,1.0,1.0,7/21,22.28%,CYP3A5;DHRS3;ALDH1A2;GPC4;AKR1C1;LPL;ABCA4
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.5865767758306741,-1.0683004951162118,0.4146341463414634,1.0,1.0,3/23,8.81%,GJA1;GRIN1;SNX6
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.7090320971843131,-1.0682981271514485,0.4246575342465753,1.0,1.0,3/5,22.25%,PAG1;ASS1;PPARA
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.7560325342838483,-1.0679329424647999,0.4,1.0,1.0,1/6,0.69%,PRKACA
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.5123026693107458,-1.067850606827418,0.3894736842105263,1.0,1.0,17/69,15.70%,EPHA7;PGK1;PLAA;TGFB1;FRA10AC1;PANK2;PTPRD;MINPP1;STAT3;AGK;GK5;PPA1;PLAAT3;PPP3CA;NUDT5;PLPP3;LRRK2
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.5612801469711318,-1.0678009999220177,0.3780487804878049,1.0,1.0,5/25,14.21%,WASF3;WASF1;DIAPH1;CFL1;MICALL2
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.6370748999137925,-1.0676454815365446,0.4868421052631579,1.0,1.0,3/12,11.44%,VEGFA;DDX3X;PDGFD
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.6079658781925135,-1.0674901232842484,0.4166666666666667,1.0,1.0,4/14,16.67%,PARP6;ARF4;PARP1;TNKS
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),-0.6550123712032156,-1.0672354264612787,0.3974358974358974,1.0,1.0,2/8,20.23%,RIMS2;SNX19
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.5142372567613783,-1.0671840353635609,0.40816326530612246,1.0,1.0,19/90,16.67%,PRKACA;CSNK1D;CSNK1G2;NAA11;CSNK1A1;PRKCI;LATS2;PDK3;STK4;PRKCB;TGFBR1;PRKDC;ROCK2;SGK1;TBK1;PARP1;CAMK2D;LRRK2;TNKS
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.6821602190891018,-1.0665502897667465,0.47297297297297297,1.0,1.0,4/6,23.90%,TGFB2;WNT2B;CSDE1;KITLG
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.5963400673236202,1.066405117460547,0.38095238095238093,0.9733671193999595,1.0,1/5,0.32%,PGF
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.5741507633509466,-1.0664002842570257,0.4146341463414634,1.0,1.0,2/19,4.96%,SOD1;RHOB
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.6677643268904856,-1.066213338641351,0.3939393939393939,1.0,1.0,1/7,2.89%,ATP6V1G1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.5809850542989795,-1.0659981807654701,0.4375,1.0,1.0,6/34,7.48%,EPN1;ADAMTS9;KLF2;PGK1;TGFB2;NIBAN2
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.49884127597797967,-1.065594879864812,0.3854166666666667,1.0,1.0,18/126,9.93%,COL4A6;ADAMTS4;ADAMTS9;CTSL;SMOC1;CD44;TGFB2;COL11A1;P4HA3;TGFB1;JAM3;ST7;ITGA5;THSD4;COL6A3;PXDN;FBN1;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.5897644926788911,-1.0655377813396527,0.3902439024390244,1.0,1.0,3/16,17.07%,TRAF3IP1;TBK1;NPLOC4
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.5659618850038496,-1.065308493355579,0.41025641025641024,1.0,1.0,6/22,19.43%,ALDH3A2;HADHA;PPARGC1A;HSD17B4;ECHDC1;ACADL
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.4916040579328333,-1.0651438897008634,0.3469387755102041,1.0,1.0,39/153,19.91%,CSF1;GJA1;NR4A3;NRG1;S1PR3;KDM1A;VEGFA;EFNB2;RPS4X;TGFB2;HDAC2;EAPP;TGFB1;PRKCI;ZFPM2;FGFR2;CCAR1;SDCBP;TBC1D8;KRAS;TGFBR1;SSR1;IL18;PDGFD;CDC123;CNOT8;AKR1C2;PRLR;FLT1;TET1;MCTS1;NAP1L1;MDM2;PID1;NAMPT;CCN4;ADAM17;PAK1;CCN1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.522995207501533,-1.0649945901949236,0.37362637362637363,1.0,1.0,10/43,13.78%,ZFP36L2;FHL1;PSMB1;PSMD14;RBX1;PSMA4;PSMB2;MYO16;RGCC;PSMA7
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.6289039330517976,-1.0649753349986584,0.5,1.0,1.0,2/11,10.09%,DDX3X;HIF1A
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.6027643403553413,-1.0649714380596598,0.44047619047619047,1.0,1.0,2/18,4.64%,SOAT1;LIPA
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.5572517447930118,-1.064729634911492,0.4444444444444444,1.0,1.0,3/33,12.80%,TWIST1;MED14;JUN
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.5689487996630628,1.0646791117597192,0.4782608695652174,0.9745536812504645,1.0,2/8,5.53%,SYNE3;SYNE2
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.501073845731412,-1.064651195933794,0.4270833333333333,1.0,1.0,33/114,26.00%,PRKACA;RHEB;ATP6V1E1;ATP6V1G1;SLC38A9;RUBCN;MTMR9;SNX6;STAT3;ATP6V1H;SREBF1;C9ORF72;EXOC1;GOLGA2;MT3;ATF6;ATP6V1D;LRRK2;GFAP;PRKAG2;TRIM5;DRAM1;WDR41;NEDD4;ATP6V0D1;DCN;TMEM59;RRAGB;SREBF2;WDR6;PIK3CB;VDAC1;ABL1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.548622182818966,-1.0645140048450434,0.3493975903614458,1.0,1.0,11/38,14.28%,VEGFA;ELOB;PSMB1;PSMD14;RBX1;RPS27A;HIF1A;PSMA4;PSMB2;PSMA7;HIF3A
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),-0.6559198029861667,-1.0641439410269085,0.4444444444444444,1.0,1.0,2/9,10.46%,TSC2;GIGYF2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.7254412958361464,-1.0635798155242382,0.4225352112676056,1.0,1.0,2/5,11.53%,LGALS3;PRKDC
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.6073537390454076,-1.0635548341472905,0.43902439024390244,1.0,1.0,3/19,14.71%,TWIST1;STAT3;CLU
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.6073537390454076,-1.0635548341472905,0.43902439024390244,1.0,1.0,3/19,14.71%,TWIST1;STAT3;CLU
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.5880449902743689,-1.0631589966069204,0.4268292682926829,1.0,1.0,1/16,0.30%,HS3ST5
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.6589716669943994,-1.0629724615651257,0.42028985507246375,1.0,1.0,6/8,30.54%,SYNDIG1;SNAP25;RIMS1;NLGN1;PCLO;PIP5K1C
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.6279484500880989,-1.0629638643506825,0.41025641025641024,1.0,1.0,4/13,11.04%,SOD1;KCNQ1;MYL3;SGCZ
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.655596869325648,-1.0627664506782464,0.42857142857142855,1.0,1.0,1/7,2.26%,CD55
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.501490219756406,-1.0626176088828254,0.36363636363636365,1.0,1.0,13/100,9.77%,DOK6;EPHA7;ROBO2;NRXN3;SPTBN4;VEGFA;EFNB2;ROBO1;NCAM1;UNC5D;ALCAM;NIBAN2;SEMA3B
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.5040339645770688,-1.062584436520436,0.3763440860215054,1.0,1.0,8/60,12.80%,ZFP36L2;TGFB2;TGFB1;SMAD6;USP15;TGFBR1;RPS27A;JUN
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.6069598193023729,-1.0625352064711062,0.47368421052631576,1.0,1.0,1/15,0.98%,GJA1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.6926426560802976,-1.0616527622183725,0.45588235294117646,1.0,1.0,5/8,23.87%,SOAT1;NPC1;SCARB1;ABCA8;STX12
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.6286946904109171,1.061267845670252,0.5,0.980331764797219,1.0,2/6,5.15%,ADCY9;ZDHHC21
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.4933682613191756,-1.0611860275515363,0.31313131313131315,1.0,1.0,39/177,19.91%,STC1;CSF1;F3;RIPOR1;VEGFA;RHOB;TMSB4X;ROBO1;TGFB1;NKD1;SOD2;TMSB10;TMEFF2;ENPP2;CCAR1;SDCBP;STAT3;AFDN;CEMIP;SEMA3B;TGFBR1;PDGFD;FRMD5;ROCK2;SGK1;HSPA5;SASH1;PPP3CA;NAV3;PRR5L;STK24;IGFBP5;FLT1;ULK4;SEMA4D;APPL2;ADAM17;PAK1;CCN1
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,-0.536155012224815,-1.0610693820721944,0.43023255813953487,1.0,1.0,11/44,14.55%,ELAVL3;PCBP3;HIVEP2;GRIN1;TSHZ1;SNAP25;GRIA3;PLP1;DLGAP1;NXPH1;SNAP91
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.7081183262435238,-1.0609153014000308,0.4533333333333333,1.0,1.0,2/5,14.71%,PLP1;CLU
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.6417234137028149,-1.0607760649303284,0.4444444444444444,1.0,1.0,4/11,19.38%,CHST11;GLCE;CSGALNACT1;EXT1
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.6268461226737634,-1.0605092116355064,0.37662337662337664,1.0,1.0,1/7,5.63%,AKAP8
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.48176596838349045,-1.0604320959623719,0.36363636363636365,1.0,1.0,32/199,15.01%,COL4A6;CSF1;NR4A3;NRG1;MPZL1;EPHA7;VAV3;ATP6V1E1;ATP6V1G1;VEGFA;TSC2;EFNB2;GRIN1;DDIT4;FGFR2;SDCBP;STMN1;STAT3;AP2A1;SHC2;ACTR3;ATP6V1H;GIGYF2;CEP57;PTPN2;PDGFD;ROCK2;ATP6V1D;ANKS1B;PRLR;ZFYVE27;APH1B
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.6473180240782792,-1.0603931825499766,0.3815789473684211,1.0,1.0,1/12,4.76%,WASF1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.6000199132929884,-1.060081311833973,0.43037974683544306,1.0,1.0,4/16,8.52%,TSC2;TGFB2;TGFB1;IFT122
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.6287042354020014,1.0600074289616765,0.46153846153846156,0.9766760506277071,1.0,2/6,9.18%,LMCD1;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6287042354020014,1.0600074289616765,0.46153846153846156,0.9766760506277071,1.0,2/6,9.18%,LMCD1;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5212402077931357,1.059951558254422,0.375,0.9736199814354456,1.0,2/11,2.97%,ERBB4;NOTCH1
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.6777832486984923,-1.0598456600936603,0.4142857142857143,1.0,1.0,2/6,4.25%,ZFPM1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.6849392723311406,-1.059789057769993,0.4155844155844156,1.0,1.0,1/8,5.47%,MTMR9
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6762900440779309,-1.0595508174910047,0.43283582089552236,1.0,1.0,2/5,15.27%,ENPP2;PDXDC1
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.72965909993971,-1.059174641757699,0.44871794871794873,1.0,1.0,2/5,10.73%,LPCAT3;SREBF1
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.72965909993971,-1.059174641757699,0.44871794871794873,1.0,1.0,2/5,10.73%,LPCAT3;SREBF1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.5355123229160386,-1.0584674769675202,0.35555555555555557,1.0,1.0,11/53,13.88%,OS9;UBA5;TMCO1;CREB3L2;SELENOS;MARCHF6;RHBDD1;RASGRF2;JUN;ATF6;HSPA5
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.6008429410295744,-1.0578857137399515,0.43023255813953487,1.0,1.0,6/17,18.61%,CD44;SLC25A37;ELF1;RAB27A;ADGRE2;WRN
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.49564409981751834,-1.0574721713752675,0.42424242424242425,1.0,1.0,47/132,27.37%,RPS21;TAF1B;DUT;RPS4X;RPL28;RPA1;RPL34;TBRG1;RPL21;FARSB;RPLP2;DARS1;RPS27A;RPL19;DONSON;RPLP1;RPS14;RPL13A;NR4A2;RPL18;PWP1;AGO2;NAP1L1;POLA1;RPL27;WRN;RPL35A;RPL31;FUBP3;EXT1;RPS12;WARS1;RPL5;RPS18;RPL27A;RPL36;RPL41;RPL32;RPL37;RPL24;RPL9;RPS20;KIN;GOLPH3;RPS2;RPL37A;RPL3
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.7210445467558024,-1.0574103092920826,0.4864864864864865,1.0,1.0,3/5,10.96%,ZFPM1;FBN1;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.5468594050265484,-1.057024497095331,0.35365853658536583,1.0,1.0,6/36,8.66%,MID1;VEGFA;TGFB2;CCN2;EIF2AK2;SDCBP
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.6442586456860042,-1.0568966790405079,0.4935064935064935,1.0,1.0,2/11,10.86%,IGFBP2;IL18
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.4361541879257556,1.0565411347974922,0.2857142857142857,0.9806308024025439,1.0,8/30,9.87%,LMOD1;SYNPO2;CDC42;BIN1;NCK1;EVL;CARMIL1;NTF3
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.5040807400706383,-1.0563356285503642,0.36666666666666664,1.0,1.0,17/47,31.26%,SRSF10;HNRNPC;PPARGC1A;NOVA1;TRA2B;NONO;RSRC1;TARDBP;TCERG1;SF3B1;PRPF3;NCBP1;WBP4;RNPC3;SFPQ;SRSF2;DHX15
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.6053009921804324,-1.0562805631768402,0.36470588235294116,1.0,1.0,2/12,11.77%,ARHGAP15;EPSTI1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.42179829552027404,1.0562477045137633,0.38461538461538464,0.9779840101259314,1.0,3/41,2.84%,NIBAN1;ATP2B4;MFHAS1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.6443993442457548,-1.0561784690941793,0.4714285714285714,1.0,1.0,1/12,0.98%,GJA1
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.6784463782189216,-1.0559040569028777,0.4142857142857143,1.0,1.0,1/5,22.54%,RAB11A
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.723453879011138,-1.0557732640817448,0.4794520547945205,1.0,1.0,2/5,8.69%,COX4I1;COX6C
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.6287329905472383,-1.0557332760727574,0.45569620253164556,1.0,1.0,6/10,25.87%,ALDH3A2;TRAM1;SERP1;APP;TRAM2;EGFR
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.6073529993193542,-1.0557103016252465,0.4230769230769231,1.0,1.0,6/18,19.44%,ANKRD17;TF;GBP2;COLEC12;NAIP;ADAM17
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.5729215968528949,-1.0549013539463443,0.4235294117647059,1.0,1.0,7/18,25.91%,SELENOS;PRKCI;PRKAG2;PID1;APPL2;INSR;IRS1
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.5960842257248655,-1.0547463219713782,0.475,1.0,1.0,3/14,5.28%,PDE4B;TGFB2;LGALS3
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.3809073389863076,1.0546494482655127,0.3333333333333333,0.9784250625042232,1.0,4/39,5.36%,ATP2B4;BCL2L1;ITGA3;ACTB
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),-0.6754724857631094,-1.054148525506542,0.48,1.0,1.0,3/6,28.34%,STAT3;AGO2;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.6754724857631094,-1.054148525506542,0.48,1.0,1.0,3/6,28.34%,STAT3;AGO2;EIF4G1
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.6406988597819878,-1.0539566696509557,0.4375,1.0,1.0,6/8,35.56%,IL18;SCARB1;LPL;RORA;NR1H3;ANGPTL4
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.3736301194642495,1.0538128197728067,0.3333333333333333,0.9768016683068691,1.0,4/35,3.72%,JPH2;GRIN2A;FGF13;CACNB2
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.6519359512663048,-1.053508049148156,0.4642857142857143,1.0,1.0,5/10,26.72%,LPCAT3;SREBF1;ACADL;SREBF2;ACADVL
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.5693321982605745,1.0534560761667922,0.4074074074074074,0.9743611287808356,1.0,1/7,2.84%,MFHAS1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.5232298165699363,-1.0531216122685063,0.375,1.0,1.0,15/46,26.00%,VEGFA;TGFB2;RHOB;ENPP2;HIF1A;ROCK2;SASH1;SCARB1;NRP2;RAB11A;RIN2;PIK3CB;KDR;CLASP2;ABL1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.37295059905005196,1.053109846191064,0.3,0.971838303368227,1.0,7/55,8.90%,HSPA1A;LEMD3;NOTCH1;SKI;BCL9L;RBPMS2;PPM1A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6124301735005697,1.0529590742654402,0.4230769230769231,0.9690365972524986,1.0,2/5,8.53%,TRAF6;RHOA
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.6618976558830076,-1.0529547983171577,0.42105263157894735,1.0,1.0,3/9,25.54%,GRIK2;APP;SLC4A10
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.58522324367614,-1.0529331734245089,0.42045454545454547,1.0,1.0,5/17,28.38%,TTC8;APP;DGCR2;MAGT1;NF1
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),-0.6542182184726921,-1.0525726540113622,0.48717948717948717,1.0,1.0,4/10,24.83%,GRIN1;FARSB;KCNC2;GRIN2B
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.6493395631415659,-1.0523810848565884,0.4788732394366197,1.0,1.0,2/6,33.99%,DDX18;WDR12
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.6467951138792374,-1.0521171107424112,0.4230769230769231,1.0,1.0,4/8,24.53%,NIBAN2;CFL1;NR2C2;RACK1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.5089374011841996,-1.0519158517796454,0.44086021505376344,1.0,1.0,7/49,12.80%,TGFB2;TGFB1;SMAD6;USP15;TGFBR1;RPS27A;JUN
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.6982968858848526,-1.0515907373277176,0.3924050632911392,1.0,1.0,4/6,29.19%,TERF2IP;PARP1;POT1;TERF1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.6034484330411256,-1.0511272364669015,0.34523809523809523,1.0,1.0,4/18,12.90%,TGFB1;GLUL;LATS2;SIN3A
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.6091878264651448,-1.0505879450406204,0.4155844155844156,1.0,1.0,4/15,8.52%,TSC2;TGFB2;TGFB1;IFT122
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.6091878264651448,-1.0505879450406204,0.4155844155844156,1.0,1.0,4/15,8.52%,TSC2;TGFB2;TGFB1;IFT122
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.4192910177433976,1.0504500578683433,0.375,0.9731736324772428,1.0,9/37,10.47%,LMOD1;CSRP2;CDC42BPB;OBSCN;MYH9;ITGB5;RHOA;EPB41L5;ITGB1
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.6560328650379315,-1.0503936620617664,0.4473684210526316,1.0,1.0,3/7,22.25%,SNX6;ERRFI1;PPARA
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.5423706293791466,-1.0499170083565783,0.4024390243902439,1.0,1.0,9/28,30.21%,FGFR2;CEP57;HNRNPF;MAPK1;GRB2;SETX;NCBP1;SPRED1;POLR2F
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.5851241030242552,-1.0496921627560103,0.39759036144578314,1.0,1.0,1/14,0.35%,WWC1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.48410557261832676,-1.0489664578964644,0.4375,1.0,1.0,26/107,19.46%,WASF3;SLC2A1;ANK3;RHOJ;WIPF1;WASF1;ELOB;TGFB1;NAPG;LIMA1;PARVB;RAD21;SPG7;DARS1;WDR19;FANCC;ZFYVE27;PPARGC1A;TEAD1;MDM4;RIMS1;LIN7A;PAWR;MDM2;ST13;TSPAN4
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.6272785131211014,1.0488360160179253,0.46153846153846156,0.9740796054890636,1.0,3/5,25.46%,NUMA1;SMC6;SIRT2
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.6383555483089466,-1.0487839712305513,0.4,1.0,1.0,4/11,26.66%,UBA5;NAE1;UBA1;DESI2
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.6458780107441892,-1.0486532328317362,0.4578313253012048,1.0,1.0,2/8,18.77%,WASF1;PID1
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.5769356910364076,-1.0484516431985158,0.3793103448275862,1.0,1.0,7/32,14.45%,MID1;CD44;NCAM1;MT2A;GBP2;RPL13A;CAMK2D
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.478106247782296,1.0483913750994505,0.47058823529411764,0.9723410995474958,1.0,1/17,0.51%,SNAP29
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.4772585695028302,-1.0481536055806528,0.4,1.0,1.0,39/139,25.02%,CSF1;PRSS23;ELOB;PSMB1;FBXL13;RHBDD1;CST3;PSMD14;RBX1;FBN1;HIF1A;PSMA4;PSMB2;TF;RBBP7;KLHL2;WSB1;MGAT4A;PSMA7;HIF3A;CP;IGFBP5;NAE1;VCAN;KLHL5;P4HB;FBXO22;BTRC;SKP1;CCN1;WDTC1;FSTL1;DCAF5;ITIH2;RAB11A;APP;PSMA3;TGOLN2;FBXL4
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.6695006254699054,-1.0479368457083196,0.5362318840579711,1.0,1.0,3/7,20.44%,TGFB1;UHMK1;NEDD4
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),-0.6905898192590656,-1.0478826781330228,0.41935483870967744,1.0,1.0,2/5,5.71%,SRA1;TGFB1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.6777495640531241,-1.047405429794374,0.4461538461538462,1.0,1.0,3/5,32.23%,ACADL;ACADVL;ETFDH
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.6646128355216072,-1.047228883563078,0.4430379746835443,1.0,1.0,4/8,28.52%,NFKBIA;PTPN2;LPL;ITGAV
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),-0.561614181790014,-1.047049493192654,0.42857142857142855,1.0,1.0,8/20,33.04%,NIBAN2;CFL1;NR2C2;INSR;CLASP2;TRIP12;SEPTIN7;B4GALT5
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.4766081920984011,1.0470448482693762,0.35,0.972269903189222,1.0,1/8,2.18%,GRIN2A
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.7119658627310372,-1.0469425671567643,0.37142857142857144,1.0,1.0,1/5,13.35%,GNAL
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.6836860600514159,-1.0465671877706193,0.4657534246575342,1.0,1.0,2/7,19.27%,HIF1A;SYBU
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.6064811516340133,1.0463872056928674,0.46875,0.9610999391850801,1.0,3/5,16.51%,ATM;TPR;APC
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.6064811516340133,1.0463872056928674,0.46875,0.9610999391850801,1.0,3/5,16.51%,ATM;TPR;APC
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.6064811516340133,1.0463872056928674,0.46875,0.9610999391850801,1.0,3/5,16.51%,ATM;TPR;APC
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.6064811516340133,1.0463872056928674,0.46875,0.9610999391850801,1.0,3/5,16.51%,ATM;TPR;APC
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.6069247919183204,-1.0462795378371397,0.4430379746835443,1.0,1.0,3/12,15.16%,RPA1;RPS27A;POLK
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.6611173918941423,-1.0458267264598207,0.43661971830985913,1.0,1.0,1/8,1.19%,ZFP36L2
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.5965916648592995,-1.045797029012945,0.4358974358974359,1.0,1.0,8/15,33.40%,TGFB1;AP2A1;NEDD4;SNX25;UVRAG;AP2B1;AP2A2;AP2M1
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.5048809311929285,-1.045737618458081,0.4270833333333333,1.0,1.0,17/88,13.99%,TWIST1;CSF1;F3;RIPOR1;VEGFA;TGFB1;SOD2;CCAR1;SDCBP;STAT3;CEMIP;SEMA3B;TGFBR1;PDGFD;ROCK2;HSPA5;PPP3CA
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.541290674071574,-1.0457292722214033,0.3977272727272727,1.0,1.0,6/31,8.57%,CD44;EPHA7;VEGFA;TGFB1;ITGA5;ENPP2
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),0.5497884433950633,1.0455782463753849,0.36666666666666664,0.960077665299734,1.0,2/8,4.97%,PTGES3;PLA2G4C
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.5919271646090505,-1.0454784606071204,0.41975308641975306,1.0,1.0,4/13,12.96%,NRCAM;ZC4H2;SIN3A;TCF4
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.6989361452149174,-1.0454524118087172,0.4927536231884058,1.0,1.0,1/5,4.68%,RUBCN
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.5625041136930189,1.045100819033242,0.4,0.9580758320434216,1.0,2/8,3.99%,SOX5;SOX6
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5774743916452688,1.0444855677667024,0.4444444444444444,0.9565628932647977,1.0,1/10,1.09%,RYR2
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.6599468195462965,-1.043944497944162,0.4868421052631579,1.0,1.0,4/10,22.89%,IFITM3;UBE2K;IRF1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.5285671141142191,-1.0438805924938386,0.3829787234042553,1.0,1.0,12/43,23.34%,CSF1;VEGFA;NFKBIA;TGFB1;MT3;CHCHD2;NSF;PID1;SFRP4;AKR1C1;PPARA;GRB2
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.5245310266455753,-1.0435811149792031,0.42045454545454547,1.0,1.0,7/49,9.93%,COL4A6;TGFB2;COL11A1;P4HA3;COL6A3;PXDN;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6336892345554005,-1.0434672974421664,0.4875,1.0,1.0,3/10,20.61%,TGFB1;PTBP2;NCOR2
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.5788844795833865,-1.043296868063259,0.44155844155844154,1.0,1.0,4/17,11.89%,KDM1A;UBA5;UFSP2;RUNX1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.5491032453014639,-1.0432190872997467,0.3950617283950617,1.0,1.0,5/23,19.43%,FADS2;ACSL4;HSD17B4;GPX4;ACADL
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.4998596272390752,-1.043093653170476,0.47959183673469385,1.0,1.0,24/64,27.91%,TENM3;TGFB2;GPM6A;STMN1;PLP1;HDGFL3;RUNX1;MICALL2;ZFYVE27;DTNBP1;UHMK1;BTG2;NEDD4;ATP8A2;NLGN1;RAB11A;GPM6B;THOC2;PTPRM;APP;LYN;UGCG;MYT1L;LAMB1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.7021810563389682,-1.0427803353009053,0.4927536231884058,1.0,1.0,1/5,8.77%,SMCHD1
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),-0.5478366965367999,-1.0426727941978875,0.4431818181818182,1.0,1.0,3/31,5.31%,ROBO2;OMG;ROBO1
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.5473418382895325,-1.042645237638021,0.449438202247191,1.0,1.0,9/33,12.80%,CSF1;CD44;TGFB1;PTPN1;CD38;STAT3;MAP3K8;PTPN2;JUN
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.5198554201566109,-1.0426165629778004,0.46511627906976744,1.0,1.0,11/40,16.03%,ELAVL3;CRMP1;PHYHIPL;DCLK1;DNER;PLEKHH2;PLP1;NXPH1;ARNT2;SNAP91;GFAP
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.5790856194701316,-1.0425974214569766,0.5063291139240507,1.0,1.0,7/20,24.86%,SYT1;DNAJC6;SNAP91;GAK;NLGN1;DNM3;SYNJ2
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.54153912988662,-1.0425188062015696,0.4625,1.0,1.0,7/21,24.45%,TRMT9B;NSUN6;DTWD2;TRMT13;SSB;TYW1B;WDR6
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.5748058368955284,-1.0423855315137747,0.475,1.0,1.0,6/19,9.93%,ZFPM1;ROBO2;TGFB2;ROBO1;ZFPM2;TGFBR1
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),-0.6498931778177081,-1.04214972056169,0.47058823529411764,1.0,1.0,3/9,11.89%,PRKCB;ELF1;RUNX1
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.6862016227087175,-1.0415066319427393,0.4868421052631579,1.0,1.0,1/7,2.34%,CAMKMT
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.5887744281800302,-1.0414757555312086,0.475,1.0,1.0,4/20,9.93%,VEGFA;TGFB2;TRAF3IP1;TGFBR1
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),-0.6967212235211702,-1.041132613630979,0.4507042253521127,1.0,1.0,1/5,3.63%,TSC2
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.5514939760592592,1.0408977627443117,0.45161290322580644,0.9633095319385022,1.0,2/6,10.35%,GUCY1B1;GUCY1A1
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.6229503127935548,1.0405668985017562,0.4230769230769231,0.9607812224795871,1.0,1/5,4.09%,ATM
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),-0.5446218626876946,-1.0399934850724142,0.45348837209302323,1.0,1.0,12/31,19.92%,KCNE4;KCND2;ATP1B3;KCNQ3;KCNQ1;SLC12A6;SLC9A9;ABCC9;KCNH7;NALCN;KCNQ5;KCNC2
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.5255084895915059,-1.0393231043482245,0.47619047619047616,1.0,1.0,6/26,14.55%,ELAVL3;PHYHIPL;SNAP25;NXPH1;NR4A2;SNAP91
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.513020938329646,-1.039163704205879,0.49473684210526314,1.0,1.0,11/47,14.71%,NRG1;VEGFA;LGALS3;RPA1;TGFB1;DDX3X;RBX1;RAP1B;SPIDR;PARP1;CLU
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.6725553262478069,-1.0386082025509469,0.49333333333333335,1.0,1.0,2/5,12.86%,KCNQ1;SGK1
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6787939119579867,-1.0385781588217398,0.4657534246575342,1.0,1.0,2/5,19.71%,STMN1;PAK1
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.6739145202776775,-1.0385084745346589,0.5211267605633803,1.0,1.0,4/7,25.79%,GPR137C;LARS1;RRAGB;SIK3
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.6304404874881905,-1.038298416449596,0.4605263157894737,1.0,1.0,3/10,12.27%,NCKAP5;STMN1;CFL1
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.4904093367229764,1.0382103989715317,0.3076923076923077,0.9645182703123819,1.0,1/13,0.29%,ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.6369905043697717,-1.0379954032520822,0.4666666666666667,1.0,1.0,3/9,24.03%,EAPP;SUPT16H;TCERG1
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.5889094270010062,-1.0378711950891357,0.4533333333333333,1.0,1.0,6/10,30.17%,BACH2;RSRC1;NEMF;MALT1;NCBP1;NUP205
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.6235051081186688,-1.0377836059977328,0.4722222222222222,1.0,1.0,3/10,13.49%,VEGFA;AFDN;RGCC
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.55392897338013,1.0373304626930697,0.47368421052631576,0.9638178299308452,1.0,1/9,4.09%,ATM
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.5078357683701613,-1.0370592864127952,0.4318181818181818,1.0,1.0,15/69,15.53%,ANKH;ETV5;EMP1;GLRX;TOR1AIP2;CFH;SNAP25;CA2;SEMA3B;GYPC;CMKLR1;PTBP2;ALDH1A2;SNAP91;AKAP12
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.6843613078449424,-1.036901280809983,0.4444444444444444,1.0,1.0,4/6,27.61%,TGFB1;ALDH1A2;ARL13B;PTCH1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.5751808526199164,-1.0367573586163383,0.4090909090909091,1.0,1.0,5/20,14.58%,GLRB;GABRE;SLC25A3;SLC1A1;SLC12A6
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.6272319242226222,-1.0367258065501697,0.4634146341463415,1.0,1.0,6/9,35.56%,IL18;SCARB1;LPL;RORA;NR1H3;ANGPTL4
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.543106442749867,-1.0365568717703029,0.42857142857142855,1.0,1.0,4/28,15.94%,PLAA;NEDD4L;SGK1;RAB27A
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.5337701330039072,1.0363643943940535,0.3076923076923077,0.9629659515428823,1.0,1/9,0.75%,SCN1A
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.5729813001121569,-1.0363369335206447,0.4074074074074074,1.0,1.0,5/15,7.94%,TWIST1;ROBO2;ROBO1;TGFB1;SMAD6
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.6213660283313112,1.0360020249279043,0.47368421052631576,0.9610934089616393,1.0,2/5,9.35%,ATF7IP;HMGB1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.4610311990638625,-1.0355093073490123,0.33,1.0,1.0,107/455,22.54%,HS3ST5;PRAG1;PRKACA;CSF1;PRSS23;CSNK1D;CSNK1G2;WIPI1;GLRX;PDK1;DCLK1;SSH1;CSNK1A1;TGFB2;ELOB;PSMB1;CDKL1;PPP1CC;TGFB1;COG7;PARP6;PRKCI;ARF4;FBXL13;PPP2R1B;OXSR1;MAPK6;RHBDD1;PTPRE;PTPRD;PTPN1;CST3;EIF2AK2;SIK2;LATS2;PSMD14;MELK;MANBA;PDK3;STK4;RBX1;FBN1;PRKCB;TGFBR1;HIF1A;MGAT1;NRBP1;PSMA4;PRKDC;PSMB2;GOLGA2;TF;RBBP7;MT3;ROCK2;KLHL2;SGK1;WSB1;MGAT4A;TBK1;PPP2R2A;PSMA7;PPP3CA;PARP1;MAK;HIF3A;CAMK2D;NPC1;CP;DUSP1;UBE2L3;CDK14;STK24;LRRK2;IGFBP5;STRADB;NAE1;TNKS;ATG4B;VCAN;CAMKK2;MAN2A1;KLHL5;P4HB;FBXO22;PRKAG2;BTRC;SKP1;PAK1;MAPKAPK2;CCN1;SERP1;EIF2AK4;MTMR2;TRIOBP;METAP1;WDTC1;MAPK1;FYN;TAOK3;FSTL1;MINK1;PPP2R3A;STK39;DCAF5;ITIH2;RAB11A
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.6384414915948874,-1.0354799498738367,0.49382716049382713,1.0,1.0,2/9,18.77%,WASF1;PID1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.456530934834812,1.0354535881003608,0.36363636363636365,0.9595739032061886,1.0,2/17,4.01%,HDAC9;CDC42
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.6655967347508672,-1.0354310169238017,0.4578313253012048,1.0,1.0,4/7,28.71%,NMNAT2;CMPK1;AK4;NMNAT3
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),-0.6468592757325639,-1.0352494072159544,0.4864864864864865,1.0,1.0,2/7,20.55%,SGK1;EIF2AK4
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.40035961995950664,1.0351503819125447,0.5454545454545454,0.9571990720673096,1.0,2/24,1.28%,PGF;ADGRA2
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.6948357453923026,-1.035032033249401,0.4810126582278481,1.0,1.0,1/5,3.69%,ANK3
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.6100868029517361,-1.0350279623744922,0.47297297297297297,1.0,1.0,2/11,15.24%,ACOT11;ACBD6
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.5999831251117153,-1.0350259509394921,0.4457831325301205,1.0,1.0,4/16,14.58%,GLRB;GABRE;SLC1A1;SLC12A6
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.5545585415155909,-1.0347539507486911,0.4659090909090909,1.0,1.0,7/25,25.91%,CRY1;STAT3;ROCK2;IGFBP5;STAT6;STAT1;IRS1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.6241907611882055,-1.034649757700171,0.5263157894736842,1.0,1.0,2/9,13.38%,KDM1A;DNMT1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.6719360923612838,-1.034648790386655,0.52,1.0,1.0,1/7,5.20%,TMSB4X
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.6857870556131708,-1.0343186406614668,0.4666666666666667,1.0,1.0,1/5,15.70%,LRRK2
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.5798943063628041,-1.034024768445062,0.4675324675324675,1.0,1.0,2/18,2.60%,TBC1D20;RIPOR1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.4955725228774872,-1.0340166808537035,0.47191011235955055,1.0,1.0,13/68,15.99%,NR4A3;SSH1;TGFB1;DIAPH1;KCNQ1;RAP1B;SPIDR;IL18;ROCK2;SLC1A1;UBE2L3;LRRK2;IGFBP5
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.5914457665899122,-1.033844089959741,0.47368421052631576,1.0,1.0,2/14,9.90%,PRKACA;PRKAR1A
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.5651153037056473,-1.033812054423556,0.4823529411764706,1.0,1.0,7/21,14.71%,JAM3;DDX3X;SMAD6;TRAF3IP1;RPL13A;HSPA5;CLU
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.46541454332562127,1.0332627224262965,0.4375,0.9598286266743595,1.0,3/11,9.24%,HDAC9;ELK4;HDAC1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.6608883867272947,-1.0330944691993331,0.47761194029850745,1.0,1.0,1/11,2.73%,WIPI1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.4692760117815105,-1.0329539776281282,0.33,1.0,1.0,97/383,24.13%,WWC1;TAF7;TWIST1;ETV5;NR4A3;KDM1A;KLF2;ZFPM1;LPIN1;VEGFA;PLAG1;MYDGF;TGFB2;KANSL3;NFKBIA;HDAC2;EAPP;AKIRIN1;TGFB1;GRIN1;ARF4;RARB;TET3;DDX3X;CDC5L;ZFPM2;FGFR2;GLIS3;STAT3;KLF15;TP63;ACTR3;RPS27A;HIF1A;HIVEP1;RNF111;SREBF1;IL18;HSF2;ELF1;PAXBP1;PRKDC;RUNX1;MED14;PLAGL1;NCOA7;CLOCK;JUN;SIN3A;TCF4;ATF6;RGCC;TBK1;ARNT2;PPP3CA;CHCHD2;PARP1;NR4A2;PPARGC1A;SENP1;TEAD1;CALCOCO1;TNKS;RNF10;MYSM1;SMARCA1;TET1;CEBPZ;PRDM10;AGO2;PID1;NAMPT;PER1;FUBP3;CCN1;PTOV1;NFIX;BMP5;CRLF3;CCNK;STAT6;PPARA;IRF1;TP53BP1;NR2C2;BCLAF3;JUNB;STAT1;ELK3;PPP3CB;DCN;SUPT16H;CCNC;TCERG1;APBB1;APP;RORA
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.5773556624386611,-1.0327324082005844,0.4891304347826087,1.0,1.0,7/23,19.12%,SMOC1;TGFB2;FBN1;ATF6;LAMA1;RAB18;CPAMD8
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.6270444252723985,-1.0323756438282872,0.47368421052631576,1.0,1.0,2/9,15.70%,NECTIN2;LRRK2
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.6533875869374179,-1.0323095755537464,0.4594594594594595,1.0,1.0,3/8,22.25%,GRIN1;RAB27A;PPARA
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.6294033267585645,-1.0319810149828683,0.5131578947368421,1.0,1.0,1/11,1.72%,SYT1
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.5621194848615143,-1.031884012069207,0.44047619047619047,1.0,1.0,5/21,18.03%,ROBO2;ROBO1;GOLGA4;ZFYVE27;SEMA4D
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.6586708200728751,-1.0314207801282929,0.4861111111111111,1.0,1.0,2/6,23.07%,COLEC12;RIOK3
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.5950493133380663,-1.0311787262860184,0.47058823529411764,1.0,1.0,7/15,23.71%,SYT1;SNAP25;RIMS2;RIMS1;LIN7A;SYN3;STXBP1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.5923225902995741,-1.031137948573461,0.4634146341463415,1.0,1.0,7/13,21.72%,MLPH;FGFR2;CEBPD;HIF1A;RUNX1;CD9;BTG1
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.6159598257063907,-1.0308658238976205,0.47435897435897434,1.0,1.0,2/11,17.74%,TUT7;AGO2
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),-0.6249988246253668,-1.0307232377373918,0.4266666666666667,1.0,1.0,2/8,18.32%,SLC2A1;PRKAG2
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.5725751653860335,-1.0306959339630555,0.4444444444444444,1.0,1.0,3/13,10.88%,PTRH2;ITGA5;ANKRD13C
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.5151656413421561,-1.0306810866491753,0.3854166666666667,1.0,1.0,15/67,23.47%,TAF7;HDAC2;RPA1;TP63;RBBP7;SGK1;MDM4;PRKAG2;WRN;MDM2;RPL5;MAP2K6;RNF34;RPL37;SUPT16H
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.5129747457331202,-1.0306385778455036,0.4175824175824176,1.0,1.0,16/43,30.78%,F3;ROBO1;DDX3X;IFT57;SENP1;ARL6IP5;MALT1;RACK1;CASP8AP2;BEX3;ANP32B;GSN;APAF1;COL4A3;SLC22A2;ST18
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.5993133009581622,-1.030355465401995,0.5,1.0,1.0,3/10,18.70%,KDM1A;WRN;MDM2
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.47655195365041414,-1.0302997130147715,0.45161290322580644,1.0,1.0,39/91,31.84%,DUT;PGK1;HDAC2;RPL34;PSMD14;CCT4;PABPC1;PSMA4;PSMB2;SLC25A3;HNRNPC;ETF1;EIF2S2;PSMA7;RPL18;EIF1AX;LDHA;UBE2L3;PWP1;NAP1L1;TRA2B;GLO1;SSB;DDX21;TARDBP;EPRS1;RACK1;RAD23B;VDAC1;RPS2;DDX18;NCBP1;HSP90AB1;PSMD1;XRCC6;SRSF2;DHX15;PSMC6;CANX
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.6202590166524691,-1.0302440024999044,0.5,1.0,1.0,4/9,21.11%,PLAA;PTGR1;AKR1C2;AKR1C1
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.5112662335993111,1.0296340887242692,0.4583333333333333,0.9629260110964635,1.0,4/12,17.24%,NOTCH1;TBX2;MEF2C;SETDB2
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.5112662335993111,1.0296340887242692,0.4583333333333333,0.9629260110964635,1.0,4/12,17.24%,NOTCH1;TBX2;MEF2C;SETDB2
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.6010601866600708,-1.0295766452945592,0.48,1.0,1.0,5/15,10.96%,TSC2;PTPRE;PTPN1;PRKCB;PTPN2
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.5164783580339694,1.0294963428323847,0.48148148148148145,0.9600826310658056,1.0,2/9,6.64%,MECOM;SETD7
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.5483646150557495,-1.0293700620220283,0.4625,1.0,1.0,5/28,8.44%,WIPI1;PIGL;DPM1;GLUL;PIGG
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.5756733455065163,1.0285131202483766,0.5185185185185185,0.9595073991485912,1.0,1/6,2.23%,HEY2
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.6669222079269912,-1.0284542926299345,0.5571428571428572,1.0,1.0,1/7,0.98%,GJA1
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.5390200830707556,-1.028337773400496,0.4523809523809524,1.0,1.0,9/39,15.70%,OMG;SOD2;ALDH1L1;CD38;PLD1;SGK1;ANKUB1;CP;LRRK2
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.47095081987438603,-1.0275786327764074,0.4444444444444444,1.0,1.0,47/165,26.55%,PELI1;RNF19A;MARCHF6;PSMB1;HERC6;FBXL13;BLMH;ARIH2;PSMD14;RBX1;RPS27A;NEDD4L;PSMA4;AMFR;PSMB2;WSB1;ZNRF1;PSMA7;SASH1;UBE2J1;UBE2L3;WWP1;TNKS;LNPEP;UBE2B;ANAPC4;FBXO22;TRIM5;BTRC;MDM2;SKP1;RNF213;RNF168;NEDD4;UBE2K;HECW1;SMURF2;BIRC2;RNF34;DZIP3;MARCHF1;PSMA3;FBXL4;MARCHF8;SIAH1;FBXL7;HECTD2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.6326137163474379,-1.027376255729027,0.4177215189873418,1.0,1.0,4/11,19.86%,PDCD4;PRKCI;RGCC;SFRP4
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.5533532752421702,-1.027035661214633,0.4868421052631579,1.0,1.0,3/25,14.45%,SYT1;ADGRV1;CAMK2D
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.6421646283732996,-1.026522973873428,0.5131578947368421,1.0,1.0,4/7,23.90%,TGFB2;WNT2B;CSDE1;KITLG
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.5388820142708501,-1.0259464442473774,0.4819277108433735,1.0,1.0,3/16,11.98%,CSNK1D;HDGFL3;GOLGA2
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.6924414965827604,-1.0257899623338338,0.425,1.0,1.0,3/5,29.19%,TERF2IP;POT1;TERF1
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.5579373776405007,-1.0256017254339813,0.4666666666666667,1.0,1.0,6/25,20.44%,PELI1;ARIH2;UBE2B;TRIM5;RNF168;NEDD4
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.53364996257788,-1.0255963901990561,0.4810126582278481,1.0,1.0,5/29,12.05%,PRKACA;SELENOS;ADM;PRKAR1A;ADORA2B
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.5760878729446299,-1.0255915550628691,0.49411764705882355,1.0,1.0,4/14,15.08%,LIMA1;PLEKHH2;HDGFL3;NAV3
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.6385980953326391,-1.0253940990043706,0.5189873417721519,1.0,1.0,1/11,3.40%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3751746219715596,1.025025140799999,0.35294117647058826,0.9655437116029879,1.0,2/38,1.30%,HSPA1A;LEMD3
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),-0.6066353444433927,-1.02497429506771,0.4642857142857143,1.0,1.0,3/11,19.54%,INTS8;INTS4;INTS2
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.6095642052311534,1.0248233302998702,0.45454545454545453,0.9597913609769024,1.0,1/5,0.80%,ARHGEF10L
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.6095642052311534,1.0248233302998702,0.45454545454545453,0.9597913609769024,1.0,1/5,0.80%,ARHGEF10L
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.4757982615771629,-1.0247674855806896,0.43010752688172044,1.0,1.0,20/110,14.20%,TTC8;RTTN;PTPDC1;NUDCD3;ARMC2;DCDC2;GALNT11;ARF4;LZTFL1;TRAF3IP1;IFT122;ARMC9;CCP110;ACTR3;IFT52;IFT140;EXOC1;ATP6V1D;MAK;WDR19
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),-0.6405574396906413,-1.0246451204775078,0.43037974683544306,1.0,1.0,2/8,21.83%,RAP1B;MINK1
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),-0.6405574396906413,-1.0246451204775078,0.43037974683544306,1.0,1.0,2/8,21.83%,RAP1B;MINK1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.6846182964114478,-1.0246141294729798,0.49333333333333335,1.0,1.0,3/6,22.12%,OXSR1;ADAM17;STK39
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.48723514374720484,-1.0246112994730965,0.41237113402061853,1.0,1.0,22/96,21.51%,ELAVL3;SYT1;PCBP3;PHYHIPL;DHRS3;DNAJC6;HIVEP2;CCN2;SNAP25;PRKCB;CCK;DLGAP1;TRIM9;NXPH1;SNAP91;ZIC4;ACSL4;KCNQ5;GABBR2;KCNC2;NBEA;CADM2
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.6053257987279517,1.0245572629469168,0.4411764705882353,0.9576027518751268,1.0,4/5,30.75%,PRKAA1;BMP6;SCAP;FGF1
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.5721614730017994,-1.0245293567335994,0.49382716049382713,1.0,1.0,5/17,14.74%,ATP6V1E1;ATP6V1G1;ATP6V1H;ATP6V1D;RAB7A
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.5115004145394111,-1.0244997158447828,0.4827586206896552,1.0,1.0,6/40,13.67%,AKIRIN1;GPM6A;CCP110;ACTR3;CDC42EP4;TAPT1
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.7003736318909248,-1.023975442805639,0.4576271186440678,1.0,1.0,1/5,11.98%,GOLGA2
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.4063315661255229,1.0238798941908596,0.38461538461538464,0.9564754627901735,1.0,5/35,6.42%,HSPA1A;MECOM;VPS35;CHMP4B;NCK1
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.565037799194135,-1.0235240635542158,0.46987951807228917,1.0,1.0,8/24,19.33%,APIP;SOD2;GRIN1;FARSB;GOLGA2;ALDH1A2;TRPA1;APPL2
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.5685997892404032,-1.0234137515076391,0.4166666666666667,1.0,1.0,5/18,7.94%,TWIST1;ROBO2;ROBO1;TGFB1;SMAD6
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.6509893293822099,-1.0232307779456216,0.4857142857142857,1.0,1.0,2/6,12.29%,SLC39A11;MT3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.5503821980703101,-1.023209414929127,0.5529411764705883,1.0,1.0,9/26,25.87%,TGFB2;FGFR2;ANKRD17;RGCC;CDKN1B;MDM2;ADAM17;APP;EGFR
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.6732943244766869,-1.0231880886145273,0.5263157894736842,1.0,1.0,2/6,12.00%,MINPP1;PPA1
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),-0.6908410315475697,-1.0230273865739639,0.5138888888888888,1.0,1.0,4/5,30.94%,APP;ABL1;PTN;EPHA4
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.5404450851224936,-1.0228957060179296,0.5116279069767442,1.0,1.0,3/23,13.57%,SEC13;NUP133;PPP2R2A
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.5404450851224936,-1.0228957060179296,0.5116279069767442,1.0,1.0,3/23,13.57%,SEC13;NUP133;PPP2R2A
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.6751630640422236,-1.022849445345753,0.5,1.0,1.0,1/5,1.96%,ZFPM1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.676233264553574,-1.0218855633483785,0.44285714285714284,1.0,1.0,3/5,26.10%,RBX1;SKP1;FBXL7
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5126535466537754,1.0218279449781706,0.39285714285714285,0.9590554423057794,1.0,2/13,2.97%,ERBB4;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.5454872573232591,-1.0217819196101756,0.5238095238095238,1.0,1.0,7/26,15.70%,EFNB2;DDIT4;MT3;TRIM13;CDKN1B;CLU;LRRK2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.5175993473418986,-1.0212849690267642,0.5119047619047619,1.0,1.0,8/33,18.40%,ANK3;STXBP6;GGA3;EXOC1;GOLGA4;VAMP5;PREPL;NSF
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.49898239850918863,1.0207594408145755,0.47368421052631576,0.9582578690677996,1.0,2/11,8.53%,CDC42;RHOA
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.47669621804261453,1.020627235385429,0.631578947368421,0.9557154762709192,1.0,1/21,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.5758451195481954,-1.0201522806111147,0.5121951219512195,1.0,1.0,8/19,28.65%,PABPC1;ANGEL2;HNRNPC;ELAVL1;MAPKAPK2;TARDBP;YBX3;YBX1
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.6233332528506037,-1.0200518606296543,0.5205479452054794,1.0,1.0,4/8,29.53%,ASPA;DLD;AASS;ALDH7A1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.6770473696160737,-1.019882303369441,0.5,1.0,1.0,2/6,11.53%,SMCHD1;PRKDC
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.5589989731659116,-1.019161615166752,0.5061728395061729,1.0,1.0,3/24,6.16%,NRCAM;DNER;GPM6A
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.5069923817593153,-1.0189243747221002,0.5056179775280899,1.0,1.0,14/53,14.89%,TP53TG5;ENO1;GJA1;FHL1;TGFB2;TGFB1;MT2A;DDX3X;ESR2;RBBP7;MT3;CDKN1B;TSPYL2;NOTCH2
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.5986036881982951,-1.0188752558876168,0.4875,1.0,1.0,2/7,4.25%,ZFPM1;TGFB2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.47044166246622077,-1.0188380329253537,0.46464646464646464,1.0,1.0,47/180,26.10%,OS9;PELI1;RNF19A;PLAA;MARCHF6;PSMB1;ARIH2;PSMD14;RBX1;NEDD4L;RNF111;PSMA4;TRIM9;AMFR;PSMB2;APPBP2;CLOCK;ZNRF1;PSMA7;TRIM13;NDFIP2;UBE2L3;WWP1;UBAP1;NPLOC4;UBE2B;ANAPC4;FBXO22;BTRC;MDM2;RNF213;RNF168;NEDD4;UBE2K;NDFIP1;OTUD7A;HECW1;SMURF2;BIRC2;RNF34;RCHY1;PSMA3;RAD23B;FBXL4;UBA1;SIAH1;FBXL7
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.5742259740208319,1.0187248433366374,0.5,0.9575052784231783,1.0,3/7,20.02%,ACTB;APPL1;ZDHHC2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.6304270243958503,-1.0187169308349464,0.5138888888888888,1.0,1.0,1/8,1.25%,NR4A3
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.4946320969351078,-1.0186413391226525,0.4725274725274725,1.0,1.0,17/59,25.91%,PDE4B;MGST1;SELENOS;PLAA;PDCD4;CTR9;PDK3;ROCK2;UBE2L3;PID1;ADNP2;LPL;RORA;SETX;LYN;EGFR;IRS1
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.6045232135233516,1.0184131574481228,0.4473684210526316,0.9554229124252717,1.0,1/5,5.61%,LARGE1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.7006736885778759,-1.0182837457787257,0.5066666666666667,1.0,1.0,2/5,18.05%,P4HA3;P4HB
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.7006736885778759,-1.0182837457787257,0.5066666666666667,1.0,1.0,2/5,18.05%,P4HA3;P4HB
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.5779189907791354,-1.0181889253372092,0.5063291139240507,1.0,1.0,5/17,13.28%,CD44;CREB3L2;TGFB1;RUNX1;WNT2B
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.6183521473897027,-1.0181190340796764,0.5,1.0,1.0,3/10,9.50%,CDH20;CDH18;CDH12
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.4619020736511359,-1.0179613808350154,0.47,1.0,1.0,38/145,21.27%,TWIST1;CSF1;GJA1;KLF2;F3;VEGFA;NOS1AP;ANK3;ROBO1;TGFB1;OLFM1;DDX3X;PTPN1;CTCF;STAT3;AFDN;KRAS;RIMS2;TGFBR1;HIF1A;MT3;ROCK2;DNMT1;RGCC;CLU;PPARGC1A;CALCOCO1;RAB27A;RIMS1;DTNBP1;AGO2;NSF;PID1;FUBP3;SFRP4;WARS1;RPL5;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.6636706164175412,-1.017946882716055,0.5277777777777778,1.0,1.0,1/8,3.40%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.6338125034729397,-1.0177596007930705,0.5194805194805194,1.0,1.0,3/8,29.03%,DDIT4;EIF4G1;SPRED1
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.4576159358455238,1.0176828837043017,0.4,0.9541466662451157,1.0,4/27,7.81%,ATP10A;PRELID2;ABCA3;ATP8B2
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.4537626319729336,-1.0175684505355305,0.41,1.0,1.0,67/246,26.10%,OS9;PELI1;RNF19A;SELENOS;UVSSA;MARCHF6;ELOB;PSMB1;HERC6;FBXL13;BLMH;ARIH2;CTR9;PSMD14;RBX1;RPS27A;NEDD4L;HIF1A;RNF111;UBR1;KLHL7;PSMA4;PRKDC;AMFR;PSMB2;RTF1;KLHL2;WSB1;WAC;ZNRF1;PSMA7;SASH1;TRIM13;UBE2J1;HIF3A;UBE2L3;WWP1;BRAP;TNKS;LNPEP;RNF10;UBE2B;FBXO22;TRIM5;BTRC;MDM2;SKP1;RNF213;RNF168;NEDD4;UBE2K;HECW1;SMURF2;BIRC2;RNF34;TRIM23;RCHY1;DZIP3;MARCHF1;PSMA3;MARCHF3;RACK1;FBXL4;UBA1;MARCHF8;SIAH1;FBXL7
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.5160030613480119,-1.0172867786585078,0.4888888888888889,1.0,1.0,7/35,10.09%,NR4A3;F3;VEGFA;MYDGF;FGFR2;TGFBR1;HIF1A
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.5638963259080764,1.0172454802152597,0.391304347826087,0.9525266621508705,1.0,3/9,5.61%,ST3GAL2;TNIP1;LARGE1
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.5815106705151644,1.0170983021703024,0.4666666666666667,0.9472196524335182,1.0,1/6,3.03%,IWS1
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.5815106705151644,1.0170983021703024,0.4666666666666667,0.9472196524335182,1.0,1/6,3.03%,IWS1
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.5882520328552934,-1.0170386879225872,0.5,1.0,1.0,1/15,1.81%,HABP4
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.6684684535282805,-1.0169261014721598,0.5454545454545454,1.0,1.0,1/5,9.21%,AFDN
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.4788704020668402,-1.0169196978637698,0.5,1.0,1.0,26/75,26.00%,OXSR1;EIF2AK2;FGFR2;SIK2;MELK;STK4;STK33;MAK;CAMK2D;STK24;LRRK2;FLT1;CAMKK2;UHMK1;PAK1;MAPKAPK2;EIF2AK4;TAOK3;MINK1;STK39;SLK;LYN;INSR;KDR;EGFR;ABL1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.534063114454395,1.0168089143867403,0.5238095238095238,0.9451127280789161,1.0,2/10,12.48%,BCL2;DAB2IP
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.7110734193865272,-1.0167097653696142,0.547945205479452,1.0,1.0,1/5,5.71%,TGFB1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.5111969697020804,-1.0165819280358752,0.47191011235955055,1.0,1.0,17/52,25.87%,TWIST1;TSC2;MYDGF;TGFB2;IL18;PDGFD;UNC5B;FLT1;SEMA4D;NEDD4;MAPK1;DCN;LYN;PIK3CB;INSR;KDR;EGFR
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.632240815205217,-1.0163954041900132,0.5416666666666666,1.0,1.0,4/11,31.92%,HIF1A;APP;INSR;SLC4A4
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.6481844657809029,-1.0163078650982107,0.5070422535211268,1.0,1.0,3/8,15.32%,PPP2R2A;PPP3CA;DUSP1
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.5793674324905242,-1.0160394791839225,0.5189873417721519,1.0,1.0,2/14,3.19%,CD44;CREB3L2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.5307911930186404,-1.0159960536656345,0.4777777777777778,1.0,1.0,8/36,20.63%,TGFB2;TGFB1;SDCBP;TGFBR1;RNF111;ADAM17;CCN1;BMP5
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.4699137965586622,-1.0158737427518585,0.43157894736842106,1.0,1.0,17/89,20.37%,SOD1;MTCH2;PDCD4;ATP1B3;ENPP2;LPCAT3;TANK;CMPK1;GBE1;OMD;SCARB1;YWHAG;DLD;GPX4;REEP5;ACADL;LAMA4
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),-0.6443922251389119,-1.015684395915299,0.5652173913043478,1.0,1.0,3/9,21.09%,SYNDIG1;RAB27A;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.6772397547860073,-1.0156534262671069,0.5588235294117647,1.0,1.0,2/5,27.49%,MTMR2;RDX
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.6176626400118188,-1.015269872936531,0.49382716049382713,1.0,1.0,1/9,0.69%,PRKACA
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.6328313999122102,-1.0149945729771754,0.5138888888888888,1.0,1.0,4/10,31.92%,HIF1A;APP;INSR;SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.6328313999122102,-1.0149945729771754,0.5138888888888888,1.0,1.0,4/10,31.92%,HIF1A;APP;INSR;SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.6316723126584796,-1.0149861662872222,0.4935064935064935,1.0,1.0,4/8,30.94%,ROCK2;CLU;SP1;EPHA4
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,-0.48829338087622465,-1.0137032152078012,0.4666666666666667,1.0,1.0,11/59,15.53%,PCDH17;CRMP1;PHYHIPL;DCLK1;UNC5D;PTPRD;SNAP25;PLD1;ARNT2;SNAP91;AKAP12
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.5406640340942453,-1.0135657950878747,0.4888888888888889,1.0,1.0,3/27,10.35%,NFKBIA;TMSB4X;CMKLR1
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.5290148990837367,1.0135417784912373,0.3333333333333333,0.950832846895386,1.0,1/9,1.44%,TNIP1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.52620423652786,-1.0133931304949553,0.44565217391304346,1.0,1.0,13/40,15.48%,TAF7;GRIN1;SCN3A;SLC6A17;NEDD4L;SLC3A2;SLC36A4;TRPM3;SLC47A1;SGK1;SLC1A1;NDFIP2;ABCC9
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.5577843173579744,-1.0131295249040335,0.5,1.0,1.0,9/16,28.52%,COL11A1;ITGA5;CTR9;RTF1;COL7A1;COL12A1;FN1;LAMB1;ITGAV
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.5204438981946975,1.013082962651593,0.47058823529411764,0.9491316980877087,1.0,4/10,9.56%,CDC42;MYH9;RHOA;GULP1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.5763881434117502,-1.0129754923568732,0.4578313253012048,1.0,1.0,5/20,15.70%,ARIH2;SREBF1;MICALL2;UBE2L3;LRRK2
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.5703520853308627,-1.0129438691142314,0.5125,1.0,1.0,7/21,27.05%,MICOS10;SPG7;AGK;ATP5F1C;DMAC2L;DNAJC11;CHCHD3
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.474491091927376,-1.0126460382257474,0.4631578947368421,1.0,1.0,18/81,14.66%,TP53TG5;ENO1;GJA1;FHL1;TGFB2;TGFB1;SPOCK1;DDX3X;ESR2;SDCBP;TGFBR1;NRG3;RBBP7;MT3;SGK1;CDKN1B;CAMK2D;TSPYL2
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.6993532738368262,-1.0125166387778737,0.5694444444444444,1.0,1.0,2/5,9.93%,TGFB1;TGFBR1
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.6870688491991108,-1.0123602895752244,0.546875,1.0,1.0,1/5,15.11%,COLEC12
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.5007627883007271,-1.0123564612105767,0.4939759036144578,1.0,1.0,11/51,14.05%,PSMB1;RPA1;PSMD14;RBX1;RPS27A;PSMA4;PSMB2;CCNH;TCF4;PSMA7;PARP1
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.5209026469352029,-1.0122547175345105,0.5609756097560976,1.0,1.0,9/36,14.74%,NRG1;VEGFA;LGALS3;TGFB1;SDCBP;SPIDR;RGCC;CLU;RAB7A
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.5104126875814247,-1.012074774335079,0.4895833333333333,1.0,1.0,10/47,11.89%,TAF7;CD44;MGST1;TGFB2;ARID3A;PTPRE;PROCR;CMKLR1;ELF1;RUNX1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.46228787422554335,1.0118945522480636,0.45,0.9492243973435655,1.0,2/19,2.50%,HSPA1A;CDK6
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.5324852797010249,-1.0113885949614476,0.5238095238095238,1.0,1.0,12/29,35.24%,TGFB1;ADM;NEDD4;CD9;DNM3;GRB2;SNX25;UVRAG;CD81;LDLRAP1;AP2M1;DNM1
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.5647302654611769,-1.0113810848146512,0.5308641975308642,1.0,1.0,4/16,15.08%,HOMER2;PDE4B;RUNX1;NAV3
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.521232409926488,-1.0113743485794966,0.4883720930232558,1.0,1.0,11/37,22.33%,CD55;CAMKMT;EFNB2;TMSB4X;ERAP1;STK24;TRIM5;APPL2;METAP1;BIRC2;IRF1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.6018018224649632,-1.0109250110885513,0.46987951807228917,1.0,1.0,2/10,11.89%,ELF1;RUNX1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),-0.5304271029929,-1.0108672837847565,0.4838709677419355,1.0,1.0,9/31,18.16%,GLRB;SLC1A2;GRIN1;TRPM3;SLC1A1;SLC12A6;SLC9A9;ATP11B;TRPA1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.6051569357018205,-1.0108108153226498,0.5714285714285714,1.0,1.0,1/14,1.25%,NR4A3
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.5743504994895071,-1.0107951134559066,0.4823529411764706,1.0,1.0,4/15,14.05%,CD55;LGALS3;IL18;PARP1
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),-0.6248915093784831,-1.0106024108059461,0.6052631578947368,1.0,1.0,1/12,1.72%,SYT1
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.5134683889521834,1.0105537230912836,0.5,0.9495460060330821,1.0,1/9,3.03%,IWS1
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.48106131107052513,-1.010484922262216,0.47959183673469385,1.0,1.0,27/120,19.91%,CSF1;F3;RIPOR1;VEGFA;PLAA;TGFB2;TGFB1;SOD2;ENPP2;CCAR1;SDCBP;STAT3;CEMIP;SEMA3B;TGFBR1;HIF1A;PDGFD;ROCK2;HSPA5;PPP3CA;FLT1;AGO2;SEMA4D;CCN4;ADAM17;PAK1;CCN1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.5585139247575667,-1.0096136968822238,0.47435897435897434,1.0,1.0,3/16,17.45%,RPS27A;RGCC;ANAPC4
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.5564713291072403,-1.0094813305315937,0.5411764705882353,1.0,1.0,1/21,0.21%,SRGN
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.4654329728611133,-1.00930687942958,0.5102040816326531,1.0,1.0,16/151,10.64%,STX6;GJA1;SEC13;WIPI1;RAB28;ARL5A;COG7;JAM3;NAPG;ARF4;SYNDIG1;SNX6;AP2A1;TBC1D8;USO1;GGA3
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",-0.484965664694364,-1.009278335341595,0.5263157894736842,1.0,1.0,14/71,15.58%,TAF7;NR4A3;TAF1B;CCN2;RARB;ESR2;TBPL1;NRBP1;CCNH;POLR1C;NR4A2;PPARGC1A;NOTCH2;TEAD1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.5594659366381545,-1.0085479411210727,0.5128205128205128,1.0,1.0,3/19,9.95%,AKIRIN1;ENPP2;ACTR3
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.4939327936769869,-1.0082993148394654,0.5108695652173914,1.0,1.0,12/48,22.92%,SEC13;NUP153;NUP133;FYTTD1;NUP88;SRSF5;SYMPK;RANBP2;ALKBH5;SMG7;CPSF2;THOC2
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.4939327936769869,-1.0082993148394654,0.5108695652173914,1.0,1.0,12/48,22.92%,SEC13;NUP153;NUP133;FYTTD1;NUP88;SRSF5;SYMPK;RANBP2;ALKBH5;SMG7;CPSF2;THOC2
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),0.4874792461639591,1.0081718298007567,0.5,0.9525252671512553,1.0,1/10,4.04%,NELFA
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.49842607223383517,-1.007962848918428,0.5056179775280899,1.0,1.0,17/48,24.11%,SYT1;MCTP2;SNCAIP;DGKI;RIMS2;GRIK1;DLGAP1;GRM7;BTBD9;NRG3;LRRK2;RIMS1;GRIK2;NLGN1;SYN3;LRRC4C;APP
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.6295137797133039,-1.0075536374203258,0.5138888888888888,1.0,1.0,2/8,16.31%,ZC3H12B;CSTF3
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.6627174036806643,-1.0075217050489182,0.5352112676056338,1.0,1.0,3/5,26.00%,LRRK2;MAPK1;ABL1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.6627174036806643,-1.0075217050489182,0.5352112676056338,1.0,1.0,3/5,26.00%,LRRK2;MAPK1;ABL1
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.4656482003256071,1.007488104253621,0.41379310344827586,0.9458248494427093,1.0,3/10,11.23%,GATAD2A;ATF7IP;KMT2E
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.4656482003256071,1.007488104253621,0.41379310344827586,0.9458248494427093,1.0,3/10,11.23%,GATAD2A;ATF7IP;KMT2E
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.4656482003256071,1.007488104253621,0.41379310344827586,0.9458248494427093,1.0,3/10,11.23%,GATAD2A;ATF7IP;KMT2E
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.5306900765048769,-1.0073134385964198,0.5340909090909091,1.0,1.0,3/27,10.62%,PIGL;PIGG;AGK
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.5602910324747564,1.0072666714239153,0.45,0.9434104053135546,1.0,3/6,7.84%,ARL6;NOTCH1;DNAH11
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.4666571904379154,-1.0071212189362395,0.5052631578947369,1.0,1.0,37/156,22.49%,OS9;PELI1;SELENOS;PLAA;MARCHF6;PSMB1;FBXL13;PSMD14;RBX1;RPS27A;NEDD4L;UBR1;PSMA4;TRIM9;AMFR;PSMB2;APPBP2;CLOCK;ZNRF1;PSMA7;HSPA5;TRIM13;UBE2J1;WWP1;NPLOC4;UBE2B;ANAPC4;BTRC;MDM2;SKP1;NEDD4;UBE2K;HECW1;SMURF2;BIRC2;NEMF;RNF34
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.6631691761883878,-1.0069635304984546,0.5671641791044776,1.0,1.0,3/5,23.95%,PMP22;CD9;EPB41L3
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.571727015065622,-1.0069470614489842,0.524390243902439,1.0,1.0,6/14,26.42%,ALDH1L1;MTHFD2L;ASS1;MTHFD1L;GCLC;ME2
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.4867609084038392,-1.006754982731475,0.5157894736842106,1.0,1.0,18/84,20.92%,PRAG1;CRMP1;TENM3;EFNB2;HDAC2;SPOCK1;CSMD3;PRKCI;CBFA2T2;CFL1;MT3;LRRK2;LRRC7;KIF13B;ULK4;PAK1;SCARB2;GAK
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.6467707200089714,-1.0066795706320106,0.5609756097560976,1.0,1.0,2/9,10.09%,TGFB1;HIF1A
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.646502284724189,-1.0066113754679256,0.4875,1.0,1.0,3/6,19.02%,NMNAT2;NAXD;NAMPT
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.46663696971312074,-1.006460121845081,0.5151515151515151,1.0,1.0,48/217,22.49%,WWC1;TAF7;ARHGAP15;VAV3;ARHGAP31;WWC2;VEGFA;ARHGAP24;RHOJ;ARHGEF9;NFKBIA;HDAC2;RHOB;TMSB4X;RPA1;DDIT4;STK4;PRKAR1A;TP63;CMKLR1;RASGRF2;FAM13A;RBBP7;ARHGAP5;SGK1;MCF2L;AKAP12;LRRK2;MDM4;ULK4;ITFG2;PRKAG2;WRN;MDM2;ARHGAP28;PAK1;NF2;AKAP13;NLGN1;RPL5;STARD13;MAPK1;TAOK3;PRKAR2A;MINK1;BIRC2;MAP2K6;RNF34
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.6603219977498713,-1.0062720231898434,0.5205479452054794,1.0,1.0,3/7,25.59%,TGFB1;FLT1;KDR
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),-0.6569976980289775,-1.0057009274804332,0.5,1.0,1.0,1/5,9.26%,CCP110
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.6316081511371027,-1.0053814613468561,0.5492957746478874,1.0,1.0,1/6,2.13%,CD44
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.6764116469525486,-1.0047760234760654,0.5070422535211268,1.0,1.0,4/6,26.72%,APPL2;ACADL;WDTC1;ACADVL
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.5134449943813503,-1.0045724679225654,0.5384615384615384,1.0,1.0,6/40,12.05%,PRKACA;LGALS3;ADM;TRAF3IP1;PRKAR1A;ADORA2B
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.5530621899664399,-1.0045609720788455,0.49382716049382713,1.0,1.0,4/16,20.73%,TF;MT3;CP;SLC40A1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.5931546312169407,-1.0045400122336572,0.48717948717948717,1.0,1.0,6/12,29.19%,HNRNPC;PARP1;DCP2;TNKS;POT1;TERF1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.604570428774198,-1.0045002515512325,0.5308641975308642,1.0,1.0,4/10,24.11%,SNX6;ERRFI1;ADAM17;APP
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.6166427127062708,-1.0041691891361024,0.44155844155844154,1.0,1.0,3/11,15.14%,NR4A3;BORCS5;SYTL4
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.5449288596721406,-1.0040713429109784,0.4186046511627907,1.0,1.0,7/21,20.76%,NR4A3;CADM1;LGALS3;CAMK2D;VCAN;ASS1;HLA-B
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.6480040318069362,-1.003978939193934,0.5194805194805194,1.0,1.0,2/8,20.40%,POLA1;XPA
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.6283099131762108,-1.0037982179990195,0.5205479452054794,1.0,1.0,3/8,18.82%,GJA1;SLC47A1;ABCA8
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.5103661054233202,-1.0031532461840682,0.46236559139784944,1.0,1.0,12/41,19.38%,HS3ST5;CHST11;OGN;SLC10A7;CEMIP;DSE;GLCE;OMD;VCAN;CSGALNACT1;GPC4;EXT1
prerank,MSigDB_Hallmark_2020__Coagulation,-0.5029564126597231,-1.0029665107161245,0.4819277108433735,1.0,1.0,11/35,16.96%,PRSS23;F3;CFH;PROS1;ARF4;C1R;FBN1;TF;C1S;CLU;LAMP2
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.5430197180005533,-1.0029058770450765,0.46835443037974683,1.0,1.0,9/32,31.87%,HNRNPL;HNRNPC;WRN;HNRNPF;NT5E;NCBP1;POLR2F;WTAP;DDX24
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.5675107385190357,-1.002699144364161,0.5,1.0,1.0,2/11,6.90%,PTRH2;ITGA5
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.6856656436842576,-1.002560107962464,0.5333333333333333,1.0,1.0,2/5,27.49%,C9ORF72;RDX
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.620277540768116,-1.0024780373322275,0.5416666666666666,1.0,1.0,3/7,28.63%,TERF2IP;TNKS;POT1
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.6841611479033569,-1.0022854197658855,0.5,1.0,1.0,2/5,15.62%,CRACD;WASHC2C
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.5194350331976729,-1.0022012140348102,0.5280898876404494,1.0,1.0,10/34,22.12%,OXSR1;TGFBR1;PRKDC;ROCK2;TBK1;CAMK2D;LRRK2;TNKS;MAPK1;STK39
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.657660662852705,-1.0020260546283635,0.5263157894736842,1.0,1.0,1/6,11.36%,SEC11A
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.633956549880556,-1.0019950716774022,0.5945945945945946,1.0,1.0,4/10,10.35%,CSF1;AKIRIN1;JAM3;CMKLR1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.5605316738768688,-1.0019233200925604,0.5185185185185185,1.0,1.0,4/20,14.58%,GLRB;GABRE;SLC1A1;SLC12A6
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.5531895020745745,-1.001884708493052,0.48148148148148145,1.0,1.0,5/21,19.44%,TGFB1;RHBDD1;ERAP1;APH1B;ADAM17
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),-0.5747639082346746,-1.0015923993811795,0.4578313253012048,1.0,1.0,4/13,7.94%,ROBO2;TGFB2;ROBO1;SMAD6
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.485619925839129,-1.0014732738044205,0.5368421052631579,1.0,1.0,14/61,14.32%,HSPA4L;PRSS23;CD44;HOMER2;PDCD4;OLFM1;ALDH3A2;COX6C;CA2;SEMA3B;AMFR;SGK1;PLAAT3;PRLR
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.5260170334925266,-1.0012284495434594,0.5777777777777777,1.0,1.0,7/35,18.61%,DUT;RPA1;TBRG1;DONSON;NAP1L1;POLA1;WRN
prerank,PanglaoDB_Augmented_2021__Immature Neurons,-0.48750275699050627,-1.0011139383623837,0.4943820224719101,1.0,1.0,14/58,14.55%,FAT3;ELAVL3;EPHA7;ROBO2;PHYHIPL;DCLK1;ROBO1;HIVEP2;SNAP25;PURG;NXPH1;UNC79;SLC1A1;SNAP91
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.4730729495455951,-1.0001402325973041,0.5217391304347826,1.0,1.0,13/78,18.58%,ATP6V1E1;ATP6V1G1;PDHX;NDUFV1;COX4I1;COX6C;HADHA;ATP6V1H;SLC25A3;ATP6V1D;LDHA;DLD;GPX4
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.6257419196308889,-1.000138344172233,0.4931506849315068,1.0,1.0,3/9,25.55%,KCNQ1;CAMK2D;CELF2
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.4733513423318681,0.9999272675707724,0.42857142857142855,0.9602276368439732,1.0,3/10,4.56%,WDFY4;CD4;PPARD
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.49072113547139906,-0.9998240731027831,0.550561797752809,1.0,1.0,10/53,20.55%,KDM1A;NFKBIA;HDAC2;TMSB4X;SUFU;CMKLR1;BTRC;ERBIN;SFRP4;EIF2AK4
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.5301084757683372,-0.9997551600815082,0.5061728395061729,1.0,1.0,3/25,10.43%,IPO5;TGFB1;CCT4
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.4827270515964003,-0.9996921219481177,0.5263157894736842,1.0,1.0,17/82,15.70%,MID1;WWC1;CD44;VEGFA;MYDGF;TGFB2;ROBO1;TGFB1;CCN2;EIF2AK2;FGFR2;PDGFD;MT3;ROCK2;JCAD;NOTCH2;LRRK2
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.5649684479468037,-0.9993130737055582,0.524390243902439,1.0,1.0,1/16,2.78%,VAV3
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),-0.5208650004034132,-0.9992273316438353,0.5057471264367817,1.0,1.0,13/43,26.00%,SYT1;TSC2;PTPN1;RIMS2;PLD1;LRRK2;SCARB1;NSF;MAPK1;RAB11A;RAB8B;RAB12;ABL1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.5216869573827143,-0.9991168293305692,0.5063291139240507,1.0,1.0,8/31,13.78%,PSMB1;EIF2AK2;PSMD14;PSMA4;PRKDC;PSMB2;RUNX1;PSMA7
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.4797936771948951,-0.9989966022084852,0.46808510638297873,1.0,1.0,17/53,25.63%,DDX3X;EIF2AK2;GIGYF2;CNOT8;IGF2BP2;ROCK2;RPL13A;IGFBP5;AGO2;BTG2;METTL16;EIF2AK4;CPEB4;CPEB2;EPRS1;RACK1;CNOT1
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.6310861208267528,-0.9989513891252164,0.5333333333333333,1.0,1.0,1/8,4.25%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.5754650577871824,-0.9987301065625812,0.5316455696202531,1.0,1.0,5/12,32.11%,TGFB1;FLT1;IRS1;PTK2B;CD81
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.603163550359251,0.9982447868344487,0.4827586206896552,0.9619152787706139,1.0,1/7,0.26%,NOX4
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.5827902452687764,-0.9975944798953846,0.5138888888888888,1.0,1.0,3/15,15.38%,TGFB2;TGFB1;UBE2L3
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.5941125376679578,-0.9974222168739588,0.46153846153846156,1.0,1.0,3/17,12.34%,SRGN;PTPRE;GBP2
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.6924705156753208,-0.9972734729623625,0.4782608695652174,1.0,1.0,2/5,7.83%,JAM3;SHROOM3
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.4881068813217987,-0.9967640286723104,0.4945054945054945,1.0,1.0,6/45,9.50%,NRCAM;DNER;GPM6A;CDH20;CDH18;CDH12
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),-0.6647214466182533,-0.9967447005650708,0.5671641791044776,1.0,1.0,2/5,21.78%,CPEB4;CPEB2
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.5717512295393246,-0.9966216131564577,0.5714285714285714,1.0,1.0,6/14,23.71%,SYT1;SNAP25;RIMS1;LIN7A;SYN3;STXBP1
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.6566427269335577,-0.9957133107097277,0.5068493150684932,1.0,1.0,2/7,22.12%,OXSR1;STK39
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.5887758244817185,-0.9955987122246482,0.5833333333333334,1.0,1.0,3/16,10.86%,VAV3;CD38;IL18
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.48131664487545217,-0.995432103434927,0.532608695652174,1.0,1.0,12/51,22.92%,SEC13;NUP153;NUP133;FYTTD1;NUP88;SRSF5;SYMPK;RANBP2;ALKBH5;SMG7;CPSF2;THOC2
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.5911188292061554,-0.9953667573524179,0.525,1.0,1.0,2/12,9.16%,WIPI1;AP2A1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.5847647294538778,-0.9952619019271218,0.5194805194805194,1.0,1.0,3/9,22.89%,DDX3X;TBK1;STAT1
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.5600413088395144,0.9952026576518457,0.4444444444444444,0.9673749526453308,1.0,3/8,7.84%,ARL6;NOTCH1;DNAH11
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.6055963460386016,-0.995012584330122,0.5194805194805194,1.0,1.0,2/11,10.57%,PRKACA;MYL3
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.5111559014430409,-0.9948252990725654,0.4777777777777778,1.0,1.0,13/37,25.59%,MYDGF;TGFB2;IL18;PDGFD;UNC5B;FLT1;SEMA4D;NEDD4;DCN;LYN;PIK3CB;INSR;KDR
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.6547454665421841,-0.9947540855538548,0.5538461538461539,1.0,1.0,2/6,7.75%,TGFB1;CST3
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.5829257588374281,-0.9943447030302031,0.5176470588235295,1.0,1.0,2/15,5.23%,WDR43;HMGN1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5866545365199287,-0.9942810321791102,0.5,1.0,1.0,5/12,15.99%,OGN;PDCD4;SOD2;CDKN1B;IGFBP5
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.5982220447605425,-0.9941603202577352,0.5595238095238095,1.0,1.0,4/16,22.89%,CTR9;STAT3;STAT6;STAT1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.666049459842192,-0.9939100325943402,0.5405405405405406,1.0,1.0,3/5,27.64%,GBE1;PRKAG2;PHKB
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.5247050881243311,-0.9937621988854338,0.5487804878048781,1.0,1.0,7/27,13.78%,FHL1;PSMB1;PSMD14;RBX1;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.6704375445473318,-0.9937402573989406,0.5205479452054794,1.0,1.0,3/5,32.64%,APP;INSR;PRNP
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),-0.6498939282225276,-0.9934497780696957,0.5194805194805194,1.0,1.0,3/6,20.44%,NEDD4L;CAMK2D;NEDD4
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.338043602876209,0.9932087404934037,0.3333333333333333,0.9696744516049953,1.0,8/80,5.77%,TAGLN;ACTA2;LMOD1;COL14A1;ACADSB;MYL9;IGFBP7;TNS2
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.551317710340291,-0.9924266840305898,0.5238095238095238,1.0,1.0,7/28,16.78%,NFKBIA;LGALS3;CEBPD;MGAT1;SAT1;ANXA5;SUSD6
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.5962187961032377,-0.9923569973669626,0.5679012345679012,1.0,1.0,2/8,17.56%,CLU;LRPAP1
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.37949744230979104,0.9922296986148738,0.46153846153846156,0.9694261363135582,1.0,5/43,3.72%,ATP2B4;RYR2;TRPC6;CACNA1C;CACNB2
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.6452756414517435,-0.9920598370429251,0.5633802816901409,1.0,1.0,3/7,32.64%,APP;INSR;PRNP
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.6206049356551135,-0.991702119616619,0.5571428571428572,1.0,1.0,2/8,12.29%,ZFP36L2;MT3
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.49634498415632,-0.9916113267073301,0.5652173913043478,1.0,1.0,2/44,5.21%,HNRNPL;NUP153
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.6370437785084151,-0.991519881735906,0.5833333333333334,1.0,1.0,1/6,5.95%,MT2A
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.5702648455452979,-0.9914557946797691,0.49382716049382713,1.0,1.0,3/12,12.29%,VEGFA;HIF1A;MT3
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.47380563613886506,0.9913185098507226,0.3684210526315789,0.9691514853956309,1.0,6/18,9.91%,MYL9;ACTB;MYH9;HSPB1;FLNA;ACTN1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.5274535849705222,-0.9912666470851582,0.5432098765432098,1.0,1.0,4/30,14.74%,TBC1D20;DDX3X;PABPC1;RAB7A
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),-0.5010467195411568,-0.9903617637675386,0.5465116279069767,1.0,1.0,6/42,16.30%,ARHGAP24;GARNL3;SIPA1L2;TBC1D8;RALGAPA2;USP6NL
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.5644761595977565,-0.9901774496589736,0.55,1.0,1.0,4/19,17.44%,CTR9;RBX1;WAC;UBE2B
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.4971325386121734,-0.9901771333546785,0.5851063829787234,1.0,1.0,9/52,11.53%,CSF1;RPS4X;NFKBIA;HDAC2;TGFB1;DDX3X;UPF3A;PLD1;PRKDC
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.4947141045498142,-0.9897212466068742,0.4880952380952381,1.0,1.0,12/45,24.19%,IPO5;SSH1;SLC38A9;DIAPH1;KCNQ1;RAP1B;IGFBP5;LARS1;CPEB4;RRAGB;AKAP6;TSHR
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.5744240700450485,-0.9892948788735987,0.5714285714285714,1.0,1.0,2/16,8.20%,IFITM3;EIF2AK2
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.5433282724644776,-0.9892542998385283,0.5625,1.0,1.0,6/22,9.93%,ZFPM1;ROBO2;TGFB2;ROBO1;ZFPM2;TGFBR1
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),-0.6328341486194305,-0.989155745405506,0.45588235294117646,1.0,1.0,4/5,34.14%,NFKBIA;EIF2AK4;FOXO1;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.6399419129485773,-0.989149755604816,0.5540540540540541,1.0,1.0,5/10,30.94%,EIF2AK4;APP;ABL1;PTN;EPHA4
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.5761674444727788,0.9890773728711899,0.48148148148148145,0.9719244212505206,1.0,1/6,3.35%,CD4
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.6116835841061795,-0.9887466615673035,0.5483870967741935,1.0,1.0,2/7,18.70%,NEDD4L;MDM2
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.6782209691921386,-0.9882487666548782,0.5866666666666667,1.0,1.0,2/5,24.11%,EIF2AK4;APP
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.36837835436405064,0.9879706303458387,0.5454545454545454,0.9719202835233508,1.0,4/48,1.99%,ZBTB7C;RALGPS1;SORBS2;C2ORF72
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.571295454332034,-0.9876035397046975,0.5384615384615384,1.0,1.0,6/16,20.47%,SPTLC3;SPTLC1;AGK;PAM;ABCA8;ASS1
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.6062481796003509,-0.9875119780926916,0.5301204819277109,1.0,1.0,4/14,22.89%,CTR9;STAT3;STAT6;STAT1
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.6266791507072993,-0.9872244535681093,0.5205479452054794,1.0,1.0,5/6,35.76%,ELF1;RUNX1;LYN;ELF2;CBFB
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.5220956694460934,-0.987018044194966,0.47058823529411764,1.0,1.0,9/31,19.87%,ZFP36L2;GIGYF2;PABPC1;CNOT8;ROCK2;PRR5L;AGO2;BTG2;METTL16
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.3644270216238848,0.9869908412726434,0.4375,0.97128292761979,1.0,5/38,8.47%,SH3RF3;RNF146;TRIM52;TRAF6;RNF185
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.4937965764952337,-0.9868564135909842,0.5862068965517241,1.0,1.0,13/55,14.66%,TP53TG5;ENO1;GJA1;FHL1;TGFB2;DIP2B;TGFB1;DDX3X;ESR2;RBBP7;MT3;CDKN1B;TSPYL2
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.657079047563161,-0.9867761508748656,0.5671641791044776,1.0,1.0,3/6,23.71%,NLGN1;SYN3;STXBP1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.6324427295359436,-0.9867725690440905,0.6296296296296297,1.0,1.0,2/10,10.09%,TGFB1;HIF1A
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.5123461905238796,-0.9866164411315256,0.5783132530120482,1.0,1.0,6/34,14.95%,CSNK1G2;SPTLC3;ALDH3A2;SPTLC1;AGK;PLPP3
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.6043172527628965,-0.9865630593865701,0.56,1.0,1.0,1/7,2.25%,ROBO2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.5697971463992308,-0.9864930330442692,0.5324675324675324,1.0,1.0,4/11,32.03%,TGFB1;FLT1;IRS1;PTK2B
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.47880229334243535,-0.9864056227124544,0.5168539325842697,1.0,1.0,18/53,24.53%,NRG1;VEGFA;LGALS3;TGFB1;DDX3X;EIF2AK2;TRAF3IP1;SPIDR;HSPA5;CLU;GFAP;FARP2;RAF1;WARS1;SLF1;RIOK3;STXBP1;RACK1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.5323712746170794,-0.98638841208818,0.5476190476190477,1.0,1.0,9/27,27.56%,IPO5;LATS2;CCNH;RGCC;CDKN1B;ADAM17;CCNK;EGFR;GTF2H1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.6294317462010879,-0.9862947873697926,0.5324675324675324,1.0,1.0,2/6,9.56%,GJA1;KCNQ1
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.5688458081324774,-0.9862707320667714,0.5454545454545454,1.0,1.0,8/13,37.39%,RAP1B;ROCK2;RACK1;GSN;PTK2B;BCAS3;KANK1;RIPOR2
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),-0.6472382787411689,-0.9860119209644828,0.4936708860759494,1.0,1.0,6/6,35.35%,RBX1;NAE1;DCUN1D4;DCUN1D2;DCUN1D1;UBA3
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.6223304911386759,-0.9859499631647378,0.5625,1.0,1.0,4/9,29.19%,CDKN1B;ABL1;POT1;TERF1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.3904099476344483,0.985860145076173,0.2857142857142857,0.971225739190872,1.0,6/21,14.44%,PDGFA;UBE2N;SMG1;UBE2V2;THOC1;YLPM1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.6195844542369919,-0.9855942514620043,0.5866666666666667,1.0,1.0,4/10,21.13%,GOLGA2;BTRC;SKP1;RPL5
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.5122840467556594,-0.9855720820481413,0.5632183908045977,1.0,1.0,9/32,25.97%,CSNK1D;GOLGA8A;GOLGA8B;GOLGA2;TNKS;SMC3;RAB11A;MAP9;CLASP2
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.47719535337006336,0.9855321807082631,0.35714285714285715,0.9692252248506049,1.0,1/16,0.02%,JPH2
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.459296401649717,-0.9850466825961018,0.6060606060606061,1.0,1.0,69/204,26.77%,WWC1;GJA1;RHEB;NRG1;PELI1;F3;SEC13;VEGFA;NOS1AP;MYDGF;TGFB2;SLC38A9;PDCD4;TGFB1;ADGRV1;DDX3X;EIF2AK2;FGFR2;USP15;PRKCB;TGFBR1;ANKRD17;IL18;PDGFD;ROCK2;TERF2IP;AKR1C2;TBK1;IQCJ-SCHIP1;SASH1;TRIM13;JCAD;NDFIP2;UNC5B;FLT1;SEMA4D;TMED4;TRIM5;DDX60;NEDD4;NDFIP1;LARS1;ALPK1;DDX21;AKAP13;NLGN1;FYN;BIRC2;GAB2;RPL37;GRB2;DCN;RRAGB;KITLG;APP;MIER1;MALT1;RACK1;LYN;PIK3CB;INSR;KDR;EGFR;IRS1;SIAH1;ZDHHC17;RPS20;GOLPH3;LPAR1
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.5691592003784283,-0.9849038191403255,0.5540540540540541,1.0,1.0,8/14,25.79%,GPR137C;SZT2;C9ORF72;ITFG2;SESN1;LARS1;RRAGB;SIK3
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.6414511271518425,-0.9844215651670906,0.53125,1.0,1.0,3/5,30.83%,NEDD4;UBE3A;UBR5
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.5524264008176987,-0.9844110587108067,0.5294117647058824,1.0,1.0,7/18,33.19%,RBM4B;PUM3;METAP1;APP;EIF2A;SAMD8;MAPKAPK5
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.4678581094232545,-0.9842147944573847,0.5568181818181818,1.0,1.0,19/56,24.91%,VAV3;PSMB1;PSMD14;PSMA4;PSMB2;JUN;PSMA7;PPP3CA;BTRC;SKP1;PAK1;MAPK1;GAB2;GRB2;PPP3CB;PSMA3;MALT1;LYN;PIK3CB
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.6275831747437557,-0.9842093438517964,0.5616438356164384,1.0,1.0,2/6,16.60%,KLF15;LGR4
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.648539682954369,-0.9841078889651449,0.546875,1.0,1.0,1/5,25.91%,IRS1
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.5000195771398324,-0.9837962458736679,0.5217391304347826,1.0,1.0,11/40,18.85%,SLC2A1;EFNB2;CST3;CEBPD;CA2;HIF1A;CMKLR1;LRRK2;SEMA4D;PID1;NRP2
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.37846999675400367,0.9837834260381281,0.5714285714285714,0.9711942299541123,1.0,5/41,3.50%,ATP2B4;TRPC6;GRIN2A;MCU;CACNA1C
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.5147556051084273,-0.983452568853207,0.5888888888888889,1.0,1.0,6/49,7.64%,STC1;PRKACA;TPT1;TMCO1;SLC10A7;TMEM165
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),0.5229237539403093,0.9833488460917947,0.5185185185185185,0.9696134433706282,1.0,2/9,6.16%,NSFL1C;CHMP4B
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.6488864145073154,-0.9833466999210249,0.5416666666666666,1.0,1.0,1/6,4.25%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.520671459253759,-0.9831467608143813,0.5512820512820513,1.0,1.0,7/26,13.78%,FHL1;PSMB1;PSMD14;RBX1;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.6564672666115215,-0.9828673074475134,0.5844155844155844,1.0,1.0,1/5,17.74%,AGO2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.5289044818158093,0.9827715501201484,0.42857142857142855,0.9682044480788325,1.0,3/8,19.92%,ZNF143;CHD8;RPTOR
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.5618914894350573,0.9826522567836294,0.5172413793103449,0.965774847748563,1.0,1/5,7.96%,RHOT1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.5784716206114305,-0.9825474639948244,0.5454545454545454,1.0,1.0,3/10,22.89%,DDX3X;TBK1;STAT1
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.517944274275576,0.9823503093963948,0.4117647058823529,0.9638177420126322,1.0,1/14,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.5823605502075528,-0.9821268680082909,0.56,1.0,1.0,7/16,19.33%,TSC2;PTPRE;PTPN1;PRKCB;PTPN2;PID1;APPL2
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.5010144875044218,-0.9819940212663055,0.5393258426966292,1.0,1.0,10/37,19.97%,SLC7A2;SLC38A4;SLC7A14;SLC3A2;ARRDC2;RAB7A;ATP11B;SLC44A1;SLC7A11;SCARB2
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.577424977699889,-0.9817118301912069,0.5625,1.0,1.0,6/13,28.83%,TGFB1;STAT3;EGFR;NRIP1;GGT7;STRN3
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.49449676049180846,-0.9815890847851818,0.5217391304347826,1.0,1.0,11/42,18.58%,RNMT;PDE4B;DUT;DGUOK;SDCBP;RBX1;POLR1C;GUK1;CSTF3;POLA1;GPX4
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.49238095153054207,-0.9812120048639897,0.5977011494252874,1.0,1.0,13/45,16.86%,ETV5;ELAVL3;CRMP1;PHYHIPL;DCLK1;SYNDIG1;SNAP25;PLP1;NXPH1;ARNT2;SNAP91;GFAP;VCAN
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.6216947747064603,0.980988630036762,0.5,0.9644285526900808,1.0,2/7,2.44%,A2M;PDGFA
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.5860767369054469,-0.9805321016845382,0.5432098765432098,1.0,1.0,5/12,28.18%,ERAP1;ENPEP;LNPEP;CPQ;GGT7
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.5253652589699467,-0.9805280981720222,0.6021505376344086,1.0,1.0,12/45,17.74%,TWIST1;F3;VEGFA;MYDGF;RHOB;ITGA5;PRKCB;HIF1A;RUNX1;SASH1;FLT1;AGO2
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.4817963813222783,-0.9802346694345153,0.5714285714285714,1.0,1.0,8/46,12.05%,PRKACA;SELENOS;ADM;LPCAT3;LRFN5;PRKAR1A;PTPN2;ADORA2B
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.6186892577717168,-0.9799334308312568,0.5625,1.0,1.0,6/7,31.58%,HIF1A;DCUN1D4;RPL5;DCUN1D2;RPL11;DCUN1D1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.5636541588982149,-0.979614093185847,0.5609756097560976,1.0,1.0,3/16,10.86%,VEGFA;STAT3;IL18
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.5830950704777583,-0.9793828350037292,0.5512820512820513,1.0,1.0,9/16,34.26%,STAT3;ERBIN;FYN;STAT6;STAT1;IRS1;PRNP;CACNA1B;STAT5B
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.4941555150002808,-0.979306248960148,0.550561797752809,1.0,1.0,6/39,16.04%,CSE1L;NUP153;TGFB1;XPO4;SRSF5;STRADB
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.5598542831640458,-0.9788963092202286,0.5975609756097561,1.0,1.0,6/15,25.87%,CST3;FMN2;MDM4;AZIN1;PPARA;EGFR
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,-0.4646074701417433,-0.978843401917162,0.5384615384615384,1.0,1.0,11/75,10.30%,PCDH17;ELAVL3;CRMP1;PHYHIPL;DCLK1;NMNAT2;TSHZ1;SCN3A;SLC7A14;SNAP25;CCK
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.516693284625355,-0.9788030146940045,0.5955056179775281,1.0,1.0,16/37,31.58%,KDM1A;CRY1;RBX1;NDFIP2;UBE2L3;LRRK2;DCUN1D4;NDFIP1;BIRC2;RCHY1;MALT1;RPS2;DCUN1D2;UBE3A;PRICKLE1;DCUN1D1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.6567616691124115,-0.9786724323411659,0.5342465753424658,1.0,1.0,2/5,10.09%,VEGFA;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.44926177731481853,0.9780128142860515,0.42857142857142855,0.9691424869791518,1.0,3/10,17.77%,VPS35;PTTG1IP;FAF1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.5179425850328065,-0.9778901027943726,0.5348837209302325,1.0,1.0,7/27,18.70%,KDM1A;RHOB;TANK;SPIDR;CLOCK;WRN;MDM2
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.554707753383091,-0.9778468458863194,0.581081081081081,1.0,1.0,3/15,17.90%,CTCF;EZH1;NAP1L1
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),-0.6560682531366168,-0.9774650331534148,0.5774647887323944,1.0,1.0,2/5,7.86%,TGFB2;ZFPM2
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.6072344102422244,-0.9773641467630301,0.5769230769230769,1.0,1.0,3/8,30.14%,RBM17;RSRC1;SFPQ
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.3128977733798488,0.9769803072249538,0.6666666666666666,0.9690659291328312,1.0,10/62,7.14%,BCAM;ARHGEF10L;C2ORF72;NOTCH3;GPRC5B;CDC42BPB;GPC6;ARHGEF17;ADCY6;MAGI1
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.5939884608548335,0.9769092785231979,0.5,0.9665609162781269,1.0,2/6,7.49%,WDFY4;MERTK
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.6003487847093226,-0.9766295314062872,0.5324675324675324,1.0,1.0,5/12,29.74%,TUBA1A;MYO10;KIF1B;KIF5C;TUBA1B
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),-0.6177406881613996,-0.9764570870262084,0.5571428571428572,1.0,1.0,3/5,32.84%,STAT3;PTPRZ1;CDH2
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.539805116461261,-0.9763338860094976,0.5172413793103449,1.0,1.0,5/19,13.89%,PDCD4;DDX3X;EIF2AK2;TERF2IP;SASH1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),-0.5519347795821558,-0.9763164186656527,0.5125,1.0,1.0,4/16,18.03%,NRG1;SEMA3B;TAPT1;SEMA4D
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),-0.6689223763443048,-0.9759639584002655,0.5466666666666666,1.0,1.0,2/5,19.75%,PTGR1;MAPKAPK2
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.6104956841723004,-0.9757449324961955,0.5128205128205128,1.0,1.0,2/11,18.32%,NOS1AP;PRKAG2
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.34177729342176305,0.9757255140175399,0.6666666666666666,0.9663322314021743,1.0,8/40,8.81%,ATP2B4;IL34;PDGFA;EDN3;MAP2K2;DIPK2A;RHOA;SLC27A1
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.6336278445495883,-0.9753838247148094,0.5671641791044776,1.0,1.0,5/7,33.73%,CTR9;TET1;AASS;NSD1;JARID2
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.554377659298045,-0.9750083244559397,0.5802469135802469,1.0,1.0,6/18,22.28%,DHRS3;ALDH3A2;GPC4;AKR1C1;LPL;ABCA4
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.6485346082023901,-0.9749156746498502,0.5657894736842105,1.0,1.0,1/5,12.67%,ROCK2
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.5638455087978512,-0.9748894123710261,0.5194805194805194,1.0,1.0,7/12,37.39%,RAP1B;ROCK2;RACK1;PTK2B;BCAS3;KANK1;RIPOR2
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),-0.5816688031920556,-0.9747866107676536,0.5492957746478874,1.0,1.0,4/10,7.94%,ROBO2;TGFB2;ROBO1;SMAD6
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5485592213883563,-0.9743664121282468,0.5189873417721519,1.0,1.0,3/15,10.04%,FHL1;ATP1B3;NEDD4L
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.6262139083034686,-0.9742046184125843,0.5211267605633803,1.0,1.0,3/5,32.03%,TSHZ3;NLGN1;PTK2B
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.4715007127702043,-0.9741007446038209,0.5052631578947369,1.0,1.0,18/56,24.82%,ARMC2;GPM6A;LIMA1;STMN1;PLP1;HDGFL3;MICALL2;ZFYVE27;DTNBP1;UHMK1;BTG2;NEDD4;NLGN1;RAB11A;GPM6B;PTPRM;APP;LYN
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.6124698330670348,-0.9739418770032475,0.6301369863013698,1.0,1.0,2/8,23.56%,ESR2;ARID1A
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.48403327432020404,0.9737912118119543,0.5185185185185185,0.968387553437051,1.0,1/13,0.72%,HDAC9
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.5578059239925088,-0.9737807980505349,0.5569620253164557,1.0,1.0,2/15,12.67%,ROBO2;ROCK2
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.5294925761461436,-0.9737219830931221,0.5465116279069767,1.0,1.0,6/25,12.67%,TGFB2;TGFB1;OLFM1;TGFBR1;HIF1A;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.6556166997818208,-0.9735300942094864,0.5974025974025974,1.0,1.0,3/6,26.72%,ACADL;WDTC1;ACADVL
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.607178985681653,-0.9734165725442034,0.5657894736842105,1.0,1.0,2/6,9.93%,VEGFA;TGFBR1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.5561360325308574,-0.973366346731976,0.6233766233766234,1.0,1.0,4/14,26.95%,SRSF10;TRA2B;SF3B1;PRPF3
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.6113706947077576,-0.9732616771087185,0.56,1.0,1.0,6/10,32.64%,CST3;LRRK2;TMEM59;CAMK2N1;EPHA4;PRNP
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.6308626706196083,-0.973109893353486,0.5972222222222222,1.0,1.0,3/6,33.04%,FARP2;APP;B4GALT5
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.5812436641891531,0.9730904558237684,0.48148148148148145,0.9672551026733435,1.0,1/5,3.37%,EDN3
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.5577667409455467,-0.9730347350230025,0.5853658536585366,1.0,1.0,4/12,9.93%,TGFB2;PDCD4;OLFM1;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.5168229526872512,-0.9724752103367739,0.5421686746987951,1.0,1.0,6/30,15.77%,MYRIP;TGFB2;TGFB1;EXOC1;SYTL4;ACSL4
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.626234914932552,-0.9724309773637538,0.5774647887323944,1.0,1.0,4/7,29.19%,PRKDC;TERF2IP;POT1;TERF1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.4836989792006664,-0.9722999631052867,0.5060240963855421,1.0,1.0,9/29,24.82%,TGFB2;NECTIN2;ERAP1;COLEC12;APPL2;HLA-B;BIRC2;IRF1;LYN
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.6508731374101648,-0.972259986310084,0.56,1.0,1.0,4/6,25.34%,ABCC9;AKR1C1;STAT1;NDUFS4
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.5498184516391424,-0.97219149007913,0.5301204819277109,1.0,1.0,5/15,18.77%,SOD1;SPART;SLC25A36;LRRK2;PID1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.390171161240442,0.9717486970573954,0.5833333333333334,0.9683726773935571,1.0,2/28,3.55%,ATP2B4;ITGA3
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.6099378134266629,-0.9717297896640911,0.6,1.0,1.0,4/7,29.55%,VPS51;CTNNA2;PAFAH1B1;SPEF2
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.6320127755633752,-0.9716797993592128,0.5833333333333334,1.0,1.0,3/6,28.65%,DDX3X;SSB;YBX1
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.44091190764167065,-0.9715274318324888,0.6,1.0,1.0,38/244,16.38%,TAF7;SCML1;ENO1;TWIST1;NRG1;KDM1A;BASP1;CRY1;SELENOS;HDAC2;PDCD4;TGFB1;DDX3X;NIBAN2;CBFA2T2;ZFPM2;EIF2AK2;CTCF;CD38;SNX6;TP63;GIGYF2;RCOR1;CNOT8;IGF2BP2;MT3;CLOCK;JUN;SIN3A;ZHX3;EID1;RPL13A;CDKN1B;TSPYL2;FOXP2;IGFBP5;WWP1;CREBZF
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.6071392928328317,-0.9712752678896244,0.6447368421052632,1.0,1.0,1/11,2.68%,SOAT1
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.6715082032234758,-0.9711792207733292,0.6060606060606061,1.0,1.0,1/5,8.39%,CTR9
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.544507271672939,-0.9707783971212581,0.581081081081081,1.0,1.0,7/15,31.25%,SDCBP;WAC;UCHL5;FHIT;HSP90AB1;RPL11;USP14
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.5805001298495989,-0.9703417719154361,0.5875,1.0,1.0,7/13,29.52%,NR4A3;MT3;PPARGC1A;PID1;NDUFS4;ACADVL;LEPR
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.6208572330277929,-0.9700137996360821,0.5974025974025974,1.0,1.0,4/6,37.58%,STAT3;STAT1;CANX;IL6ST
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.6123067638839723,-0.9699300979392742,0.6363636363636364,1.0,1.0,4/8,29.23%,INTS8;INTS2;SSB;INTS6L
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.577611572235436,0.9699155357242668,0.5185185185185185,0.9701685878442361,1.0,3/9,5.97%,LMOD1;ARPC5;IQGAP2
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.4357175982687645,-0.9697650281302529,0.57,1.0,1.0,39/185,17.13%,SOD1;TWIST1;CSF1;GJA1;HABP4;F3;TAF1B;CADM1;VEGFA;NOS1AP;ANK3;RPS4X;ROBO1;TGFB1;OLFM1;DDX3X;UPF3A;EIF2AK2;CTCF;STAT3;AFDN;KRAS;RIMS2;TGFBR1;PLD1;HIF1A;PRKDC;MT3;ROCK2;POLR1C;DNMT1;RGCC;CLU;PPARGC1A;CALCOCO1;RAB27A;RIMS1;DTNBP1;ELAVL1
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.5628839456037906,-0.969661600488826,0.5903614457831325,1.0,1.0,5/17,20.61%,CRY1;PIAS2;CLOCK;PER1;NCOR2
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.4853189400696167,0.969444128844481,0.45454545454545453,0.9687255120250703,1.0,3/15,4.52%,MYH11;HEY2;BIN1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.5453883529616685,-0.9694108873962848,0.5641025641025641,1.0,1.0,6/18,19.33%,APIP;SOD2;GOLGA2;ALDH1A2;TRPA1;APPL2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.4586929458590772,-0.9692541878293168,0.6179775280898876,1.0,1.0,24/112,17.32%,KLF2;F3;TGFB2;ROBO1;PRKCI;GRIN1;DCDC2;ITGA5;FGFR2;ARMC9;STAT3;RIMS2;PRKCB;TP63;TGFBR1;HIF1A;MT3;SASH1;JCAD;UCHL5;LRRK2;RIMS1;TTC23;TSPAN5
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.44467442639744925,-0.9689890051129884,0.61,1.0,1.0,41/176,26.21%,WWC1;CREM;WWC2;PLAG1;SRSF10;RBM4B;SUFU;HCFC2;ESR2;CTR9;CCAR1;STAT3;ZNF138;TGFBR1;HIF1A;ANKRD17;TERF2IP;CLOCK;ARNT2;PPARGC1A;UBE2L3;SMC3;YAF2;PUM3;BNC2;METAP1;NONO;HINT1;BTG1;NR2C2;ZNF536;APBB1;APP;RORA;INSR;ZNF331;YY1AP1;NLK;SP1;ABL1;EIF2A
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.5966670256647839,-0.9681081573830304,0.4810126582278481,1.0,1.0,5/7,30.65%,SPG7;PMPCB;MIPEP;YME1L1;AFG3L2
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.5314352271443868,-0.9680695736903648,0.5975609756097561,1.0,1.0,4/21,16.03%,SNCAIP;RAP1B;ROCK2;GFAP
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),-0.6052215292806067,-0.9680505713192935,0.620253164556962,1.0,1.0,6/10,29.52%,GBE1;MT3;PRKAG2;PID1;PHKB;LEPR
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.6693494058043217,-0.9675835123685359,0.5970149253731343,1.0,1.0,2/5,24.11%,CLU;APP
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.5325959737264508,-0.967506385463967,0.5555555555555556,1.0,1.0,5/20,23.40%,ALCAM;C9ORF72;NRP2;EIF2AK4;PPP3CB
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.4659227128752138,-0.9673344491470036,0.6276595744680851,1.0,1.0,17/87,13.55%,SOD1;TWIST1;ZFPM1;F3;CADM1;PDE4B;TGFB1;EIF2AK2;STAT3;HIF1A;IL18;PRKDC;RUNX1;ROCK2;POLR1C;RGCC;TBK1
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.5683602137240493,0.9671015061765775,0.4782608695652174,0.9721339519037391,1.0,1/7,4.01%,CDC42
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.5251686501612488,-0.9668761395347983,0.5,1.0,1.0,9/23,23.23%,VEGFA;TGFB1;FGFR2;TGFBR1;ARNT2;ALDH1A2;BMP5;FUT8;DEAF1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.5500098575919753,-0.9668232016366622,0.5609756097560976,1.0,1.0,3/17,17.36%,CTR9;DNMT1;TET1
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.6779326773456595,-0.9667975790637531,0.6338028169014085,1.0,1.0,4/5,32.11%,CD9;JAM2;ADAM12;CD81
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.5872132576126723,-0.9666414254266679,0.5362318840579711,1.0,1.0,1/8,12.43%,SCD
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.506091672294685,0.9665953396746157,0.5,0.9707455997320616,1.0,1/9,0.87%,ST3GAL2
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.5622841885872175,-0.9664066092748482,0.5581395348837209,1.0,1.0,7/18,27.37%,DHX29;DDX3X;RPS14;RPL5;RPL24;EIF2A;RPL3
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.5340909805901365,-0.9662413486934008,0.5555555555555556,1.0,1.0,6/19,23.50%,RPA1;RPS27A;POLK;POLA1;WRN;ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.5220248787730902,-0.9660106283680534,0.5913978494623656,1.0,1.0,11/40,17.74%,TWIST1;F3;VEGFA;MYDGF;RHOB;PRKCB;HIF1A;RUNX1;SASH1;FLT1;AGO2
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.5762242294176626,-0.9646383920913932,0.5316455696202531,1.0,1.0,2/11,8.63%,VAV3;CD38
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.5509350381132637,-0.9645054380386159,0.5974025974025974,1.0,1.0,4/15,9.30%,PIGL;DPM1;PIGG;SCCPDH
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.5404919771803895,-0.9644280316713273,0.5844155844155844,1.0,1.0,3/18,3.40%,NRCAM;CRMP1;VEGFA
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.46575323368262783,-0.9641240934574883,0.5913978494623656,1.0,1.0,17/62,27.41%,STX6;SNX6;AP2A1;DENND2A;RHOBTB3;RAB7A;WASHC2C;GOSR1;PREPL;VPS50;GAK;VPS51;EEA1;SNX2;CCDC91;SLC66A2;RAB6A
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.6032229106956308,0.9639995828737083,0.5384615384615384,0.9741561311822322,1.0,2/5,5.60%,NOTCH1;SKI
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.4549294488920008,-0.9637869695668686,0.5384615384615384,1.0,1.0,11/74,15.38%,RIPOR1;IPO5;ANK3;TGFB1;XPO4;ARIH2;CEMIP;TP63;MICALL2;PRR5L;UBE2L3
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.5157658233113014,-0.9636048588665185,0.5844155844155844,1.0,1.0,11/24,28.34%,TGFB2;DDX3X;SDCBP;TGFBR1;ADAM17;ADNP2;AKAP6;INSR;EGFR;NCBP1;EIF4G1
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.5243537049955741,-0.9634156267988089,0.5294117647058824,1.0,1.0,7/25,19.86%,CSNK1A1;WNT2B;NR4A2;PLPP3;LRRK2;DIXDC1;SFRP4
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.47416873183792135,-0.9633550002224951,0.5684210526315789,1.0,1.0,16/47,26.00%,VEGFA;RHOB;TMSB4X;TGFB1;HIF1A;ROCK2;SASH1;PLPP3;SCARB1;NRP2;ADAM17;RIN2;PIK3CB;KDR;SP1;ABL1
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.49811584947274123,-0.9632600525666108,0.5316455696202531,1.0,1.0,8/33,13.78%,PSMB1;EIF2AK2;PSMD14;PSMA4;PRKDC;PSMB2;RUNX1;PSMA7
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.5428271492651852,-0.9631427871686841,0.5555555555555556,1.0,1.0,5/19,27.48%,WIPI1;GABARAPL1;MAP1LC3B;WDR45B;ATG12
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.46277490645098274,-0.962943265631731,0.5681818181818182,1.0,1.0,8/41,14.16%,IGFBP2;PLAG1;TGFB2;FGGY;SLC16A7;ARPP21;SGK1;NR4A2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.5163323963422457,-0.9627745692982477,0.5747126436781609,1.0,1.0,11/31,29.98%,F3;ROBO1;IFT57;SENP1;RACK1;CASP8AP2;BEX3;ANP32B;APAF1;COL4A3;SLC22A2
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.47663975937363506,-0.9626026249425632,0.5567010309278351,1.0,1.0,17/78,13.89%,TWIST1;F3;CEMIP2;VEGFA;RHOJ;PGK1;MYDGF;TGFB2;RHOB;GLUL;NIBAN2;PRKCB;HIF1A;RUNX1;ROCK2;RGCC;SASH1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.5407756162299686,-0.9623686446232022,0.5802469135802469,1.0,1.0,11/21,26.32%,HOMER2;GRIN1;GRIA3;GRIK1;GRM7;GRIK2;CPEB4;GNAQ;APP;GRIN2B;GRIA4
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.6073322624640907,-0.9617205926063018,0.5492957746478874,1.0,1.0,2/7,15.70%,CMKLR1;LRRK2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.4394201919721082,-0.9610096163420311,0.5876288659793815,1.0,1.0,22/142,14.20%,EMP1;TTC8;PTPDC1;NUDCD3;DCDC2;GALNT11;ARF4;PARVB;LZTFL1;TRAF3IP1;IFT122;SDCBP;ARMC9;RAP1B;ACTR3;IFT52;IFT140;EXOC1;PMP22;ATP6V1D;MAK;WDR19
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.6227193148522125,-0.9610016053164046,0.59375,1.0,1.0,1/6,8.89%,STMN1
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.6780009794066004,-0.9608369253465641,0.6268656716417911,1.0,1.0,3/5,24.88%,AK4;NT5E;AK9
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.6329563073893922,-0.9607082368117696,0.5526315789473685,1.0,1.0,4/6,33.40%,AP2A1;AP2B1;AP2A2;AP2M1
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.6329563073893922,-0.9607082368117696,0.5526315789473685,1.0,1.0,4/6,33.40%,AP2A1;AP2B1;AP2A2;AP2M1
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.4946722564283435,0.9605983717044907,0.5238095238095238,0.9796777357126027,1.0,5/17,11.36%,WTIP;CNOT7;CELF1;CNOT6;MOV10
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.5677904522246361,0.9605969487073694,0.5333333333333333,0.9770370949155339,1.0,1/6,0.88%,MOCS1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.5298290746313823,0.9605069623442464,0.52,0.9745139710834864,1.0,1/8,3.35%,CD4
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.6644426201865271,-0.9601848733199597,0.5714285714285714,1.0,1.0,1/5,3.40%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.570443871364166,-0.9599859136894956,0.581081081081081,1.0,1.0,2/11,13.67%,CCP110;TAPT1
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.6488443529789656,-0.9597247446612469,0.5373134328358209,1.0,1.0,4/5,33.51%,DENND4C;DENND4A;MADD;DENND1A
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.5607367061911406,-0.9596238331974482,0.6266666666666667,1.0,1.0,1/13,0.85%,TWIST1
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5219396224080184,0.9595682030194721,0.5555555555555556,0.9742970822425326,1.0,3/11,7.33%,TNIP1;MAP3K1;TRAF6
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.551077938402281,-0.9594864450378012,0.5769230769230769,1.0,1.0,3/15,6.72%,VEGFA;TGFB1;ADM
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.4389712313517845,0.9592943600384373,0.3684210526315789,0.9723086145797537,1.0,3/11,5.87%,NOTCH1;SERGEF;PNKD
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.4516666554130954,-0.959250965274592,0.6082474226804123,1.0,1.0,22/161,15.32%,PRKACA;TWIST1;CSF1;ZFP36L2;F3;VEGFA;TGFB1;MT2A;OXSR1;CEBPD;STAT3;RPS27A;TANK;HIF1A;IL18;PTPN2;GBP2;TBK1;RPL13A;CDKN1B;PRLR;DUSP1
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.5715978610722537,-0.9590208518949054,0.5405405405405406,1.0,1.0,4/13,10.35%,CSF1;LGALS3;AKIRIN1;CMKLR1
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.4542765742707519,-0.9583598448642915,0.6185567010309279,1.0,1.0,20/87,19.67%,AGPAT4;RNF19A;SLC2A1;RANBP10;ALDH1L1;KLF3;GMPS;MINPP1;SDCBP;CA2;USP15;GYPC;SLC25A37;ELL2;EZH1;LAMP2;TSPAN5;BTRC;BTG2;SLC7A11
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.6665885516957539,-0.9582780055491182,0.6233766233766234,1.0,1.0,3/5,30.98%,SMCHD1;TP53BP1;SHLD2
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.5164417639007295,-0.9582766994305185,0.5679012345679012,1.0,1.0,8/22,30.90%,TMSB4X;ERAP1;APPL2;BIRC2;IRF1;CYLD;IL1R1;BCL6
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.5560339820101503,-0.958108998862737,0.5555555555555556,1.0,1.0,6/13,31.46%,NFKBIA;LPCAT3;ABCA8;PTCH1;ABCA5;NR1H3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.4435319555069722,-0.9578423245950314,0.58,1.0,1.0,40/150,24.70%,RNMT;TAF7;NR4A3;ELOB;CCN2;INTS8;RARB;ESR2;CEBPD;GLIS3;CTR9;TBPL1;NRBP1;CCNH;RTF1;ELL2;SYMPK;PARP1;NR4A2;PPARGC1A;NOTCH2;TEAD1;CSTF3;INTS4;AFF4;INTS2;PKNOX1;NFIX;NCOR2;DDX21;CPSF2;CCNK;PPARA;NR2C2;DEAF1;SUPT16H;ZBTB1;RORA;NR2C1;SETX
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.6111273712089504,-0.9577187933785215,0.5853658536585366,1.0,1.0,3/9,21.05%,SOD2;HIF1A;NONO
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.5186546957947741,-0.9572090365209844,0.573170731707317,1.0,1.0,6/19,23.50%,RPA1;RPS27A;POLK;NPLOC4;RCHY1;ZBTB1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.41601670816788844,0.9571596781179051,0.3888888888888889,0.9753785526049058,1.0,6/16,8.36%,PDGFA;ATM;DACH1;HMBOX1;SMOC2;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5318098306360551,-0.9570590000149534,0.6125,1.0,1.0,3/15,5.79%,GLRX;ANK3;ATP1B3
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.5755770912767968,-0.9567876781634335,0.5679012345679012,1.0,1.0,2/9,15.59%,SMCHD1;EZH1
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.5587651636327932,-0.9565715695233259,0.5774647887323944,1.0,1.0,4/11,18.08%,MCCC2;BCKDHB;BCAT2;DLD
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.5587651636327932,-0.9565715695233259,0.5774647887323944,1.0,1.0,4/11,18.08%,MCCC2;BCKDHB;BCAT2;DLD
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.5729757873763115,-0.9564816339646927,0.6575342465753424,1.0,1.0,1/12,4.25%,TGFB2
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.6008954521311383,-0.9564599964064922,0.5802469135802469,1.0,1.0,5/8,35.07%,CMTR1;VIRMA;METTL16;WTAP;NSUN2
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.49926549694117084,-0.9559290085274914,0.6046511627906976,1.0,1.0,13/36,36.59%,PTPN1;PTPN2;ELF1;RUNX1;BIRC2;STAT1;RACK1;CYLD;HSP90AB1;MADD;RBCK1;CBFB;PIAS1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.6577544527390778,-0.9556816160809029,0.618421052631579,1.0,1.0,2/5,21.05%,HIF1A;NONO
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.536159174734361,-0.955631572556253,0.5949367088607594,1.0,1.0,3/17,3.69%,NKAIN3;SPTBN4;ANK3
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.47156488817786457,-0.9555683580058415,0.5806451612903226,1.0,1.0,6/55,7.52%,ROBO2;TENM3;ROBO1;PRKCI;PTPRD;CBFA2T2
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.5740888956407589,-0.9551002328560564,0.6024096385542169,1.0,1.0,4/11,9.93%,SOD1;TGFB1;GRIN1;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.6347316813650508,-0.9550034584219202,0.6329113924050633,1.0,1.0,3/6,30.98%,NECTIN2;TP53BP1;SHLD2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.5515383972547105,-0.9548842630242749,0.5974025974025974,1.0,1.0,2/14,9.95%,AKIRIN1;ACTR3
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.46166616202121324,-0.9542702844661898,0.5894736842105263,1.0,1.0,22/74,28.62%,SRSF10;TGFB1;MT2A;CTCF;RAD21;STMN1;HIF1A;CDKN1B;FANCC;NOTCH2;WRN;TRA2B;UCK2;PURA;NASP;ARID4A;RAD23B;ABL1;CASP8AP2;SMC1A;MTF2;PAFAH1B1
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.6315030880104492,-0.9539150559858708,0.5897435897435898,1.0,1.0,1/5,7.94%,SMAD6
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.43644983379387087,-0.9538001224481975,0.66,1.0,1.0,36/193,18.75%,TBC1D20;COG2;CSNK1D;WASF3;ATL1;RANBP10;CSNK1A1;TOR1AIP2;GOLGA8A;ARMC2;COG7;PRKCI;DIAPH1;NECTIN2;PEX3;AGTPBP1;GOLGA8B;DPYSL2;SLC25A36;GOLGA2;CFL1;GEM;PLAAT3;CHCHD2;PARP1;WDR73;RAB7A;PPARGC1A;FAM174B;LRRK2;FMNL2;USP6NL;NPLOC4;TMED4;REEP5;RAB18
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.5462966147339722,-0.9536748522335016,0.6025641025641025,1.0,1.0,3/15,19.33%,TGFB1;PRR5L;APPL2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.5177130541938306,-0.9534545218018713,0.625,1.0,1.0,10/23,26.32%,CNIH3;GRIN1;GRIA3;DLGAP1;LRRC7;NLGN1;MINK1;APP;GRIN2B;GRIA4
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.43115723465139966,-0.9533178558631858,0.63,1.0,1.0,84/399,21.86%,WWC1;NELL1;PRDM6;TWIST1;CSF1;GJA1;HNRNPL;F3;PCBP3;CREM;WWC2;VEGFA;NOS1AP;ANK3;PLAG1;PTRH2;TGFB2;ZC3H7A;SRSF10;ROBO1;TGFB1;SUFU;ZC3H7B;OLFM1;HCFC2;DDX3X;ESR2;CTCF;CTR9;CCAR1;STAT3;AFDN;ZNF138;KRAS;RIMS2;TGFBR1;HIF1A;PTBP2;RUNX1;FAM50A;IGF2BP2;MT3;ROCK2;TERF2IP;CLOCK;DNMT1;RGCC;ARNT2;CLU;PPARGC1A;AFF2;NOTCH2;NDFIP2;UBE2L3;CALCOCO1;RAB27A;RIMS1;NOVA1;DTNBP1;CGGBP1;PRDM10;AGO2;CLK1;AFF4;TRIM5;YAF2;PID1;HNRNPF;TRA2B;CCN4;PER1;FUBP3;ADNP2;SFRP4;METTL16;BNC2;WARS1;NDFIP1;NONO;RPL5;MAPK1;HINT1;BTG1;TARDBP
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.4423076301057054,-0.9532651363663391,0.5543478260869565,1.0,1.0,14/64,17.44%,CSNK1D;CSNK1G2;PSMB1;TGFB1;DDX3X;FGFR2;PSMD14;PSMA4;PSMB2;PSMA7;LRRK2;LGR4;TNKS;UBE2B
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.5705967541061714,-0.9531374231201689,0.5714285714285714,1.0,1.0,4/10,13.92%,VEGFA;FGFR2;TGFBR1;ARNT2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.5508864516657582,-0.9530930122718622,0.569620253164557,1.0,1.0,7/17,23.80%,VEGFA;TGFB1;RGCC;ASS1;NF2;PPARA;MBP
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.6380227435142773,-0.952686946095422,0.6,1.0,1.0,2/5,18.61%,POLA1;WRN
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),-0.6093542283264448,-0.9526729806704161,0.5679012345679012,1.0,1.0,2/6,16.62%,PANK2;DCAKD
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.6093542283264448,-0.9526729806704161,0.5679012345679012,1.0,1.0,2/6,16.62%,PANK2;DCAKD
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.6093542283264448,-0.9526729806704161,0.5679012345679012,1.0,1.0,2/6,16.62%,PANK2;DCAKD
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.6093542283264448,-0.9526729806704161,0.5679012345679012,1.0,1.0,2/6,16.62%,PANK2;DCAKD
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.5026394270373002,-0.9526437630999266,0.5494505494505495,1.0,1.0,4/26,11.45%,TGFB2;TGFB1;DDX3X;DELE1
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.5069029613473672,-0.9525464475357218,0.5930232558139535,1.0,1.0,5/21,17.92%,ANK3;RHOB;STMN1;ROCK2;MITD1
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),0.5421659550819795,0.9524810293629632,0.5416666666666666,0.9848720730124086,1.0,1/6,1.09%,RYR2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.34971223625685544,0.9522822526729788,0.6,0.9825910167060898,1.0,6/54,6.29%,HSPA1A;LEMD3;ITGA3;BCL9;SKI;BCL9L
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.4438326443721801,-0.9521151754982907,0.6632653061224489,1.0,1.0,43/155,30.14%,WWC1;CREM;WWC2;PLAG1;SRSF10;SUFU;HCFC2;ESR2;CTR9;CCAR1;STAT3;ZNF138;TGFBR1;HIF1A;TERF2IP;CLOCK;ARNT2;PPARGC1A;UBE2L3;YAF2;BNC2;NONO;HINT1;BTG1;NR2C2;ZNF536;APBB1;RORA;INSR;ZNF331;YY1AP1;NLK;SP1;ABL1;SP3;MTF2;YBX1;NFX1;NSD1;RALY;CEBPB;DENND4A;SFPQ
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.5649937254316342,-0.9519857665701771,0.575,1.0,1.0,4/11,25.67%,SREBF1;CAMKK2;SREBF2;VDAC1
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.44136727656944374,-0.951951405806184,0.5894736842105263,1.0,1.0,36/123,26.37%,PRKACA;TSC2;SRA1;TGFB2;RHOB;PDCD4;TGFB1;TBRG1;FGFR2;SDCBP;STAT3;TGFBR1;ANKRD17;CDC123;PLAGL1;JUN;RGCC;CDKN1B;TSPYL2;NOTCH2;DUSP1;MDM2;UHMK1;NF2;CRLF3;TARDBP;BIRC2;MAP2K6;IRF1;JUNB;APBB1;WDR6;RACK1;YY1AP1;ABL1;RPS6KA2
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.4697564010080606,-0.9517913158738472,0.6235294117647059,1.0,1.0,8/47,15.27%,CSNK1G2;SPTLC3;ALDH3A2;ENPP2;SPTLC1;AGK;PLPP3;PDXDC1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.45687431579940607,-0.9516960246726249,0.5934065934065934,1.0,1.0,14/47,25.63%,DDX3X;EIF2AK2;GIGYF2;GGA3;CNOT8;IGF2BP2;RPL13A;CLU;IGFBP5;RTN1;BTG2;EPRS1;RACK1;CNOT1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.45926914622055215,-0.9510311809059184,0.6043956043956044,1.0,1.0,22/64,34.95%,SEC13;PPP1CC;NUP133;STMN1;GOLGA2;GPSM2;RANBP2;TNKS;SMC3;RAB11A;MAP9;CLASP2;NEK9;SMC1A;PAFAH1B1;SPC25;NUP160;CLIP1;DYNLL1;NUP107;EML4;TAOK1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.5325770971304233,-0.9510118422330006,0.620253164556962,1.0,1.0,7/16,28.46%,PABPC1;SYMPK;CSTF3;CPSF2;AHCYL1;APP;GRSF1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.5325770971304233,-0.9510118422330006,0.620253164556962,1.0,1.0,7/16,28.46%,PABPC1;SYMPK;CSTF3;CPSF2;AHCYL1;APP;GRSF1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.44168815323776345,-0.9506807643084619,0.5625,1.0,1.0,12/89,11.32%,WWC1;TWIST1;EPM2A;PDE10A;WWC2;TSC2;TMSB4X;DDIT4;DDX3X;TANK;NPRL3;UBR1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.41597237830747946,0.9506060653039008,0.5555555555555556,0.983804568519752,1.0,8/23,13.28%,BCL2L1;ATM;BCL2L11;BCL2;EP300;IFI16;MSH2;PML
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.5545406466876008,-0.9502976218704605,0.618421052631579,1.0,1.0,3/13,9.93%,BASP1;HES4;TGFBR1
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.5890366292628799,-0.9499712255671292,0.6025641025641025,1.0,1.0,2/8,19.44%,APH1B;ADAM17
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.601335589798581,-0.9498455090060904,0.59375,1.0,1.0,1/6,6.50%,NUP88
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.6168910421919112,-0.9493825771759015,0.6388888888888888,1.0,1.0,1/5,14.85%,NPC1
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),-0.6239614267162314,-0.9491273374149278,0.684931506849315,1.0,1.0,2/7,21.09%,PTPRD;NLGN1
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),-0.6239614267162314,-0.9491273374149278,0.684931506849315,1.0,1.0,2/7,21.09%,PTPRD;NLGN1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.5325310157330582,-0.9486404429781972,0.569620253164557,1.0,1.0,5/21,27.48%,WIPI1;GABARAPL1;MAP1LC3B;WDR45B;ATG12
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.5605243648506577,-0.9485190485677474,0.6233766233766234,1.0,1.0,4/13,28.06%,NUDT5;ENTPD4;NCBP1;RNASEH2C
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.6374012282912778,-0.9481282465063154,0.6486486486486487,1.0,1.0,3/6,30.98%,TGFB1;TP53BP1;SHLD2
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.550713972956687,-0.9479296829880821,0.5769230769230769,1.0,1.0,4/12,20.10%,CTR9;WAC;SKP1;RNF168
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.489707470286479,0.9477677967492952,0.47368421052631576,0.9882568903518225,1.0,4/11,15.54%,SYNE3;SYNE2;CLMN;HOOK3
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.5696587732581603,-0.9476531469361998,0.5833333333333334,1.0,1.0,2/10,14.45%,TMCO1;CAMK2D
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.4807701010138384,-0.9475359178007038,0.5764705882352941,1.0,1.0,13/39,25.91%,LPIN1;SELENOS;PRKCI;PRKDC;DENND4C;PARP1;CPEB2;RAB8B;PKM;RAB12;EPRS1;INSR;IRS1
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.6213592770251892,-0.9473587950315041,0.6486486486486487,1.0,1.0,5/8,32.19%,FGFR2;NOTCH2;KLF9;STXBP4;CASK
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.35886155785219104,0.9472844973742086,0.625,0.9871986727410459,1.0,5/39,7.94%,LEMD3;NOTCH1;ITGA3;SKI;RBPMS2
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.5941576811311762,-0.9471214312374229,0.6753246753246753,1.0,1.0,4/9,30.48%,MYSM1;INSR;TRIP12;PTN
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.6211460044691985,-0.9464099811481511,0.631578947368421,1.0,1.0,2/5,28.89%,CLU;HSP90AB1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.547174121193639,-0.9462826204669603,0.5492957746478874,1.0,1.0,5/14,27.80%,TGFB1;NEDD4;SIAH1;SNX25;UVRAG
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.4883316801823422,-0.9461568980614702,0.6,1.0,1.0,6/31,7.64%,STC1;TPT1;TMCO1;SLC10A7;GRIN1;TMEM165
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4789800407125993,0.9460438778220804,0.56,0.9878357390608963,1.0,2/11,3.67%,ATP2B4;LMCD1
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.6439917214413398,-0.9458388699788269,0.6973684210526315,1.0,1.0,1/5,3.21%,MGST1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.40709057991739983,0.9454812421785875,0.5,0.9866835490865556,1.0,4/13,16.79%,CDKN1A;MAPK14;PML;TBX2
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.4946670534166119,0.9454063147723185,0.4117647058823529,0.9842327925269101,1.0,1/8,1.15%,TRPC6
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),-0.49066144481509927,-0.9451944970265792,0.5930232558139535,1.0,1.0,10/33,29.52%,CRY1;STAT3;HIF1A;PTPN2;PPARGC1A;APPL2;INSR;IRS1;FOXO1;LEPR
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),-0.6245388138997957,-0.9449876879605458,0.5757575757575758,1.0,1.0,3/6,33.56%,INSR;IRS1;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),-0.6245388138997957,-0.9449876879605458,0.5757575757575758,1.0,1.0,3/6,33.56%,INSR;IRS1;SORBS1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.3145071876718798,0.9447985413954608,0.6666666666666666,0.9831710546320698,1.0,8/78,4.81%,TAGLN;SLIT3;LMOD1;CSPG4;COL14A1;SOX6;COL5A2;IGFBP7
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.5696833726309647,-0.9447633658408242,0.6125,1.0,1.0,2/14,8.63%,VAV3;CD38
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.44975688218493987,-0.9446978408905594,0.6179775280898876,1.0,1.0,14/67,17.24%,NRCAM;TGFB2;DNER;SPOCK1;GPM6A;DCDC2;DDIT4;PTPRD;CCK;RUNX1;WNT2B;NR4A2;ACSL4;SMARCA1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.6180165953305914,-0.9444642063481986,0.5866666666666667,1.0,1.0,4/6,28.07%,ATP6V1G1;CPEB4;ATP6V0D1;NDUFS2
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.5687876920841772,-0.9442145550974104,0.5802469135802469,1.0,1.0,5/11,31.57%,RPA1;POLA1;PURA;RPA3;ORC3
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.4829091855412113,-0.9441592188674767,0.5955056179775281,1.0,1.0,16/46,24.11%,NRCAM;ANK3;DNER;GPM6A;PTPRD;LRFN5;ZC4H2;LRRK2;KIRREL3;GPC4;NEDD4;NLGN1;FARP1;DNM3;LRRC4C;APP
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.436408892455971,-0.9436259740467199,0.6702127659574468,1.0,1.0,18/90,15.99%,SMOC1;NXN;EFNB2;WBP1L;ITGA5;SVEP1;SMAD6;C1R;FBN1;STXBP6;FAM114A1;PROCR;CMKLR1;PMP22;C1S;PLPP3;APH1B;IGFBP5
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.6437742320753846,-0.9435903990561275,0.6,1.0,1.0,1/5,17.74%,AGO2
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.6437742320753846,-0.9435903990561275,0.6,1.0,1.0,1/5,17.74%,AGO2
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.6113453368119326,-0.943494050943936,0.6216216216216216,1.0,1.0,3/9,19.86%,CSNK1D;RNF213;SFRP4
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.5726744003519771,-0.9433651312005872,0.6265060240963856,1.0,1.0,3/11,23.07%,TGFB2;EIF2AK4;RIOK3
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5860329123647519,-0.9433439001249903,0.5584415584415584,1.0,1.0,2/8,18.03%,SEMA3B;SEMA4D
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.5948732778876862,-0.94313923032579,0.5866666666666667,1.0,1.0,1/8,3.40%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.6004888320118129,-0.9430126381374824,0.5942028985507246,1.0,1.0,1/9,0.85%,TWIST1
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.4308049121630785,0.9426097929022194,0.5,0.9859333773868539,1.0,4/17,3.56%,HDAC9;ADGRA2;HEY2;HEYL
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.5934630652626358,-0.9425813240749014,0.6455696202531646,1.0,1.0,2/8,17.90%,NIBAN2;NAP1L1
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.5854292214409673,0.942552253740206,0.5263157894736842,0.9835036116079823,1.0,1/8,0.87%,ST3GAL2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.5441727986040417,-0.9422053045880686,0.6153846153846154,1.0,1.0,4/17,14.45%,NR4A3;ROCK2;PARP1;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.5798560562672164,-0.9421863749391973,0.5925925925925926,1.0,1.0,3/10,19.44%,HDAC2;HIF1A;ADAM17
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5559520268653365,-0.942080413663598,0.6,1.0,1.0,1/9,1.25%,NR4A3
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.4441793671251377,-0.942020919227722,0.6702127659574468,1.0,1.0,17/95,19.10%,PRKACA;PPME1;CSNK1D;TUBA1A;LATS2;MELK;CCP110;CEP57;CCNH;NINL;PPP2R2A;CDKN1B;CDK14;PHLDA1;YWHAG;BTRC;SKP1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.42615322771902203,-0.9415911927623101,0.6354166666666666,1.0,1.0,46/128,25.91%,ZFP36L2;NRG1;SPTBN4;PSMB1;NCAM1;PPP1CC;TGFB1;GRIN1;FGFR2;PSMD14;MAP3K8;RBX1;SHC2;KRAS;RPS27A;IL18;PSMA4;PSMB2;RASGRF2;MT3;PSMA7;LRRK2;LRRC7;BRAP;CAMKK2;PEBP1;BTRC;SKP1;PAK1;MAPKAPK2;RAF1;MAPK1;FYN;TAOK3;MINK1;GRB2;MBP;KITLG;RASA3;PSMA3;SETX;GRIN2B;PIK3CB;KDR;EGFR;IRS1
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.6291570907691348,-0.9411802224981878,0.5714285714285714,1.0,1.0,1/5,20.55%,EIF2AK4
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.4832508181919929,0.9406623832438202,0.56,0.985630078713678,1.0,3/9,15.50%,MYLK;ITGB1;PTK2
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),-0.5937556063510778,-0.9402467424475409,0.6363636363636364,1.0,1.0,4/9,30.48%,WDR43;ELAVL1;CNOT1;PTN
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.5039444778558486,-0.9395059497068977,0.575,1.0,1.0,4/26,11.12%,IFITM3;DDX3X;EIF2AK2;PABPC1
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.5861027545080595,-0.939193670250149,0.5875,1.0,1.0,5/9,35.07%,CMTR1;VIRMA;METTL16;WTAP;NSUN2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.5665570337585535,-0.938923350050197,0.6521739130434783,1.0,1.0,1/11,0.74%,SOD1
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.5175928661985663,-0.938710904552822,0.5697674418604651,1.0,1.0,5/20,23.40%,SLC2A1;SNAP25;CLOCK;KCNC2;PPP3CB
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.528980463132831,-0.938655254695946,0.618421052631579,1.0,1.0,1/17,0.74%,SOD1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.5747555464708543,-0.9386339847750865,0.6455696202531646,1.0,1.0,2/8,18.01%,CDK14;POLA1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.5479665008745882,-0.9386319811418139,0.6621621621621622,1.0,1.0,2/12,10.96%,ZFP36L2;PTPN2
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.4992614252278873,0.9385840282429471,0.6153846153846154,0.9881665869036848,1.0,3/8,12.45%,CHMP4B;SORT1;VCP
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.5376036664625533,-0.9381255913229917,0.6578947368421053,1.0,1.0,2/15,3.06%,STC1;PDE4B
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.5979417110688071,0.9380107044795877,0.64,0.9873553952005719,1.0,1/5,4.52%,BIN1
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.49911703323165846,0.9378112301023888,0.4838709677419355,0.9850454552542532,1.0,5/5,50.13%,SMC6;SMC5;RAD52;MSH3;NSMCE2
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.5423882446418643,-0.9377072324966779,0.6111111111111112,1.0,1.0,1/13,4.73%,HDAC2
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.4873531332288189,-0.9374226557006599,0.5783132530120482,1.0,1.0,5/24,9.93%,ZFPM1;VEGFA;TGFB2;OLFM1;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.5028651880476273,-0.9371982314258269,0.6296296296296297,1.0,1.0,6/26,26.88%,VEGFA;TF;CLU;SFRP4;INSR;SGIP1
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.4439533933986832,-0.937030830199921,0.6354166666666666,1.0,1.0,22/71,29.90%,TWIST1;PTPN1;HIF1A;CNOT8;ATF6;PRR5L;LRRK2;TRIM5;PPARA;DCN;TMEM59;APP;PIK3CB;INSR;CNOT1;IRS1;RDX;GRSF1;FOXO1;ADAM9;RNF152;SNX9
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.5868656109713122,-0.9368553471654434,0.5797101449275363,1.0,1.0,2/7,19.44%,APH1B;ADAM17
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.6031300641872815,-0.9368240012415965,0.6153846153846154,1.0,1.0,4/7,37.58%,STAT3;STAT1;CANX;IL6ST
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.46831117486867097,0.9364724521261816,0.6086956521739131,0.9860895073265648,1.0,3/12,15.50%,MYLK;ITGB1;PTK2
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.5326081612692367,-0.9364613583172976,0.6666666666666666,1.0,1.0,3/13,17.45%,UBE2L3;UBE2B;ANAPC4
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.6371544013244475,-0.9361575984134018,0.6338028169014085,1.0,1.0,4/5,36.32%,CLU;SCARB1;ABCA5;ABCA1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.44693521904462535,-0.9360612417732026,0.6063829787234043,1.0,1.0,35/97,26.03%,CRY1;NXN;TSC2;SUFU;NKD1;DDIT4;PTPRE;PTPN1;NIBAN2;IFT122;PRKCB;PTPN2;NR4A2;LRRK2;IGFBP5;BRAP;LGR4;LRPAP1;BTRC;PID1;SFRP4;NEDD4;MTMR2;BMP5;APOD;DCN;RACK1;LYN;PIK3CB;WWOX;CNOT1;EGFR;NLK;IRS1;SIAH1
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),-0.6316248560010193,-0.9357869623894952,0.6883116883116883,1.0,1.0,5/7,31.75%,TGFB1;TGFBR1;GRAMD1A;PTCH1;TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.42985455891340696,-0.9357532582034938,0.6464646464646465,1.0,1.0,26/200,14.13%,TAF7;SCML1;ENO1;TWIST1;NRG1;KDM1A;BASP1;CRY1;HDAC2;PDCD4;TGFB1;NIBAN2;CBFA2T2;ZFPM2;CTCF;CD38;SNX6;TP63;RCOR1;MT3;CLOCK;JUN;SIN3A;ZHX3;EID1;CDKN1B
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.5821050691908058,-0.9356028138210501,0.5972222222222222,1.0,1.0,2/11,17.45%,DUSP1;ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.60471378932936,-0.9353780024978305,0.6547619047619048,1.0,1.0,3/8,19.78%,ANKRD17;APPL2;DDX60
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.3102156934237062,0.9351260760527582,0.8571428571428571,0.9869566476499377,1.0,16/81,10.44%,FAT1;CSRNP3;LMOD1;FAM13C;GPRC5B;NFASC;GPC6;ADCY6;CAP2;MAGI1;CHST3;SLIT2;PTPN21;GULP1;EML1;EDIL3
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.48692718772480315,-0.9350751028881682,0.5697674418604651,1.0,1.0,3/26,13.57%,SEC13;NUP133;PPP2R2A
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.56762527357225,-0.9350322067486599,0.6883116883116883,1.0,1.0,3/11,19.44%,SDCBP;RNF111;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.56762527357225,-0.9350322067486599,0.6883116883116883,1.0,1.0,3/11,19.44%,SDCBP;RNF111;ADAM17
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.422749180711209,-0.9349813669175564,0.5979381443298969,1.0,1.0,33/105,25.91%,NR4A3;PDE4B;SELENOS;IPO5;PLAA;SSH1;SLC38A9;PDCD4;CTR9;PDK3;KCNQ1;RAP1B;MT3;ROCK2;JUN;IGFBP5;CAMKK2;MTR;PID1;ADNP2;KCNC2;LARS1;CPEB4;MAPK1;LPL;RRAGB;AKAP6;RORA;TSHR;SETX;LYN;EGFR;IRS1
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5425792252749849,-0.9346417803955138,0.6296296296296297,1.0,1.0,2/16,13.94%,IFITM3;TRIM13
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.4252245646076404,-0.9343192510146787,0.6767676767676768,1.0,1.0,38/185,18.03%,SOD1;TPT1;CD44;IFIT3;APIP;VEGFA;PTRH2;MYDGF;NFKBIA;HDAC2;SOD2;PRKCI;ARF4;ITGA5;RHBDD1;DDX3X;NIBAN2;SMAD6;CD38;SNX6;FHL2;RPS27A;PRKDC;CFL1;MT3;ANXA5;HSPA5;FMN2;WDR73;NR4A2;PRLR;PPARGC1A;NOTCH2;NAIP;NAA15;UNC5B;DNAJA1;SEMA4D
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.4454579241955467,-0.9342560406180636,0.6354166666666666,1.0,1.0,10/50,15.99%,ROBO2;TGFB1;STAT3;TGFBR1;IL18;PTPN2;SLC1A1;TBK1;LRRK2;IGFBP5
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.5020204196633644,0.9339440017918031,0.6153846153846154,0.9875993271672473,1.0,4/19,10.96%,TTC7A;PIK3CD;PIP4K2B;SMG1
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.6312110600750465,-0.9338711569407082,0.589041095890411,1.0,1.0,2/5,26.16%,PRKCB;ZDHHC17
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.6262099644283861,-0.9338109768813937,0.5555555555555556,1.0,1.0,2/6,23.31%,PTS;MTHFD1L
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.4975079142727241,-0.9337693938202166,0.6046511627906976,1.0,1.0,6/28,12.67%,TGFB2;TGFB1;FGFR2;TGFBR1;HIF1A;ROCK2
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.5881944154834668,-0.933749448928725,0.6447368421052632,1.0,1.0,3/8,34.26%,STAT3;IRS1;STAT5B
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.5881944154834668,-0.933749448928725,0.6447368421052632,1.0,1.0,3/8,34.26%,STAT3;IRS1;STAT5B
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.46986347440793363,-0.9337386440846039,0.6022727272727273,1.0,1.0,4/37,9.80%,PRAG1;ROBO1;STMN1;HEG1
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.5170551585061051,-0.9335364541431537,0.6329113924050633,1.0,1.0,9/22,31.84%,OLFM2;RIMS2;SNX19;RAB8B;RAB12;ARFGAP3;GOLPH3;SEL1L;CANX
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.4247536361333526,0.933497653854263,0.6086956521739131,0.9862145645044614,1.0,4/12,12.48%,SPRY3;SLIT2;MAPKAP1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.5287954039730962,-0.9334843920949804,0.6144578313253012,1.0,1.0,5/16,24.03%,WDR43;EAPP;RNF168;SUPT16H;TCERG1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.5593918210427161,-0.9333250116835786,0.6582278481012658,1.0,1.0,3/10,27.17%,PPP2R1B;WWOX;CYLD
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),-0.5806083847223861,-0.9331664641417371,0.6666666666666666,1.0,1.0,6/9,36.94%,CTR9;VIRMA;NCBP1;CPSF6;CCNT1;ZC3H14
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),-0.5949940323452831,-0.9329127105401193,0.5492957746478874,1.0,1.0,4/7,27.83%,SPTLC1;AGK;SERINC1;ST3GAL6
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.5300268790195158,-0.9328582320951216,0.547945205479452,1.0,1.0,3/10,19.10%,TAPT1;HSPA5;SKP1
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.5669877063243386,-0.9328322043086691,0.575,1.0,1.0,2/10,10.86%,CD55;IL18
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.5811735867591165,-0.9327764105589553,0.6388888888888888,1.0,1.0,3/10,11.93%,VEGFA;FGFR2;ERRFI1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),-0.5538674105299357,-0.9325222658826136,0.6351351351351351,1.0,1.0,1/10,4.20%,PDLIM1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),-0.5538674105299357,-0.9325222658826136,0.6351351351351351,1.0,1.0,1/10,4.20%,PDLIM1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.5347923255970892,-0.9324906082879075,0.6046511627906976,1.0,1.0,3/16,12.29%,OMG;DIP2B;MT3
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.6052185857010561,-0.9323500318617007,0.6521739130434783,1.0,1.0,1/6,8.66%,SDCBP
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.6354149943811206,-0.932324268581421,0.6376811594202898,1.0,1.0,5/5,36.53%,GRIN1;CPEB4;APP;PTK2B;GRIA2
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.4195560066039163,-0.9321922300956701,0.77,1.0,1.0,111/484,24.13%,TAF7;TWIST1;ETV5;NR4A3;KDM1A;KLF2;ZFPM1;LPIN1;CREB3L2;VEGFA;PLAG1;MYDGF;KANSL3;NFKBIA;HDAC2;WDR43;HMGN1;AKIRIN1;TGFB1;GRIN1;ARF4;RARB;TET3;DDX3X;NIBAN2;CDC5L;ZFPM2;ESR2;FGFR2;CTCF;GLIS3;CD38;STAT3;KLF15;TP63;TGFBR1;ACTR3;RPS27A;HIF1A;HIVEP1;RNF111;SREBF1;IL18;HSF2;ELF1;PAXBP1;PRKDC;RUNX1;MED14;MT3;PLAGL1;NCOA7;CLOCK;JUN;SIN3A;TCF4;ATF6;RGCC;TBK1;WAC;ARNT2;PPP3CA;CHCHD2;PARP1;NR4A2;PPARGC1A;SENP1;TEAD1;CALCOCO1;TNKS;NAA15;RNF10;MYSM1;CAMKK2;SMARCA1;TET1;CEBPZ;PRDM10;AGO2;BTRC;YAF2;PID1;NAMPT;PER1;KDM3A;FUBP3;CCN1;PTOV1;NFIX;BMP5;CRLF3;CCNK;STAT6;PPARA;IRF1;TP53BP1;NR2C2;BCLAF3;JUNB;STAT1;ELK3;DEAF1;PPP3CB;DCN;SUPT16H;ARID1A;CCNC;TCERG1;APBB1;APP;RORA
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.40358860634772986,0.9320055834264791,0.5555555555555556,0.9872450841273059,1.0,4/23,8.45%,LEMD3;BIN1;CHMP4B;NUP54
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.5561459631692818,-0.9319418370972716,0.5833333333333334,1.0,1.0,2/11,15.77%,MYRIP;ACSL4
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.5826490804191087,-0.9318370822213482,0.5945945945945946,1.0,1.0,3/9,10.35%,CSF1;AKIRIN1;CMKLR1
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4679327069703605,-0.9316807933326122,0.611764705882353,1.0,1.0,12/40,26.00%,NR4A3;VAV3;WIPF1;ACTR3;PAK1;MYO10;MAPK1;FYN;GRB2;LYN;PIK3CB;ABL1
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.35452980836502196,0.9316775717310463,0.5,0.9855285062258508,1.0,3/37,2.79%,ATP2B4;PSMF1;PSMD7
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.4803781952369031,-0.931626004782402,0.632183908045977,1.0,1.0,8/31,23.07%,DDX3X;PRKDC;POLR1C;TBK1;STAT6;IRF1;STAT1;RIOK3
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.3568647247038041,0.9313135127587695,0.3333333333333333,0.9842320341952439,1.0,2/51,0.35%,HSPA1A;RBM20
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.5165348983870014,-0.9312257029032069,0.6444444444444445,1.0,1.0,8/23,18.17%,OGN;CD44;CEMIP2;TGFB1;CEMIP;OMD;VCAN;GPC4
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),-0.5582370768028548,-0.9310772134958489,0.6056338028169014,1.0,1.0,3/9,10.04%,SLC2A1;PRKCB;NEDD4L
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.5582802973215781,-0.9310482216332404,0.6626506024096386,1.0,1.0,1/11,3.50%,NOS1AP
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),-0.5623554583899807,-0.9309810316339856,0.6067415730337079,1.0,1.0,3/10,19.54%,INTS8;INTS4;INTS2
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.5697787727397964,-0.9309054499095804,0.6301369863013698,1.0,1.0,5/10,17.39%,SYT1;ANK3;RIMS2;RIMS1;GRIK2
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.6115356906497043,-0.9308229824704907,0.6,1.0,1.0,4/6,37.91%,TP53BP1;SHLD2;SUPT6H;PAXIP1
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.5494879683567899,-0.9308099440238536,0.5844155844155844,1.0,1.0,1/9,8.66%,SDCBP
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.5870342435714525,-0.9305979921164541,0.647887323943662,1.0,1.0,4/8,28.89%,RGCC;ADAM17;EGFR;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.478535494575406,-0.9302792686034486,0.5925925925925926,1.0,1.0,3/27,7.41%,VEGFA;SYNDIG1;PTPRD
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.6315070337456365,-0.9302202557427237,0.6164383561643836,1.0,1.0,1/5,10.97%,GBE1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.6315070337456365,-0.9302202557427237,0.6164383561643836,1.0,1.0,1/5,10.97%,GBE1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.5257635467988316,-0.9301528116095886,0.6266666666666667,1.0,1.0,8/14,28.52%,COL11A1;ITGA5;DUSP1;COL7A1;COL12A1;FN1;LAMB1;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.5149673922009741,-0.9299308785806035,0.6352941176470588,1.0,1.0,5/23,10.96%,SELENOS;TRAF3IP1;LPCAT3;LRFN5;PTPN2
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,-0.44012310684703787,-0.9298032136866659,0.6666666666666666,1.0,1.0,13/70,12.37%,GJA1;ELAVL3;NRXN3;DPP6;PHYHIPL;SLC1A2;ALDH1L1;CDH20;GRIA3;PLP1;TRPM3;MT3;CDC42EP4
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.6388260061302985,-0.9297712442441638,0.6301369863013698,1.0,1.0,1/6,5.28%,LGALS3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.571441277516861,-0.9296416489046719,0.6265060240963856,1.0,1.0,3/12,12.90%,SUFU;LATS2;SIN3A
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.600627808725051,-0.9290093136562859,0.6268656716417911,1.0,1.0,1/8,0.85%,TWIST1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.4289153558588668,-0.9284499559767362,0.711340206185567,1.0,1.0,44/198,19.71%,CSF1;NRG1;S1PR3;VEGFA;EFNB2;RPS4X;TGFB2;HDAC2;EAPP;TGFB1;GRIN1;CCN2;DDX3X;FGFR2;CCAR1;SDCBP;TBC1D8;KRAS;TGFBR1;ANKRD17;SSR1;PDGFD;CDC123;FRMD5;CNOT8;MT3;AKR1C2;TRIM13;PPP3CA;CDKN1B;PRLR;COLEC12;RAB27A;RNF10;FLT1;TET1;MCTS1;NAP1L1;P4HB;MDM2;NAMPT;ADAM17;ADNP2;PAK1
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.4229787180744714,-0.928410175567812,0.6836734693877551,1.0,1.0,27/159,17.93%,SLC2A3;CD44;CD55;MGST1;PSMB1;LGALS3;DIAPH1;DDX3X;CST3;CRISPLD2;PSMD14;SNAP25;SDCBP;MANBA;RAP1B;FTH1;PLD1;SRP14;ATP6V1D;RAB7A;PDXK;LRRC7;RAB27A;LAMP2;PYGB;ATP11A;ATP11B
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.5348899592075514,0.9280626347666836,0.5714285714285714,0.9895330086475354,1.0,2/9,3.99%,SOX5;SOX6
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.6070511547566748,-0.9278837125451166,0.6164383561643836,1.0,1.0,4/5,39.33%,PPARA;ITGAV;NR1H3;PRKN
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.5718197133498986,0.9276214321853106,0.5483870967741935,0.9883052451725298,1.0,2/5,11.52%,ERCC6;APLF
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.4228607625268208,-0.927152954759322,0.6836734693877551,1.0,1.0,27/160,17.93%,SLC2A3;CD44;CD55;MGST1;PSMB1;LGALS3;DIAPH1;DDX3X;CST3;CRISPLD2;PSMD14;SNAP25;SDCBP;MANBA;RAP1B;FTH1;PLD1;SRP14;ATP6V1D;RAB7A;PDXK;LRRC7;RAB27A;LAMP2;PYGB;ATP11A;ATP11B
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.58011282266384,-0.9268874408286726,0.6133333333333333,1.0,1.0,3/6,29.27%,PPP3CA;PPP3CB;NFAT5
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.58011282266384,-0.9268874408286726,0.6133333333333333,1.0,1.0,3/6,29.27%,PPP3CA;PPP3CB;NFAT5
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.4461913850067206,-0.926823837544535,0.6451612903225806,1.0,1.0,27/104,22.49%,PELI1;PLAA;MARCHF6;PSMB1;RHBDD1;PSMD14;RBX1;NEDD4L;PSMA4;TRIM9;PSMB2;APPBP2;CLOCK;ZNRF1;PSMA7;TRIM13;WWP1;UBE2B;ERLEC1;BTRC;MDM2;NEDD4;UBE2K;HECW1;SMURF2;BIRC2;RNF34
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.5771424375007898,-0.9267916937218279,0.6338028169014085,1.0,1.0,3/10,29.48%,RAB27A;RAB11A;KIF5C
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.5846854457856805,-0.9266067425140089,0.6486486486486487,1.0,1.0,2/6,14.05%,SLC25A36;PARP1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.45723155677098554,-0.9265747297384753,0.6395348837209303,1.0,1.0,17/60,18.03%,ADAMTS4;PHYHIPL;ASPA;OMG;SLC1A2;FGFR2;ENPP2;PLP1;TF;MT3;ARRDC2;KLHL2;NPC1;GFAP;KIF13B;ARSG;SEMA4D
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5801746607821209,-0.9264689952604317,0.6142857142857143,1.0,1.0,1/7,1.65%,TPT1
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.5264381104451229,-0.9263913549629974,0.6585365853658537,1.0,1.0,2/18,1.92%,GNPAT;AGPAT4
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.549789154282317,-0.9258464252160921,0.6463414634146342,1.0,1.0,7/15,35.66%,TSC2;PPARA;RACK1;PIK3CB;PLEKHA1;PHLPP1;PHLPP2
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.5664608256482342,-0.9256930978929976,0.6973684210526315,1.0,1.0,3/12,27.94%,XPO4;UHMK1;ANP32B
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.605871880792509,-0.9253931096763399,0.6164383561643836,1.0,1.0,2/8,10.41%,AGTPBP1;AGBL1
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,-0.4639115927235342,-0.9250751946959372,0.6292134831460674,1.0,1.0,9/60,10.81%,ELAVL3;CRMP1;PHYHIPL;ATL1;DCLK1;PTPRD;SNAP25;LRFN5;PLP1
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.5461494791949854,0.92507257727049,0.5,0.9916718021487939,1.0,1/5,2.49%,WDFY4
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.48723286091720086,-0.9250097495477425,0.5974025974025974,1.0,1.0,9/29,24.82%,PRKACA;ADM;PRKAR1A;ADORA2B;ADAM17;FYN;PRKAR2A;TSHR;LYN
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.5562350372551897,0.9248187004743514,0.5357142857142857,0.9896540829155571,1.0,1/5,3.96%,DTNA
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.5248379019991768,-0.9248117699090781,0.5875,1.0,1.0,7/16,21.83%,VEGFA;SASH1;DUSP1;MAP3K4;ULK4;PER1;MINK1
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.5917223383804906,-0.9247010149523331,0.6052631578947368,1.0,1.0,2/6,18.82%,NPC1;ABCA8
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.4460532882785714,-0.9245168534358346,0.6170212765957447,1.0,1.0,16/72,16.51%,FAT3;GJA1;PCDH17;CRMP1;PHYHIPL;DCLK1;SYNDIG1;PTPRD;PLP1;PURG;PDGFD;ARNT2;SNAP91;IGFBP5;GFAP;NOVA1
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.5633676418737157,0.9240211954979979,0.6060606060606061,0.9889371306855143,1.0,1/5,1.09%,RYR2
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.3467069268479698,0.9237362179265797,0.5555555555555556,0.9872700137173106,1.0,4/35,3.50%,RCAN2;RYR2;MCU;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.5093047762277556,-0.9236072534782664,0.6309523809523809,1.0,1.0,3/17,9.56%,NOS1AP;ATP1B3;KCNQ1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.5446781835138557,-0.9234646526955065,0.6493506493506493,1.0,1.0,4/13,11.89%,ZFPM2;FGFR2;TGFBR1;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.395319179120165,0.923329040693783,0.5217391304347826,0.9856587179090909,1.0,5/26,9.35%,SH3RF3;MFHAS1;TRAF6;MTURN;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.5037941695095227,-0.9230843375259866,0.6703296703296703,1.0,1.0,12/36,24.11%,NFKBIA;PDCD4;TGFB1;USP15;ANKRD17;IL18;SASH1;CCN4;DDX60;LPL;RIOK3;APP
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.6423880192280104,-0.9229095655716458,0.6301369863013698,1.0,1.0,5/6,31.46%,NFKBIA;PPARA;ITGAV;ABCA5;NR1H3
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.37253285092029037,0.9228488980280835,0.5625,0.9842451817314982,1.0,6/33,12.11%,HEY2;CDKN1A;ATF7IP;MED24;MOV10;RUNX2
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.4580969128672975,-0.9224725296058003,0.6593406593406593,1.0,1.0,11/50,20.87%,SEC13;NUP153;NUP133;FYTTD1;NUP88;SRSF5;SYMPK;RANBP2;ALKBH5;SMG7;CPSF2
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.533126031515745,-0.9223835384249869,0.6125,1.0,1.0,3/16,17.84%,SOAT1;MT3;LSS
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.6015176907391122,-0.9223340026187312,0.609375,1.0,1.0,1/6,4.97%,TUT7
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.3663321599397572,0.9214015899406135,0.5555555555555556,0.9851106302283106,1.0,2/33,0.32%,CAV2;PGF
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.4669382445406817,-0.9211030269229673,0.5813953488372093,1.0,1.0,11/41,24.05%,TAF1B;CTCF;RBBP7;POLR1C;DNMT1;CREBZF;CGGBP1;DDX21;EED;TAF1D;SF3B1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.4422171947612429,-0.9208904655190026,0.7010309278350515,1.0,1.0,19/77,21.13%,KLF2;NOS1AP;RPS4X;DDX3X;UPF3A;PLD1;HIF1A;SREBF1;PTPN2;SLC25A37;PRKDC;RGCC;CLU;PPARGC1A;ELAVL1;SCARB1;ATAD5;ASS1;RPL5
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.4585818606497912,-0.9208334478893953,0.6593406593406593,1.0,1.0,22/62,30.00%,EPHA7;ROBO2;GRIN1;DDIT4;SLC6A17;ARNT2;AFF2;SMARCA1;RAB18;VPS51;APOD;GRIN2B;SYNJ2;NDUFS4;CTNNA2;PTCH1;COL4A1;NF1;PAFAH1B1;SPEF2;UBE3A;ADGRL3
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.5480329541608907,-0.9205702737400816,0.6282051282051282,1.0,1.0,2/12,7.35%,OXSR1;DDX3X
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.5717024686224896,-0.9204964771319941,0.65625,1.0,1.0,1/8,6.10%,JAM3
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.5644619606054075,-0.920075860377525,0.6493506493506493,1.0,1.0,3/10,22.18%,SGCZ;BMP5;SGCD
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.5694717509275758,-0.9200725482663268,0.6086956521739131,1.0,1.0,1/6,15.01%,APH1B
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.5947543404419519,-0.9198998284979195,0.6557377049180327,1.0,1.0,1/6,14.87%,SENP1
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.5053508088799936,-0.9198335148753042,0.6052631578947368,1.0,1.0,2/18,8.89%,TRAF3IP1;STMN1
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.4174683836200073,-0.9188952280825295,0.7171717171717171,1.0,1.0,27/161,17.93%,SLC2A3;CD44;CD55;MGST1;PSMB1;LGALS3;DIAPH1;DDX3X;CST3;CRISPLD2;PSMD14;SNAP25;SDCBP;MANBA;RAP1B;FTH1;PLD1;SRP14;ATP6V1D;RAB7A;PDXK;LRRC7;RAB27A;LAMP2;PYGB;ATP11A;ATP11B
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.46971275560162895,-0.9188601852729874,0.6593406593406593,1.0,1.0,7/39,20.55%,HABP4;DDX3X;CDC123;CSDE1;AGO2;UHMK1;EIF2AK4
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.45403989481974105,-0.9187468582155341,0.6559139784946236,1.0,1.0,11/62,15.58%,TAF7;NR4A3;CCN2;RARB;ESR2;NRBP1;CCNH;NR4A2;PPARGC1A;NOTCH2;TEAD1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.512007621601717,-0.918690139800197,0.5925925925925926,1.0,1.0,5/13,27.16%,CD55;HLA-B;ZBTB1;MALT1;FBXO38
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.5157416704093336,0.9183506232642447,0.45454545454545453,0.9896075719307018,1.0,1/5,4.36%,ERCC6
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),-0.5764292636955678,-0.9182541627496278,0.647887323943662,1.0,1.0,1/8,4.59%,DPM1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),-0.5682760247023997,-0.918059924986422,0.6710526315789473,1.0,1.0,3/9,28.42%,PTPRD;NLGN1;PCLO
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.5317257619454324,-0.9179315481162018,0.6219512195121951,1.0,1.0,4/13,15.70%,TMEM165;CA2;SLC9A9;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.6246030141403947,-0.9178646765928591,0.7297297297297297,1.0,1.0,3/6,30.88%,RPL5;ABL1;RPL11
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),-0.5335251298544319,-0.9178477030026113,0.6075949367088608,1.0,1.0,1/14,2.21%,CYTH1
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.5709728149009897,-0.9175956344525671,0.6027397260273972,1.0,1.0,2/6,13.01%,PTPN1;ATF6
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.5124861076029922,-0.9174378737031973,0.6585365853658537,1.0,1.0,4/20,12.67%,SOD1;TBC1D8;SGCZ;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.6005849487023933,-0.9171235075855965,0.6231884057971014,1.0,1.0,3/7,25.87%,RGCC;ADAM17;EGFR
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.6062202796381657,-0.9168117526135038,0.6578947368421053,1.0,1.0,5/6,39.12%,CCT4;CCT8;TERF1;CCT3;CCT6A
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.5920571190715884,-0.9167412474006288,0.6176470588235294,1.0,1.0,3/6,33.32%,NAMPT;SH3PXD2B;PGRMC2
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.5146150933572481,-0.9166642111621259,0.6309523809523809,1.0,1.0,1/18,7.35%,DDX3X
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.5564015901426422,-0.9165500104582532,0.609375,1.0,1.0,3/7,33.99%,PRKDC;LAS1L;WDR12
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.522865275134288,-0.9164113139660601,0.6805555555555556,1.0,1.0,2/17,5.47%,PIP4P2;MTMR9
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.5366895006895527,-0.9159785960275459,0.6710526315789473,1.0,1.0,3/14,12.70%,RPA1;ANKRD28;TERF2IP
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.5366895006895527,-0.9159785960275459,0.6710526315789473,1.0,1.0,3/14,12.70%,RPA1;ANKRD28;TERF2IP
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.411370140852821,-0.9158911148115622,0.85,1.0,1.0,189/774,24.77%,WWC1;PRDM6;TAF7;ENO1;TWIST1;ETV5;NR4A3;KDM1A;KLF2;ZFPM1;CRY1;PURB;LPIN1;CREM;CREB3L2;JDP2;WWC2;VEGFA;SRA1;PLAG1;MYDGF;PIAS2;KANSL3;NFKBIA;PKNOX2;HDAC2;AKIRIN1;ARID3A;TGFB1;SUFU;ZNF235;HIVEP2;SOD2;GRIN1;ARF4;ZMYM5;HCFC2;RARB;TSHZ1;TET3;BACH2;DDX3X;CDC5L;MED12L;HES4;ZFPM2;KLF3;SMAD6;ESR2;FGFR2;CTCF;CEBPD;GLIS3;CTR9;ZNF608;SDCBP;SAP130;RAD21;STAT3;KLF15;FHL2;PRKCB;PRKAR1A;TP63;ACTR3;RPS27A;NEDD4L;HIF1A;HIVEP1;RNF111;SREBF1;IL18;RCOR1;HSF2;ELF1;HDGFL3;PURG;PAXBP1;PRKDC;CCNH;RUNX1;ZKSCAN1;MED14;MAFK;TSHZ2;RTF1;RPS14;PLAGL1;NCOA7;CLOCK;JUN;SIN3A;ZHX3;TCF4;ATF6;ZSCAN18;RGCC;ZNF595;TBK1;EID1;SP110;ARNT2;PPP3CA;CHCHD2;PARP1;NR4A2;HIF3A;CAMK2D;ZIC4;PPARGC1A;SENP1;FOXP2;TEAD1;EZH1;ZNF814;CALCOCO1;CHD1;MDM4;CREBZF;ZNF790;TNKS;RNF10;MYSM1;SMARCA1;ZNF83;TET1;CEBPZ;CGGBP1;PRDM10;CHD2;AGO2;SEMA4D;MDM2;PID1;NAMPT;PER1;KDM3A;FUBP3;PKNOX1;CCN1;PTOV1;NFIX;CBX7;ZNF565;NCOR2;BMP5;ZNF528;TSHZ3;CRLF3;SMURF2;ZNF483;ZNF25;CCNK;ZNF397;STAT6;PPARA;IRF1;TP53BP1;ZNF43;NR2C2;BCLAF3;JUNB;ZNF654;STAT1;EED;ZBTB40;ELK3;DEAF1;KCTD1;PPP3CB;DCN;ZBTB1;ARID1A;ZNF536;PURA;ZNF302;CCNC;YEATS2;TCERG1;APBB1;APP;RORA;NR2C1;SREBF2;MIER1;ZNF490;SETX;ARID4A;HDX
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.5702931993893405,-0.9158061333965483,0.6176470588235294,1.0,1.0,1/9,3.56%,ARHGAP24
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.514163978376058,-0.9147215037927233,0.6428571428571429,1.0,1.0,2/18,5.23%,EAPP;HMGN1
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.577309478666788,-0.9147097811084399,0.6197183098591549,1.0,1.0,3/8,23.44%,AKIRIN1;BTG1;BOC
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.4065056078071857,0.9146524962319467,0.6363636363636364,0.9957310311110051,1.0,3/15,4.52%,SERPINH1;SERPINI1;BIN1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.5984694065842283,-0.9146404065277934,0.684931506849315,1.0,1.0,2/6,25.97%,CFL1;CLASP2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.5642253815342654,-0.9141100503479949,0.72,1.0,1.0,2/7,10.54%,CRMP1;DPYSL2
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.5094242686363996,-0.9140547677475056,0.6547619047619048,1.0,1.0,4/16,12.77%,RHOB;TANK;SPIDR;CLOCK
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.44411948920199046,0.913662013086627,0.6428571428571429,0.9953169042182357,1.0,4/9,17.16%,ANO5;ANO6;ANO10;SLC4A11
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.4123894373157947,-0.9134104982660752,0.76,1.0,1.0,54/297,16.92%,SOD1;TPT1;MTCH2;CD44;IFIT3;APIP;VAV3;VEGFA;SRA1;MYDGF;ARHGEF9;NFKBIA;HDAC2;RHOB;PRKCI;OLFM1;ARF4;RHBDD1;DDX3X;NIBAN2;SMAD6;LATS2;CD38;CCAR1;MELK;STK4;FHL2;TP63;RPS27A;SPTLC1;ANKRD13C;IFT57;PRKDC;RASGRF2;CFL1;MT3;DDX42;JUN;SGK1;ATF6;ANXA5;HSPA5;FMN2;WDR73;PRLR;CLU;NOTCH2;APH1B;MCF2L;PHLDA1;NAE1;NAIP;NAA15;PAWR
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.47328380021946814,-0.9133571704745123,0.6436781609195402,1.0,1.0,11/35,30.72%,TRAF3IP1;PRKDC;POLR1C;TBK1;NPLOC4;POLA1;STAT6;IRF1;CYLD;POLR2F;XRCC6
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.4721395674570922,-0.9132803456071417,0.6373626373626373,1.0,1.0,9/42,14.77%,SLC22A6;CYP3A5;ATP5MK;SPTLC3;ALDH1L1;SLC16A7;PLD1;ACOT11;PPARGC1A
prerank,MSigDB_Hallmark_2020__Complement,-0.4490151757807984,-0.9132069191332309,0.6304347826086957,1.0,1.0,16/65,14.93%,CTSL;F3;CD55;CFH;LIPA;LGALS3;ZFPM2;CA2;C1R;USP15;MT3;C1S;ANXA5;HSPA5;CLU;CP
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),-0.6287605365477866,-0.9132063309205479,0.6956521739130435,1.0,1.0,3/5,27.61%,GRAMD1A;RORA;PTCH1
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.579483957054467,-0.9131375781498376,0.5897435897435898,1.0,1.0,3/9,31.34%,RBBP7;NASP;MIS18BP1
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.579483957054467,-0.9131375781498376,0.5897435897435898,1.0,1.0,3/9,31.34%,RBBP7;NASP;MIS18BP1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.579483957054467,-0.9131375781498376,0.5897435897435898,1.0,1.0,3/9,31.34%,RBBP7;NASP;MIS18BP1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.45505023435232284,-0.9127403522496855,0.6477272727272727,1.0,1.0,7/43,17.08%,SOD1;EPHA7;FGFR2;CDKN1B;TSPYL2;FLT1;CAMKK2
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.596778814338151,-0.9122961302818072,0.6857142857142857,1.0,1.0,5/6,40.34%,ADAM9;SNX9;SH3D19;NRDC;TNFRSF1B
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.6366070311862393,-0.9122038325918382,0.7323943661971831,1.0,1.0,2/5,5.71%,CSF1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.5359455142858953,-0.9122012381250727,0.726027397260274,1.0,1.0,1/13,3.40%,VEGFA
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.6231558325876094,-0.9116385717804021,0.7083333333333334,1.0,1.0,1/5,6.51%,GLUL
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.48043708361190207,0.9114399617484829,0.6086956521739131,0.9983264525124473,1.0,2/8,4.97%,INPP5F;PLA2G4C
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,-0.4573939623509129,-0.911439557969018,0.6744186046511628,1.0,1.0,15/42,23.58%,ELAVL3;PDE10A;PHYHIPL;SPOCK1;SNAP25;CCK;PLP1;NXPH1;SNAP91;GFAP;KCNC2;CADM2;NEGR1;LRRC4C;ZNF536
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.4236986996084126,0.9113932723993837,0.6,0.995944192323115,1.0,2/16,2.86%,NRG2;ERBB4
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.48936173911165753,-0.91096346463075,0.618421052631579,1.0,1.0,6/26,13.78%,PSMB1;PSMD14;RPS27A;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.5741574855806714,-0.9106478961984309,0.676056338028169,1.0,1.0,3/8,23.34%,DDIT4;ZFYVE27;GRB2
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),-0.45587200204815015,-0.9106181959341505,0.6162790697674418,1.0,1.0,10/38,18.94%,HNRNPL;PCBP3;PTBP2;FAM50A;IGF2BP2;AFF2;NOVA1;CLK1;HNRNPF;TRA2B
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.5938140905821226,-0.9100019951203939,0.6438356164383562,1.0,1.0,3/8,10.35%,CSF1;AKIRIN1;CMKLR1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.4622817528313336,0.90999595480763,0.5862068965517241,0.9962788747862129,1.0,3/11,3.87%,HCN2;ATP1B2;KCNJ8
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.41190605119580714,-0.9097802546936096,0.7346938775510204,1.0,1.0,32/191,17.77%,CSNK1D;WIPI1;TTC8;DHX29;PTPDC1;GOLGA8A;NUDCD3;DCDC2;GALNT11;ARF4;DDX3X;LZTFL1;TRAF3IP1;IFT122;GOLGA8B;ARMC9;ACTR3;IFT52;IFT140;C9ORF72;EXOC1;ATG16L2;GOLGA2;ATP6V1D;MAK;WDR19;RAB7A;PATL1;TNKS;CSDE1;SCLT1;FARP2
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.43228799165217296,0.9097124877394911,0.5294117647058824,0.9946110814699048,1.0,2/12,2.09%,ATP2B4;ATP1B2
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.4230868482186818,-0.9096477279514092,0.7244897959183674,1.0,1.0,24/140,15.61%,SOD1;MTCH2;EPHA7;VAV3;PTRH2;TGFB2;ARHGEF9;RHOB;OLFM1;DDX3X;LATS2;CCAR1;MELK;STK4;TP63;TGFBR1;RPS27A;RASGRF2;JUN;ATF6;CLU;APH1B;MCF2L;PHLDA1
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),-0.5160845268715388,-0.9095333635084515,0.6125,1.0,1.0,3/11,19.75%,PTGR1;GPX4;MAPKAPK2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5114131430716972,0.9094094376382551,0.48484848484848486,0.9906281521789569,1.0,1/5,0.29%,ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.5114131430716972,0.9094094376382551,0.48484848484848486,0.9906281521789569,1.0,1/5,0.29%,ATP2B4
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.5161853257866914,-0.9093679318531336,0.6164383561643836,1.0,1.0,7/15,31.84%,OLFM2;RAB8B;RAB12;ARFGAP3;GOLPH3;SEL1L;CANX
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.4902767168418057,-0.9090630820121292,0.6470588235294118,1.0,1.0,10/26,19.47%,ARID3A;PRKDC;CNOT8;PLAGL1;RGCC;WAC;CDKN1B;MDM4;MDM2;BTG2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.4321930228901497,0.9088548108966498,0.5625,0.9894479291740087,1.0,2/13,5.20%,MCU;VPS35
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.5128149437199724,-0.9086093112409742,0.589041095890411,1.0,1.0,1/14,3.40%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.5772301138425218,-0.9081930748252782,0.6486486486486487,1.0,1.0,6/7,42.33%,CAMKK2;VPS13D;VDAC1;PRKN;SLC25A4;HTT
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.33203803877499083,0.908190444072112,0.625,0.9883655370453283,1.0,9/45,12.48%,SPRY3;RALGPS1;NOTCH1;STARD8;DLC1;OPHN1;MAPKAP1;ARHGAP44;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.4336220359527422,-0.907708916662012,0.6842105263157895,1.0,1.0,17/86,14.95%,KDM1A;VEGFA;NFKBIA;PRKCI;ESR2;EIF2AK2;STAT3;PRKCB;RPS27A;IL18;TERF2IP;CLOCK;RGCC;TRIM13;CLU;PPARGC1A;PLPP3
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.5335135131706488,-0.9076167278878705,0.6621621621621622,1.0,1.0,2/13,17.77%,WASF1;FARP2
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.42795296434239066,-0.9072171327910669,0.6842105263157895,1.0,1.0,5/73,9.93%,ZFP36L2;CD44;VEGFA;TGFB1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.5761195394499806,-0.9070524315786526,0.6923076923076923,1.0,1.0,3/5,20.63%,IGFBP2;IGFBP5;BMP5
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.4958112233242316,-0.9068867637255009,0.5609756097560976,1.0,1.0,2/16,11.04%,KDM1A;SGCZ
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.4796000595011722,-0.9066735786755686,0.6781609195402298,1.0,1.0,5/30,10.07%,CSNK1G2;SPTLC3;ALDH3A2;SCCPDH;SPTLC1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.5578682836410322,-0.9063219450298745,0.6438356164383562,1.0,1.0,2/11,9.26%,ARHGAP24;CCP110
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.49258075203162854,-0.9061579915517229,0.6375,1.0,1.0,5/22,20.56%,VEGFA;SDCBP;LRPAP1;SFRP4;MTMR2
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.6214176159570177,-0.9056052827176415,0.6811594202898551,1.0,1.0,2/5,14.52%,DONSON;ZRANB3
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.45601916103015466,0.9053537473364014,0.56,0.9908945018377524,1.0,1/6,1.32%,CSPG4
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.45601916103015466,0.9053537473364014,0.56,0.9908945018377524,1.0,1/6,1.32%,CSPG4
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),-0.44675071356091,-0.9052035575573603,0.611764705882353,1.0,1.0,10/52,23.56%,HDAC2;HCFC2;HNRNPC;NUDT5;EZH1;MYSM1;SMARCA1;PAK1;ZBTB1;ARID1A
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),-0.6498573131006984,-0.904926870606137,0.647887323943662,1.0,1.0,2/5,32.03%,PRLR;PTK2B
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.5990372372701447,-0.9045792047906515,0.6578947368421053,1.0,1.0,4/5,35.76%,RUNX1;IRF1;BCL6;CBFB
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),-0.5294380097740231,-0.9043893088413159,0.6219512195121951,1.0,1.0,1/11,4.59%,DPM1
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.5966306000770207,-0.9043764353554259,0.7215189873417721,1.0,1.0,3/6,29.23%,INTS8;INTS2;INTS6L
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.4600561493082065,-0.9043209118346378,0.717391304347826,1.0,1.0,12/38,28.26%,PANK2;SREBF1;SCD;SIN3A;LSS;PRKAG2;NCOR2;PPARA;RORA;SREBF2;SP1;OPA3
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.3917808527758634,0.9037456658160158,0.4444444444444444,0.9922872201789696,1.0,3/19,7.41%,NSUN3;TFB1M;TRDMT1
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.5219322430184656,-0.9034611062416166,0.6097560975609756,1.0,1.0,1/13,5.53%,RPA1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.432637401289348,-0.9033770554787388,0.6979166666666666,1.0,1.0,33/97,32.24%,RPA1;RAD21;RPS27A;PRKDC;TERF2IP;DNMT1;PARP1;FAN1;FANCC;ZRANB3;POLK;UBE2B;POLA1;WRN;BTG2;XPA;DDX21;NT5E;ZBTB1;PURA;USP3;PARP4;GTF2H1;UVRAG;SMC1A;POT1;RPA3;TERF1;XRCC6;PARG;ORC3;UHRF2;RAD17
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.6104640132281445,-0.9030725849544066,0.6891891891891891,1.0,1.0,3/5,26.48%,SMAD6;LDLRAD4;SNX25
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.4122371147077887,-0.9028628115113614,0.68,1.0,1.0,27/119,17.44%,CSNK1D;CSNK1G2;IGFBP2;MCC;CSNK1A1;PSMB1;TGFB1;NKD1;DDX3X;FGFR2;LATS2;PSMD14;STK4;RBX1;BICC1;PSMA4;AMFR;PSMB2;UBAC2;PSMA7;CDK14;LRRK2;TLE4;LGR4;TNKS;TMEM64;UBE2B
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.5187845696600959,-0.9027452793012062,0.6493506493506493,1.0,1.0,6/12,24.93%,KCNQ1;NEDD4L;NEDD4;AHCYL1;AKAP6;CHRM3
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.4639500978438757,-0.902193482988758,0.6235294117647059,1.0,1.0,6/34,19.92%,SLC2A1;MYRIP;SNAP25;CLOCK;ACSL4;KCNC2
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.5600681715595455,-0.9018787282031422,0.6794871794871795,1.0,1.0,4/11,27.64%,GBE1;PYGB;PRKAG2;PHKB
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),-0.6079986815632996,-0.9014944623179632,0.7272727272727273,1.0,1.0,3/6,30.03%,FGFR2;CLMP;SRP54
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.4969581887491409,-0.9014381574178902,0.6875,1.0,1.0,2/16,3.69%,FHL1;ANK3
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.6069399816798625,-0.9013701324925777,0.6666666666666666,1.0,1.0,2/6,13.59%,LPCAT3;PLAAT3
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.5332925575536285,-0.900773621942378,0.6626506024096386,1.0,1.0,2/13,12.67%,KLF2;ROCK2
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.45846968950461464,-0.9007464960531365,0.7157894736842105,1.0,1.0,9/51,10.96%,SELENOS;NFKBIA;TMSB4X;PDCD4;SNX6;LPCAT3;LRFN5;IL18;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.6049598990988005,-0.900677024736583,0.6533333333333333,1.0,1.0,2/7,9.93%,TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.6079623049424461,-0.9006724930336726,0.6764705882352942,1.0,1.0,1/5,10.03%,ERAP1
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.4477168645900549,-0.9005930708905936,0.6373626373626373,1.0,1.0,7/47,15.14%,SLC2A1;TGFB2;TGFB1;SNAP25;EXOC1;CLOCK;SYTL4
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.6219555386417683,-0.9004025172484063,0.6944444444444444,1.0,1.0,2/5,23.63%,CCT4;CCT8
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.4935579011113863,-0.9002964593076732,0.6666666666666666,1.0,1.0,9/24,35.24%,ADM;NEDD4;CD9;DNM3;GRB2;CD81;LDLRAP1;AP2M1;DNM1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.5580912889814479,-0.9001277217930688,0.6625,1.0,1.0,2/8,25.26%,ETF1;INSR
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.594963326875662,-0.9000643646851932,0.5945945945945946,1.0,1.0,1/5,9.02%,STAT3
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.5556329701832163,-0.8997843792173088,0.6506024096385542,1.0,1.0,3/10,31.34%,RBBP7;NASP;MIS18BP1
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.32064109386510575,0.8997747167916766,0.6666666666666666,0.9989684094659411,1.0,4/69,2.79%,HSPA1A;PSMF1;CNOT7;PSMD7
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.5053904556717089,-0.8994696605865231,0.6582278481012658,1.0,1.0,3/16,3.06%,PRKACA;NR4A3;PDE4B
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.5617003621091956,-0.8993962632230099,0.7051282051282052,1.0,1.0,1/9,8.36%,TRAF3IP1
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.5258446436336633,-0.8993796088159495,0.6153846153846154,1.0,1.0,3/13,10.96%,EFNB2;TGFB1;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.41368603137419907,-0.8993325897874239,0.6847826086956522,1.0,1.0,14/74,17.44%,CSNK1D;CSNK1G2;PSMB1;TGFB1;DDX3X;FGFR2;PSMD14;PSMA4;PSMB2;PSMA7;LRRK2;LGR4;TNKS;UBE2B
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.44510839013015163,-0.8989803918302899,0.6458333333333334,1.0,1.0,17/62,28.89%,STRAP;DHX29;SRSF10;PRKDC;SRSF5;RPS14;EIF2S2;MCTS1;EIF2S3;RPL5;RPL24;SF3B1;SETX;CELF2;RPL3;NCBP1;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.5103319433405309,-0.8987338598302224,0.7027027027027027,1.0,1.0,2/19,14.77%,FYCO1;PPARGC1A
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.3521364334441997,0.8985783150103082,0.5833333333333334,0.9997433860171799,1.0,7/48,4.54%,RCAN2;CSRNP3;SORBS2;C2ORF72;FAM13C;EDN3;NFASC
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.5776968530371174,-0.8984683474919267,0.6533333333333333,1.0,1.0,4/6,36.40%,APPL2;NF1;PTN;KDM2B
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.6095824986066605,-0.8983136519001299,0.6486486486486487,1.0,1.0,1/5,24.82%,LYN
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.3777318318696971,0.8979027157404489,0.6470588235294118,0.998856449472578,1.0,3/27,2.09%,SCN1A;HCN2;ATP1B2
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.48807814444526865,-0.8978151028577842,0.581081081081081,1.0,1.0,2/15,5.28%,STC1;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.5086032502294089,-0.8977871067328657,0.6341463414634146,1.0,1.0,7/20,20.98%,SMCHD1;SPIDR;PRKDC;FMN2;PARP1;WDR48;SLF1
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.539503985859456,0.8974888326008615,0.5517241379310345,0.9974977911562102,1.0,1/5,1.15%,TRPC6
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.5202462309924918,-0.8967341704765656,0.6744186046511628,1.0,1.0,6/16,18.83%,MUCL1;GALNT15;GALNT11;GALNT10;GALNT7;XXYLT1
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.5742490114554453,-0.8960134827781377,0.6973684210526315,1.0,1.0,1/7,6.51%,GLUL
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.5347754685745332,-0.8958209255828318,0.6785714285714286,1.0,1.0,1/12,0.69%,PRKACA
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.6015258809164438,-0.8958186353224051,0.6986301369863014,1.0,1.0,1/5,1.72%,SYT1
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.5599682284482101,-0.8953372490645275,0.6575342465753424,1.0,1.0,2/10,9.64%,TGFB1;FHL2
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.5340598992247356,-0.8947868934073406,0.7441860465116279,1.0,1.0,6/13,31.46%,NFKBIA;ABCA8;SREBF2;PTCH1;ABCA5;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4829481363540793,0.8947666885252475,0.4838709677419355,1.0,1.0,1/5,2.12%,CNOT7
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.5981408328598072,-0.8947194778465039,0.6911764705882353,1.0,1.0,2/6,20.76%,NECTIN2;HLA-B
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.5608396577981922,-0.894660319354705,0.6521739130434783,1.0,1.0,3/7,26.77%,GNAQ;EGFR;LPAR1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.5697849827054532,-0.8938769970391791,0.676923076923077,1.0,1.0,3/5,24.53%,PTPN1;HSPA5;RACK1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.507705937788357,-0.8935431884622528,0.7294117647058823,1.0,1.0,7/17,35.60%,RBBP7;DNMT1;CREBZF;EED;MTF2;JARID2;MACROH2A1
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.4435940299481175,-0.8928472298013732,0.7021276595744681,1.0,1.0,22/68,29.39%,DPP6;SPTBN4;ANK3;ATP1B3;AFDN;ROCK2;DENND4C;ZFYVE27;TSPAN5;DPP10;GAK;RAB11A;STXBP1;RAB8B;EPB41L3;RAB12;CLASP2;MAP7;RDX;PTCH1;KCNIP4;BSG
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),-0.5119565129274813,-0.8926950162444433,0.6714285714285714,1.0,1.0,1/14,2.36%,CRY1
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.5505853746502805,-0.8924193234870458,0.6805555555555556,1.0,1.0,2/8,15.69%,ESR2;CALCOCO1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.5189319864597923,-0.8923507409056186,0.631578947368421,1.0,1.0,3/15,12.70%,RPA1;ANKRD28;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5992059660640123,-0.8922893556029228,0.6764705882352942,1.0,1.0,2/5,13.49%,VEGFA;RGCC
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),-0.4683185151563935,-0.89217627265644,0.6666666666666666,1.0,1.0,3/25,10.96%,CRY1;STAT3;PTPN2
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.5886980253652272,-0.8919055291701716,0.6470588235294118,1.0,1.0,5/5,41.19%,EIF4G1;MACROH2A1;ABCB1;SLC38A2;CORO2B
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.4286663728580517,-0.8917551433488736,0.723404255319149,1.0,1.0,14/79,16.79%,GJA1;PCDH17;CD44;VEGFA;DCLK1;COL11A1;GLUL;PTPRD;CA2;PLP1;CLU;PLPP3;IGFBP5;ATG4B
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),-0.5727572018575207,-0.8916344154853104,0.6883116883116883,1.0,1.0,1/7,3.40%,VEGFA
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.5395854786140755,-0.8915196632035609,0.7023809523809523,1.0,1.0,1/13,2.78%,VAV3
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),-0.5440860059229915,-0.891107513689172,0.691358024691358,1.0,1.0,4/15,20.53%,PTPN1;NDFIP2;DNAJA1;NDFIP1
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.5081623405351517,-0.8909610453181804,0.6923076923076923,1.0,1.0,4/15,13.28%,CREB3L2;TGFB1;RUNX1;WNT2B
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.5949814830520533,-0.8906139215184157,0.7101449275362319,1.0,1.0,4/5,36.81%,TCF4;SUPT6H;MCM3AP;SETD2
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),-0.5463775622295333,-0.8902937144524835,0.7222222222222222,1.0,1.0,4/8,30.01%,ATP6V1H;ATP6V0D1;ATP6V0E1;DMXL1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.4689002024748432,-0.8901979569410393,0.6666666666666666,1.0,1.0,10/39,17.76%,CHST11;OGN;MGST1;SLC10A7;DSE;GLCE;OMD;PAPSS1;VCAN;CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.4135582813550315,-0.8900472233294291,0.7127659574468085,1.0,1.0,24/67,26.77%,WWC1;EPHA7;APIP;MYDGF;FGFR2;STK4;ROCK2;JCAD;DUSP1;FLT1;ULK4;PEBP1;TRIM5;PAK1;CCN1;MAPK1;TAOK3;MINK1;LYN;INSR;KDR;EGFR;ZDHHC17;LPAR1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.6045067697677811,-0.8898632550185657,0.6818181818181818,1.0,1.0,1/6,15.70%,LRRK2
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.5743909634963272,-0.8896515533985033,0.6341463414634146,1.0,1.0,2/7,22.38%,PLPP3;PTS
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.42824176419419174,-0.889624951590041,0.6593406593406593,1.0,1.0,10/60,13.35%,NRG1;HOMER2;SPTBN4;DNER;SPOCK1;DCDC2;TRAF3IP1;ARFGEF3;IFT140;GNAL
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.4329849146946408,-0.8890220247491223,0.7204301075268817,1.0,1.0,14/63,26.07%,SEC13;NUP153;NUP133;NUP88;SDCBP;HIF1A;CDKN1B;RANBP2;PRKAG2;APP;LYN;NDUFS4;EGFR;KCTD20
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.47653569681875185,-0.8886379463789372,0.6521739130434783,1.0,1.0,9/25,32.24%,ANKRD17;TSPYL2;SMC3;ATAD5;EGFR;TERF1;RBBP6;ORC3;RAD17
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.47252179118533444,0.8884749192706298,0.7647058823529411,1.0,1.0,4/11,6.77%,BCL2L1;ERBB4;VPS35;BCL2
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.5156385947652692,0.8884610575958258,0.5652173913043478,1.0,1.0,3/5,8.53%,SLIT3;SLIT2;RHOA
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.506377648287401,-0.8879697117816874,0.6623376623376623,1.0,1.0,3/14,14.52%,NIBAN2;TERF2IP;ZRANB3
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.39549988736995834,0.8879340507525749,0.6363636363636364,1.0,1.0,2/25,1.97%,HSPA1A;SERPINH1
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.42546663010516583,-0.8877216598093389,0.6956521739130435,1.0,1.0,6/81,5.04%,ADAMTS9;GJA1;GPR161;PDE10A;TENM3;PAPPA
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.5576973384483737,-0.8876201418967417,0.581081081081081,1.0,1.0,1/6,0.91%,CSF1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.5610376543643529,-0.8876088680904926,0.7236842105263158,1.0,1.0,4/10,26.26%,CPEB4;CPEB2;PKM;YBX3
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.48804665795576346,-0.8874927877818831,0.6829268292682927,1.0,1.0,3/26,14.31%,PRKACA;PSMD14;UCHL5
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),-0.5754432689634283,-0.8873651579493812,0.691358024691358,1.0,1.0,1/6,9.93%,TGFBR1
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.5604526508609278,-0.8869881580128529,0.6935483870967742,1.0,1.0,2/5,24.35%,CST3;PSMA3
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.5193696637572616,-0.8865498963154136,0.6578947368421053,1.0,1.0,3/12,17.74%,TUT7;MOV10L1;AGO2
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.44276668505065636,-0.8863824959967336,0.7252747252747253,1.0,1.0,11/42,19.79%,CD44;SPTBN4;VEGFA;TGFB1;DDIT4;STK4;TERF2IP;TBK1;MTCP1;PAK1;RAF1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.4788413048636304,-0.8860906792205638,0.6666666666666666,1.0,1.0,6/26,25.87%,TGFB1;ADAM17;ERBIN;GRB2;REPS2;EGFR
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.5712710225617205,-0.8856918740015295,0.675,1.0,1.0,4/7,38.32%,XKR4;MEGF10;RHOBTB1;RAC1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.6061573460332798,-0.8856409348849232,0.7333333333333333,1.0,1.0,5/6,39.12%,CCT4;CCT8;LARP7;CCT3;CCT6A
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.6061573460332798,-0.8856409348849232,0.7333333333333333,1.0,1.0,5/6,39.12%,CCT4;CCT8;LARP7;CCT3;CCT6A
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.5246299963593561,0.8851340460303311,0.6551724137931034,1.0,1.0,3/7,3.56%,HEY2;NOTCH1;HEYL
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.5180232444145731,-0.8845370555719753,0.6585365853658537,1.0,1.0,4/11,24.48%,STAT3;LPL;APP;MALT1
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.4855386199941807,-0.8845094380848421,0.6941176470588235,1.0,1.0,8/19,32.64%,FMN2;CLU;MDM4;AZIN1;EGFR;ITGAV;HSP90AB1;PRNP
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.47043089609224686,0.8844026339759338,0.65,1.0,1.0,2/10,3.99%,SOX5;SOX6
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.4436398858834551,0.88405339649076,0.5789473684210527,1.0,1.0,2/14,3.96%,RYR2;DTNA
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.5577673446960978,-0.8839685745987781,0.6666666666666666,1.0,1.0,1/8,4.01%,PIP4P2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.5511992798723844,-0.8838826773776287,0.6962025316455697,1.0,1.0,4/10,27.43%,SOD2;LRRK2;FYN;PDE8A
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.5164796224762539,-0.8838388698473755,0.6904761904761905,1.0,1.0,5/14,31.75%,VEGFA;PAK1;KDR;COL4A1;TGFBR2
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.5528994612960559,-0.8825870976689356,0.6621621621621622,1.0,1.0,2/6,12.05%,DCDC2;ADORA2B
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.5712278242506748,-0.8825094836038667,0.7142857142857143,1.0,1.0,5/7,35.90%,DLGAP1;ROCK2;APP;AKAP9;TMEM108
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.5337817286597484,-0.8824830229119449,0.6623376623376623,1.0,1.0,4/9,29.19%,HNRNPC;DCP2;POT1;TERF1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.5377038852193571,-0.8817638039730241,0.704225352112676,1.0,1.0,3/9,20.79%,TUT7;DCP2;SSB
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5266543460884124,-0.881219528911633,0.6875,1.0,1.0,3/10,24.53%,DDIT4;PDE4D;RACK1
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.5629911787898991,-0.8811290949656894,0.6805555555555556,1.0,1.0,2/5,23.12%,SNAP91;DNM3
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.4470279625525589,0.8808006797727982,0.5238095238095238,1.0,1.0,2/11,9.91%,DLC1;ACTN1
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.49199479632984683,-0.8807362121060482,0.6805555555555556,1.0,1.0,5/17,19.06%,RIPOR1;TGFB1;PTPN1;PRR5L;UHMK1
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.3867332873206594,0.8803585470952884,0.5882352941176471,1.0,1.0,3/14,9.56%,CDC42;MYH9;GULP1
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.5775328046662453,-0.8802976930700377,0.7375,1.0,1.0,2/7,19.27%,HIF1A;SYBU
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.5744925760673375,-0.8801458724818199,0.6233766233766234,1.0,1.0,2/5,28.25%,STAT1;COL4A1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.5420832696088742,-0.8799734086619957,0.675,1.0,1.0,5/9,29.98%,SLC47A1;SLC1A1;SLC6A20;SLC6A13;SLC22A2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.5578702871611001,-0.8796762193793988,0.6805555555555556,1.0,1.0,1/6,15.32%,DUSP1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.4216535870664362,-0.8793284575877335,0.7628865979381443,1.0,1.0,7/81,4.96%,ARHGAP15;VAV3;ARHGAP31;ARHGAP24;RHOJ;ARHGEF9;RHOB
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.5596459006216472,-0.8792637752154407,0.7402597402597403,1.0,1.0,1/9,0.69%,PRKACA
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.4384222549366228,0.8792485534868771,0.5625,1.0,1.0,1/15,2.97%,NOTCH1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.41219790104805976,-0.8791581755381739,0.7578947368421053,1.0,1.0,8/87,10.62%,GNPAT;AGPAT4;LPIN1;MTMR9;SELENOI;LPCAT3;PLD1;AGK
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.5180625271230761,-0.8789232275875938,0.6987951807228916,1.0,1.0,4/10,24.48%,STAT3;LPL;APP;MALT1
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.4743438889218518,-0.878510239237432,0.6438356164383562,1.0,1.0,3/17,9.74%,PDE7B;PDE7A;RIMS2
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.5925156178648217,-0.8785048426472762,0.6986301369863014,1.0,1.0,1/6,4.96%,RHOB
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.5028761937088135,-0.8778542659444725,0.6933333333333334,1.0,1.0,1/18,0.74%,SOD1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),-0.5078826908774456,-0.8777541662361117,0.6891891891891891,1.0,1.0,3/13,25.62%,MORF4L1;MORF4L2;PHF20L1
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.41942549090834735,-0.877692137365961,0.6947368421052632,1.0,1.0,29/86,29.32%,TSC2;NFKBIA;RHOB;PDCD4;DDIT4;MELK;STK4;TP63;YARS1;IFT57;PLAGL1;PARP1;NOTCH2;NAE1;PAWR;PRUNE2;MDM2;RAF1;AHCYL1;IRF1;APP;VDAC1;SIAH1;DCC;FOXO1;TCHP;RNF152;APAF1;ELMO1
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.46419710526918057,-0.8776821370282556,0.7142857142857143,1.0,1.0,5/21,20.79%,TRMT9B;NSUN6;ZBTB8OS;DTWD2;SSB
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.49268229688220866,-0.8775979828024155,0.6962025316455697,1.0,1.0,2/20,10.04%,DDX3X;NEDD4L
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.4617912569790531,-0.877306266305527,0.6551724137931034,1.0,1.0,15/30,24.43%,LGALS3;FADS2;ALCAM;PDK3;SEMA3B;ERRFI1;SCD;ANXA5;CLU;LSS;CD9;CPEB2;LPL;CHKA;SREBF2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.42662607888414616,-0.8772944691625432,0.7634408602150538,1.0,1.0,21/65,28.15%,GJA1;PELI1;PRKCB;ANKRD17;TERF2IP;TBK1;TRIM13;NDFIP2;TMED4;TRIM5;NDFIP1;ALPK1;DDX21;AKAP13;BIRC2;MIER1;MALT1;ZDHHC17;LPAR1;MAP3K14;TFG
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.4518928491415919,-0.8771728622960885,0.7721518987341772,1.0,1.0,7/33,21.83%,MAP3K8;RPS27A;ADORA2B;BTRC;SKP1;MAPK1;MINK1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,-0.4117673996295625,-0.8765905390515948,0.7444444444444445,1.0,1.0,11/71,17.24%,GJA1;CRMP1;TENM3;DCLK1;SYNDIG1;SHC2;ARNT2;PLPP3;TEAD1;IGFBP5;SMARCA1
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.4768013379611734,-0.8765779625656386,0.7415730337078652,1.0,1.0,9/30,19.65%,RPA1;MORF4L1;PSMD14;RAD21;SPIDR;PARP1;FAN1;WRN;ZSWIM7
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),-0.5064625478708422,-0.8762056206976682,0.6266666666666667,1.0,1.0,5/11,29.55%,FGFR2;TGFBR1;SFRP4;WWOX;SPEF2
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.4836513771796319,-0.8757855348980987,0.6951219512195121,1.0,1.0,6/19,23.07%,PTPN1;ERAP1;APPL2;BIRC2;IRF1;RIOK3
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.49335201697664477,-0.8756165600301786,0.6951219512195121,1.0,1.0,5/15,28.52%,PIP4P2;RAB27A;SCARB1;RACK1;ITGAV
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.4934290888436146,-0.8756135560795786,0.7261904761904762,1.0,1.0,3/19,12.34%,TANK;HIF1A;GBP2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.4475486541181625,0.8750494227274205,0.6052631578947368,1.0,1.0,2/5,19.70%,NCOA3;NUMA1
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.45723705812887944,0.8745955388117423,0.5769230769230769,1.0,1.0,1/9,1.41%,LRCH1
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.4643558813426623,0.8744744348135922,0.5428571428571428,1.0,1.0,1/7,5.13%,SMYD3
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.4934476008751779,-0.8740997675194858,0.7037037037037037,1.0,1.0,4/18,10.57%,TGFB2;TGFB1;FGFR2;MYL3
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.4827873215948326,-0.8736748540069049,0.6341463414634146,1.0,1.0,4/19,9.80%,ARHGAP24;TGFB2;STMN1;HEG1
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.5529478198960326,-0.8735706769250988,0.6818181818181818,1.0,1.0,1/6,10.27%,NPRL3
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),-0.6056414602303225,-0.8735582205269511,0.7662337662337663,1.0,1.0,4/6,23.36%,PTPRD;LRFN5;GPC4;LRRC4C
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.48433241808729377,-0.8734265912103742,0.6904761904761905,1.0,1.0,3/16,17.26%,DDX3X;C9ORF72;CSDE1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.5362424562591213,-0.8730169912654892,0.6410256410256411,1.0,1.0,4/10,21.94%,VEGFA;FGFR2;HECA;LOXL3
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),-0.5412749550962426,-0.8729442617932321,0.7205882352941176,1.0,1.0,3/9,22.25%,PANK2;PRKAG2;PPARA
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.45898537639582165,0.8723967858451903,0.6153846153846154,1.0,1.0,2/14,5.20%,ZDHHC15;VPS35
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.43339473757093633,-0.872271938265631,0.7528089887640449,1.0,1.0,15/54,25.89%,NXN;TSC2;NKD1;DCDC2;FGFR2;RUNX1;CDK14;LRRK2;BTRC;SFRP4;GNAQ;APP;RACK1;WWOX;NLK
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.5671483205128461,-0.8720834841478728,0.6891891891891891,1.0,1.0,2/6,27.49%,MTMR2;RDX
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.5736059236965234,-0.8717788151773668,0.75,1.0,1.0,2/6,23.63%,CCT4;CCT8
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5749661184803341,-0.8717759750586092,0.7352941176470589,1.0,1.0,1/6,5.71%,TGFB1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.4061547659960622,-0.8717275722610192,0.7525773195876289,1.0,1.0,34/118,29.13%,RPA1;XRCC4;RAD21;RPS27A;PRKDC;PARP1;FAN1;FANCC;ZRANB3;POLK;ALKBH5;WDR48;UBE2B;POLA1;WRN;BTG2;RNF168;XPA;TP53BP1;UIMC1;ZBTB1;APTX;APBB1;SETX;RAD23B;USP3;EYA1;ABL1;PARP4;BRCC3;GTF2H1;UVRAG;SMC1A;RPA3
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.44276728412241395,-0.8715967538630724,0.6463414634146342,1.0,1.0,6/26,24.09%,KANSL3;MORF4L1;EP400;PER1;MORF4L2;APBB1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.5048469251002912,-0.871346823050801,0.6506024096385542,1.0,1.0,9/13,34.68%,GOLGA2;UBE2L3;BTRC;SKP1;DCUN1D4;RPS2;DCUN1D2;DCUN1D1;RAB1A
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.5158335731801027,0.8712109572046041,0.6216216216216216,1.0,1.0,2/5,8.66%,PPP2R3C;DOCK11
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.5248216066879003,-0.8711920213331367,0.6857142857142857,1.0,1.0,3/11,17.74%,ZFP36L2;PABPC1;AGO2
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.5248216066879003,-0.8711920213331367,0.6857142857142857,1.0,1.0,3/11,17.74%,ZFP36L2;PABPC1;AGO2
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.4519802707206804,-0.871108867336987,0.7415730337078652,1.0,1.0,11/27,33.38%,SRSF10;KHDRBS2;RBM39;METTL16;KHDRBS3;AHCYL1;NCBP1;CWC22;LARP7;SUPT6H;SAFB
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.4400228498807781,-0.8710119191279303,0.691358024691358,1.0,1.0,7/33,17.45%,PSMB1;PSMD14;RPS27A;PSMA4;PSMB2;PSMA7;ANAPC4
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.48417259554130165,-0.8706482130171302,0.7407407407407407,1.0,1.0,2/19,7.59%,WASF1;PARVB
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.5548515609290494,-0.8702915636087533,0.7105263157894737,1.0,1.0,2/7,25.87%,ATAD5;EGFR
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.5446106678918041,-0.8702786898077698,0.717948717948718,1.0,1.0,1/8,8.77%,SMCHD1
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.4296891956355043,-0.870216480984352,0.7553191489361702,1.0,1.0,10/58,13.78%,ZFP36L2;NFKBIA;TMSB4X;PSMB1;PSMD14;TANK;PSMA4;PSMB2;GBP2;PSMA7
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.3285883276244358,0.870172854231491,0.7272727272727273,1.0,1.0,2/39,1.44%,SPRY3;TNIP1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.3319314414304796,0.8697321181782323,0.8,1.0,1.0,6/46,6.95%,NOX4;HDAC9;MFHAS1;PLA2G4C;AFAP1L2;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.5177566016608438,-0.8697200545636401,0.7108433734939759,1.0,1.0,4/10,31.46%,NFKBIA;ABCA8;PTCH1;NR1H3
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),-0.5461285127030189,-0.8693978602339718,0.675,1.0,1.0,5/10,30.09%,SPIDR;DNAJA1;KIAA0586;CEP120;GAPVD1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.6056256834949956,-0.8689999105987902,0.6973684210526315,1.0,1.0,4/5,39.33%,P4HB;FYN;LANCL1;PRKN
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.5694276716514841,-0.8689508575341034,0.7,1.0,1.0,2/5,35.24%,DNM3;DNM1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.5694276716514841,-0.8689508575341034,0.7,1.0,1.0,2/5,35.24%,DNM3;DNM1
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.5667744143341118,-0.8688437245429641,0.6944444444444444,1.0,1.0,2/5,24.24%,GABARAPL1;MAP1LC3B
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.5667744143341118,-0.8688437245429641,0.6944444444444444,1.0,1.0,2/5,24.24%,GABARAPL1;MAP1LC3B
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.6005892355623743,-0.8686002708513574,0.6901408450704225,1.0,1.0,2/5,22.25%,FYN;PPARA
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5112427561165072,-0.8683505443329005,0.6708860759493671,1.0,1.0,6/9,40.34%,ADAM9;SNX9;SH3D19;TIMP2;NRDC;TNFRSF1B
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.45140037794925325,-0.8682648263597905,0.691358024691358,1.0,1.0,2/23,7.41%,ANK3;PTPRD
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.49150815215439664,-0.8677911385394906,0.684931506849315,1.0,1.0,5/17,18.45%,HDAC2;RHBDD1;TANK;WDR48;BTRC
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.3192278253972139,0.8677798541972447,0.8333333333333334,1.0,1.0,1/51,0.10%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.5942831815319819,-0.8676854758524836,0.7464788732394366,1.0,1.0,3/5,27.78%,NEDD4L;GPM6B;GOPC
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.4292463132559938,-0.8673578568580059,0.7558139534883721,1.0,1.0,14/48,21.22%,NKD1;NEDD4L;FMN2;CDKN1B;RAB7A;GFAP;MDM4;WWP1;AZIN1;NSF;MDM2;NEDD4;HECW1;SMURF2
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.46781665250806326,-0.8672477642370553,0.6551724137931034,1.0,1.0,5/23,21.09%,NEDD4L;TF;CLU;APPL2;NLGN1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.43859000655137886,-0.8669489084526032,0.7159090909090909,1.0,1.0,7/39,13.78%,NFKBIA;TMSB4X;PSMB1;PSMD14;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.5480670750311047,-0.8668300809688715,0.7466666666666667,1.0,1.0,3/10,10.35%,CSF1;AKIRIN1;CMKLR1
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),-0.5630876985958829,-0.8666200067839219,0.7272727272727273,1.0,1.0,3/5,36.61%,MALT1;RC3H2;NFKBIZ
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5186126646748676,-0.8665409608225738,0.7195121951219512,1.0,1.0,4/12,20.40%,RPA1;PARP1;WRN;XPA
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.404488671778108,-0.8664367851478474,0.7157894736842105,1.0,1.0,15/123,13.11%,EPN1;SYT1;ANK3;TOR1AIP2;DNAJC6;NAPG;PRKCI;LPCAT3;AP2A1;ACTR3;RPS27A;USO1;SGCZ;TF;REPS1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5168698580278098,-0.8662876425367168,0.7037037037037037,1.0,1.0,1/11,0.69%,PRKACA
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5132797931690264,0.865922764541898,0.5,1.0,1.0,1/5,4.56%,PPARD
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.55306484439437,-0.8658434360091284,0.725,1.0,1.0,1/6,8.57%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5044235767159585,-0.8657221474531808,0.7088607594936709,1.0,1.0,8/16,37.28%,ARIH2;MICALL2;UBE2L3;SREBF2;UBL5;UBE2D3;CSNK2A2;SH3GLB1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.32441183117453576,0.8656413128711278,0.6666666666666666,1.0,1.0,6/36,9.06%,LMOD1;SYNPO2;BIN1;NCK1;EVL;CARMIL1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.5315496755360023,-0.8655505166834536,0.7733333333333333,1.0,1.0,2/15,13.09%,TGFB1;SYMPK
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.5541477747726277,-0.8652387496272481,0.717948717948718,1.0,1.0,4/8,21.83%,VEGFA;SASH1;MAP3K4;MINK1
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.579843620401135,-0.865001666471897,0.7,1.0,1.0,3/5,36.04%,AFG1L;YME1L1;BNIP3L
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.506869511156675,-0.8648319775695158,0.6710526315789473,1.0,1.0,3/13,26.00%,C9ORF72;AKAP13;ABL1
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.3442962572138381,0.8647386042295969,0.8,1.0,1.0,7/69,6.42%,HSPA1A;DNAI4;ARL6;PTGES3;BIN1;CHMP4B;NCK1
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.41514265353844443,-0.8646552142213709,0.735632183908046,1.0,1.0,12/59,16.03%,GJA1;PHYHIPL;SLC1A2;ALDH1L1;CDH20;SYNDIG1;SNAP25;GRIA3;PLP1;MT3;TEAD1;GFAP
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.4450298637968551,-0.8644851909843254,0.7011494252873564,1.0,1.0,4/28,15.54%,SDCBP;CCP110;TAPT1;GPSM2
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.5292531215421284,-0.864162464029026,0.7215189873417721,1.0,1.0,6/11,25.57%,ALDH3A2;TRAM1;EMC3;SERP1;APP;TRAM2
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.49454625801276864,-0.8639099999706298,0.6351351351351351,1.0,1.0,2/12,15.77%,SCD;ACSL4
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5528549429306522,-0.8637474157008993,0.6956521739130435,1.0,1.0,2/6,13.88%,PTPN1;HSPA5
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.5199574897770318,-0.863468133779823,0.7051282051282052,1.0,1.0,1/9,6.72%,ADM
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.5156958777171353,-0.8634306027269111,0.7051282051282052,1.0,1.0,2/9,20.55%,AGO2;EIF2AK4
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.5858020135983616,-0.8633837500752388,0.7162162162162162,1.0,1.0,2/5,23.72%,UBE2B;PDE4D
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.5493362353363238,-0.8628329826741754,0.6986301369863014,1.0,1.0,2/7,19.94%,LGALS3;PAG1
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.5632088969086488,-0.8625286344556201,0.8055555555555556,1.0,1.0,2/8,18.37%,TRIM13;TRIM5
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.5328749618260624,-0.8624448636255178,0.726027397260274,1.0,1.0,4/9,21.33%,SASH1;MAP3K4;PAK1;TAOK3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.5239869223946395,-0.862386865212611,0.7303370786516854,1.0,1.0,1/11,7.12%,DDIT4
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.47661011111007057,-0.8616385861045383,0.759493670886076,1.0,1.0,10/28,26.77%,PRAG1;ROBO1;NOTCH2;LPAR6;ERBIN;AKAP13;GRB2;LYN;PIK3CB;LPAR1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.542837740533835,-0.8614930439902151,0.7213114754098361,1.0,1.0,2/7,27.51%,AHCYL1;NCBP1
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.5095665055724787,-0.8603368386333116,0.6625,1.0,1.0,4/9,31.92%,CA2;SLC9A9;SLC4A10;SLC4A4
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.3296055416978209,0.8599086963655699,0.6,1.0,1.0,4/26,7.94%,LEMD3;NOTCH1;SKI;RBPMS2
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.5171284110024519,-0.8597637483170781,0.7222222222222222,1.0,1.0,4/11,20.87%,TUT7;DCP2;SSB;CPSF2
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.5238405664379658,-0.8594911523988605,0.7317073170731707,1.0,1.0,2/10,22.17%,RAB7A;EEA1
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.4797961558048523,0.8590239850972767,0.6129032258064516,1.0,1.0,1/5,4.01%,CDC42
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.49016073020846446,-0.8590193099977866,0.7375,1.0,1.0,4/14,7.94%,ZFPM1;TGFB2;OLFM1;SMAD6
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.4150531766144048,-0.8588507674720133,0.7340425531914894,1.0,1.0,12/65,15.45%,TGFB2;MARCHF6;PROS1;MT2A;MCCC2;SLC35D1;CA2;PTGR1;AKR1C2;NPC1;ENPEP;GSR
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.5748360346178927,-0.8584894197572994,0.7272727272727273,1.0,1.0,4/6,35.00%,PRKDC;XRCC6;CD47;HSPD1
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.5708593852974855,-0.8577178539254354,0.726027397260274,1.0,1.0,2/6,26.16%,PRKCB;ZDHHC17
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.4619558361665138,-0.8567886274372818,0.6708860759493671,1.0,1.0,4/17,25.97%,TMEFF2;STMN1;ARHGAP28;CLASP2
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.5465908764577969,-0.8566904747466842,0.7435897435897436,1.0,1.0,5/7,38.96%,TSPYL2;TERF1;RAD17;PDS5A;WAPL
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.38430024586346784,-0.8566217608925724,0.97,1.0,1.0,179/738,26.00%,WWC1;TAF7;SCML1;ENO1;TWIST1;ETV5;NR4A3;NRG1;KDM1A;KLF2;BASP1;CRY1;PURB;CREM;CREB3L2;JDP2;WWC2;VEGFA;SRA1;PLAG1;PIAS2;PKNOX2;HDAC2;SRSF10;PDCD4;ARID3A;TGFB1;SUFU;ZNF235;HIVEP2;SOD2;HCFC2;TSHZ1;BACH2;NIBAN2;CBFA2T2;CDC5L;MED12L;HES4;ZFPM2;KLF3;SMAD6;ESR2;CTCF;CEBPD;GLIS3;CTR9;ZNF608;CD38;CCAR1;SNX6;RAD21;STAT3;KLF15;ZNF138;PRKCB;PRKAR1A;TP63;TGFBR1;HIF1A;HIVEP1;RNF111;SREBF1;RCOR1;HSF2;ELF1;HDGFL3;PURG;CCNH;RUNX1;ZKSCAN1;MED14;MT3;MAFK;TSHZ2;PLAGL1;NCOA7;TERF2IP;CLOCK;JUN;SIN3A;ZHX3;TCF4;ATF6;ZSCAN18;ZNF595;WAC;EID1;SP110;ARNT2;CDKN1B;NR4A2;HIF3A;CAMK2D;ZIC4;PPARGC1A;FOXP2;UBE2L3;CDK14;TEAD1;ZNF814;CALCOCO1;CHD1;MDM4;WWP1;CREBZF;ZNF790;NAA15;RNF10;CAMKK2;SMARCA1;ZNF83;CHD2;POLA1;BTRC;YAF2;MDM2;PER1;KDM3A;FUBP3;PKNOX1;BNC2;NFIX;ZNF565;NCOR2;ZNF528;TSHZ3;CRLF3;NONO;SMURF2;ZNF483;HINT1;BTG1;ZNF25;CCNK;LOXL3;ZNF397;STAT6;PPARA;IRF1;TP53BP1;ZNF43;NR2C2;JUNB;ZNF654;UIMC1;STAT1;EED;ZBTB40;ELK3;DEAF1;KCTD1;PPP3CB;ZBTB1;ARID1A;ZNF536;PURA;ZNF302;CCNC;YEATS2;APBB1;RORA;NR2C1;SREBF2;ZNF490;ARID4A;HDX;PHF10;INSR;KLF9;ZNF331;PHF20L1;YY1AP1;GCLC;EGFR;NLK;SP1;ZHX2;ABL1
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.5399096703147539,-0.8563683631095836,0.6973684210526315,1.0,1.0,3/9,22.89%,SIN3A;EIF2AK4;STAT1
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),-0.5725417335800286,-0.8561839299446733,0.7246376811594203,1.0,1.0,3/5,20.89%,ATP11B;SCARB2;ATP8A2
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.3772984351385565,0.8560351178655137,0.7142857142857143,1.0,1.0,5/20,9.06%,LMOD1;BIN1;NCK1;EVL;CARMIL1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.5505968382549207,-0.8558673266896369,0.7051282051282052,1.0,1.0,4/9,24.91%,ROBO1;JCAD;DCN;PIK3CB
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.4392447239275613,0.8556398486859619,0.75,1.0,1.0,2/11,5.15%,ZDHHC15;ZDHHC21
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.3798883955060342,0.8555719118649545,0.7894736842105263,1.0,1.0,3/18,6.95%,HDAC9;BCL2;PIK3CD
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.5110979397657771,0.854604006585631,0.6285714285714286,1.0,1.0,3/5,27.82%,TENT4B;PARN;DIS3L2
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.4099433371089582,0.8545934901018309,0.7727272727272727,1.0,1.0,4/11,14.93%,AFAP1L2;HIP1;ARAP1;FBXW7
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.5369229062243512,-0.8544913137424968,0.7361111111111112,1.0,1.0,2/6,19.86%,FGFR2;SFRP4
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.5410419823593489,-0.8544706617622617,0.7361111111111112,1.0,1.0,6/10,35.00%,WDR43;RCL1;DDX18;LAS1L;SLC19A1;HSPD1
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.48084912939151914,-0.8543639514788332,0.7380952380952381,1.0,1.0,11/21,33.40%,DNAJC6;AP2A1;GPR107;SNAP91;GAK;SGIP1;AP2B1;PIP5K1C;AP2A2;CANX;AP2M1
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.4080521098084635,0.8537616684231625,0.5833333333333334,1.0,1.0,2/14,4.01%,ITGA3;CDC42
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.5724564836382349,-0.8536777013320876,0.7848101265822784,1.0,1.0,1/6,17.74%,AGO2
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.49446139027131153,0.8536430856619438,0.5862068965517241,1.0,1.0,5/5,50.59%,PARD3;DGKH;PRKD3;DGKD;PLPP1
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.42033851937106737,0.85358500623768,0.5862068965517241,1.0,1.0,2/10,3.35%,NOTCH1;CD4
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.4884158573574929,0.8534224172476684,0.6666666666666666,1.0,1.0,2/6,3.43%,MECOM;ETV6
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.4071019179719159,-0.8532701460198178,0.8315789473684211,1.0,1.0,26/99,23.95%,ADAMTS9;CD55;NCEH1;CFH;GPM6A;MLPH;NIBAN2;LIMA1;ENPP2;DGKI;C1R;C1S;PLPP3;DUSP1;SMARCA1;GRIK2;PID1;ABCA8;EXT1;STARD13;ITGA9;SGCD;RIN2;DNM3;DCN;EPB41L3
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.5032165990111002,0.8531302513198608,0.6060606060606061,1.0,1.0,2/6,16.76%,HACD2;TECR
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.5032165990111002,0.8531302513198608,0.6060606060606061,1.0,1.0,2/6,16.76%,HACD2;TECR
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),-0.4474435079565273,-0.8525526861455847,0.7294117647058823,1.0,1.0,7/34,17.05%,TGFB2;TGFB1;EXOC1;RGCC;SYTL4;RAB27A;DTNBP1
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.45861746844767337,-0.852303739817814,0.6627906976744186,1.0,1.0,12/27,28.57%,SMCHD1;SPIDR;FMN2;PARP1;RNF168;SLF1;UIMC1;EYA2;EYA1;EGFR;BRCC3;SPIRE1
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.4750904938845809,0.8516141031654773,0.6086956521739131,1.0,1.0,3/7,14.81%,INPP5F;TBC1D16;KIF16B
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5504719335967452,-0.8512412614699569,0.7692307692307693,1.0,1.0,3/7,32.64%,ROCK2;RANBP9;PRNP
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.5297970326053927,-0.8511957488055294,0.7361111111111112,1.0,1.0,2/6,23.12%,SNAP91;DNM3
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.35722771068639547,0.850875738030262,0.7692307692307693,1.0,1.0,5/41,6.42%,HSPA1A;VPS35;CELF1;CHMP4B;NCK1
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.387795112253469,-0.8507444633359887,0.7835051546391752,1.0,1.0,32/147,18.58%,TPT1;CD44;IFIT3;APIP;VEGFA;MYDGF;NFKBIA;HDAC2;PRKCI;ARF4;RHBDD1;DDX3X;NIBAN2;SMAD6;CD38;FHL2;RPS27A;PRKDC;CFL1;MT3;ANXA5;HSPA5;FMN2;WDR73;PRLR;RAB7A;NOTCH2;NAIP;NAA15;DNAJA1;SEMA4D;GPX4
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.5403435964995604,-0.8504457268940461,0.717948717948718,1.0,1.0,2/7,13.59%,LPCAT3;PLAAT3
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.4466781552696764,-0.8504061792614828,0.7441860465116279,1.0,1.0,7/34,19.44%,FHL1;DDX3X;ANKRD17;MYO16;RGCC;APPL2;ADAM17
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.4602160790743641,-0.8498267979925778,0.7126436781609196,1.0,1.0,2/28,2.36%,CAMKMT;CRY1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.32140896011655135,0.8495807206709459,1.0,1.0,1.0,4/72,1.28%,INF2;ZDHHC15;WTIP;ADGRA2
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.5050791882788714,0.849365244129289,0.6785714285714286,1.0,1.0,1/6,8.05%,PIP4K2B
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.43870670327767647,-0.8492477616345916,0.7,1.0,1.0,11/39,19.62%,MUCL1;GALNT15;DPM1;GALNT11;TET3;GALNT10;GALNT7;PGM3;TET1;XXYLT1;GALNTL6
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.4073847029207087,-0.8490962285587399,0.7526881720430108,1.0,1.0,12/74,9.53%,GJA1;CRMP1;WASF3;DCLK1;TGFB2;COL11A1;CCN2;ADM;SYNDIG1;PTPRD;LRFN5;SHC2
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.4466662034011439,-0.8486295199958848,0.7682926829268293,1.0,1.0,12/40,26.00%,IPO5;PTPN1;LATS2;HEG1;PRKAR1A;CDKN1B;DUSP1;PRKAR2A;PKIG;LYN;PIK3CB;ABL1
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.5455426535906747,-0.8484962646064704,0.7571428571428571,1.0,1.0,3/6,27.62%,MTMR9;MTMR2;MTMR1
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.40534814999030555,-0.8483406682045606,0.8241758241758241,1.0,1.0,6/86,5.84%,ARHGAP15;SOD1;TBC1D20;VAV3;RGS7;MMUT
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.5172602675979157,-0.8475391542487787,0.7702702702702703,1.0,1.0,5/10,27.51%,SYMPK;CSTF3;CPSF2;SETX;NCBP1
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.453168002852715,-0.8474963336349298,0.7236842105263158,1.0,1.0,4/17,18.32%,PRLR;HSD17B4;LSS;PRKAG2
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.3855803255432636,0.8469806298610394,0.7619047619047619,1.0,1.0,1/16,0.29%,ATP2B4
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.46471797096667034,-0.8469166013608137,0.7195121951219512,1.0,1.0,2/18,4.38%,KDM1A;PIAS2
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.48373911627804933,-0.8466605700361408,0.7764705882352941,1.0,1.0,3/17,20.60%,JAM3;GGA3;FBLN5
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.519047407804927,0.8465063527113319,0.6521739130434783,1.0,1.0,2/7,8.60%,ATM;DLG5
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.3938139716936087,0.8460472606512626,0.6521739130434783,1.0,1.0,2/8,7.86%,SLC44A2;SLC25A26
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.4216496496872613,-0.8460407796009094,0.7934782608695652,1.0,1.0,17/68,29.10%,SOD1;COG2;NAPG;ATP6V1H;USO1;GOLGA4;PAM;LAMP2;MAPK1;SNX2;STX12;EGFR;ARFGAP3;AP2B1;TOM1L1;SEC24D;KIF1B
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.545031305185423,-0.8459839600717666,0.7123287671232876,1.0,1.0,5/5,45.56%,GOPC;PRNP;ABCB1;GRM5;TCAF1
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.5630968980867018,-0.8456661437804478,0.7647058823529411,1.0,1.0,1/5,20.79%,SSB
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.42977666190691566,-0.8448628613414771,0.7619047619047619,1.0,1.0,12/40,14.28%,KLF2;VEGFA;ELOB;PSMB1;PSMD14;RBX1;RPS27A;HIF1A;PSMA4;PSMB2;PSMA7;HIF3A
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.4819864936087891,0.8442649067637936,0.7272727272727273,1.0,1.0,1/6,6.95%,PIK3CD
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.440585673226546,0.8440652266949596,0.5789473684210527,1.0,1.0,1/9,1.56%,FMNL3
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),-0.39680819414228774,-0.8430997449209627,0.7096774193548387,1.0,1.0,21/65,25.91%,ATP6V1E1;LPIN1;ATP6V1G1;SELENOS;PRKCI;ATP6V1H;PTPN2;PRKDC;DENND4C;ATP6V1D;PARP1;NAMPT;CPEB2;ATP6V0D1;GRB2;RAB8B;PKM;RAB12;EPRS1;INSR;IRS1
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.4429794276847564,-0.842455122367306,0.7439024390243902,1.0,1.0,10/27,24.83%,SYT1;RIMS2;RIMS1;DTNBP1;GRIK2;EIF2AK4;TSHZ3;NLGN1;APP;GRIN2B
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.4795827555487726,-0.8421722770570763,0.7702702702702703,1.0,1.0,4/15,10.04%,GJA1;KCNE4;KCNQ1;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.3099807272027327,0.8421601186271397,0.9090909090909091,1.0,1.0,7/40,8.15%,ZDHHC15;ATP1B2;SERPINI1;ARSB;CAPRIN2;PLXNB2;SNX3
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.4188839633703434,-0.8419568603561929,0.7333333333333333,1.0,1.0,10/55,9.93%,ZFPM1;NXN;TSC2;PDLIM1;TGFB2;TGFB1;ZFPM2;FBN1;HEG1;TGFBR1
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),-0.4314804068513924,-0.8416475959638208,0.7333333333333333,1.0,1.0,12/39,22.12%,GALNT11;OXSR1;TGFBR1;PRKDC;ROCK2;TBK1;CAMK2D;LRRK2;TNKS;GALNTL6;MAPK1;STK39
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.5545414389071148,-0.8409980081895233,0.6818181818181818,1.0,1.0,1/5,0.91%,CSF1
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.38935568793289677,-0.8409458637743938,0.782608695652174,1.0,1.0,20/108,13.15%,GJA1;BASP1;CD44;IGFBP2;CADM1;VEGFA;WIPF1;COL11A1;RHOB;TGFB1;SPOCK1;CCN2;ITGA5;COL6A3;FBN1;MATN2;SAT1;JUN;PMP22;GEM
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.4737137759202017,-0.8408899900430553,0.7142857142857143,1.0,1.0,4/11,16.23%,SYT1;SNAP25;RIMS2;RIMS1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.5774503498131968,-0.8405369913863451,0.75,1.0,1.0,5/6,40.47%,PYGB;PHKB;PGM2L1;RB1CC1;AGL
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.5255084554329243,-0.8402400138447254,0.75,1.0,1.0,1/8,7.49%,LIMA1
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.5040112974687576,-0.8401383757135286,0.7428571428571429,1.0,1.0,4/8,39.20%,GPSM2;MAP9;RNF4;DYNC1H1
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.44610541499022605,-0.8399824239778133,0.6707317073170732,1.0,1.0,4/18,25.97%,TMEFF2;STMN1;ARHGAP28;CLASP2
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.5228281289813496,-0.8397431078587768,0.7530864197530864,1.0,1.0,3/8,16.67%,TERF2IP;PARP1;TNKS
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),-0.5247661967309382,-0.8396300090871286,0.7083333333333334,1.0,1.0,4/9,25.91%,ADM;PPM1K;PPARA;IRS1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.5592161341504326,-0.8395779001927685,0.7466666666666667,1.0,1.0,2/5,10.96%,CSF1;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5588388738001633,-0.8385538440661983,0.8026315789473685,1.0,1.0,3/6,17.47%,NOS1AP;HIF1A;SCARB1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.34384451846789793,0.838441779390705,0.8333333333333334,1.0,1.0,3/27,3.63%,CACUL1;CDK6;CUL2
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.5468805490701767,-0.8383334756776153,0.7397260273972602,1.0,1.0,2/8,32.24%,SMG7;RAD17
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.4755655549259865,-0.8382040867307831,0.6578947368421053,1.0,1.0,5/14,29.47%,DONSON;ZRANB3;WRN;BOD1L1;MMS22L
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.4506904041266762,-0.837616546069686,0.691358024691358,1.0,1.0,4/19,19.43%,HADHA;HSD17B4;ECHDC1;ACADL
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.3944091983498499,-0.8375603201607064,0.7894736842105263,1.0,1.0,9/61,13.46%,WASF3;RANBP10;RHOB;PRKCI;DIAPH1;NECTIN2;DPYSL2;CFL1;RHOBTB3
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.4194949771552773,-0.8374498851881786,0.7717391304347826,1.0,1.0,13/37,29.16%,RHOB;XRCC4;TANK;SPIDR;CLOCK;TRIM13;RNF168;UIMC1;GRB2;EYA1;MRNIP;BRCC3;IKBIP
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.47552101528914764,-0.8372459999942581,0.7560975609756098,1.0,1.0,8/18,34.22%,GGA3;ROCK2;CLU;RTN1;SP1;EPHA4;PRNP;RTN3
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.521133452176396,-0.8370939263584474,0.8157894736842105,1.0,1.0,1/9,4.43%,KANSL3
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.521133452176396,-0.8370939263584474,0.8157894736842105,1.0,1.0,1/9,4.43%,KANSL3
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.3941882298786524,-0.8370225163564227,0.7340425531914894,1.0,1.0,14/70,16.51%,CNTN3;PCDH17;PHYHIPL;PDZRN4;THSD7A;PTPRD;SNAP25;SHC2;SNAP91;PPARGC1A;ABCC9;IGFBP5;FGF14;NOVA1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),-0.4896243050354404,-0.8369421651009995,0.7105263157894737,1.0,1.0,1/10,8.87%,RAD21
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.41506632598672527,-0.8366101928945174,0.7209302325581395,1.0,1.0,8/40,10.30%,DPP6;ASPA;SLC1A2;MCF2L2;SLC7A14;KCNQ1;PRKCB;CCK
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.4007765554159875,-0.8361236465521616,0.8181818181818182,1.0,1.0,18/64,24.91%,VAV3;PDE4B;PSMB1;PSMD14;CD38;PRKCB;PSMA4;PSMB2;PSMA7;BTRC;SKP1;PAK1;PAG1;FYN;PDE4D;PSMA3;MALT1;PIK3CB
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.3821377930592421,-0.8360905202672531,0.7551020408163265,1.0,1.0,37/119,26.00%,SOD1;CSNK1D;EPHA7;SPTBN4;VEGFA;MYDGF;AKAP8;TGFB1;TRAF3IP1;STK4;KRAS;PRKDC;C9ORF72;MT3;ROCK2;TERF2IP;TSPYL2;PLPP3;PRR5L;LRRK2;CAMKK2;SEMA4D;PID1;ADAM17;PAK1;CCN1;WARS1;FYN;TARDBP;APP;RACK1;LYN;INSR;NDUFS4;KDR;EGFR;ABL1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.5818544700183412,-0.8358645273945357,0.7777777777777778,1.0,1.0,2/5,13.49%,TGFB1;RGCC
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.5247629085734861,-0.8354199312896946,0.76,1.0,1.0,3/8,35.16%,PPARGC1A;ETFDH;SLC25A13
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,0.36064412793511835,0.8353539350253902,0.7142857142857143,1.0,1.0,4/17,5.05%,WDFY4;CD4;ETV6;DOCK8
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.38564324732605776,0.8352565213502463,0.7777777777777778,1.0,1.0,7/17,10.03%,SLC35F1;TTC7A;SLC26A3;SMOC2;GULP1;ANPEP;PMEPA1
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.41905064852280766,-0.8352504154680876,0.7934782608695652,1.0,1.0,12/48,24.82%,IFITM3;DDX3X;ANKRD17;TBK1;TRIM13;COLEC12;TRIM5;ALPK1;FYN;APP;MALT1;LYN
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.41687788705334544,0.835189218185398,0.5714285714285714,1.0,1.0,3/13,9.18%,SYNPO2;CDC42;SLC9A1
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.3982072508458899,0.8351034893242267,0.7272727272727273,1.0,1.0,5/15,10.60%,WDFY4;DOCK8;RASGRP2;MITF;RCSD1
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.5259833104774714,-0.8350814212697513,0.7837837837837838,1.0,1.0,1/8,7.41%,PTPRD
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-0.5740684520745101,-0.8350794531957789,0.7941176470588235,1.0,1.0,2/5,35.60%,SLF1;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-0.5740684520745101,-0.8350794531957789,0.7941176470588235,1.0,1.0,2/5,35.60%,SLF1;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-0.5740684520745101,-0.8350794531957789,0.7941176470588235,1.0,1.0,2/5,35.60%,SLF1;MACROH2A1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.457894948979071,-0.8346831750795042,0.7407407407407407,1.0,1.0,4/19,25.89%,PPP3CA;AGO2;PPP3CB;NLK
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.35272748007746,0.8338704470663956,0.7777777777777778,1.0,1.0,3/22,5.20%,MCU;BCL2L11;VPS35
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),-0.5171359876830748,-0.8329644239332604,0.8048780487804879,1.0,1.0,3/11,19.87%,GIGYF2;ROCK2;METTL16
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.5001132103768663,-0.8329178079540572,0.7701149425287356,1.0,1.0,1/12,0.77%,CHST11
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.4076501381125459,-0.8328418618048152,0.6875,1.0,1.0,3/27,9.91%,FGFR2;CCP110;TP63
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5009446336565505,-0.8326345484072525,0.7654320987654321,1.0,1.0,3/13,31.34%,RBBP7;NASP;MIS18BP1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.4470319659663061,-0.8323362300159409,0.8068181818181818,1.0,1.0,11/28,32.03%,FGFR2;PRLR;FLT1;FYN;LYN;INSR;KDR;EGFR;ABL1;EPHA4;PTK2B
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.49796017859950126,0.8322048216925645,0.6521739130434783,1.0,1.0,1/6,6.16%,CHMP4B
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.40274367013068346,-0.8321093387658829,0.7659574468085106,1.0,1.0,9/74,12.98%,NRG1;F3;TSC2;MYDGF;TGFB1;FGFR2;TGFBR1;IL18;AKR1C2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.5051584354290175,0.831984796375596,0.5652173913043478,1.0,1.0,1/6,0.83%,GALNT16
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.383972333521451,-0.8319273952753038,0.83,1.0,1.0,48/153,29.02%,CRY1;VAV3;RPA1;STK33;TANK;SPIDR;PRKDC;WAC;FMN2;PARP1;FAN1;FANCC;ZRANB3;POLK;WDR48;SUSD6;UBE2B;POLA1;WRN;BTG2;PAK1;MAPKAPK2;RNF168;XPA;SLF1;TAOK3;CCNK;MAP2K6;TP53BP1;ZBTB40;GRB2;ZBTB1;APTX;APBB1;BOD1L1;SETX;LYN;USP3;UBA1;ABL1;PARP4;KIN;MRNIP;GTF2H1;UVRAG;SMC1A;FOXO1;TRIP12
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.49464763486198887,-0.8315500729521119,0.7560975609756098,1.0,1.0,3/10,17.89%,GGA3;CLU;RTN1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.4100543414445865,-0.8312683326148491,0.8043478260869565,1.0,1.0,16/79,12.01%,IGFBP2;NXN;MCC;TSC2;CSNK1A1;PSMB1;NKD1;LATS2;PSMD14;STK4;RBX1;BICC1;PSMA4;AMFR;PSMB2;UBAC2
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.4436355836104916,0.8309057394321295,0.6428571428571429,1.0,1.0,4/5,27.85%,SETDB1;RESF1;TASOR;TOP2B
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),-0.45847160698213585,-0.8304351330641971,0.7586206896551724,1.0,1.0,4/21,9.42%,ROBO2;SYNDIG1;PTPRD;LRFN5
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.565728854903682,-0.8302023525991822,0.7341772151898734,1.0,1.0,2/5,28.22%,CAMK2D;GSN
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),-0.5018459084564332,-0.8298906733980737,0.7613636363636364,1.0,1.0,1/11,0.77%,CHST11
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.41957439296705545,-0.8296229465196683,0.7261904761904762,1.0,1.0,3/37,14.74%,UBA5;RPS27A;RAB7A
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.5132295357049812,-0.8296220705969328,0.6842105263157895,1.0,1.0,1/8,17.05%,DTNBP1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,-0.3926303300065367,-0.8294719288666582,0.7659574468085106,1.0,1.0,4/56,3.45%,MID1;FHL1;NXN;TENM3
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.5173038258267657,-0.8292019064389243,0.7391304347826086,1.0,1.0,2/7,13.59%,LPCAT3;PLAAT3
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.5248576791436766,-0.8290517189776243,0.6933333333333334,1.0,1.0,4/7,23.68%,SESN1;EIF2AK4;LARS1;RRAGB
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.5300242735825177,-0.8288071795696023,0.696969696969697,1.0,1.0,1/5,8.36%,TRAF3IP1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.4435124867186014,-0.8287450091931263,0.7532467532467533,1.0,1.0,7/24,20.45%,WASF3;WASF1;DIAPH1;HDGFL3;MICALL2;GPX4;UBE2K
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.4042331860071224,-0.8285539684026684,0.7956989247311828,1.0,1.0,12/67,11.04%,ZFPM1;VEGFA;TSC2;PDLIM1;TGFB2;TGFB1;ZFPM2;IFT122;FBN1;HEG1;TGFBR1;SGCZ
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.37646498155877733,-0.8280351162960258,0.826530612244898,1.0,1.0,10/125,7.57%,MID1;GJA1;VEGFA;ARHGAP24;PROS1;CCN2;ADM;THSD7A;THSD4;PLEKHH2
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.4158377741101542,-0.8277971518304303,0.6931818181818182,1.0,1.0,6/35,15.26%,RIPOR1;TGFB2;TGFB1;EXOC1;SYTL4;PRR5L
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.4496478137880347,0.8276775580886171,0.6551724137931034,1.0,1.0,1/7,8.05%,PIP4K2B
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.4700167989844612,-0.8276258826352083,0.7341772151898734,1.0,1.0,2/12,7.75%,SPOCK1;CST3
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.33489507912044786,0.8276208473885757,0.8,1.0,1.0,5/29,9.06%,LMOD1;BIN1;NCK1;EVL;CARMIL1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.4522517628011406,-0.8272524267032176,0.7790697674418605,1.0,1.0,6/26,18.05%,VEGFA;TGFB2;AFDN;FRMD5;PPP3CA;P4HB
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.4840073741595675,-0.8271837169337152,0.8076923076923077,1.0,1.0,2/15,17.20%,PLAA;ULK4
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.4504431214539505,0.8270735288508755,0.7142857142857143,1.0,1.0,3/11,5.41%,ST3GAL2;GLB1;B3GNT2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.540189921121566,-0.8269142162423107,0.7567567567567568,1.0,1.0,4/6,32.03%,KDR;EGFR;ABL1;PTK2B
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.5382714821849097,-0.8268889660423197,0.75,1.0,1.0,5/7,29.19%,TERF2IP;SIN3A;MIER1;POT1;TERF1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.4989081372633575,0.8268768581107722,0.72,1.0,1.0,2/5,8.53%,DOCK8;RHOA
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.4770378314996827,0.826476082808866,0.7586206896551724,1.0,1.0,1/6,9.66%,ULK2
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.4770378314996827,0.826476082808866,0.7586206896551724,1.0,1.0,1/6,9.66%,ULK2
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.5038272299436158,-0.8263888240144602,0.7272727272727273,1.0,1.0,3/8,20.69%,UBR1;SESN1;LARS1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.5038272299436158,-0.8263888240144602,0.7272727272727273,1.0,1.0,3/8,20.69%,UBR1;SESN1;LARS1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.39303922258257407,-0.8263025056701034,0.8105263157894737,1.0,1.0,26/77,31.07%,GJA1;BASP1;VEGFA;CCN2;NIBAN2;ENPP2;CFL1;TAPT1;AGO2;BMP5;NLGN1;SMURF2;TP53BP1;NR2C2;DCN;INSR;KDR;CLASP2;ADGRL1;SPIRE1;HSP90AB1;CEBPB;DDHD1;PTN;SHLD2;ACVR1B
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.47263680775992395,-0.8262433079151007,0.8055555555555556,1.0,1.0,6/20,27.62%,PIP4P2;MTMR9;PLPP3;MTMR2;SYNJ2;MTMR1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.48377660764298847,-0.8262078419629372,0.7349397590361446,1.0,1.0,3/11,20.10%,UBE2B;SKP1;RNF168
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5574566914749839,-0.8258156259839815,0.76,1.0,1.0,2/6,12.90%,TMSB4X;SIN3A
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.40929088964141713,-0.8257787583762447,0.7956989247311828,1.0,1.0,15/64,16.51%,ROBO2;COL11A1;PDZRN4;JAM3;UNC5D;TBRG1;PTPRD;SCN3A;GRIA3;TRPM3;FMN2;SNAP91;RAB27A;FGF14;NOVA1
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.3781334541317765,-0.8256099980935805,0.88,1.0,1.0,27/151,16.60%,SRGN;ZFP36L2;VEGFA;PTRH2;TGFB2;ROBO1;TGFB1;OLFM1;DDX3X;EIF2AK2;HIF1A;GIGYF2;PTBP2;RUNX1;CNOT8;IGF2BP2;RBBP7;ROCK2;DNMT1;RGCC;RPL13A;NOTCH2;NDFIP2;DCP2;IGFBP5;CREBZF;LGR4
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.41057344626346065,-0.8253913128853182,0.7857142857142857,1.0,1.0,8/37,26.00%,VEGFA;ROCK2;GPM6B;APOD;SLK;KDR;CLASP2;ABL1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.41986616418526646,-0.824583708106928,0.7444444444444445,1.0,1.0,9/31,19.79%,CD44;VEGFA;TGFB1;STK4;TERF2IP;TBK1;MTCP1;PAK1;RAF1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.5400208365261914,-0.8245010465811374,0.8051948051948052,1.0,1.0,3/6,22.89%,UBE2K;IRF1;STAT1
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.47824895619645746,0.8243862857255405,0.6818181818181818,1.0,1.0,1/9,0.13%,MYH11
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.4838167726022836,-0.824363693763061,0.7317073170731707,1.0,1.0,6/15,29.64%,CD55;ARRDC2;IRF1;JUNB;OSTF1;CEBPB
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.3923479712609562,-0.8242867746400587,0.6966292134831461,1.0,1.0,2/46,2.13%,ADAMTS9;CD44
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.490350029489581,-0.823946717117111,0.8266666666666667,1.0,1.0,1/12,4.43%,KANSL3
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.415447823160661,-0.8236093776484769,0.75,1.0,1.0,12/49,17.36%,DPM1;COG7;TET3;TMEM165;MGAT1;GOLGA2;MGAT4A;NPC1;GALNT10;GALNT7;PGM3;TET1
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.31005894380739984,0.8234216315267243,0.8333333333333334,1.0,1.0,7/32,9.42%,LMOD1;BIN1;NCK1;SLIT2;EVL;CARMIL1;PLEKHG2
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.4899843876102449,-0.8225924318453692,0.7142857142857143,1.0,1.0,4/8,35.93%,DEAF1;KIAA1217;COL1A1;SULF2
prerank,PanglaoDB_Augmented_2021__Microglia,0.35515359560981785,0.8221970318791648,0.75,1.0,1.0,5/20,7.49%,WDFY4;CD4;SKI;ITGB5;MERTK
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.4170682171564371,-0.8219557471656591,0.8,1.0,1.0,6/33,20.97%,TGFB1;JAM3;SPOCK1;DUSP1;SEMA4D;NF2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.4017635164404385,-0.8217161838600743,0.7741935483870968,1.0,1.0,8/59,12.98%,NRG1;F3;MYDGF;TGFB1;FGFR2;TGFBR1;IL18;AKR1C2
prerank,PanglaoDB_Augmented_2021__Neurons,-0.3761183765579872,-0.8216551707390269,0.8144329896907216,1.0,1.0,18/104,15.77%,ELAVL3;IFIT3;PHYHIPL;DNER;NAPG;SLC6A17;SNAP25;GRIA3;ATP6V1H;CCK;SLC36A4;MATN2;DLGAP1;NXPH1;UNC79;SLC1A1;SNAP91;ACSL4
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.5757054968678645,-0.8214142495146447,0.7837837837837838,1.0,1.0,4/5,40.47%,PYGB;PHKB;PGM2L1;AGL
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.5757054968678645,-0.8214142495146447,0.7837837837837838,1.0,1.0,4/5,40.47%,PYGB;PHKB;PGM2L1;AGL
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.4963400003196754,-0.8213752774818193,0.7948717948717948,1.0,1.0,2/11,11.45%,DDX3X;DELE1
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.5115345521683275,-0.821174144259021,0.7532467532467533,1.0,1.0,3/10,23.63%,CCT4;DCP2;CCT8
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.4582925420362738,-0.8211033138761133,0.8192771084337349,1.0,1.0,4/21,18.37%,IFITM3;EIF2AK2;TRIM13;TRIM5
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.2742592610646167,0.8209923242370987,1.0,1.0,1.0,14/59,10.17%,MOCS1;FKBP9;PLS3;GPC6;ARHGEF17;ADCY6;CAP2;MAGI1;ITGB5;CHST3;PTPN21;PC;MYO1B;GALNT18
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.4751700860395816,-0.8209545850708255,0.6973684210526315,1.0,1.0,6/15,23.40%,CD44;PTPN2;PPP3CA;KIF13B;EIF2AK4;PPP3CB
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.4220754572638614,-0.8207051447692317,0.7586206896551724,1.0,1.0,8/33,27.48%,WIPI1;ATG16L2;RAB7A;GABARAPL1;STX12;MAP1LC3B;WDR45B;ATG12
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.4011060372191412,-0.8205209421908066,0.7555555555555555,1.0,1.0,16/61,23.85%,SSH1;PPP1CC;FRA10AC1;PPP2R1B;PTPRE;PTPRD;PTPN1;PPP2R2A;PPP3CA;PLPP3;DUSP1;BTRC;MTMR2;PPP2R3A;PPP3CB;PTPRM
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),-0.526144390360827,-0.8203660589544065,0.7307692307692307,1.0,1.0,1/9,8.87%,RAD21
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.4272770210544591,-0.8200889148795316,0.7439024390243902,1.0,1.0,6/29,23.50%,ATL1;ELAVL1;RNF213;KCNC2;TP53BP1;ZBTB1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.38696766490923357,-0.8200292629027932,0.8181818181818182,1.0,1.0,14/85,13.49%,SRGN;CD55;EMP1;SLC2A1;RHOJ;CFH;GPM6A;CCN2;C1R;FHL2;PROCR;SGK1;C1S;RGCC
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.4681822467752822,-0.8199761842708018,0.7945205479452054,1.0,1.0,5/13,35.00%,HSPA5;SEC62;SRP54;PEX1;HSPD1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.3503416343672474,0.8199709113534942,0.8181818181818182,1.0,1.0,1/17,1.09%,RYR2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),0.5034110394665874,0.8199082062898805,0.7317073170731707,1.0,1.0,1/5,0.27%,CAV2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.5386081824031947,-0.819655996832362,0.72,1.0,1.0,1/5,16.71%,PAPSS1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.4924698256423367,-0.8187736803137353,0.7733333333333333,1.0,1.0,3/14,23.34%,DDIT4;ZFYVE27;GRB2
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.4686049078890526,-0.8186825248571831,0.7560975609756098,1.0,1.0,5/15,34.26%,TGFBR1;RACK1;ACVR1B;TGFBR2;STAT5B
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.5091033004357588,-0.8186810168875946,0.8028169014084507,1.0,1.0,3/10,23.40%,MYRIP;ACSL4;PPP3CB
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.4663656745055166,0.8183448637664288,0.7037037037037037,1.0,1.0,2/5,15.61%,RAB22A;PICALM
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.4295118818240204,0.8183052247149027,0.6129032258064516,1.0,1.0,6/6,57.09%,TRIM37;CENATAC;KAT2B;CDK5RAP2;BRCA1;TMEM67
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.3871070902146407,0.8178096874281422,0.6666666666666666,1.0,1.0,4/15,13.20%,ZDHHC15;CAPRIN2;ARHGAP44;PDLIM5
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.4487064979690639,-0.817702229787019,0.7865168539325843,1.0,1.0,7/25,22.67%,CSF1;VEGFA;RUNX1;PARP1;FARP2;GLO1;GAB2
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.4281650378235722,-0.8174879641120583,0.7294117647058823,1.0,1.0,10/26,21.33%,VEGFA;ROBO1;TGFB1;PDGFD;SASH1;MAP3K4;LRRK2;FLT1;PAK1;TAOK3
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.42141721123831133,-0.8172941471919369,0.7126436781609196,1.0,1.0,4/33,12.67%,ANK3;RHOB;STMN1;ROCK2
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),-0.5221201221050824,-0.8171124676029788,0.7590361445783133,1.0,1.0,2/7,23.16%,CSGALNACT1;EXTL2
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.5178855761860921,-0.8166192705455727,0.7777777777777778,1.0,1.0,3/8,25.87%,TGFB1;NCOR2;EGFR
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.5235725252489777,-0.8164401612964887,0.6712328767123288,1.0,1.0,1/5,11.97%,SLC39A11
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.463886048544511,-0.8163075402972295,0.7469879518072289,1.0,1.0,9/17,30.72%,RPA1;PRKDC;TERF2IP;PARP1;WRN;POT1;RPA3;TERF1;XRCC6
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.4701961540585705,-0.815924246765249,0.7402597402597403,1.0,1.0,2/15,8.93%,MICOS10;SPG7
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.49568638933362946,0.8158270852600692,0.6944444444444444,1.0,1.0,4/7,17.37%,CDC42;NTF3;NRP1;BAIAP2L2
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.39834623528873175,-0.8156873460909885,0.8,1.0,1.0,23/70,29.39%,DPP6;SPTBN4;ANK3;ATP1B3;ROCK2;DENND4C;WDR19;ZFYVE27;LIN7A;TSPAN5;DPP10;GAK;RAB11A;STXBP1;RAB8B;EPB41L3;RAB12;CLASP2;MAP7;RDX;PTCH1;KCNIP4;BSG
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.5223975411150957,-0.8155049284927939,0.7631578947368421,1.0,1.0,1/7,6.19%,PARP6
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.47649387477020155,0.815085636256062,0.7307692307692307,1.0,1.0,3/7,3.99%,SOX5;LTBP3;SOX6
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.4389568074926049,-0.8150281250668505,0.8095238095238095,1.0,1.0,4/25,7.65%,SLC22A6;DCDC1;ALDH1L1;DNAH7
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.4357648504103214,-0.8141107119680878,0.7682926829268293,1.0,1.0,11/25,36.81%,CTCF;NAP1L1;SUPT16H;ARID1A;NASP;ANP32B;SUPT6H;ARID2;MACROH2A1;MCM3AP;SETD2
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),-0.47838736020550043,-0.8137475845497667,0.7733333333333333,1.0,1.0,4/13,22.65%,LPIN1;LPCAT3;SLC44A1;CHKA
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.5195874843584627,-0.8133889282674435,0.8,1.0,1.0,2/6,13.99%,AKIRIN1;PPP3CA
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.39965142754521044,-0.8132665840852508,0.8043478260869565,1.0,1.0,17/68,16.94%,IGFBP2;MCC;CSNK1A1;PSMB1;NKD1;LATS2;PSMD14;STK4;RBX1;BICC1;PSMA4;AMFR;PSMB2;UBAC2;PSMA7;TLE4;TMEM64
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.3921420901914201,-0.8132040401588424,0.8295454545454546,1.0,1.0,10/55,14.55%,ELAVL3;PCBP3;ARHGEF9;NCAM1;SLC1A2;CDH20;SNAP25;TRPM3;UNC79;SNAP91
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4471009973395067,0.8131936127434615,0.76,1.0,1.0,2/7,12.46%,ACTN4;CORO1C
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4471009973395067,0.8131936127434615,0.76,1.0,1.0,2/7,12.46%,ACTN4;CORO1C
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.4515650490501599,-0.8130906577680493,0.7272727272727273,1.0,1.0,3/21,15.70%,NPRL3;C9ORF72;LRRK2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.438916771754006,-0.8125734109929174,0.7906976744186046,1.0,1.0,8/23,19.47%,ARID3A;CNOT8;PLAGL1;RGCC;CDKN1B;MDM4;MDM2;BTG2
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.40998499212767797,-0.8124171539269388,0.7441860465116279,1.0,1.0,9/37,22.65%,SLCO1A2;PITPNC1;PEX3;PITPNA;SCARB1;ABCA8;AKR1C1;ABCA4;CHKA
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),-0.5321086995322158,-0.812297109025968,0.7647058823529411,1.0,1.0,2/5,20.73%,SLC25A37;SLC40A1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5176384647288083,-0.8120427953216115,0.8076923076923077,1.0,1.0,5/8,42.16%,ATP5F1C;DMAC2L;ATP5F1E;ATP5ME;ATP5MC2
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.5176384647288083,-0.8120427953216115,0.8076923076923077,1.0,1.0,5/8,42.16%,ATP5F1C;DMAC2L;ATP5F1E;ATP5ME;ATP5MC2
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.41933050186336623,0.8115071725718086,0.75,1.0,1.0,4/15,4.33%,ATP1B2;PDGFA;CDC42;QRICH2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.4419169344019421,0.8114412288880531,0.6896551724137931,1.0,1.0,2/9,7.97%,PDGFA;SLIT2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.4022095924508529,-0.8105817741013177,0.8229166666666666,1.0,1.0,17/64,23.34%,CTSL;WASF1;DNAJC6;ADM;HSPH1;AP2A1;GPR107;SNAP91;COLEC12;SCARB1;AP4E1;SCARB2;NEDD4;GAK;CD9;DNM3;GRB2
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.4074380374922041,-0.810533679073042,0.8131868131868132,1.0,1.0,13/56,18.70%,CSNK1D;RNF19A;CSNK1A1;ELOB;ARIH2;SDCBP;RBX1;WAC;UCHL5;CLU;LRRK2;FBXO22;MDM2
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.44998689437589134,-0.8103405986318326,0.7402597402597403,1.0,1.0,2/17,9.95%,AKIRIN1;ACTR3
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),-0.5344852006751072,-0.8102796254962794,0.7837837837837838,1.0,1.0,2/5,17.47%,SREBF1;SCARB1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.4169707911204992,-0.8101531390286143,0.7926829268292683,1.0,1.0,2/30,9.26%,DCDC1;CCP110
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.505340361957958,-0.8100620181670248,0.7733333333333333,1.0,1.0,4/8,35.10%,FKBP5;PPIB;PPIG;PPIA
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.45344724344681214,-0.8098376361241929,0.7625,1.0,1.0,4/16,9.91%,CDKL1;NKD1;ITGA5;TP63
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.5317729608456038,-0.8097185092434133,0.8271604938271605,1.0,1.0,3/7,17.47%,NOS1AP;HIF1A;SCARB1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.4162150949381006,0.8096670897056637,0.6956521739130435,1.0,1.0,2/9,8.60%,CAPRIN2;DLG5
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.398283403231331,-0.8093544722988519,0.7415730337078652,1.0,1.0,15/53,15.70%,SOD1;ETV5;SELENOS;SOD2;DDX3X;MT3;TXNRD1;CHCHD2;PARP1;FANCC;PPARGC1A;PRR5L;GSR;PYROXD1;LRRK2
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.3970536451543612,-0.8092879121638452,0.7613636363636364,1.0,1.0,17/36,36.08%,MANBA;PRKDC;PARP1;UBE2L3;FBXO22;SERP1;CHRM3;ABL1;PARP4;ST3GAL6;CPE;UBL5;MSRA;UBE2D3;USP25;UBA3;FBXW2
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.39519736287889606,0.808783080880216,0.6956521739130435,1.0,1.0,3/13,11.74%,MRPL1;MRPL33;MRPL3
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.3627330845027058,0.808782567038511,0.7333333333333333,1.0,1.0,3/12,6.93%,ADCY9;ADCY6;CAP2
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.4415964606044803,0.8085767927113586,0.72,1.0,1.0,1/8,5.15%,ZDHHC21
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.37633791715393716,0.808305981990794,0.782608695652174,1.0,1.0,3/20,2.79%,OAZ2;PSMF1;PSMD7
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.42047701581199376,-0.808101017234246,0.7065217391304348,1.0,1.0,6/28,19.33%,TWIST1;PTPN1;LPCAT3;CLU;BRAP;APPL2
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.40107423227812844,-0.8076830296703994,0.8470588235294118,1.0,1.0,7/43,21.19%,SYT1;ADGRV1;PPP3CA;CAMK2D;NEDD4;NLGN1;AHCYL1
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.513327280059969,-0.8073905611735942,0.8169014084507042,1.0,1.0,4/9,28.89%,IL18;NT5E;APP;HSP90AB1
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.548331535259772,-0.8073444265716032,0.8108108108108109,1.0,1.0,1/5,2.12%,OGN
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.42705304273089223,-0.8070713126099585,0.7529411764705882,1.0,1.0,5/22,18.53%,LPIN1;ENPP2;LPCAT3;PLAAT3;SLC44A1
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.5103599791164626,-0.8066781988220746,0.7611940298507462,1.0,1.0,1/6,1.96%,ZFPM1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.3830291106012004,-0.80645229184433,0.797752808988764,1.0,1.0,17/66,17.08%,SOD1;ETV5;SELENOS;SOD2;HIF1A;MT3;JUN;TXNRD1;CHCHD2;PARP1;FANCC;PPARGC1A;PRR5L;GSR;PYROXD1;LRRK2;CAMKK2
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.47727622388328467,-0.8063625133589799,0.8243243243243243,1.0,1.0,7/14,42.62%,PABPC1;ELAVL1;YBX1;CIRBP;HNRNPU;NBAS;FMR1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.47643418283675404,-0.8062752712942456,0.8421052631578947,1.0,1.0,2/13,8.36%,FGFR2;TRAF3IP1
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.4955233648728142,-0.8059416915833366,0.7848101265822784,1.0,1.0,3/10,25.92%,JUN;CHD1;SP1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.4565078926156303,-0.8057264764598498,0.7701149425287356,1.0,1.0,9/20,30.72%,RPA1;PRKDC;TERF2IP;PARP1;WRN;POT1;RPA3;TERF1;XRCC6
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.47407776785968914,-0.8057032947778574,0.7261904761904762,1.0,1.0,3/11,17.89%,GGA3;CLU;RTN1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.4804762381851355,-0.8056449283266679,0.7837837837837838,1.0,1.0,4/11,24.48%,PDE4B;RUNX1;PDE4D;MALT1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.28221778191442926,0.805544411311162,1.0,1.0,1.0,9/60,10.80%,INPP4B;INPP5F;MTMR14;PLA2G4C;PIK3CD;PIP4K2B;SLC27A1;PIP5K1B;MTMR12
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.46475577703481946,-0.8050530762265576,0.7567567567567568,1.0,1.0,1/11,1.19%,ZFP36L2
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.3889280950997303,-0.8050216713813694,0.8602150537634409,1.0,1.0,25/69,30.72%,RPA1;MORF4L1;PSMD14;XRCC4;RAD21;SPIDR;PRKDC;PARP1;FAN1;POLA1;WRN;ZSWIM7;RNF168;TP53BP1;UIMC1;APTX;APBB1;SETX;EYA1;BRCC3;KDM2A;RPA3;MMS22L;SFPQ;XRCC6
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.44475640226419555,-0.8049434873028136,0.8068181818181818,1.0,1.0,8/28,19.65%,RPA1;MORF4L1;PSMD14;SPIDR;PARP1;FAN1;WRN;ZSWIM7
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.5042545030088166,-0.8046738682381208,0.84,1.0,1.0,3/9,14.13%,PDCD4;SOD2;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.41456274614182725,-0.8046217839220056,0.8152173913043478,1.0,1.0,1/33,0.91%,CSF1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.46414782337347416,0.8043330967755156,0.71875,1.0,1.0,3/6,12.67%,NOTCH1;PARP9;PPP1R12A
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.43555362719891383,-0.8042482921625127,0.7906976744186046,1.0,1.0,7/27,21.50%,STX6;MICALL2;RAB7A;WASHC2C;VPS39;VPS50;VPS51
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.4261900754030248,-0.8038069528334952,0.782608695652174,1.0,1.0,8/27,19.44%,F3;VEGFA;MYDGF;TGFBR1;HIF1A;JCAD;NRP2;ADAM17
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.4516498316090301,-0.8035538501623712,0.7532467532467533,1.0,1.0,5/13,31.46%,PTPN2;STAT1;HSP90AB1;PARP14;NR1H3
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.4710936325524631,-0.8033584905444124,0.7926829268292683,1.0,1.0,2/10,4.25%,ZFPM1;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.43782885126553933,-0.8033440486077748,0.8068181818181818,1.0,1.0,5/29,8.21%,MCC;TGFB2;ROBO1;TGFB1;FGFR2
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.5053612482841962,-0.8030463422972582,0.7432432432432432,1.0,1.0,2/6,16.67%,PARP1;TNKS
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.4844679461351837,-0.8026392465553328,0.7215189873417721,1.0,1.0,3/11,22.89%,SIN3A;EIF2AK4;STAT1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.42367574988077167,-0.8022861492153672,0.7802197802197802,1.0,1.0,5/33,10.96%,SELENOS;TRAF3IP1;LPCAT3;LRFN5;PTPN2
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.5224497148992719,-0.8021110670574498,0.7692307692307693,1.0,1.0,2/5,21.59%,FBN1;FSTL1
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.32067348168058374,0.8018503123223519,0.875,1.0,1.0,4/25,10.15%,INF2;VPS35;RHOT1;EP300
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.378604778967479,0.8017195145627131,0.6875,1.0,1.0,4/19,6.77%,BCL2L1;BCL2L11;DAPK2;BCL2
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.48996944124262676,-0.8012093415923346,0.8513513513513513,1.0,1.0,7/11,40.34%,RNF10;PTPRZ1;JAM2;PTN;EIF2AK3;DICER1;TNFRSF1B
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.5065540782523446,-0.8009664681650698,0.8,1.0,1.0,3/8,10.04%,KCNE4;KCNQ1;NEDD4L
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.541824129552565,-0.8009017024367406,0.8732394366197183,1.0,1.0,2/8,15.85%,MT3;CHD1
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.3889118084752211,-0.8006257039122137,0.8602150537634409,1.0,1.0,26/89,27.24%,GJA1;PELI1;PRKCB;TANK;ANKRD17;TERF2IP;TBK1;TRIM13;NDFIP2;TMED4;TRIM5;PER1;NDFIP1;OTUD7A;ALPK1;DDX21;AKAP13;BIRC2;STAT1;RIOK3;RORA;MIER1;MALT1;ZDHHC17;LPAR1;MAP3K14
prerank,PanglaoDB_Augmented_2021__T Cells,-0.4613961041676984,-0.8004510958376464,0.8488372093023255,1.0,1.0,2/19,3.14%,IFIT3;CREM
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.39708047358546306,-0.8003311136860346,0.8222222222222222,1.0,1.0,8/34,17.16%,PRKCI;ALDH3A2;PEX3;SDCBP;SSR1;TRAM1;SRP14;NACA
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.5230239929878752,-0.8001865823971568,0.8591549295774648,1.0,1.0,1/6,9.61%,RAP1B
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.4664907650587523,0.7996746584975891,0.7666666666666667,1.0,1.0,1/6,3.35%,CD4
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.4099934125532878,0.7996540774322688,0.6086956521739131,1.0,1.0,2/7,4.38%,PRPSAP1;HPRT1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.39249162816198696,-0.7990465553640288,0.8152173913043478,1.0,1.0,3/47,2.18%,PRKACA;ZFP36L2;PCBP3
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.45385997940564365,-0.7989787755819154,0.788235294117647,1.0,1.0,5/19,21.59%,TGFB1;LATS2;SFRP4;SMURF2;FSTL1
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.426314639355684,-0.7989421052816645,0.8072289156626506,1.0,1.0,8/30,27.48%,WIPI1;ATG16L2;RAB7A;GABARAPL1;STX12;MAP1LC3B;WDR45B;ATG12
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.3914683251327694,-0.7979924071153529,0.8555555555555555,1.0,1.0,6/44,15.83%,PIAS2;NUP153;NUP133;NUP88;SENP1;RANBP2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.4943788022406022,-0.797766655674876,0.7733333333333333,1.0,1.0,2/7,23.50%,IL18;ZBTB1
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.5385402736533218,-0.7975884151392059,0.8333333333333334,1.0,1.0,4/5,25.59%,LRRK2;DCN;RACK1;KDR
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),-0.5481213113185954,-0.7975215263165207,0.75,1.0,1.0,2/5,30.46%,GPSM2;EPB41L2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.5481213113185954,-0.7975215263165207,0.75,1.0,1.0,2/5,30.46%,GPSM2;EPB41L2
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.3970351958252831,0.7974848677559002,0.7727272727272727,1.0,1.0,1/14,0.56%,MECOM
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.3844103760876636,0.7971953991217939,0.7894736842105263,1.0,1.0,1/18,2.02%,TIPRL
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.37349304985659587,-0.7971399959365997,0.8877551020408163,1.0,1.0,22/126,17.71%,SOD1;MTCH2;VAV3;ARHGEF9;RHOB;OLFM1;DDX3X;LATS2;CCAR1;MELK;STK4;RPS27A;RASGRF2;JUN;ATF6;CLU;APH1B;MCF2L;PHLDA1;LRRK2;PAWR;DNAJA1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.514456127804503,-0.7959148229819122,0.8461538461538461,1.0,1.0,2/6,24.93%,TSHR;CHRM3
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),-0.5345765843178594,-0.7955231459808998,0.8787878787878788,1.0,1.0,2/7,29.48%,RAB27A;KIF5C
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.50632838636732,-0.7954828467703127,0.7916666666666666,1.0,1.0,5/9,47.21%,PPARGC1A;GLYR1;PAXIP1;ARRB1;BRCA1
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.5378784236917766,-0.7949997537623786,0.7866666666666666,1.0,1.0,2/5,17.47%,SREBF1;SCARB1
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.4763330257355896,0.794383807238814,0.7647058823529411,1.0,1.0,3/6,18.06%,SLC27A1;PLEKHA3;CERT1
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.4905314044129026,0.7942388848390832,0.75,1.0,1.0,2/5,12.03%,CDKN1A;MAPK14
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.3747545806072029,-0.7940465007459601,0.8865979381443299,1.0,1.0,31/93,29.39%,DPP6;SPTBN4;ANK3;ARL5A;ATP1B3;ROCK2;DENND4C;WDR19;ZFYVE27;NPC1;LRRC7;LIN7A;TSPAN5;TM9SF2;TM9SF3;DPP10;GAK;NLGN1;RAB11A;STXBP1;RAB8B;EPB41L3;RAB12;CLASP2;MAP7;SH3PXD2B;RDX;PTCH1;CPE;KCNIP4;BSG
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.4191546978048906,-0.7940225507909073,0.8271604938271605,1.0,1.0,9/27,30.16%,RHOB;JUN;CAMKK2;MAPK1;SETX;EGFR;ABL1;MAPK9;PLEKHA1
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.4501213595320616,-0.7939205319110023,0.8352941176470589,1.0,1.0,9/23,28.87%,STK33;DONSON;PRKDC;WAC;TAOK3;UIMC1;MRNIP;BRCC3;NEK11
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.42655983631674677,-0.7938189485920955,0.8068181818181818,1.0,1.0,6/33,13.96%,VEGFA;RHOJ;TMSB4X;TGFB1;HIF1A;JCAD
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.4198915193011413,-0.793703327599747,0.788235294117647,1.0,1.0,4/23,16.65%,TUT7;CNOT8;DCP2;PATL1
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),-0.4634854535981505,-0.793349084008074,0.8202247191011236,1.0,1.0,7/14,26.18%,CHST11;DSE;VCAN;CSGALNACT1;CHST15;DCN;CHSY1
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.38483956561343463,0.7932581001783415,0.6153846153846154,1.0,1.0,3/14,4.80%,CSPG4;GLB1;ARSB
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4509467284755659,-0.7927601152392689,0.7466666666666667,1.0,1.0,7/12,44.08%,NAV3;PAK1;CLIP1;AKAP9;RAC1;DRG1;SLAIN2
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.45977938582794325,-0.7926471386690979,0.8148148148148148,1.0,1.0,7/15,26.32%,GRIN1;GRIA3;LRRC7;NLGN1;APP;GRIN2B;GRIA4
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.4449858095460183,-0.792153901889149,0.75,1.0,1.0,2/12,5.71%,TGFB2;TGFB1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.45787710634962153,0.7920673312459514,0.65,1.0,1.0,1/5,2.94%,FGF13
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.44884117559045694,-0.7913051647564421,0.7432432432432432,1.0,1.0,3/13,25.91%,PRKCI;INSR;IRS1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.34832278457329774,0.7912495335283037,0.8095238095238095,1.0,1.0,3/21,6.77%,BCL2L1;BCL2L11;BCL2
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.541168605370604,-0.7909007880564034,0.8648648648648649,1.0,1.0,5/6,44.82%,NPC1;LDLRAP1;ABCA1;OSBP;LRP6
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.43920046470094065,0.7908428807090457,0.6774193548387096,1.0,1.0,2/7,10.78%,PPARD;CREB1
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.470442860560841,0.7896995098574481,0.7142857142857143,1.0,1.0,2/7,9.35%,MTERF1;HMGB1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.4158601189936757,-0.7895281926858382,0.7804878048780488,1.0,1.0,13/31,34.83%,ELOB;CTR9;CCNH;RTF1;AFF4;CCNK;SUPT16H;NCBP1;GTF2H1;POLR2F;SUPT6H;ELP2;CCNT1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.4158601189936757,-0.7895281926858382,0.7804878048780488,1.0,1.0,13/31,34.83%,ELOB;CTR9;CCNH;RTF1;AFF4;CCNK;SUPT16H;NCBP1;GTF2H1;POLR2F;SUPT6H;ELP2;CCNT1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.4728845894114627,-0.7892636188738057,0.7948717948717948,1.0,1.0,7/15,34.36%,SPG7;ATP5F1C;DMAC2L;DNAJC11;CHCHD3;AFG3L2;ATP5F1E
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.4645083019987016,-0.7883922503089403,0.7468354430379747,1.0,1.0,4/11,28.89%,NEDD4L;GPM6B;GOPC;HSP90AB1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.4293211651154722,-0.7880722533477539,0.8045977011494253,1.0,1.0,5/26,7.35%,ENO1;TPT1;SELENOS;SOD2;DDX3X
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.4541617806561885,-0.7877606884108528,0.8095238095238095,1.0,1.0,2/16,11.85%,FHL1;MYO16
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.5083202700649437,-0.7875468625738693,0.8051948051948052,1.0,1.0,1/6,13.25%,NINL
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.49312814367565483,-0.7872344419951801,0.7733333333333333,1.0,1.0,1/7,9.34%,HADHA
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.5172405508200779,-0.7871579078413266,0.8059701492537313,1.0,1.0,2/5,7.48%,PTPN1;NIBAN2
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.5055406651541956,-0.787067354004132,0.76,1.0,1.0,3/10,15.70%,GRIN1;GABRE;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.3993625603326524,-0.7868623563187053,0.7906976744186046,1.0,1.0,9/32,21.22%,NKD1;NEDD4L;CDKN1B;RAB7A;WWP1;NSF;NEDD4;HECW1;SMURF2
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.44879320809398465,-0.7868413237544765,0.8076923076923077,1.0,1.0,3/13,6.51%,ASPA;MMUT;GLUL
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.4458121303435949,0.7867108539430656,0.8181818181818182,1.0,1.0,1/9,6.16%,CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.44293150340240495,0.7864182607947396,0.7272727272727273,1.0,1.0,2/7,3.37%,RYR2;EDN3
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.3680734739304359,-0.7863401334014094,0.8387096774193549,1.0,1.0,17/81,15.99%,GJA1;CD44;EMP1;EFNB2;COL11A1;ITGA5;SVEP1;FGFR2;COL6A3;C1R;FBN1;HIF1A;FAM114A1;MRC2;C1S;PLPP3;IGFBP5
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.48875101651418845,-0.7861673301130798,0.7777777777777778,1.0,1.0,3/8,22.12%,NEDD4L;CAMK2D;STK39
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.4968877425521083,-0.7861663185635909,0.8611111111111112,1.0,1.0,2/9,17.36%,DNMT1;TET1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.42125580949828645,-0.785692104582159,0.8636363636363636,1.0,1.0,2/27,9.93%,LGALS3;TGFBR1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.40273879170858345,-0.784953828440826,0.8068181818181818,1.0,1.0,13/37,25.57%,ATL1;TOR1AIP2;ALDH3A2;LPCAT3;TRAM1;LRRK2;REEP5;RAB18;SERP1;GAK;APP;VAPB;TRAM2
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.39964647276233317,0.784938308308431,0.8076923076923077,1.0,1.0,11/11,60.11%,TENT4B;MTREX;PARN;DIS3L2;SND1;XRN1;ZCCHC8;TUT4;DIS3L;EXOSC10;DIS3
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.334805038125944,0.7847348308577304,0.7333333333333333,1.0,1.0,3/21,6.66%,TIPRL;MFHAS1;DLC1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.400291792853677,0.7837032577970515,0.782608695652174,1.0,1.0,2/8,7.25%,DGKB;PGS1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.3912532045329368,0.7834668833902698,0.7307692307692307,1.0,1.0,4/11,21.29%,ZNF143;CHD8;RPTOR;ZNF345
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.44942262860918614,-0.7830158123465198,0.7530864197530864,1.0,1.0,4/12,20.97%,SH3BP5;PTPN2;SEMA4D;NF2
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.4250117787668018,-0.7829259482920666,0.8470588235294118,1.0,1.0,6/22,23.34%,ARF4;PDK3;MT3;PID1;AKR1C1;GRB2
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.44120142162397435,-0.7827956980013752,0.825,1.0,1.0,4/18,28.68%,CCP110;LRRK2;NBDY;TCHP
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.5011215748588583,-0.7825124473323676,0.863013698630137,1.0,1.0,3/6,45.65%,ADH1B;ALDH2;ADH5
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.5011215748588583,-0.7825124473323676,0.863013698630137,1.0,1.0,3/6,45.65%,ADH1B;ALDH2;ADH5
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.5053966986903716,-0.7824134615828221,0.8493150684931506,1.0,1.0,4/7,35.10%,FKBP5;PPIB;PPIG;PPIA
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.39626280109533424,-0.7823764332435927,0.8235294117647058,1.0,1.0,13/39,29.32%,VAV3;WIPF1;ACTR3;PAK1;MYO10;MAPK1;FYN;GRB2;LYN;PIK3CB;ABL1;HSP90AB1;ELMO1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.39626280109533424,-0.7823764332435927,0.8235294117647058,1.0,1.0,13/39,29.32%,VAV3;WIPF1;ACTR3;PAK1;MYO10;MAPK1;FYN;GRB2;LYN;PIK3CB;ABL1;HSP90AB1;ELMO1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.45510919782335396,-0.7819867081030778,0.8227848101265823,1.0,1.0,4/11,23.72%,ENTPD4;HINT1;NT5E;PDE4D
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.49722669341105713,-0.7817087171995207,0.821917808219178,1.0,1.0,2/7,25.97%,RACK1;CLASP2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.4610295990803637,-0.7817043669726669,0.8333333333333334,1.0,1.0,4/14,23.55%,TGFB1;LZTFL1;PID1;TMEM59
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.37476338380094715,-0.7816710982617459,0.8631578947368421,1.0,1.0,10/77,12.29%,CD44;EPHA7;APIP;TGFB1;CCN2;PTPN1;FGFR2;PTPN2;PDGFD;MT3
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.5065750734971802,-0.7810657815192038,0.7611940298507462,1.0,1.0,2/5,20.81%,NAA15;METAP1
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.5000485612079519,-0.7808631320864171,0.8,1.0,1.0,3/6,39.33%,MAP1LC3B;AMBRA1;PRKN
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.4632649766915843,-0.7805955524897004,0.8395061728395061,1.0,1.0,4/12,23.55%,TGFB1;LZTFL1;PID1;TMEM59
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.38631452615811834,-0.7805180695821872,0.8494623655913979,1.0,1.0,11/54,27.17%,RHOB;DIAPH1;TRAF3IP1;ROCK2;RHOBTB3;IQCJ-SCHIP1;PAK1;MAPK1;GPM6B;ABL1;CYLD
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.4994657374291397,0.7804684318225907,0.696969696969697,1.0,1.0,2/5,8.53%,CHMP4B;RHOA
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.3495577416282261,0.7804243511479534,0.8571428571428571,1.0,1.0,1/21,0.51%,SNAP29
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),-0.5356934896536959,-0.7802723861549209,0.8450704225352113,1.0,1.0,3/5,42.49%,PID1;PRKN;HUWE1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.4119247607718614,-0.7799411953276999,0.8295454545454546,1.0,1.0,10/40,18.70%,CSNK1D;RNF19A;CSNK1A1;ELOB;ARIH2;RBX1;CLU;LRRK2;FBXO22;MDM2
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.398548306757585,0.7797094435417598,0.68,1.0,1.0,3/12,11.74%,MRPL1;MRPL33;MRPL3
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.42717024514163415,-0.7795104709838172,0.7738095238095238,1.0,1.0,6/21,27.61%,SPIDR;AKR1C2;GRAMD1A;KLF9;GOLPH3;PTCH1
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.3536326212715272,-0.7789037979426197,0.9591836734693877,1.0,1.0,67/266,22.89%,CSF1;NR4A3;NRG1;S1PR3;IFIT3;VEGFA;TSC2;EFNB2;RPS4X;TGFB2;HDAC2;EAPP;TGFB1;SOD2;TBRG1;NIBAN2;SMAD6;EIF2AK2;FGFR2;CTCF;CCAR1;SDCBP;STAT3;TBC1D8;FTH1;KRAS;TGFBR1;SSR1;PTPN2;PDGFD;PRKDC;CDC123;MYO16;RUNX1;CNOT8;JUN;SGK1;AKR1C2;RGCC;CDKN1B;PRLR;ALDH1A2;CLU;COL18A1;MDM4;FLT1;TET1;MCTS1;NAP1L1;MDM2;NAMPT;ADAM17;BTG2;PAK1;RAF1;SFRP4;WARS1;BMP5;ATP8A2;NF2;BTG1;BIRC2;STAT6;IRF1;GAB2;JUNB;STAT1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.4190769878281147,-0.7787574902668536,0.8117647058823529,1.0,1.0,7/21,20.71%,CSMD3;NEDD4L;LZTS1;SEMA4D;NEDD4;BMP5;HECW1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),-0.5121358312834161,-0.778026765044971,0.7875,1.0,1.0,4/7,29.19%,NDFIP2;DNAJA1;NDFIP1;TERF1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.41119307468268407,0.7777528081792344,0.75,1.0,1.0,4/10,17.24%,SMYD3;SETDB1;PRDM5;SETDB2
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),0.40130379554759743,0.7775555232907962,0.6666666666666666,1.0,1.0,2/6,8.15%,SERGEF;SNX3
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.38637325017111124,-0.7774489110304135,0.826530612244898,1.0,1.0,17/57,25.91%,RPS4X;TGFB2;DDX3X;UPF3A;HSPH1;PLD1;SLC25A37;PRKDC;RGCC;ELAVL1;ATAD5;NAMPT;RPL5;INSR;KDR;EGFR;IRS1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.402365789096678,-0.7772667736614903,0.8333333333333334,1.0,1.0,10/29,24.48%,PSMB1;PSMD14;PSMA4;PSMB2;PSMA7;BTRC;SKP1;BIRC2;PSMA3;MALT1
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.33272396613000027,0.7769570372962752,0.8888888888888888,1.0,1.0,2/18,4.81%,RYR2;IGFBP7
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.40080430709344433,0.7769269753062061,0.7037037037037037,1.0,1.0,3/8,7.97%,MCU;DAPK2;SLIT2
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.5361674491192725,-0.7768113973773164,0.7721518987341772,1.0,1.0,1/5,22.38%,PTS
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.37008168306707934,0.7766012762062965,0.875,1.0,1.0,6/21,9.91%,MYL9;ACTB;MYH9;HSPB1;FLNA;ACTN1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.45608410896149154,-0.7764629318715883,0.7763157894736842,1.0,1.0,3/8,30.67%,FRMD5;CD9;FBLN1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.44156280526424974,-0.7764018240564757,0.782051282051282,1.0,1.0,4/16,18.85%,SEMA3B;FARP2;SEMA4D;NRP2
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.32349428573503247,0.776319290583331,0.7058823529411765,1.0,1.0,6/26,9.06%,ARHGEF10L;SYNPO2;CDC42;EVL;RHOA;CARMIL1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.4373093594477443,0.776301644726423,0.782608695652174,1.0,1.0,5/5,56.30%,RPS19;IL6R;RPL30;OPTN;DROSHA
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.40093072942716695,-0.7758385299454491,0.8111111111111111,1.0,1.0,11/37,32.19%,CSF1;ROCK2;NF2;MINK1;GPM6B;SLK;PIK3CB;NF1;PTK2B;RASA1;CASK
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.4884390010923592,-0.7757424941485703,0.8,1.0,1.0,3/7,40.78%,NF1;CEBPB;TGFBR3
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.4256310012281791,-0.7755605412226495,0.8024691358024691,1.0,1.0,6/21,33.46%,STMN1;NAV3;PAK1;ABL1;CLIP1;AKAP9
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5218181409157241,-0.7755545575690779,0.8289473684210527,1.0,1.0,2/6,14.45%,NOS1AP;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.5157175455503104,-0.7752235437369298,0.7878787878787878,1.0,1.0,3/7,9.56%,TGFB2;ADM;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-0.5075808449934949,-0.7750540949250171,0.8115942028985508,1.0,1.0,3/7,21.91%,PRKAR1A;PRKAR2A;PKIG
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.42643752007709623,0.7744835459777186,0.6666666666666666,1.0,1.0,8/8,57.41%,THADA;PKD2;ATP1A2;UBQLN1;YWHAE;GNB5;CALM1;FMR1
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.5023711932378992,-0.774391444963927,0.7761194029850746,1.0,1.0,2/5,28.38%,NRP2;NF1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.4020960254066823,-0.7741356369672282,0.7857142857142857,1.0,1.0,9/28,29.19%,CCT4;HNRNPC;DCP2;MAP3K4;TNKS;MAPK1;CCT8;POT1;TERF1
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),-0.4914728584930153,-0.7740040919230914,0.8024691358024691,1.0,1.0,4/8,30.75%,CSGALNACT1;FUT8;EXTL2;PARG
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.3577483075289209,-0.773938123216143,0.8969072164948454,1.0,1.0,14/108,15.99%,GJA1;F3;ARHGEF9;COL11A1;BCKDHB;FHL2;RUNX1;ADORA2B;PMP22;CDKN1B;NOTCH2;PLPP3;DUSP1;IGFBP5
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.4750594869037606,-0.7738283631649395,0.7866666666666666,1.0,1.0,2/10,10.96%,NFKBIA;PTPN2
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.4241784059456113,0.7737591158149987,0.7857142857142857,1.0,1.0,1/7,3.58%,SERGEF
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.46356591222999644,-0.7734727808981687,0.7066666666666667,1.0,1.0,2/10,9.80%,STMN1;HEG1
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.4521160940840834,-0.7730725898874874,0.8243243243243243,1.0,1.0,5/13,30.16%,MYO16;PIK3CB;IRS1;NF1;PLEKHA1
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.46100900317941,-0.7728838731800701,0.7631578947368421,1.0,1.0,4/9,32.45%,FMN2;IHO1;PTN;DIAPH2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.4313486934906392,-0.7727810729439601,0.8170731707317073,1.0,1.0,3/16,15.08%,STMN1;HDGFL3;NAV3
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.5053776151682176,-0.772617760818675,0.7733333333333333,1.0,1.0,1/5,10.62%,AGK
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.4190330434024916,-0.7718959271298096,0.8314606741573034,1.0,1.0,8/27,21.09%,NRCAM;ZC4H2;SIN3A;TCF4;LRRK2;YWHAG;EIF2AK4;NLGN1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.4582375015317627,-0.771809366047355,0.7702702702702703,1.0,1.0,6/8,49.87%,PATL1;DYNC1H1;ATXN2;LSM14A;RC3H1;EIF4ENIF1
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.49926728191082304,-0.771523405216526,0.8181818181818182,1.0,1.0,1/7,13.25%,NINL
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.44351493095409894,-0.7710779955220189,0.7951807228915663,1.0,1.0,3/15,7.94%,TWIST1;SUFU;SMAD6
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.45380130503936245,-0.7708087076885917,0.8933333333333333,1.0,1.0,3/10,17.47%,PITPNC1;PITPNA;SCARB1
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.432723185613359,0.7700547245941959,0.78125,1.0,1.0,6/6,56.77%,FAP;APOE;ST3GAL4;CAV1;THBS1;TFPI
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.5025147060370261,-0.7697429668787734,0.7794117647058824,1.0,1.0,2/5,20.76%,LNPEP;HLA-B
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.5045221796579865,-0.7685559842300435,0.8194444444444444,1.0,1.0,2/5,34.62%,GSN;WASHC5
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.40949765347105593,0.7680316509312419,0.7,1.0,1.0,4/7,15.96%,EXT2;B3GNT2;CSGALNACT2;NDST1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.4009993060635095,-0.7676574216927685,0.8313253012048193,1.0,1.0,5/28,21.93%,CTSL;RPS27A;COLEC12;MAPKAPK2;BIRC2
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.44990366088631994,0.7676241881220395,0.6818181818181818,1.0,1.0,6/6,55.05%,TRIM37;ALMS1;KAT2B;CDK5RAP2;BRCA1;CEP295
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.4700647608676365,-0.7676228174842797,0.8055555555555556,1.0,1.0,2/10,10.04%,ATP1B3;NEDD4L
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.5159749530582682,-0.7674243391912184,0.8064516129032258,1.0,1.0,1/5,18.85%,NRP2
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.49765650115727345,-0.7673264665590623,0.8481012658227848,1.0,1.0,1/8,9.02%,STAT3
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.529888388237974,-0.7671894986294779,0.7777777777777778,1.0,1.0,2/5,28.83%,CNOT1;STRN3
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.4699031361088923,-0.7669377957666601,0.8271604938271605,1.0,1.0,6/14,32.61%,SCARB1;XKR4;ITGAV;MEGF10;NR1H3;RHOBTB1
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.48629262816371727,-0.7666942110155189,0.7721518987341772,1.0,1.0,2/7,27.41%,SNX2;RAB6A
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),-0.5027370817012158,-0.7666256287406819,0.8333333333333334,1.0,1.0,1/5,18.32%,PRKAG2
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),-0.4530497981227461,-0.7658208384656452,0.8961038961038961,1.0,1.0,6/15,24.93%,FHL1;NEDD4L;NEDD4;AHCYL1;STK39;CHRM3
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.33027113566934724,0.7651482469633516,0.9090909090909091,1.0,1.0,2/19,5.15%,ZDHHC15;ZDHHC21
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.35695908658094855,0.7651413318446371,0.8095238095238095,1.0,1.0,2/19,5.47%,SNAP29;NSFL1C
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.4048936863381373,-0.7649236460413643,0.8152173913043478,1.0,1.0,5/30,19.84%,ZFP36L2;TANK;GBP2;PID1;ERBIN
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.3663547922181871,-0.7646731568301373,0.9139784946236559,1.0,1.0,11/55,19.59%,CYTH1;EPHA7;VEGFA;IL18;FRMD5;ROCK2;PPP3CA;DUSP1;SEMA4D;P4HB;PKP4
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.3665875914661451,-0.7645975569433575,0.8494623655913979,1.0,1.0,19/55,31.36%,PSMB1;PSMD14;AP2A1;PSMA4;PSMB2;PSMA7;PPP3CA;AGO2;SFRP4;SMURF2;PPP3CB;DAAM1;PSMA3;NLK;AP2B1;PRICKLE1;PSMD1;PSMC6;AP2A2
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.31148412429273786,0.7645201590864893,0.8,1.0,1.0,3/22,4.11%,PDGFA;ITGA3;COL5A2
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.4831673066656088,-0.7641729565907429,0.8051948051948052,1.0,1.0,3/10,31.34%,RBBP7;NASP;MIS18BP1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.4596043271510595,-0.7637094512718492,0.8192771084337349,1.0,1.0,1/11,0.91%,CSF1
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.4719871975676305,-0.7636416429980437,0.8311688311688312,1.0,1.0,1/13,5.28%,LGALS3
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.4690769638558798,0.7636266615709886,0.75,1.0,1.0,1/16,0.56%,MECOM
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.41311954340005247,-0.7630849717606533,0.8705882352941177,1.0,1.0,8/32,19.47%,ARID3A;CNOT8;PLAGL1;RGCC;CDKN1B;MDM4;MDM2;BTG2
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.3938466980415873,-0.761870147973908,0.8351648351648352,1.0,1.0,11/39,24.48%,CRY1;TANK;NDFIP2;UBE2L3;LRRK2;WDR48;DCUN1D4;NDFIP1;BIRC2;RCHY1;MALT1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.44743338849737,-0.7616346032945077,0.7831325301204819,1.0,1.0,2/14,7.35%,LGALS3;DDX3X
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.3936981065177068,-0.7611695637422645,0.9,1.0,1.0,8/30,25.62%,MORF4L1;BRD1;EP400;PER1;MORF4L2;YEATS2;APBB1;PHF20L1
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.4543124769221103,-0.760555667633686,0.8055555555555556,1.0,1.0,2/12,3.79%,VEGFA;RHOJ
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),0.44063821988003693,0.7605454235264972,0.76,1.0,1.0,2/8,4.38%,PRPSAP1;HPRT1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.4097266119796673,-0.7600901362320482,0.7816091954022989,1.0,1.0,4/22,10.96%,VEGFA;STAT3;IL18;PTPN2
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.43888088672542747,-0.7599149719301522,0.7662337662337663,1.0,1.0,3/10,12.29%,SOD1;SOD2;MT3
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.34723718416012056,0.7598353045192934,0.8333333333333334,1.0,1.0,3/18,11.74%,MRPL1;MRPL33;MRPL3
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),-0.4742003250487683,-0.7598107614649136,0.8169014084507042,1.0,1.0,2/9,10.04%,ATP1B3;NEDD4L
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.4742003250487683,-0.7598107614649136,0.8169014084507042,1.0,1.0,2/9,10.04%,ATP1B3;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.43686471989900305,-0.7597843568184679,0.8690476190476191,1.0,1.0,6/23,17.71%,LZTFL1;LATS2;NEDD4L;ROCK2;SIN3A;DNAJA1
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.35561872487483703,-0.7596939162876671,0.8541666666666666,1.0,1.0,25/80,28.52%,EMP1;ZC3H7A;FBN1;TP63;FAM114A1;SYNC;FILIP1L;PMP22;SASH1;PLPP3;TEAD1;NRP2;BNC2;LAMA4;STARD13;FSTL1;PPARA;SLK;EGFR;COL12A1;SH3PXD2B;FN1;LAMB1;COL4A1;ITGAV
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.488673658944904,-0.759681433895539,0.8028169014084507,1.0,1.0,1/6,0.91%,CSF1
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.3828292738203411,-0.7592597573635151,0.8444444444444444,1.0,1.0,10/42,14.55%,ELAVL3;PHYHIPL;SLC1A2;GRIN1;SNAP25;TRPM3;NXPH1;UNC79;SLC1A1;SNAP91
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.3412931691749115,-0.7592558901752446,0.95,1.0,1.0,43/207,24.13%,KLF2;CREB3L2;HDAC2;TGFB1;NIBAN2;ESR2;CTCF;CD38;STAT3;TP63;TGFBR1;HIF1A;RNF111;ELF1;RUNX1;MED14;MT3;CLOCK;JUN;TCF4;WAC;ARNT2;PPARGC1A;TEAD1;CALCOCO1;NAA15;RNF10;CAMKK2;SMARCA1;BTRC;YAF2;KDM3A;FUBP3;CRLF3;PPARA;IRF1;TP53BP1;STAT1;DEAF1;PPP3CB;ARID1A;APBB1;RORA
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.47010277813316503,-0.7591994578842393,0.8,1.0,1.0,4/6,39.44%,RSRC1;NUP205;PSIP1;NUP98
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.49853551332268986,-0.7590661176398357,0.821917808219178,1.0,1.0,2/6,40.78%,NF1;TGFBR3
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.3794104973237964,-0.7587860632251935,0.8433734939759037,1.0,1.0,9/41,19.10%,PSMB1;FBXL13;PSMD14;RBX1;PSMA4;PSMB2;PSMA7;BTRC;SKP1
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.4418029647251721,0.7586460097574335,0.7142857142857143,1.0,1.0,2/5,9.43%,ACTN4;MITF
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.4619884845066926,-0.758543529117425,0.8157894736842105,1.0,1.0,3/13,5.41%,CRY1;RBM4B;PPP1CC
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.49172828999598406,0.7584496610622294,0.75,1.0,1.0,2/5,6.77%,BCL2L1;BCL2
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.4924803365267259,-0.7583731431734959,0.8918918918918919,1.0,1.0,2/6,24.75%,GAK;CCDC91
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.4842862279720273,-0.75798682055984,0.8181818181818182,1.0,1.0,4/9,24.11%,OXSR1;ADAM17;STK39;APP
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.438124310495957,-0.7573338492635246,0.8658536585365854,1.0,1.0,2/17,11.85%,FHL1;MYO16
prerank,PanglaoDB_Augmented_2021__Ductal Cells,0.4364224630162091,0.756811498741522,0.9375,1.0,1.0,2/10,3.64%,GPRC5C;TINAGL1
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.43177687094820394,-0.756338118102506,0.8518518518518519,1.0,1.0,3/15,25.30%,MDM4;HINT1;FHIT
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.3326217760936294,0.7562548327935016,0.8695652173913043,1.0,1.0,4/14,14.63%,GPC6;ACTB;GPC5;APPL1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.34243869572899727,-0.7560605365098104,0.9595959595959596,1.0,1.0,50/222,21.72%,TP53TG5;ENO1;GJA1;FHL1;IFIT3;TSC2;PIP4P2;TGFB2;RHOB;PDCD4;TGFB1;SOD2;CCN2;DDX3X;TBRG1;NIBAN2;SMAD6;ESR2;EIF2AK2;CTCF;LPCAT3;FTH1;PTPN2;MYO16;RBBP7;MT3;RGCC;CDKN1B;ALDH1A2;TSPYL2;CLU;DUSP1;COL18A1;MDM4;LRPAP1;SEMA4D;CCN4;APPL2;BTG2;ADNP2;RAF1;SFRP4;CCN1;WARS1;BMP5;ATP8A2;NF2;CRLF3;CD9;BTG1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.4320464616559634,-0.7557718439872355,0.8522727272727273,1.0,1.0,8/20,24.13%,SOAT1;LIMA1;IL18;NPC1;SCARB1;AKR1C1;LPL;RORA
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.4320464616559634,-0.7557718439872355,0.8522727272727273,1.0,1.0,8/20,24.13%,SOAT1;LIMA1;IL18;NPC1;SCARB1;AKR1C1;LPL;RORA
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.39763005328653034,0.7556375169236157,0.6086956521739131,1.0,1.0,3/7,14.63%,MFHAS1;DAB2IP;APPL1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.4561793659493282,-0.7552618413045712,0.8470588235294118,1.0,1.0,2/14,8.45%,TGFB1;LATS2
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4038475983751212,-0.7549565266579423,0.8181818181818182,1.0,1.0,8/24,33.38%,ESR2;CALCOCO1;KDM3A;NEDD4;ARID1A;UBE3A;UBR5;SAFB
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.36355957279898315,-0.7548904014066645,0.9166666666666666,1.0,1.0,17/72,24.48%,TPT1;SRA1;TP63;IFT57;DDX42;SGK1;CLU;LRRK2;NAE1;WRN;RAF1;NF2;TARDBP;BIRC2;STAT1;SLK;MALT1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.3755633931928601,0.7548621472751089,0.8888888888888888,1.0,1.0,1/8,1.32%,CSPG4
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.45054125038262527,-0.7534552053626169,0.875,1.0,1.0,2/11,7.59%,RHOJ;PARVB
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.4330758004587505,0.753256242644875,0.8076923076923077,1.0,1.0,1/5,2.55%,ARL3
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.41742018715293777,-0.7524564359639655,0.8913043478260869,1.0,1.0,14/29,44.08%,CLIP4;WDR73;RAB11A;SLK;DST;CLIP1;DLG1;TUBGCP3;DYNC1H1;FIGN;CCDC88A;TUBGCP5;CLIP2;SLAIN2
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.47170078719792785,-0.7522259871771331,0.821917808219178,1.0,1.0,2/9,12.67%,LGALS3;ROCK2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.5169359917502167,-0.752014228436942,0.8285714285714286,1.0,1.0,2/7,24.40%,SUPT16H;NASP
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.39995642445413127,-0.752006759568687,0.8441558441558441,1.0,1.0,6/17,25.34%,KCNQ1;RAP1B;IGFBP5;STAT1;AKAP6;NDUFS4
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),-0.48711847338537384,-0.7517486806406442,0.8059701492537313,1.0,1.0,2/5,35.90%,NLGN1;TMEM108
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),-0.47605236081239793,-0.7515727859506008,0.821917808219178,1.0,1.0,1/7,1.27%,NRG1
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.5012129617486671,-0.7513255425198889,0.835820895522388,1.0,1.0,3/6,18.27%,SZT2;ITFG2;SESN1
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.42586618399612747,0.7512171909564219,0.7916666666666666,1.0,1.0,1/7,2.84%,MFHAS1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.5371789429436236,-0.7511929566569245,0.9014084507042254,1.0,1.0,2/5,19.44%,GBP2;ADAM17
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),-0.4753817686282039,-0.7509191306143015,0.8169014084507042,1.0,1.0,3/7,9.56%,PRKACA;PDE4B;KCNQ1
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),-0.4753817686282039,-0.7509191306143015,0.8169014084507042,1.0,1.0,3/7,9.56%,PRKACA;PDE4B;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.40536071102074966,-0.7508505067881862,0.8588235294117647,1.0,1.0,10/41,18.70%,CSNK1D;RNF19A;CSNK1A1;ELOB;ARIH2;RBX1;CLU;LRRK2;FBXO22;MDM2
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.4047641330313245,-0.7506051925089939,0.8604651162790697,1.0,1.0,2/18,9.70%,SPG7;PITRM1
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.3691610920033042,-0.7495650319532998,0.845360824742268,1.0,1.0,12/47,21.13%,HABP4;RPS4X;DDX3X;UPF3A;PLD1;PRKDC;CDC123;ELAVL1;AGO2;UHMK1;EIF2S3;RPL5
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.5129242630845058,-0.7495158351625367,0.8382352941176471,1.0,1.0,3/6,20.56%,SDCBP;LRPAP1;MTMR2
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.3488369048440327,0.749370108098535,1.0,1.0,1.0,2/22,2.86%,PKN1;ERBB4
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.2935792390399285,0.7488263899706313,0.9333333333333333,1.0,1.0,5/36,2.97%,CSRNP3;ATP1B2;SLC35F1;OPCML;NOTCH1
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.4355434259110611,0.7486748963467322,0.7096774193548387,1.0,1.0,5/5,56.48%,VCP;IDE;IFNAR1;TRAP1;PNPT1
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.3773838958481112,-0.7481159296984715,0.8863636363636364,1.0,1.0,6/34,15.48%,PRKACA;TGFB2;ATP1B3;KCNQ1;CAMK2D;ABCC9
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.3668543637043282,0.7474602489566778,0.8095238095238095,1.0,1.0,3/14,9.87%,CDC42;IQGAP2;NTF3
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.3258056592330127,0.7468809161670509,0.8823529411764706,1.0,1.0,4/29,5.49%,ZDHHC15;ARL6;ZDHHC21;SYNE3
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.3824241241636131,0.7465743033792043,0.7692307692307693,1.0,1.0,1/11,0.58%,AP3M1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.39577718226220104,0.7461008258306508,0.7692307692307693,1.0,1.0,1/9,2.97%,NOTCH1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.43202223508402243,-0.7460936641867673,0.8181818181818182,1.0,1.0,3/11,28.89%,PTPN2;STAT1;HSP90AB1
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.3883893968723892,-0.7456927710249849,0.8369565217391305,1.0,1.0,4/39,8.20%,IFITM3;IFIT3;DDIT4;EIF2AK2
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.43169492087978223,0.7456913157560615,0.8333333333333334,1.0,1.0,1/6,4.91%,PACS2
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.3802299441574085,-0.745617702854703,0.8705882352941177,1.0,1.0,3/33,6.29%,TGFB2;TGFB1;PRKCI
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.4518288032201794,-0.745431083067781,0.9090909090909091,1.0,1.0,4/18,19.27%,SOD1;HIF1A;DTNBP1;SYBU
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.45595016302550173,-0.7452460230603576,0.7945205479452054,1.0,1.0,3/6,45.00%,PEX1;HSPD1;DNAJC15
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.43506551654913356,0.7452038683058598,0.6153846153846154,1.0,1.0,2/7,9.66%,FGF13;ULK2
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.48353783766073133,-0.7450131154527413,0.8205128205128205,1.0,1.0,1/8,4.38%,PIAS2
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.4775814181836623,-0.7449330427483855,0.8292682926829268,1.0,1.0,1/6,4.86%,WDR43
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.42498954394714655,-0.744068538283643,0.7866666666666666,1.0,1.0,4/14,26.77%,FLT1;GNAQ;EGFR;LPAR1
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.44953849956840364,-0.7438439601091776,0.8831168831168831,1.0,1.0,3/8,31.92%,CA2;SLC4A10;SLC4A4
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.3893808164714739,-0.7432919150152698,0.8478260869565217,1.0,1.0,4/38,8.20%,IFITM3;IFIT3;DDIT4;EIF2AK2
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.36561768871952605,-0.7429500212704031,0.8617021276595744,1.0,1.0,19/59,29.31%,EPHA7;TGFB1;FGFR2;CCT4;UBE2L3;MAP3K4;TNKS;FLT1;DCUN1D4;MAPK1;LMO4;SERINC1;INSR;KDR;EGFR;RPS2;POT1;HSP90AB1;DCUN1D2
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.39732152539063587,0.7428232771238519,0.7692307692307693,1.0,1.0,2/9,16.76%,HACD2;TECR
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),-0.47690346011333895,-0.7425926771012065,0.8378378378378378,1.0,1.0,1/6,14.58%,SLC12A6
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),-0.49009921892630437,-0.7425843921744191,0.8378378378378378,1.0,1.0,2/5,33.56%,IRS1;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),-0.49009921892630437,-0.7425843921744191,0.8378378378378378,1.0,1.0,2/5,33.56%,IRS1;SORBS1
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.4682345242790802,-0.7423180465772823,0.8507462686567164,1.0,1.0,4/7,28.59%,SEC11A;SRP14;STXBP1;FOXO1
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.4709071625754952,0.7423171728834015,0.8,1.0,1.0,2/5,7.97%,SLIT3;SLIT2
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.4709071625754952,0.7423171728834015,0.8,1.0,1.0,2/5,7.97%,SLIT3;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),-0.4129016720271704,-0.7422788803110886,0.85,1.0,1.0,4/17,25.49%,DDX3X;PABPC1;PPARA;VAPB
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.44434831673884234,-0.7419436265308891,0.8765432098765432,1.0,1.0,2/10,8.21%,ZFPM2;FGFR2
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.39952461748189677,0.7416192188123286,0.7272727272727273,1.0,1.0,3/12,8.53%,LRCH1;DOCK8;RHOA
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.3811728081313296,-0.7412132441820461,0.898876404494382,1.0,1.0,3/48,8.21%,CSF1;EPHA7;FGFR2
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.34888212610771163,-0.7410228707020975,0.8924731182795699,1.0,1.0,7/64,17.24%,MID1;TENM3;SMAD6;ERRFI1;TEAD1;TTC23;SMARCA1
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.42623213999036763,0.7400286499737515,0.7586206896551724,1.0,1.0,5/5,57.41%,PKD2;UBQLN1;GNB5;CALM1;FMR1
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.34941504674080226,0.7395745288598917,0.85,1.0,1.0,3/14,4.36%,TIPRL;ATM;ERCC6
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.4320328170132116,-0.7394501771070001,0.8133333333333334,1.0,1.0,3/9,29.03%,BMP5;LDLRAD4;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.37302090528422877,-0.7392200396720209,0.9130434782608695,1.0,1.0,8/44,10.86%,CD44;VEGFA;TGFB1;ITGA5;PTPN1;ENPP2;STAT3;IL18
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.408884979506509,-0.7389426838744876,0.8452380952380952,1.0,1.0,3/17,9.77%,EPHA7;ROBO1;SEMA3B
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.3339430913241406,0.7389265920472148,0.9166666666666666,1.0,1.0,3/22,6.00%,EEFSEC;MRPL1;MRPL33
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.4006382769189669,-0.7389018325313049,0.8636363636363636,1.0,1.0,6/23,27.51%,SRSF10;SRSF5;SF3B1;SETX;CELF2;NCBP1
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.3947362764666866,-0.7385134489439472,0.8518518518518519,1.0,1.0,6/26,8.21%,BASP1;VEGFA;PGK1;HDAC2;LGALS3;FGFR2
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.3852236833779309,-0.7383499575331314,0.8452380952380952,1.0,1.0,2/30,6.74%,WWC1;GALNT11
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.3555431046904056,-0.7376824272439612,0.9021739130434783,1.0,1.0,20/62,34.73%,IFITM3;EIF2AK2;STAT3;PTPN2;TBK1;ALDH1A2;PID1;MAPKAPK2;STAT1;AKAP6;APP;GGT7;ADAM9;NFAT5;IL1R1;COL3A1;LDLRAP1;PTPN9;PRKCA;PTPN14
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.42481586595343457,-0.7376219073078324,0.8705882352941177,1.0,1.0,5/21,22.35%,ACOT11;ACBD6;LRRK2;HINT1;AK4
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.2777797661071284,0.7375853679415398,1.0,1.0,1.0,9/42,9.67%,SKI;ADD1;HMBOX1;CAPRIN2;DERL1;ZNF618;PARP9;HMGB1;TIAM1
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),-0.4905865495909627,-0.7375513734690227,0.8636363636363636,1.0,1.0,1/5,23.71%,STXBP1
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.34590546381805576,-0.7375427785744055,0.96,1.0,1.0,27/156,18.78%,COL4A6;NCKAP5;TGFB2;SNCAIP;COL11A1;RHOB;P4HA3;CLIP4;CST3;SHROOM3;STMN1;COL6A3;PXDN;TGFBR1;RPS27A;GGA3;HDGFL3;RHOBTB3;WDR73;APH1B;COL7A1;COL18A1;GFAP;TSPAN5;P4HB;MDM2;PPIB
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.41658739508617126,-0.737146511753418,0.8518518518518519,1.0,1.0,2/15,12.09%,TUT7;CNOT8
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.44109742495641835,-0.7367499148382807,0.8783783783783784,1.0,1.0,5/13,18.40%,SYT1;RIMS2;RIMS1;GRIK2;NSF
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.4573149041427831,-0.7366269075010379,0.8658536585365854,1.0,1.0,2/7,8.04%,GMPS;DGUOK
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.42139666849008167,-0.735292204221769,0.803030303030303,1.0,1.0,3/14,14.21%,PRKCI;AFDN;MICALL2
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.36773439971351823,-0.7351562351266241,0.9176470588235294,1.0,1.0,9/48,11.89%,NRG1;VEGFA;TGFB2;LGALS3;TGFB1;TGFBR1;NEDD4L;SPIDR;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.4488824889919927,-0.735136841863959,0.8513513513513513,1.0,1.0,3/13,15.21%,NIBAN2;HNRNPC;DCP2
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.46416522767257934,-0.7349691349123311,0.9066666666666666,1.0,1.0,6/10,39.06%,RPL5;RPL24;RPL3;RPL11;DHX30;RPL23A
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.37072302081467445,-0.73443469182128,0.9239130434782609,1.0,1.0,7/52,17.73%,DNAJC6;AP2A1;FTH1;STXBP6;EXOC1;DTNBP1;AP4E1
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.36762870162769323,-0.734218782813139,0.8888888888888888,1.0,1.0,12/45,18.77%,GALNT15;SLC1A2;GLUL;CDH20;ENPP2;GRIA3;PLP1;MT3;LRRK2;GFAP;RTN1;PID1
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.3502257477399361,-0.7341114809974332,0.9010989010989011,1.0,1.0,15/87,20.69%,TBC1D20;ARHGAP24;GARNL3;RGS7;MMUT;SIPA1L2;AFDN;TBC1D8;RALGAPA2;ZC3H15;USP6NL;SEMA4D;PKP4;TBC1D15;LARS1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.417814514961171,-0.7338074856451066,0.8571428571428571,1.0,1.0,4/13,24.48%,STAT3;LPL;APP;MALT1
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.48151923226552873,-0.7337800235580584,0.8571428571428571,1.0,1.0,3/7,29.53%,DLD;AASS;ALDH7A1
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.48151923226552873,-0.7337800235580584,0.8571428571428571,1.0,1.0,3/7,29.53%,DLD;AASS;ALDH7A1
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.4001339639170267,-0.7336681697896258,0.8705882352941177,1.0,1.0,6/32,12.67%,PRAG1;NRG1;VEGFA;DIAPH1;TGFBR1;ROCK2
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.28445981697839595,0.7326184904565115,1.0,1.0,1.0,3/34,3.63%,CACUL1;CDK6;CUL2
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),-0.4495807672236226,-0.7326062841929518,0.8115942028985508,1.0,1.0,2/9,14.58%,ATP1B3;SLC12A6
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.44109900830978344,-0.7325119849814723,0.8311688311688312,1.0,1.0,2/11,15.70%,TMEM165;LRRK2
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.41032654858666007,-0.7320026934365066,0.8433734939759037,1.0,1.0,5/17,24.51%,DGKI;GK5;PLAAT3;LPL;LMF1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.3805684526746637,-0.7317720163596518,0.8681318681318682,1.0,1.0,9/38,23.34%,THSD7A;PTPN1;PARVB;MICALL2;DTNBP1;FARP2;PAK1;MINK1;GRB2
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.41210172509616394,0.7316113577967754,0.8275862068965517,1.0,1.0,1/6,6.64%,SETD7
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.41252206565220884,-0.730890425422535,0.7674418604651163,1.0,1.0,4/15,14.93%,FTH1;TF;MT3;CP
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.4804533582586554,0.7308640212237223,0.8095238095238095,1.0,1.0,2/5,12.03%,HMGB1;MAPK14
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.36592515150563715,-0.7307125252182364,0.9032258064516129,1.0,1.0,14/50,18.82%,CNTN3;PHYHIPL;RHOJ;ADM;PTPRD;ENPP2;GRIA3;DENND2A;C1S;PPARGC1A;PLPP3;FGF14;TRPA1;ABCA8
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.41741267156556683,-0.7299868961707631,0.8658536585365854,1.0,1.0,6/19,24.83%,GRIN1;DDX3X;FYN;ARL6IP5;MALT1;GRIN2B
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.4305510742905498,-0.7296672398869485,0.8405797101449275,1.0,1.0,4/11,24.45%,TRMT1L;NSUN6;TRMT13;WDR6
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.3735614521993522,-0.7296150714590814,0.8674698795180723,1.0,1.0,10/38,15.62%,VEGFA;RUBCN;LGALS3;DDX3X;CRACD;TMEFF2;TRAF3IP1;HSPA5;CLU;WASHC2C
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.47132739074153873,-0.7286986107451126,0.8674698795180723,1.0,1.0,2/9,3.40%,F3;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3789882299399955,-0.7286569679124025,0.8850574712643678,1.0,1.0,10/45,18.70%,CSNK1D;RNF19A;CSNK1A1;ELOB;ARIH2;RBX1;CLU;LRRK2;FBXO22;MDM2
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.38263351424818415,0.7278626836841486,0.8,1.0,1.0,3/13,8.53%,LRCH1;DOCK8;RHOA
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.469271986944402,-0.727833296299954,0.8873239436619719,1.0,1.0,1/7,17.45%,ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.469271986944402,-0.727833296299954,0.8873239436619719,1.0,1.0,1/7,17.45%,ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.469271986944402,-0.727833296299954,0.8873239436619719,1.0,1.0,1/7,17.45%,ANAPC4
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.3887788994904117,-0.7272893751078635,0.8767123287671232,1.0,1.0,3/18,21.88%,SCD;GPX4;LPL
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.36422319966487193,0.7267747905755144,0.9333333333333333,1.0,1.0,2/9,12.96%,OSBPL6;CYP27A1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.42788667725152063,-0.7265331306010814,0.8607594936708861,1.0,1.0,3/14,5.41%,CRY1;RBM4B;PPP1CC
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.41570418360521066,-0.7264697642893284,0.8088235294117647,1.0,1.0,3/15,14.21%,PRKCI;AFDN;MICALL2
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),-0.40188178280929354,-0.7262167718704736,0.872093023255814,1.0,1.0,5/23,24.40%,HDAC2;HNRNPC;SMARCA1;ARID1A;NASP
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),-0.3447763682722361,-0.7259500535187159,0.8791208791208791,1.0,1.0,12/66,23.56%,HDAC2;HMGN1;HCFC2;FAM50A;NUDT5;EZH1;CHD1;MYSM1;SMARCA1;PAK1;ZBTB1;ARID1A
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.4710284728765659,-0.7254209021048487,0.8205128205128205,1.0,1.0,1/6,31.25%,USP14
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.44983885687600106,-0.7253845026529308,0.8524590163934426,1.0,1.0,1/5,29.03%,SPRED1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.39367477889253627,-0.725271873096453,0.8780487804878049,1.0,1.0,5/24,17.37%,ADAMTS9;MANBA;HIF1A;MGAT4A;MAN2A1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.3496369398596969,0.724946542307581,0.8421052631578947,1.0,1.0,3/15,10.47%,MYLK;SMOC2;ITGB1
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.3655880679385149,-0.724833699985619,0.8522727272727273,1.0,1.0,8/38,16.99%,VEGFA;ROBO1;TGFB1;PTPN1;PDGFD;DUSP1;LRRK2;FLT1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.44105997786948087,-0.7247609164660692,0.8382352941176471,1.0,1.0,3/10,32.77%,PPARA;KDR;CAST
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.33335433405571885,-0.7246089845316361,0.8947368421052632,1.0,1.0,17/68,16.01%,CD55;NECTIN2;CST3;C1R;SHC2;SEMA3B;FAM114A1;MATN2;TF;CDC42EP4;C1S;PRLR;CLU;NOTCH2;PLPP3;IGFBP5;COL18A1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.4315056818212394,-0.7238900979754438,0.85,1.0,1.0,4/11,33.91%,LRRC7;NLGN1;PTN;DLG1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),0.3061230311957691,0.7235654640009057,0.7727272727272727,1.0,1.0,1/13,4.09%,ATM
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.36500763641021294,-0.7232162271245789,0.9310344827586207,1.0,1.0,7/49,9.87%,CNTN3;PCDH17;PHYHIPL;PTPRD;SNAP25;SHC2;GRIA3
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.403078038948427,0.7229626681433219,0.8,1.0,1.0,4/8,17.02%,SKI;SORT1;PLD3;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.4364784773594168,-0.7225194693659673,0.8837209302325582,1.0,1.0,5/11,28.52%,SDCBP;LRPAP1;MTMR2;APP;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.4616330545204144,-0.7223709638586979,0.8289473684210527,1.0,1.0,6/9,41.19%,CCT4;CCT8;CEP120;CCT3;CCT6A;CORO2B
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3808238256407906,-0.7222047866372518,0.8352941176470589,1.0,1.0,7/22,30.88%,SDCBP;WAC;UCHL5;RPL5;FHIT;HSP90AB1;RPL11
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.39572912847309416,0.7208417870193432,0.8666666666666667,1.0,1.0,2/9,7.94%,RYR2;RBPMS2
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.4763623685349897,-0.7203176972274427,0.8571428571428571,1.0,1.0,2/5,31.10%,ALKBH5;ASCC3
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.4763623685349897,-0.7203176972274427,0.8571428571428571,1.0,1.0,2/5,31.10%,ALKBH5;ASCC3
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.39345970130719277,-0.7200610779864308,0.8690476190476191,1.0,1.0,6/21,24.91%,PDCD4;PTPN1;DUSP1;DNAJA1;LYN;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.4949234196164622,-0.7198920119734598,0.8472222222222222,1.0,1.0,2/5,26.26%,PKM;YBX3
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),-0.43840542649660214,-0.7198541395690417,0.8354430379746836,1.0,1.0,5/11,35.69%,NEDD4;ABL1;CTNNA2;EPHA4;IL1RAPL1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.4766956141817895,-0.7193459269594926,0.8484848484848485,1.0,1.0,1/5,3.40%,VEGFA
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.36381357196508307,-0.7193363214286065,0.9176470588235294,1.0,1.0,8/56,10.81%,PCDH17;PHYHIPL;DHRS3;DCLK1;SYNDIG1;PTPRD;SHC2;PLP1
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.46409466393962195,-0.7190691235238339,0.8194444444444444,1.0,1.0,2/5,31.50%,FN1;COL3A1
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.3335317867863995,-0.7190671478713705,0.98989898989899,1.0,1.0,31/144,20.63%,CSF1;CSNK1D;CD44;VEGFA;MYDGF;TGFB2;TGFB1;ITGA5;DDX3X;ENPP2;SDCBP;STK4;CEMIP;KRAS;TGFBR1;PDGFD;MT3;ROCK2;TERF2IP;TBK1;LRRK2;CAMKK2;SEMA4D;PRKAG2;MTCP1;ADAM17;PAK1;RAF1;CCN1;UBE2K;BMP5
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.34403122895111593,-0.7189146312968574,0.8850574712643678,1.0,1.0,19/71,27.65%,SSH1;PPP1CC;PPP2R1B;PTPRE;PTPRD;PTPN1;PTPN2;PPP2R2A;PPP3CA;DUSP1;BTRC;MTMR2;PPP2R3A;PPP3CB;PTPRM;EYA2;EYA1;DUSP16;PTPRZ1
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.42149088539556956,-0.718567294601073,0.825,1.0,1.0,5/13,31.70%,ATP6V1H;ATP6V0D1;DMAC2L;ATP6V0E1;ATP1A1
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.3529656677606827,0.7185408107083735,0.9130434782608695,1.0,1.0,2/10,7.97%,ITGA3;SLIT2
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.32950939499355575,-0.718040581876692,0.9696969696969697,1.0,1.0,28/125,27.45%,NFKBIA;PSMB1;PSMD14;CCP110;USP15;JOSD1;TGFBR1;RPS27A;HIF1A;PSMA4;PSMB2;PSMA7;UCHL5;SENP1;MDM4;WDR48;MYSM1;MDM2;OTUD7A;SMURF2;BIRC2;UIMC1;PSMA3;RAD23B;USP3;DESI2;CYLD;BRCC3
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.44020481591097255,0.7179653773468407,0.8484848484848485,1.0,1.0,1/5,6.95%,PIK3CD
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),-0.34933091943424216,-0.7177864279547109,0.8172043010752689,1.0,1.0,12/59,15.83%,SEC13;NUP153;RPA1;NUP133;NUP88;HSPH1;DNAJC7;AMFR;ROCK2;CHCHD2;CAMK2D;RANBP2
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.46158379304909225,-0.7177688992889358,0.8641975308641975,1.0,1.0,1/8,4.86%,WDR43
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.4238552446131875,-0.7174018980544313,0.8780487804878049,1.0,1.0,6/14,34.83%,JUN;CHD1;TARDBP;SP1;NAPEPLD;CCNT1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.33857442643113467,-0.7172827252463083,0.9534883720930233,1.0,1.0,17/66,21.72%,SRA1;PSMB1;TGFB1;PSMD14;SDCBP;PSMA4;PSMB2;ANGEL2;PSMA7;CDKN1B;ANAPC4;BTRC;MDM2;SKP1;BTG2;HECA;BTG1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.3409844651119708,-0.7170067021622591,0.9191919191919192,1.0,1.0,16/85,17.74%,VEGFA;PTRH2;TGFB2;ROBO1;TGFB1;OLFM1;SDCBP;HIF1A;RUNX1;ROCK2;DNMT1;NOTCH2;NDFIP2;TET1;LRPAP1;AGO2
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.37026652641261176,-0.7167749689534378,0.8571428571428571,1.0,1.0,6/33,22.92%,TUT7;SRSF5;SYMPK;CSTF3;CPSF2;THOC2
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.42527366341785816,-0.7165093399296136,0.8125,1.0,1.0,1/11,5.21%,NUP153
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.3830914243068728,-0.7158928417666801,0.8732394366197183,1.0,1.0,3/19,14.21%,PRKCI;AFDN;MICALL2
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.4437128633370805,-0.7155644001515667,0.8227848101265823,1.0,1.0,7/7,55.69%,DLG1;BMPER;SEMA5A;LOXL2;ITGB1BP1;PRKX;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.39099793819055684,-0.7152634071681507,0.8666666666666667,1.0,1.0,7/26,24.11%,NFKBIA;PDCD4;IL18;CCN4;LPL;RIOK3;APP
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.43694538087164203,-0.715043184209913,0.8947368421052632,1.0,1.0,1/9,4.25%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.35560370690376547,0.7149749174794008,0.8095238095238095,1.0,1.0,2/16,6.42%,DOCK8;NCK1
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.49631214615048524,-0.7149427086030608,0.9285714285714286,1.0,1.0,2/6,7.62%,ANK3;SCN3A
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.4198931200691639,0.7142066703589923,0.8518518518518519,1.0,1.0,1/7,9.87%,NTF3
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.4407000151792591,-0.7135929061009272,0.8961038961038961,1.0,1.0,6/12,35.74%,SREBF1;SCARB1;PPARA;NR1H3;SORBS1;MTOR
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.369468330632708,0.7135743434841576,0.72,1.0,1.0,1/10,0.80%,ARHGEF10L
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.46595634229585914,-0.7132283851337855,0.8333333333333334,1.0,1.0,3/7,24.03%,EAPP;RNF168;TCERG1
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.4440637305081052,0.7131357991638688,0.7073170731707317,1.0,1.0,1/5,1.44%,TNIP1
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.4650832943943655,-0.7130264864155079,0.9,1.0,1.0,1/7,9.90%,PRKAR1A
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.4630551650437377,0.7129211703185377,0.7916666666666666,1.0,1.0,1/5,1.44%,TNIP1
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.35655356927309806,-0.7125761338047941,0.9560439560439561,1.0,1.0,23/70,29.42%,GJA1;SVEP1;C1R;FAM114A1;MATN2;C1S;SASH1;PRLR;PLPP3;IGFBP5;ABCA8;ASS1;DCN;KDR;EGFR;TACC2;COL12A1;PDE8A;PTCH1;COL4A1;CPE;LAMA2;KIAA1217
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.43369126108990474,-0.7125750152568033,0.8375,1.0,1.0,3/8,30.72%,PRKDC;ZBTB1;XRCC6
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.38937805168216527,-0.7119031027795661,0.8902439024390244,1.0,1.0,5/29,17.97%,ARIH2;TP63;MICALL2;UBE2L3;YWHAG
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.4212993254480577,0.7116065198026994,0.8888888888888888,1.0,1.0,2/6,2.97%,HEY2;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.45880378797407917,-0.7111632927661689,0.8823529411764706,1.0,1.0,1/5,5.79%,ATP1B3
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.3822623008644365,-0.7111615190145538,0.875,1.0,1.0,3/19,16.11%,CD44;CFL1;FMNL2
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.4422781890442812,-0.711111897700052,0.8493150684931506,1.0,1.0,5/8,42.73%,ZBTB1;BCL6;GLI3;ZMIZ1;CD46
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.4484088272350537,-0.7110054766413509,0.9125,1.0,1.0,3/8,24.03%,EAPP;RNF168;TCERG1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.39610319164152263,-0.7105951353528552,0.9176470588235294,1.0,1.0,4/17,14.58%,GLUL;SNAP25;SLC47A1;SLC12A6
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),-0.44779610837540706,-0.7105742170170735,0.8260869565217391,1.0,1.0,1/5,21.09%,NLGN1
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),-0.44779610837540706,-0.7105742170170735,0.8260869565217391,1.0,1.0,1/5,21.09%,NLGN1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.37445172472982763,-0.7099246403200677,0.8395061728395061,1.0,1.0,12/26,38.79%,ANK3;SYTL4;NSF;SERP1;EPB41L3;UGCG;SNX9;A4GALT;ARL8B;EHD2;MYOF;PLSCR1
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.4240262048726517,-0.7097441779412286,0.8701298701298701,1.0,1.0,2/10,15.98%,MTMR9;PPP6R2
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.4319214153786485,-0.7096720222160653,0.8648648648648649,1.0,1.0,3/10,23.05%,MGAT4A;MAN2A1;FUT8
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.4526744447902906,-0.7093094323674713,0.8837209302325582,1.0,1.0,2/9,22.35%,LRRK2;AK4
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.4526744447902906,-0.7093094323674713,0.8837209302325582,1.0,1.0,2/9,22.35%,LRRK2;AK4
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),-0.4031340290456722,-0.7092579434480702,0.8205128205128205,1.0,1.0,4/12,21.09%,SYNDIG1;PTPRD;SEMA4D;NLGN1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.40466975900042623,-0.7089884538947637,0.8850574712643678,1.0,1.0,3/18,25.30%,DDIT4;HINT1;FHIT
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),0.40985876322995085,0.7087608050454889,0.7894736842105263,1.0,1.0,1/5,3.13%,INPP5F
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.4368288639175363,-0.7085898128142631,0.8783783783783784,0.9998013566718551,1.0,3/8,31.70%,CAMK2D;GSN;ATP1A1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.4368288639175363,-0.7085898128142631,0.8783783783783784,0.9998013566718551,1.0,3/8,31.70%,CAMK2D;GSN;ATP1A1
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.43626352999521123,-0.708476964430974,0.8837209302325582,0.9995492256662097,1.0,5/12,35.00%,CMKLR1;HLA-B;CD47;IL16;HSPD1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.3725709816600601,-0.7082483882103913,0.8846153846153846,0.9993773426137798,1.0,5/30,13.78%,PSMB1;PSMD14;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.37993570525763964,-0.7081834045841203,0.88,0.9990295594852763,1.0,3/15,15.99%,KCNQ1;RAP1B;IGFBP5
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3333166200909743,0.7072830935581057,0.8947368421052632,1.0,1.0,2/14,8.31%,VPS35;MARK1
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.4330605565233147,0.7068808041432727,0.7391304347826086,1.0,1.0,1/7,0.72%,HDAC9
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.4622842494604539,-0.7061439232142201,0.8846153846153846,1.0,1.0,2/5,32.24%,NEK11;RAD17
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.45086127797153325,-0.7054039902616301,0.875,1.0,1.0,2/7,22.35%,GMPS;AK4
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.3961899865303352,0.7052856564167368,0.7777777777777778,1.0,1.0,2/5,7.92%,LARGE1;CHST3
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.34859911383606224,0.7052749761303185,0.8518518518518519,1.0,1.0,1/11,1.68%,USP16
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.46814758591514694,-0.7052710880769039,0.88,1.0,1.0,2/6,21.72%,SFRP4;BTG1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.4583303592994287,-0.7051478889397226,0.9041095890410958,1.0,1.0,2/6,36.25%,SNX9;EHD2
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.33621056134581323,0.7049640803919566,0.85,1.0,1.0,1/11,6.16%,CHMP4B
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.43019999083513305,-0.7048487839033393,0.8783783783783784,1.0,1.0,2/7,20.63%,DUSP1;BMP5
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.42023696838178193,-0.704251782123518,0.8289473684210527,1.0,1.0,3/11,21.27%,MAP3K4;TNKS;MAPK1
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.355508677689943,-0.7039047614934721,0.9195402298850575,1.0,1.0,13/41,22.25%,TGFB1;TRAF3IP1;PRKDC;C9ORF72;TERF2IP;CDKN1B;PLPP3;PRR5L;LRRK2;PID1;WARS1;TARDBP;PPARA
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.34048588931933776,-0.7036988605121479,0.9418604651162791,1.0,1.0,15/58,24.91%,PDE4B;PSMB1;PSMD14;PSMA4;PSMB2;PSMA7;BTRC;SKP1;PAK1;PAG1;FYN;PDE4D;PSMA3;MALT1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.4083386928354522,-0.7031716132565559,0.9,1.0,1.0,2/11,8.21%,ZFPM2;FGFR2
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),-0.4707025675274803,-0.7030100932575988,0.8783783783783784,1.0,1.0,5/6,52.42%,NAPEPLD;HNRNPU;SIRT1;FTO;RREB1
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.43376896453954356,-0.70251387378649,0.9135802469135802,1.0,1.0,4/13,15.34%,SLC22A6;SLC47A1;SLC13A3;ENPEP
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.3810364598753698,-0.7024597427722685,0.8271604938271605,0.9997991746794399,1.0,4/18,26.53%,ROCK2;AKR1C2;KLF9;GOLPH3
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.2939340366484663,0.702325534755121,0.9444444444444444,1.0,1.0,8/31,11.69%,ATM;DAPK2;FBXL2;PIP4K2B;HSPB1;EP300;DEPP1;IFI16
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.3917741154971621,-0.7017940212953163,0.8837209302325582,1.0,1.0,6/19,28.33%,GOLGA2;SMC3;RAB11A;MAP9;CLASP2;SMC1A
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.32069287969003923,-0.7014647305832825,0.967391304347826,1.0,1.0,15/78,19.87%,ZFP36L2;PSMB1;PSMD14;RPS27A;GIGYF2;PABPC1;PSMA4;PSMB2;IGF2BP2;ROCK2;PSMA7;DCP2;ELAVL1;MAPKAPK2;METTL16
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.40003418502706345,-0.7014287267161005,0.881578947368421,0.9996961297090733,1.0,6/14,28.89%,CCNH;CDKN1B;CCNK;GTF2H1;CAMK2N1;HSP90AB1
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.3738971735568025,0.7009463019422254,0.7857142857142857,1.0,1.0,3/12,10.78%,ATM;WNT5B;CREB1
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.4835123470511492,-0.7009208282811217,0.8571428571428571,0.9998473649069628,1.0,1/5,10.84%,SPIDR
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.36889928833944885,-0.70067324975153,0.8918918918918919,0.9997560630219631,1.0,6/32,16.73%,PSMB1;PSMD14;PSMA4;PSMB2;PSMA7;LNPEP
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.4147681063577454,-0.7005238256474944,0.8356164383561644,0.9994979877601524,1.0,4/13,26.07%,SDCBP;APP;EGFR;KCTD20
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.37001928020565567,0.7003186218018846,0.8,1.0,1.0,10/10,63.06%,RB1;PHF8;AKAP8L;MCPH1;TENT4A;ACIN1;GPER1;CSNK2A1;TTN;CSNK2A2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.4532756163540674,0.7002571553780387,0.8108108108108109,1.0,1.0,1/5,4.94%,MAPRE2
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.3221441587907561,-0.700216447589733,0.9494949494949495,0.9994426334727446,1.0,27/121,27.45%,NFKBIA;PSMB1;PSMD14;CCP110;USP15;JOSD1;TGFBR1;RPS27A;HIF1A;PSMA4;PSMB2;PSMA7;UCHL5;MDM4;WDR48;MYSM1;MDM2;OTUD7A;SMURF2;BIRC2;UIMC1;PSMA3;RAD23B;USP3;DESI2;CYLD;BRCC3
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.38385728559480015,0.6998186595093792,0.8275862068965517,1.0,1.0,1/6,8.55%,HSPB1
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.38385728559480015,0.6998186595093792,0.8275862068965517,1.0,1.0,1/6,8.55%,HSPB1
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.38385728559480015,0.6998186595093792,0.8275862068965517,1.0,1.0,1/6,8.55%,HSPB1
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.4544081225794153,-0.6986354606161763,0.8701298701298701,1.0,1.0,3/5,35.60%,MTF2;SUPT6H;MACROH2A1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),-0.4527182358118337,-0.6986339462943367,0.9193548387096774,1.0,1.0,1/7,5.79%,ATP1B3
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.3935116895697929,-0.6984092714034859,0.9404761904761905,1.0,1.0,6/20,23.95%,RHOB;ROCK2;RHOBTB3;FMNL2;NLGN1;EPB41L3
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.377972986975003,-0.6981629602680806,0.9176470588235294,0.9998480748410857,1.0,9/26,30.75%,MT3;PUM3;PPIB;WARS1;LYN;NDUFS4;FN1;SPRED1;PARG
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.4259560409302401,0.6979381822502866,0.7586206896551724,1.0,1.0,1/5,8.08%,ABCC5
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.4259560409302401,0.6979381822502866,0.7586206896551724,1.0,1.0,1/5,8.08%,ABCC5
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.30760160373146217,0.6977268125763224,0.8181818181818182,1.0,1.0,2/10,7.97%,EDN3;SLIT2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.40435618435110743,0.6973480470331292,0.7857142857142857,1.0,1.0,1/5,5.15%,ZDHHC21
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.43830164202026545,-0.6973210690069368,0.921875,1.0,1.0,2/6,33.91%,RAB11A;DLG1
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.4351548527609792,0.6967296105981728,0.7878787878787878,1.0,1.0,1/6,4.94%,MAPRE2
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.3724868745808353,-0.6965509545947675,0.8717948717948718,1.0,1.0,7/21,16.35%,PSMB1;PSMD14;PSMA4;PSMB2;PPM1K;PSMA7;AZIN1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.3549714492327524,-0.6956838045893347,0.9438202247191011,1.0,1.0,10/37,28.46%,PABPC1;SRSF5;SYMPK;CSTF3;CPSF2;AHCYL1;THOC2;APP;NCBP1;GRSF1
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.4327421978250576,-0.6946090817950191,0.8472222222222222,1.0,1.0,1/6,5.79%,ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.39022155367928263,-0.69441790648649,0.8831168831168831,1.0,1.0,6/16,28.89%,CCT4;MAP3K4;TNKS;MAPK1;POT1;HSP90AB1
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.41926100373984254,-0.694134164887078,0.9125,1.0,1.0,4/15,12.77%,CDC5L;STK33;DONSON;CLOCK
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.4422316727381431,-0.6938399491778617,0.8961038961038961,1.0,1.0,1/8,12.90%,SIN3A
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.3964677573356336,-0.6921400270247287,0.8395061728395061,1.0,1.0,4/17,14.71%,KLF2;NOS1AP;ROCK2;CLU
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.4046688486711747,-0.692103501345743,0.8571428571428571,1.0,1.0,3/11,17.44%,CTR9;WAC;UBE2B
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.26468003386755046,0.6920779960260068,0.8888888888888888,1.0,1.0,5/55,6.80%,HDAC9;USP16;PHC1;UBE2N;TBL1X
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.41495593063877523,-0.6919924226068918,0.8974358974358975,1.0,1.0,3/13,13.83%,IFITM3;GBP2;RPL13A
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.35646550393918647,-0.6901747248591174,0.9186046511627907,1.0,1.0,9/31,14.36%,VEGFA;PGK1;LGALS3;TGFB1;FGFR2;IFT122;ERRFI1;AKR1C2;ALDH1A2
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.4130755032029552,-0.6901538770839489,0.8701298701298701,1.0,1.0,6/13,40.94%,TRA2B;TRA2A;NCBP1;CIRBP;NUP98;DHX36
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.4629472398909894,-0.6901287261529123,0.8955223880597015,1.0,1.0,1/5,4.51%,SECISBP2L
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.4629472398909894,-0.6901287261529123,0.8955223880597015,1.0,1.0,1/5,4.51%,SECISBP2L
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.37368091199693515,-0.6896417459558493,0.935064935064935,1.0,1.0,11/27,24.35%,PSMB1;PANK2;PSMD14;PSMA4;PSMB2;PSMA7;AZIN1;PRKAG2;NCOR2;PPARA;PSMA3
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.35478583794947005,-0.6896369355063882,0.8780487804878049,1.0,1.0,6/34,13.78%,PSMB1;PSMD14;AP2A1;PSMA4;PSMB2;PSMA7
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.41887729097956683,-0.689567938459347,0.8734177215189873,1.0,1.0,5/11,39.44%,TRA2B;TRA2A;NCBP1;CIRBP;NUP98
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.36061823147479377,-0.6893973583537111,0.9666666666666667,1.0,1.0,7/48,14.89%,CD44;TGFB1;CCN2;FGFR2;PDGFD;MT3;NOTCH2
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.37940810431043237,-0.6889870745091657,0.891566265060241,1.0,1.0,4/22,17.44%,RPA1;RPS27A;POLK;UBE2B
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),-0.3911032393462254,-0.6887318956166517,0.92,1.0,1.0,6/18,23.36%,GRIK1;BTBD9;NRG3;GRIK2;NLGN1;LRRC4C
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.43562311229261763,-0.6884312897227524,0.8356164383561644,1.0,1.0,1/6,8.68%,DGKI
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.3764710886408227,-0.6883382607003066,0.8928571428571429,1.0,1.0,3/24,10.57%,TOR1AIP2;ATP1B3;MYL3
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.4197777937831426,-0.6881380557855323,0.8641975308641975,0.999862167986079,1.0,4/10,15.70%,UBAC2;TAPT1;HSPA5;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),-0.460456989207443,-0.688107882938789,0.9066666666666666,0.999493057653649,1.0,4/5,44.29%,RNF10;DICER1;TNFRSF1B;TENM4
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.31596869021096474,0.6880788567384476,0.8947368421052632,1.0,1.0,3/17,9.66%,SLIT3;SLIT2;ULK2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.352980482556581,-0.6877232650097556,0.9047619047619048,0.999442255361203,1.0,6/36,13.78%,PSMB1;PSMD14;AP2A1;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.40746464120847153,-0.6872685726413088,0.8933333333333333,0.9994464378026022,1.0,4/12,29.47%,ZRANB3;WRN;BOD1L1;MMS22L
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.45213040446030534,0.6870168762620236,0.9,1.0,1.0,1/5,6.22%,NIPAL2
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.3407722503599185,-0.6863237103659563,0.9368421052631579,0.9999213934737275,1.0,7/51,10.20%,F3;VEGFA;CCN2;THSD4;SHROOM3;SEMA3B;FAM114A1
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),-0.44726388378229176,-0.6859094482257084,0.8734177215189873,0.9994981665768021,1.0,5/8,28.34%,PTPRD;LRFN5;GPC4;APP;EIF4G1
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),-0.44726388378229176,-0.6859094482257084,0.8734177215189873,0.9994981665768021,1.0,5/8,28.34%,PTPRD;LRFN5;GPC4;APP;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.31491465498821986,-0.685742357001788,0.94,0.9992907179533745,1.0,28/104,26.07%,CSNK1D;EPHA7;VEGFA;MYDGF;TGFB1;FGFR2;SDCBP;STK4;KRAS;HIF1A;MT3;ROCK2;LRRK2;FLT1;CAMKK2;SEMA4D;ADAM17;PAK1;CCN1;LMO4;APP;RACK1;LYN;INSR;KDR;EGFR;ABL1;KCTD20
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.4690081614004131,-0.6853761983414521,0.9342105263157895,0.9992636146237149,1.0,2/7,23.63%,CCT4;CCT8
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.44165296075884025,-0.68523865636025,0.8831168831168831,0.9986341104310671,1.0,1/6,27.17%,CYLD
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.44165296075884025,-0.68523865636025,0.8831168831168831,0.9986341104310671,1.0,1/6,27.17%,CYLD
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.4710385704352204,-0.6848770331331355,0.9027777777777778,0.9985212178637685,1.0,4/5,52.89%,KMT2A;BRCA1;HDAC5;ZNF451
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.25617531877510086,0.684778547294484,1.0,1.0,1.0,4/32,8.53%,EDN3;CDC42;NSFL1C;RHOA
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.41165704388249413,-0.6845401464107839,0.918918918918919,0.9983771248150036,1.0,3/9,24.13%,CD38;STAT6;RORA
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.45233155780712553,-0.6843979240593855,0.8309859154929577,0.9980806738408843,1.0,2/6,21.72%,TP63;BTG1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.4105043198673771,-0.683897706248232,0.9036144578313253,0.9981009970517403,1.0,2/10,15.93%,WDR43;PWP1
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.40343363031585533,-0.6834983816474313,0.9014084507042254,0.9981017722968586,1.0,3/12,20.45%,PTPN1;PTPN2;UBE2K
prerank,PanglaoDB_Augmented_2021__Basophils,-0.36027106010487664,-0.6833537155388252,0.9186046511627907,0.9978409159933219,1.0,5/31,12.05%,CD44;SNCAIP;FADS2;PDK3;ADORA2B
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.4428944859622218,-0.6827575967607308,0.8787878787878788,0.9979237631785747,1.0,2/5,22.12%,NEDD4L;STK39
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.4527199698480212,-0.682509811087987,0.7916666666666666,0.9977178040639366,1.0,2/5,21.72%,TP63;BTG1
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.4070442410336008,-0.6824540259264643,0.9027777777777778,0.9973754894154746,1.0,1/8,12.70%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.4550820996381578,-0.6814094802566045,0.9253731343283582,0.9978444125042202,1.0,1/5,5.79%,ATP1B3
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3630407004355133,-0.6813641237718874,0.85,0.9974945183278515,1.0,4/19,19.84%,PRKCI;LRRC7;LIN7A;ERBIN
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.39723040417041683,0.6804434180815886,0.8214285714285714,1.0,1.0,1/5,6.95%,PIK3CD
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,0.45878795110812376,0.6804258929483522,0.7916666666666666,1.0,1.0,1/5,2.49%,WDFY4
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),-0.3664712099579173,-0.679522460614831,0.9411764705882353,0.998812340860743,1.0,10/25,32.03%,FGFR2;FLT1;FYN;LYN;INSR;KDR;EGFR;ABL1;EPHA4;PTK2B
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.4634209905164482,-0.6790862124119091,0.8985507246376812,0.9987232682440802,1.0,2/5,3.50%,VEGFA;NOS1AP
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.34790053203823423,0.6788766501668906,0.9,1.0,1.0,2/9,11.28%,CELF1;PRKRA
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),0.38097429937863425,0.6778573341582731,0.9375,1.0,1.0,1/11,5.31%,MRPL1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.4008905494742546,-0.676830304890851,0.8735632183908046,1.0,1.0,4/18,10.35%,CSF1;VEGFA;AKIRIN1;CMKLR1
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.3690477277770034,-0.6762765096104112,0.85,1.0,1.0,2/20,3.79%,VEGFA;RHOJ
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.42949614138213965,-0.6761162335526313,0.8493150684931506,0.999965744412709,1.0,1/5,20.63%,BMP5
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.3532249999615488,-0.6760009401806825,0.8863636363636364,0.9997013867114155,1.0,7/29,20.32%,CHST11;COG7;MGAT1;GOLGA2;NPC1;CSGALNACT1;SERP1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.3532353116154446,-0.6759807425120199,0.9176470588235294,0.9993283989657726,1.0,7/41,22.79%,RHOB;C9ORF72;ROCK2;RHOBTB3;NOTCH2;PAK1;GPM6B
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.32375872055441013,0.6758272819048515,0.95,1.0,1.0,1/16,1.91%,JADE3
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.4242596561794272,-0.6754885004050968,0.7894736842105263,0.9992704167361702,1.0,2/7,21.27%,LRRK2;MAPK1
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.40969512135272323,-0.6746990885056896,0.92,0.999565915904732,1.0,4/9,19.92%,SPIDR;MT3;MTR;KCNC2
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.38152436412123036,-0.6746245442395095,0.9213483146067416,0.9992283521181208,1.0,6/24,24.11%,NFKBIA;PDCD4;IL18;CCN4;LPL;APP
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3000168354019331,0.674417699860471,0.875,1.0,1.0,6/18,16.12%,CDC42;CARMIL1;FLNA;ILK;DOCK1;NRP1
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.3944033136570869,-0.6740643461633785,0.8552631578947368,0.999341236370165,1.0,5/11,20.44%,SZT2;GGA3;RAB7A;SCARB2;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.3843985443712387,0.6737003035985875,0.875,1.0,1.0,1/6,3.37%,EDN3
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.347668931326358,0.6731904985327165,0.8571428571428571,1.0,1.0,2/11,5.57%,CNOT7;TOB1
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.4370609764175705,-0.6725093956287769,0.8767123287671232,1.0,1.0,1/5,0.74%,SOD1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.3960253427668393,-0.6712291777957476,0.922077922077922,1.0,1.0,1/12,4.96%,RHOB
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),-0.33822129376715204,-0.6707743558914575,0.9213483146067416,1.0,1.0,9/44,15.83%,SEC13;NUP153;RPA1;NUP133;NUP88;HSPH1;DNAJC7;CAMK2D;RANBP2
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.3936051047607624,-0.6703102935301526,0.8846153846153846,1.0,1.0,2/8,20.55%,HSPA5;EIF2AK4
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.2834773528922039,0.6700334805080392,0.8823529411764706,1.0,1.0,5/25,9.06%,ARHGEF10L;CDC42;EVL;RHOA;CARMIL1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.4092309271737924,-0.6695822958120519,0.8421052631578947,1.0,1.0,4/8,28.25%,PXDN;NID1;LAMB1;COL4A1
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.39422872513340035,-0.6691262190381978,0.922077922077922,1.0,1.0,3/10,23.71%,LRRK2;MTMR2;STXBP1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.4219485047298876,0.6689313596928528,0.7586206896551724,1.0,1.0,1/5,3.24%,FAM117A
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.4117203919925134,-0.6688122330821704,0.8701298701298701,1.0,1.0,1/9,2.12%,OGN
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3658871567452657,-0.6684298237765413,0.9125,1.0,1.0,5/19,23.63%,CCT4;MAP3K4;TNKS;MAPK1;CCT8
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.328657072914,-0.6680991955057043,0.9550561797752809,1.0,1.0,16/55,25.92%,PSMB1;PSMD14;SREBF1;PSMA4;PSMB2;SCD;ROCK2;SIN3A;PSMA7;AZIN1;LSS;NCOR2;PPARA;PSMA3;SREBF2;SP1
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.36482915480846473,-0.6677352840601815,0.9651162790697675,1.0,1.0,8/24,26.00%,CDC5L;STK33;DONSON;CLOCK;MDM4;TP53BP1;GRB2;ABL1
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),-0.44982339661309595,-0.667128178852567,0.9324324324324325,1.0,1.0,3/5,24.43%,SCARB1;LPL;SREBF2
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.30458292329629144,-0.6666624948451554,0.9895833333333334,1.0,1.0,31/139,20.97%,NELL1;OGN;IFIT3;MCC;TSC2;TGFB2;TGFB1;SOD2;TBRG1;NIBAN2;SMAD6;EIF2AK2;CTCF;FTH1;PTPN2;MYO16;RGCC;CDKN1B;ALDH1A2;IGFBP5;COL18A1;MDM4;APPL2;BTG2;PAK1;RAF1;SFRP4;WARS1;BMP5;ATP8A2;NF2
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.31639516134456874,-0.6665593046471275,0.9069767441860465,1.0,1.0,8/47,17.73%,PRKCI;SDCBP;PITRM1;SRP14;KIF13B;LAMP2;NACA;AP4E1
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.37567973928155907,-0.6658967131099719,0.9615384615384616,1.0,1.0,5/18,25.87%,CREM;MOV10L1;CCDC30;CCDC91;EGFR
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.32630939334759523,-0.6645392020127222,0.9690721649484536,1.0,1.0,17/79,18.16%,TMCO1;KCND2;ATP1B3;KCNQ3;SCN3A;TMEM165;SLC6A17;KCNQ1;ATP6V1H;TRPM3;SLC39A11;SLC9A9;ABCC9;KCNH7;NALCN;KCNQ5;TRPA1
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.379947134809438,-0.6638872527478626,0.9310344827586207,1.0,1.0,1/16,4.32%,OMG
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.40104991945282475,0.6635701215608385,0.8333333333333334,1.0,1.0,3/5,21.08%,SLIT2;NTN1;CHN1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3306812003655396,-0.663274753421203,0.9565217391304348,1.0,1.0,11/55,14.71%,NFKBIA;PRKCI;EIF2AK2;STAT3;PRKCB;RPS27A;IL18;TERF2IP;CLOCK;TRIM13;CLU
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.3917860568495575,0.6630626850575609,0.9032258064516129,1.0,1.0,1/5,8.26%,PCGF3
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.3229882182511096,-0.6629008696209133,0.945054945054945,1.0,1.0,15/62,17.98%,ANKH;HOMER2;SAT1;SCD;APPBP2;ELL2;SGK1;UBE2J1;MAK;UAP1;GSR;AKAP12;CAMKK2;PGM3;FKBP5
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.4365994525494334,0.6628304647925802,0.7741935483870968,1.0,1.0,1/5,2.97%,NOTCH1
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.37164619874727856,0.662312575475082,0.8461538461538461,1.0,1.0,1/7,1.86%,GRID1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.34407009671794575,0.6618507409453354,0.9285714285714286,1.0,1.0,1/8,2.84%,MFHAS1
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.4161049953650011,-0.6601825850874319,0.8857142857142857,1.0,1.0,3/8,24.67%,TGFB2;SEMA4D;BOD1L1
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.40240227473942786,-0.6595418176316865,0.9382716049382716,1.0,1.0,1/10,5.20%,TMSB4X
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.37990578985634027,-0.6594029260888432,0.8589743589743589,1.0,1.0,2/14,19.44%,ERAP1;ADAM17
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.39728401384870826,-0.6594013322158483,0.9078947368421053,1.0,1.0,3/10,16.65%,CNOT8;DCP2;PATL1
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.33715305788528954,-0.6585169339580993,0.9456521739130435,1.0,1.0,8/40,17.13%,RPS4X;DDX3X;UPF3A;PLD1;PRKDC;ROCK2;CLU;ELAVL1
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.34967770791370084,-0.6583530124464136,0.9746835443037974,1.0,1.0,6/22,24.05%,TAF1B;POLR1C;DDX21;TAF1D;ARID1A;SF3B1
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.41487334388602864,-0.6582730651477329,0.8765432098765432,1.0,1.0,4/11,33.41%,KIAA0586;ARL13B;PTCH1;GLI3
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.40544536356753214,0.6579785041350881,0.8235294117647058,1.0,1.0,1/5,4.56%,PPARD
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.4077030136562506,-0.6579301618780763,0.9367088607594937,1.0,1.0,2/9,16.17%,TGFB2;MDM4
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.3120965100510486,-0.6578368161575928,0.979381443298969,1.0,1.0,3/118,4.76%,MID1;CSNK1D;WASF1
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),-0.35064567071995556,-0.6576483031900312,0.9195402298850575,1.0,1.0,4/24,12.90%,HDAC2;MORF4L1;RCOR1;SIN3A
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.31057467607751105,-0.6575229919045189,0.9578947368421052,1.0,1.0,19/89,19.91%,CSNK1D;VEGFA;NOS1AP;MYDGF;TGFB1;DDX3X;STK4;KRAS;GOLGA2;MT3;ROCK2;TERF2IP;SYMPK;LRRK2;CAMKK2;SEMA4D;ADAM17;PAK1;CCN1
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.33808831748718415,-0.657415066419581,0.8620689655172413,1.0,1.0,4/21,22.55%,GPM6A;MYO10;NLGN1;CAPZB
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4348683847568181,-0.6571926214137979,0.9375,1.0,1.0,5/7,36.32%,CD9;LPL;SREBF2;CD81;ABCA1
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.32547315433854024,-0.6571774088185895,0.9666666666666667,1.0,1.0,7/64,10.07%,CSNK1G2;LPIN1;MGST1;SPTLC3;ALDH3A2;LPCAT3;SPTLC1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.3132741740019503,-0.65696973768534,0.9782608695652174,1.0,1.0,3/73,2.53%,ADAMTS9;GJA1;IGFBP2
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.4053827494328349,-0.6566637254621301,0.9178082191780822,1.0,1.0,5/9,40.94%,MED14;PSMC6;PAXIP1;SUB1;DHX36
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.31735444829307574,-0.6559815297398189,0.9782608695652174,1.0,1.0,8/57,16.11%,SLC23A2;KAZN;ALCAM;SEMA3B;ARNT2;TEAD1;GFAP;FMNL2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.3634135008523288,-0.655072446865289,0.9390243902439024,1.0,1.0,5/28,13.49%,PGK1;TGFB2;NIBAN2;ROCK2;RGCC
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.3764975849602854,-0.6549302835664105,0.8961038961038961,1.0,1.0,1/13,12.70%,TERF2IP
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.32153335088919077,0.6544945754001481,0.8095238095238095,1.0,1.0,1/11,6.16%,CHMP4B
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.4127960981092397,-0.6542397176407825,0.9259259259259259,1.0,1.0,2/10,11.53%,SMCHD1;PRKDC
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.34638495751495557,0.6541702689939898,0.9130434782608695,1.0,1.0,3/5,20.68%,ANTXR1;SLC22A3;ANTXR2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.3517026824301492,-0.6540857276777131,0.9,1.0,1.0,5/21,23.63%,CCT4;MAP3K4;TNKS;MAPK1;CCT8
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.42060861310212155,-0.6534838638866695,0.8918918918918919,0.9992811214505372,1.0,3/7,22.54%,MLPH;RAB27A;RAB11A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.42060861310212155,-0.6534838638866695,0.8918918918918919,0.9992811214505372,1.0,3/7,22.54%,MLPH;RAB27A;RAB11A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.42060861310212155,-0.6534838638866695,0.8918918918918919,0.9992811214505372,1.0,3/7,22.54%,MLPH;RAB27A;RAB11A
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.42060861310212155,-0.6534838638866695,0.8918918918918919,0.9992811214505372,1.0,3/7,22.54%,MLPH;RAB27A;RAB11A
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.3487475268987014,-0.6533300717765472,0.9186046511627907,0.9990142832026381,1.0,6/32,21.30%,TPT1;SLC3A2;MT3;NDFIP2;NDFIP1;FYN
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),-0.3142976200608725,-0.6526106468797329,0.9545454545454546,0.9991825547116694,1.0,5/42,13.80%,ATP6V1E1;ATP6V1G1;ATP6V1H;PTPN2;ATP6V1D
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.36990041760359793,0.6520998772826608,0.782608695652174,1.0,1.0,8/8,63.06%,RB1;PHF8;AKAP8L;MCPH1;TENT4A;CSNK2A1;TTN;CSNK2A2
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.3239936829637663,-0.6519487591087951,0.9222222222222223,0.9993087501891548,1.0,9/38,31.75%,NUP153;SRSF5;THOC2;SIDT1;NCBP1;YBX1;KIF5C;SRSF2;TGFBR2
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.44275189152391325,-0.651636525570262,0.9459459459459459,0.9991984999066932,1.0,1/5,9.56%,KCNQ1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.4042070562632843,-0.651574567436033,0.9102564102564102,0.9988825567749003,1.0,2/9,15.43%,SPG7;PMPCB
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.3121478392708927,-0.651434923328823,0.989247311827957,0.9986049442133246,1.0,22/83,23.87%,MTMR9;ATP1B3;COG7;NAPG;TBRG1;STK4;CCT4;CCNH;MT3;CLU;PPARGC1A;PLPP3;MDM4;NAA15;LAMP2;UBE2B;PPIB;ZSWIM7;RPL5;GNAQ;CCT8;STX12
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.39128165959872463,-0.6513961194623595,0.95,0.9982437694565087,1.0,2/13,8.63%,BACH2;CD38
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.3168847842068465,0.6513698852362538,0.9047619047619048,1.0,1.0,2/14,7.17%,TTL;SMOC2
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.4141858148745081,-0.6513000507068737,0.92,0.9979551877075389,1.0,1/10,0.93%,TBC1D20
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.4237415750856165,-0.6511689762235823,0.922077922077922,0.9976858479760732,1.0,2/6,38.47%,PARG;HNRNPU
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.38533291947688864,-0.6508811020776675,0.9605263157894737,0.9975574403182095,1.0,3/12,21.11%,NPC1;HSD17B4;AKR1C1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.3543467000225513,-0.6506586901620415,0.8809523809523809,0.9973302757058254,1.0,3/23,13.88%,BASP1;PLP1;HSPA5
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.3377350954047913,-0.6505203600590748,0.9340659340659341,0.9970576744441119,1.0,6/36,22.75%,TGFB1;SMAD6;TGFBR1;NCOR2;SMURF2;JUNB
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.4233205407421613,-0.6502384484285665,0.8904109589041096,0.9968650614686049,1.0,2/6,14.71%,SOD2;CLU
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.342531910011448,-0.650033635037352,0.9111111111111111,0.9966156267062642,1.0,8/24,31.68%,CCP110;RBBP7;YAF2;EED;TOM1L1;TERF1;APAF1;TFDP2
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.27115372825224465,0.6495995183560729,1.0,1.0,1.0,9/27,16.12%,CDC42;ACTN4;CARMIL1;FLNA;CORO1C;ILK;PTK2;DOCK1;NRP1
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.36413606117902353,0.6491404582695612,0.9117647058823529,1.0,1.0,1/5,8.63%,NFE2L1
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.3457639815034307,0.649139870942501,0.896551724137931,1.0,1.0,3/13,10.78%,ATM;WNT5B;CREB1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.38802790200797327,-0.647761450484115,0.9166666666666666,0.9977672313543574,1.0,3/12,26.00%,STMN1;CLASP2;ABL1
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.3156482400793386,-0.6476385410333145,0.9887640449438202,0.9974796958834092,1.0,11/56,20.69%,TBC1D20;MTMR9;RGS7;MMUT;AFDN;ZC3H15;USP6NL;SEMA4D;WRN;PKP4;LARS1
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.39900967843037277,-0.646853053799648,0.9090909090909091,0.9976817372843072,1.0,3/9,16.65%,CNOT8;DCP2;PATL1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.32999727224009134,0.6468481333322449,0.9285714285714286,1.0,1.0,2/13,5.57%,CNOT7;TOB1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.3714244100773765,0.6467511994041307,0.8846153846153846,1.0,1.0,3/7,11.57%,DNAI4;DNAH11;DNAH9
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.3119704880099144,0.6466107468188097,0.9411764705882353,1.0,1.0,3/13,11.41%,TIPRL;SMG1;MAPKAP1
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.34967868111567474,0.6458436128628725,0.9666666666666667,1.0,1.0,1/5,6.77%,BCL2
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.4138083979481906,-0.6457686846151892,0.875,0.9981035671520676,1.0,1/6,16.03%,GFAP
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.3542966855891021,0.6442306221383415,0.9166666666666666,1.0,1.0,2/8,9.35%,AKT3;HMGB1
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.4144313212337906,-0.6441103431814662,0.9315068493150684,0.9989079359610599,1.0,1/5,8.82%,LPCAT3
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.32956756341718096,-0.643983137092611,0.9318181818181818,0.9986241932567556,1.0,10/34,27.85%,PSMD14;XRCC4;PRKDC;POLA1;RNF168;TP53BP1;UIMC1;BRCC3;UVRAG;KDM2A
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.4072931985831328,-0.6432377509770338,0.9459459459459459,0.9988255025005568,1.0,1/8,13.38%,DNMT1
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.31065343775075027,-0.6429821356194046,0.9230769230769231,0.9986177311196309,1.0,8/58,19.68%,WIPI1;PLAA;LIX1L;ATG4B;LAMP2;VPS39;PRKAG2;GABARAPL1
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.36432241490044964,0.6418358841341864,0.8275862068965517,1.0,1.0,6/6,63.60%,ACACA;MLYCD;ACSS1;ACAT1;ACACB;DIP2A
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.3863238046929719,-0.6414851854214475,0.9651162790697675,0.9992693030822338,1.0,2/12,13.59%,LPCAT3;PLAAT3
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.37598330390110773,0.6412967796370898,0.9,1.0,1.0,5/5,62.43%,TPR;GAS6;AXL;IFNAR1;RO60
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.3898620169836398,-0.6407068875244714,0.9452054794520548,0.9994436596714571,1.0,1/9,7.35%,DDX3X
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.2879635831535557,0.6402924320541332,0.875,1.0,1.0,3/16,9.24%,SERPINH1;SERPINI1;HDAC1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.3925154229461737,-0.6399322550363559,0.8765432098765432,0.9996254499724032,1.0,3/10,39.33%,DNM3;DNM1;PRKN
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.3022645656987822,-0.6393636751754678,0.968421052631579,0.9996067261467967,1.0,15/73,25.91%,MPZL1;JAM3;NECTIN2;LIMA1;FBN1;SYMPK;VCAN;TSPAN4;NF2;ITGA9;CADM2;NEGR1;PIK3CB;EGFR;IRS1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.36028091567289533,-0.6391554341836353,0.8902439024390244,0.9993574788095337,1.0,3/16,21.27%,MAP3K4;TNKS;MAPK1
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.3204238452949846,0.6383753949878186,0.8571428571428571,1.0,1.0,3/9,8.28%,CACNA1C;CAP2;GRM3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.3426033990473681,-0.6381345227514009,0.8977272727272727,0.9997166582293784,1.0,1/27,5.71%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.34454238219758515,0.6368112631550081,0.9565217391304348,1.0,1.0,1/9,2.82%,AATF
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.3982021048638998,-0.6367091458343872,0.922077922077922,1.0,1.0,3/10,14.89%,TGFB1;GALNT11;NOTCH2
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.39922435370200937,-0.6360869183214635,0.9512195121951219,1.0,1.0,3/8,26.00%,LGALS3;PAG1;ABL1
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.4306413341013968,-0.636058585564026,0.9130434782608695,1.0,1.0,2/5,10.09%,ROBO1;HIF1A
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.39331321086808535,-0.6357489778307169,0.8780487804878049,0.9999020795669286,1.0,6/8,36.32%,SCARB1;LPL;PPARA;SREBF2;NR1H3;ABCA1
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.4376982195463145,-0.635380112319267,0.9565217391304348,0.9998380513344695,1.0,2/5,22.12%,SLC12A6;STK39
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.36757240679314845,-0.6332366423980839,0.9230769230769231,1.0,1.0,5/13,30.11%,RPS27A;ALPK1;MAP2K6;CYLD;TAB2
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.36823428698598165,-0.633041658908783,0.9240506329113924,1.0,1.0,4/11,20.44%,ANK3;ZC4H2;LRRK2;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.3401040562839217,-0.6314923188208509,0.9325842696629213,1.0,1.0,10/36,28.63%,SMCHD1;RGCC;WRN;RNF168;UIMC1;EYA2;EYA1;EGFR;BRCC3;POT1
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.3845264832326082,-0.6312457199963412,0.9186046511627907,1.0,1.0,4/10,44.90%,IHO1;CSNK2A2;CSNK2A1;ZNF207
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.3746076995201179,-0.6305075227776891,0.9367088607594937,1.0,1.0,3/12,14.45%,KCNQ1;MYL3;CAMK2D
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),-0.41724134298161997,-0.6303501027793067,0.9166666666666666,1.0,1.0,3/5,19.92%,MT3;MTR;KCNC2
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),-0.41724134298161997,-0.6303501027793067,0.9166666666666666,1.0,1.0,3/5,19.92%,MT3;MTR;KCNC2
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),-0.41724134298161997,-0.6303501027793067,0.9166666666666666,1.0,1.0,3/5,19.92%,MT3;MTR;KCNC2
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.3039215080297548,-0.6300804986740396,0.9555555555555556,0.9998878045294386,1.0,9/46,21.22%,NKD1;NEDD4L;CDKN1B;RAB7A;WWP1;NSF;NEDD4;HECW1;SMURF2
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.3924247290936932,-0.629931521615649,0.927710843373494,0.9996136380136137,1.0,2/9,16.17%,TGFB2;MDM4
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.3508939486536397,-0.6297238605474843,0.9325842696629213,0.9993734741150334,1.0,10/22,40.30%,GLUL;RPL35A;RPL5;RPL11;RPS24;WDR12;RPL14;RPS16;RPS6;RPS28
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.4210007904272158,-0.6284352264365416,0.9428571428571428,0.9995503917627306,1.0,1/5,25.97%,CLASP2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.4210007904272158,-0.6284352264365416,0.9428571428571428,0.9995503917627306,1.0,1/5,25.97%,CLASP2
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.36604826883558733,0.6278968234520279,0.8571428571428571,1.0,1.0,1/5,2.50%,CDK6
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.372389660570385,-0.627217267895064,0.925,1.0,1.0,2/14,19.59%,FGFR2;PKP4
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.3484117907439159,-0.6263387658783587,0.9647058823529412,1.0,1.0,4/20,16.71%,PANK2;GMPS;DCAKD;PAPSS1
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.3322387567863043,-0.6263353704278786,0.925,0.999918358319253,1.0,8/27,28.60%,PARVB;TMEFF2;MICALL2;ATRNL1;FN1;LAMB1;ITGAV;RADIL
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.42356509143187554,-0.6254077486361792,0.9365079365079365,1.0,1.0,3/5,42.70%,JAM2;MIA3;SLC8B1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),-0.412499814518941,-0.6242585428680071,0.958904109589041,1.0,1.0,3/7,32.23%,PPARGC1A;POR;ETFDH
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.3067751683083064,-0.6242337428040796,0.967391304347826,1.0,1.0,5/49,9.91%,ANK3;LGALS3;PRKCI;CEMIP;TP63
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.3958928997701085,0.6233502069700293,0.8461538461538461,1.0,1.0,1/6,6.16%,CHMP4B
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.2930111137889869,-0.6233384315048371,0.98,1.0,1.0,26/101,26.21%,RPS4X;RBM4B;DDX3X;UPF3A;EIF2AK2;PLD1;GIGYF2;PRKDC;CNOT8;IGF2BP2;ETF1;RPL13A;IGFBP5;ELAVL1;CSDE1;PUM3;BTG2;EIF2AK4;METAP1;RPL5;NEMF;APP;EPRS1;RACK1;CNOT1;EIF2A
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.3729966336378007,-0.6232904814815587,0.9629629629629629,1.0,1.0,7/13,37.91%,PARP1;WDR48;TP53BP1;MRNIP;SHLD2;ARID2;PAXIP1
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),-0.3267546214033891,-0.6229731752787668,0.9135802469135802,0.9998215314003988,1.0,1/15,6.16%,GPM6A
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),-0.3644908098880797,-0.6223204414344157,0.9736842105263158,0.999859024011605,1.0,4/16,21.09%,SYNDIG1;PTPRD;NAP1L1;NLGN1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.25399831541461554,0.621507321664798,1.0,1.0,1.0,3/30,8.53%,INPP5F;PIK3CD;RHOA
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.31872990047478184,-0.6213820128395937,0.9759036144578314,1.0,1.0,2/37,5.71%,NRG1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.3573156893416048,-0.6211985038600893,0.9431818181818182,0.9997433912739497,1.0,4/17,20.56%,SDCBP;MT3;LRPAP1;MTMR2
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.38573408682826515,-0.6206295562565324,0.9342105263157895,0.9997397906495722,1.0,2/9,16.17%,TGFB2;MDM4
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.37485270764925316,-0.6202649728400432,0.9324324324324325,0.9996316626787726,1.0,1/7,9.62%,FTH1
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.32131340188743623,-0.6198808084895082,0.9333333333333333,0.9994713688991842,1.0,9/35,32.10%,INTS8;ELL2;INTS4;INTS2;CCNK;SP1;NCBP1;POLR2F;GTF2E2
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.38620591854894315,-0.6183818181004513,0.8378378378378378,1.0,1.0,2/7,26.74%,DUSP1;DUSP16
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.38120855129629794,-0.6182891846325583,0.925,0.9997142274937751,1.0,4/10,29.19%,PARP1;TNKS;POT1;TERF1
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.30400440870404405,0.6178751313532621,0.9230769230769231,1.0,1.0,1/13,1.41%,LRCH1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.38320550330285996,-0.616642886315173,0.975609756097561,1.0,1.0,6/10,31.58%,UBE2L3;DCUN1D4;ABL1;RPS2;DCUN1D2;DCUN1D1
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.34821909500887566,-0.6166318209595246,0.881578947368421,1.0,1.0,4/13,35.74%,PRKAG2;PPARA;SORBS1;MTOR
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.3229315360944937,-0.6160561023084211,0.9438202247191011,0.9999418828973927,1.0,9/34,32.10%,INTS8;ELL2;INTS4;INTS2;CCNK;SP1;NCBP1;POLR2F;GTF2E2
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.4140699003528657,-0.6155971319051398,0.9242424242424242,0.9998190650958401,1.0,2/5,32.85%,RACK1;SAMD8
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.3597955985682446,0.6154318135304576,0.9,1.0,1.0,1/8,2.01%,NOTCH3
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.321181949574434,0.6150430437006196,0.9259259259259259,1.0,1.0,7/7,67.92%,SAR1B;SAR1A;TM9SF4;GCC2;SEC16A;TMEM30A;CD81
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.3378228311166123,-0.6147005556014199,1.0,0.999968059148766,1.0,5/21,30.11%,RPS27A;ADORA2B;MINK1;MAPK9;TAB2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.3977151068430246,-0.6144360792041318,0.9305555555555556,0.9997857887512016,1.0,3/9,22.49%,DDX3X;BMP5;RNF34
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.32574712288821966,-0.6140746326268403,0.9759036144578314,0.9996148109812443,1.0,6/28,17.12%,ATP1B3;SCN3A;SLC6A17;NEDD4L;SGK1;NALCN
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.2788906784682646,0.6140687306119753,0.9523809523809523,1.0,1.0,1/17,1.68%,USP16
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.40332575134460336,-0.613547360996209,0.9333333333333333,0.999548065878275,1.0,2/7,12.95%,ALDH3A2;PMP22
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.3730763280435082,0.6130955072519463,0.8461538461538461,1.0,1.0,2/7,5.97%,ARPC5;IQGAP2
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.35326849932485305,-0.6121104185541469,0.9651162790697675,1.0,1.0,2/11,15.08%,HDGFL3;NAV3
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.32593427393199614,-0.6120940255788717,0.9080459770114943,0.9996859446344804,1.0,11/27,32.55%,SMCHD1;RNF168;UIMC1;EYA2;EYA1;EGFR;BRCC3;TRIP12;PARG;UBR5;NPAS2
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.39080620581690856,-0.611077494609539,0.96,0.9997900909715978,1.0,2/8,15.70%,GRIN1;LRRK2
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.34969558145887664,-0.6109313684009027,0.9746835443037974,0.9995191846696884,1.0,2/19,6.18%,HDAC2;NKD1
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.36972226681650355,0.6108971955837741,0.8823529411764706,1.0,1.0,5/5,63.06%,TPR;NUMA1;CSNK2A1;PLSCR1;CSNK2A2
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),-0.36984459089664296,-0.6101635508222721,0.8860759493670886,0.9995676466895251,1.0,4/10,39.04%,FLT1;ABL1;FGFR1;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.37211383715831403,-0.6101557304544895,0.961038961038961,0.999207983270686,1.0,2/8,19.33%,FBN1;APPL2
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.2978738063320702,-0.6099764647835738,0.9894736842105263,0.998904212108002,1.0,10/62,15.70%,WASF1;MIGA1;AGTPBP1;SPG7;PITRM1;SLC25A36;CHCHD2;PARP1;PPARGC1A;LRRK2
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.29206784537101405,-0.6099140358972481,0.9887640449438202,0.9985821279726017,1.0,4/65,8.44%,PIGL;DPM1;MTMR9;PIGG
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3423215395501667,0.60953729524038,0.8787878787878788,1.0,1.0,1/6,6.71%,KLF7
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.37315588146491696,-0.6087599973495321,0.9487179487179487,0.9988235655227283,1.0,3/11,23.55%,TGFB1;PID1;TMEM59
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.3875049648773716,-0.6072310610649747,0.9605263157894737,0.9992611626953143,1.0,2/9,15.70%,GRIN1;LRRK2
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.3115484732242876,0.6070127256875932,0.9130434782608695,1.0,1.0,1/10,3.19%,TPM2
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.3115484732242876,0.6070127256875932,0.9130434782608695,1.0,1.0,1/10,3.19%,TPM2
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.3771429418358098,-0.6068310809941846,0.8961038961038961,0.9990837231226096,1.0,2/9,24.11%,BORCS5;APP
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.3048804831791077,-0.6056829875039295,1.0,0.9993839394743935,1.0,12/48,26.77%,CCN2;TMEFF2;STMN1;TGFBR1;ROCK2;RGCC;ARHGAP28;PAK1;NF2;CLASP2;ABL1;LPAR1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.3531069630694605,-0.6054495704042433,0.9302325581395349,0.9991214758338046,1.0,2/13,19.33%,RAB27A;APPL2
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.335452551583315,-0.6047927343478632,0.9871794871794872,0.9991107391327091,1.0,3/16,21.88%,ALDH1A2;HSD17B4;LPL
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.29546986446254414,-0.6046645698661133,0.9690721649484536,0.9988115907709161,1.0,14/67,21.83%,CSF1;VEGFA;TGFB2;DDX3X;PTPN1;STK4;CLU;STRADB;PRKAG2;MTCP1;PAK1;CCN1;TAOK3;MINK1
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.36514142688050694,-0.6043223046397337,0.9620253164556962,0.9982767652347072,1.0,2/7,23.34%,STAT3;GRB2
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.36514142688050694,-0.6043223046397337,0.9620253164556962,0.9982767652347072,1.0,2/7,23.34%,STAT3;GRB2
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.3284862031915072,-0.6039953578832151,0.9753086419753086,0.9980779779482541,1.0,7/32,31.65%,STK4;AMFR;LRRK2;APP;ABL1;RPL11;NMD3
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.2939286861548346,0.6036576383808342,0.9230769230769231,1.0,1.0,8/8,70.64%,PALLD;NEXN;CNTN4;DSCAM;NPTN;CNTN6;DSCAML1;BSG
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.3691001757290889,-0.6030720815517419,0.9487179487179487,0.9983187173165543,1.0,1/9,13.38%,DNMT1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.3457258315556225,-0.6030075893120137,0.9506172839506173,0.9979724227150416,1.0,4/15,35.60%,NAP1L1;NASP;ANP32B;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.3133951780121737,-0.6022583336779863,0.9782608695652174,0.9979732018816643,1.0,5/33,13.49%,VEGFA;TMSB4X;TGFB1;HIF1A;RGCC
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.3389344681868999,-0.602183608739015,0.987012987012987,0.9976346627609212,1.0,4/16,29.76%,PARVB;ARHGEF4;GOLPH3;ABLIM1
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.3465751389757893,0.6015114837696363,0.9310344827586207,1.0,1.0,2/5,11.21%,OSBPL11;OSBPL8
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.3472356895648628,-0.6011547383455491,0.9886363636363636,0.9977498582188113,1.0,6/19,27.45%,DONSON;NAE1;TAOK3;UIMC1;MRNIP;BRCC3
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.34700921458699774,-0.6011134566741582,0.9629629629629629,0.9973932198747659,1.0,4/20,17.74%,ZC3H7A;ZC3H7B;CNOT8;AGO2
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.3624979932573447,0.5999297766109294,0.9696969696969697,1.0,1.0,5/5,63.78%,MAPK14;CFLAR;FLOT1;RIPOR2;EHD2
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.375952110806873,-0.5998884630032026,0.9436619718309859,0.9975821033792918,1.0,1/7,12.67%,ROCK2
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.3700197334103878,-0.5998067931341216,0.9342105263157895,0.9972773462353414,1.0,2/9,23.56%,KDM3A;ARID1A
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.3939530810113111,-0.5994725613642945,0.9545454545454546,0.9970538045590962,1.0,1/7,5.79%,ATP1B3
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.28660930934115375,0.5991904689165986,1.0,1.0,1.0,4/15,12.85%,MRPL1;MRPL33;MRPL3;GSPT1
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.36278997382502565,-0.5989502499902345,0.961038961038961,0.996955551682702,1.0,5/13,30.11%,RPS27A;MAP2K6;RNF34;CYLD;TAB2
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.32113037893384716,0.5981180722433438,0.92,1.0,1.0,6/6,67.92%,SAR1B;SAR1A;TM9SF4;SEC16A;TMEM30A;CD81
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.4053602911500989,-0.5974109642773239,0.9130434782608695,0.9973540129782335,1.0,2/5,49.10%,ATL3;TMEM33
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.3459685191133954,0.5973222303321122,0.9615384615384616,1.0,1.0,8/8,65.45%,GNL3L;SAE1;HDAC4;EGR1;CTNNB1;ZMIZ1;PIAS1;UBA2
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.4035626569937236,-0.5970140536100815,0.918918918918919,0.9971968824315843,1.0,2/5,35.00%,RNF168;HSPD1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.2834885962094442,0.5966236909631059,0.9259259259259259,1.0,1.0,8/8,71.69%,KCNB1;RPTOR;PRKAA1;RPS6KB1;PRKAA2;ULK1;MTOR;EIF4G1
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.288995983935743,0.5964223248288304,0.9583333333333334,1.0,1.0,9/9,71.14%,MAP2;GBA2;PTEN;ARHGAP35;RAPGEF2;HSP90AA1;NTRK2;B4GALT5;HSP90AB1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.2920698349145213,0.5955305515054129,1.0,1.0,1.0,4/20,11.10%,ADGRA2;MYH9;RHOA;PTP4A3
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.3335937967524385,-0.595435646593713,0.8961038961038961,0.9975839374355855,1.0,8/20,29.19%,CCT4;MAP3K4;TNKS;MAPK1;PARP4;POT1;HSP90AB1;TERF1
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.33172690763052226,0.5949804997625299,0.84,1.0,1.0,9/9,66.88%,HMGB1;KPNB1;EXOG;CECR2;ACIN1;GPER1;DICER1;BLCAP;KPNA1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.3906071516157008,-0.5945984013089168,0.9130434782608695,0.9976142533585589,1.0,2/6,22.12%,NEDD4L;STK39
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),-0.3130470200680807,-0.5944569718042153,1.0,0.9973249542016664,1.0,4/27,12.90%,HDAC2;MORF4L1;RCOR1;SIN3A
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.34470044911339903,-0.5914747740575872,0.9518072289156626,0.9986920040250585,1.0,2/13,15.08%,HDGFL3;NAV3
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.2759634292446708,0.5878234223838932,0.96,1.0,1.0,3/14,12.96%,OSBPL6;AKR1C3;CYP27A1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.32057087397313083,-0.5875555557837567,0.975609756097561,1.0,1.0,2/19,9.02%,TGFB1;STAT3
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.35436410613719577,0.5872608043720321,0.9142857142857143,1.0,1.0,1/5,6.71%,KLF7
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.3111903782550535,-0.5866163263691347,0.9764705882352941,1.0,1.0,8/27,28.89%,CCT4;RGCC;MAP3K4;TNKS;MAPK1;CCT8;POT1;HSP90AB1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.3316736267266302,0.5853430558369594,0.8636363636363636,1.0,1.0,8/8,66.88%,HMGB1;KPNB1;FBH1;DNASE1;EXOG;CECR2;DICER1;KPNA1
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.34110940893802366,0.5848051143844828,0.8888888888888888,1.0,1.0,1/6,9.35%,HMGB1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.3181603436645304,-0.5837067491595143,0.9473684210526315,1.0,1.0,2/19,17.13%,PABPC1;ELAVL1
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.37044588922335153,-0.5828972093386322,0.9264705882352942,1.0,1.0,3/6,28.22%,CFL1;MICAL3;GSN
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.2996642667859817,-0.5824891004844979,0.975609756097561,1.0,1.0,15/33,34.15%,ITGA5;PLPP3;ERBIN;ABL1;FN1;ITGAV;ADAM9;NEDD9;PTN;FBLN1;COL3A1;DST;PTK2B;CD47;PTPRA
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.2688724702858977,0.5822762222995539,0.95,1.0,1.0,8/8,73.15%,HIP1;PICALM;CLTA;FCHO2;CLTC;PIK3C2A;EPS15;SGIP1
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),-0.3638923917603314,-0.580617808910433,0.9552238805970149,1.0,1.0,1/7,6.32%,NUP133
prerank,MSigDB_Hallmark_2020__Apical Surface,0.2643499550113367,0.5803033047681845,0.95,1.0,1.0,2/14,8.55%,AFAP1L2;HSPB1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.31834428269713677,0.5798962906061129,0.9032258064516129,1.0,1.0,2/8,9.22%,INPP5F;PPP2R1A
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),0.3638407193320489,0.5798542644401412,0.96,1.0,1.0,6/6,63.65%,ZCCHC17;NAF1;TENT2;NRDE2;FMR1;SLIRP
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.3381724369450234,-0.5795119714355704,0.9102564102564102,1.0,1.0,4/14,31.10%,ZRANB3;WRN;POT1;ASCC3
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.3606597064385745,-0.5779442987701664,0.9852941176470589,1.0,1.0,1/8,8.39%,CTR9
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.31042235426369025,0.5772253331246274,0.96,1.0,1.0,7/7,68.99%,MBNL3;PTBP1;RPL8;EIF3B;TRAP1;CCT3;LAS1L
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),-0.3094875914880645,-0.5770175110512302,0.987012987012987,1.0,1.0,9/20,36.43%,DCDC2;MINK1;FARP1;CTNNA2;PTN;TMEM106B;PAK3;BTBD3;DIP2A
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.35381642240338157,-0.5767747372411854,0.935064935064935,1.0,1.0,1/6,13.88%,HSPA5
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.26490811148136345,0.5764779773072103,1.0,1.0,1.0,6/20,17.10%,CDC42;RHOT1;NDE1;TRAK1;DYNC1I1;UBB
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.3401255916985876,-0.5759203027119698,0.9634146341463414,1.0,1.0,2/10,32.19%,CLASP2;CASK
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.3602905519287307,-0.5757092816487821,0.9518072289156626,1.0,1.0,3/8,26.82%,PARP1;WDR48;MRNIP
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),0.37845393029923863,0.5745832844500217,0.9393939393939394,1.0,1.0,1/5,7.11%,HLA-E
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.2964387708273415,-0.5739932365444482,0.9761904761904762,1.0,1.0,10/38,28.60%,PARVB;TMEFF2;MICALL2;RILPL1;ATRNL1;ARL13B;FN1;LAMB1;ITGAV;RADIL
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.37599198380895926,-0.5737271091927381,0.9642857142857143,1.0,1.0,1/7,14.13%,CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3374892228953968,-0.5720123476356791,0.9873417721518988,1.0,1.0,5/13,28.52%,NOTCH2;ERBIN;GRB2;LYN;ITGAV
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.3817700433576642,-0.5716495707539643,0.9859154929577465,1.0,1.0,2/6,25.84%,ROCK2;GCLC
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.3817700433576642,-0.5716495707539643,0.9859154929577465,1.0,1.0,2/6,25.84%,ROCK2;GCLC
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.3365153567451927,-0.5708772683656126,0.9487179487179487,1.0,1.0,4/11,30.72%,XRCC4;BRCC3;IKBIP;XRCC6
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.29937037814150314,0.5706474351857023,0.9,1.0,1.0,2/11,7.11%,CD4;HLA-E
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.33657956207222295,0.5704597709451246,1.0,1.0,1.0,4/7,13.88%,SLIT2;HMGB1;ANO6;NBL1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.32092671621346747,0.5695556283684473,0.96875,1.0,1.0,2/7,9.22%,INPP5F;PPP2R1A
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.26537844227775503,0.5693325247498374,1.0,0.999367286342877,1.0,2/17,6.56%,PHC1;RYBP
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.26537844227775503,0.5693325247498374,1.0,0.999367286342877,1.0,2/17,6.56%,PHC1;RYBP
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.3973758624663197,-0.5682465316904146,0.9577464788732394,1.0,1.0,1/5,15.93%,PWP1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.35470594054418436,-0.5681342886506788,0.9452054794520548,1.0,1.0,1/8,15.77%,ACSL4
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.3205044993014378,-0.5676913602535691,0.987012987012987,1.0,1.0,6/11,45.30%,OTUD7A;MINDY2;USP25;USP8;USP37;USP34
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.3417937225111287,-0.5672324728494426,0.972972972972973,1.0,1.0,3/12,25.26%,RGCC;ANAPC4;INSR
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.33847482887121544,-0.5670675866087747,0.9629629629629629,1.0,1.0,2/11,16.92%,LIMA1;PAWR
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.32407353047748977,-0.5650602815975946,0.9294117647058824,1.0,1.0,5/15,27.45%,DONSON;TAOK3;UIMC1;MRNIP;BRCC3
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),-0.32459607795503886,-0.5650084597214139,0.948051948051948,1.0,1.0,3/12,23.29%,USP6NL;MAPK1;PDE4DIP
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.29268440171856097,-0.5647714357999851,1.0,1.0,1.0,10/35,33.78%,EXOC1;MYO16;GAB2;PIK3CB;IRS1;NF1;PLCL1;PLEKHA1;PI4KB;NGF
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.32262349584246314,-0.5629373940179033,0.9733333333333334,1.0,1.0,4/11,26.72%,ACADL;BMP5;WDTC1;ACADVL
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.3610345164274812,-0.562906807990608,0.9285714285714286,1.0,1.0,2/7,35.74%,CLASP2;MTOR
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.3703233147088748,-0.5621217053770414,0.8904109589041096,1.0,1.0,1/5,12.98%,AKR1C2
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.38727458991338426,-0.5620498497795486,0.96,1.0,1.0,2/5,24.51%,LPL;LMF1
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.3344269005145414,0.5620189150048305,0.875,1.0,1.0,1/6,5.65%,VIT
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.2946789567492185,0.561703307274514,1.0,1.0,1.0,2/8,13.14%,FLNA;PHACTR4
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.28884477580915763,0.5616836081548913,0.9411764705882353,0.9994092434523049,1.0,2/16,9.91%,DLC1;ACTN1
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.2886012651402716,0.5611895837405421,0.95,0.9982150287537209,1.0,1/9,3.37%,EDN3
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.3794551150422937,-0.5604641202504326,0.96875,1.0,1.0,3/6,39.08%,EGFR;MVB12B;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.3517806362375091,-0.5603795437577017,0.9615384615384616,1.0,1.0,1/8,9.35%,CEMIP
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.28941419618602876,0.5603319280438841,0.9523809523809523,0.9971786020262762,1.0,3/18,8.90%,TNIP1;MAPKBP1;PPM1A
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.26660358136078205,-0.5592632607227499,1.0,1.0,1.0,9/69,15.99%,F3;SVEP1;C1R;FAM114A1;MATN2;GBP2;C1S;PLPP3;IGFBP5
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.3284085434398588,0.5561536811341501,0.9615384615384616,0.9981341817083614,1.0,7/7,67.20%,PTK2;PKD1;PKD2;CTNNB1;JUP;TTN;CDH2
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.3400604287410065,-0.5540721626094943,0.95,1.0,1.0,2/10,16.92%,LIMA1;PAWR
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.29769993445270826,-0.5518113238198914,0.9583333333333334,1.0,1.0,3/18,14.31%,SDCBP;WAC;UCHL5
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.3631477553027169,-0.5514808192580903,0.9459459459459459,1.0,1.0,2/7,20.23%,RIMS2;SNX19
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.326260775263636,-0.5507840340396969,0.9324324324324325,1.0,1.0,2/8,28.65%,SIDT1;YBX1
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.3294451298065494,0.5497666643686882,0.9310344827586207,1.0,1.0,1/6,3.55%,ITGA3
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.32671873054418016,-0.5496108781138724,0.96,1.0,1.0,4/9,40.73%,PRKAG2;SGPP1;ABCD3;PLEKHA8
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.31920180382776,0.5494095653485405,0.8666666666666667,0.9988219466431578,1.0,1/6,5.20%,VPS35
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.2683008959304712,-0.5491106993940253,1.0,1.0,1.0,7/43,27.49%,DIAPH1;USP6NL;SCARB2;MAPK1;PDE4DIP;GOLPH3;RDX
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.3092943912105881,0.5490458733713519,0.9473684210526315,0.9975954127838434,1.0,1/6,5.50%,MYH9
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.336854851111856,-0.5486855885071275,0.9696969696969697,1.0,1.0,1/7,25.97%,CLASP2
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.32400718965683806,-0.5478661546095112,0.9506172839506173,1.0,1.0,2/12,22.54%,RAB27A;RAB11A
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.3017483236316827,0.5473942344041237,1.0,0.9969294635066411,1.0,2/10,8.15%,MAP2K2;SNX3
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.2863337080456078,0.5454645009879733,0.9545454545454546,0.9964879310400466,1.0,7/7,71.40%,MSH2;MSH6;MSH3;SIRT1;SSBP1;CHTOP;POT1
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.28939697676208376,-0.5448548816673663,0.9767441860465116,1.0,1.0,4/26,20.58%,PTPRD;PRKDC;P4HB;TRIOBP
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.2937306910931739,-0.5445953278415712,0.9594594594594594,1.0,1.0,8/16,33.72%,PLP1;PMP22;MBP;EPB41L3;NF1;ACER3;B4GALT5;SBF2
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.29342448281022526,-0.5434276414666418,0.9625,1.0,1.0,3/17,23.13%,ROCK2;GPM6B;SLK
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.30606199625897856,0.5423451513028621,0.9473684210526315,0.9967280635662384,1.0,1/9,2.12%,CNOT7
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.3456968529222864,0.5422948404107218,0.9230769230769231,0.9953313798843902,1.0,6/6,65.46%,PLEKHA3;CERT1;PSAP;PLEKHA8;ABCB1;SGPP1
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.3434887319605272,-0.5406307591185325,0.9710144927536232,1.0,1.0,2/5,31.79%,ZBTB1;SUPT6H
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.2843800371624512,-0.53948505471933,1.0,1.0,1.0,8/41,21.30%,VAV3;VEGFA;SHC2;ROCK2;FLT1;NRP2;MAPKAPK2;FYN
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.2871796431035407,-0.5394148333911788,1.0,1.0,1.0,8/36,27.80%,DDX3X;CCNH;CDKN1B;MTCP1;CCNK;ABL1;GTF2H1;UVRAG
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.3369625553766904,-0.5352504848757764,0.9594594594594594,1.0,1.0,3/9,28.22%,TRIOBP;CAPZB;GSN
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.3369625553766904,-0.5352504848757764,0.9594594594594594,1.0,1.0,3/9,28.22%,TRIOBP;CAPZB;GSN
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.3613421718011247,-0.5351491748133874,0.9864864864864865,1.0,1.0,3/7,40.87%,PPARA;ABCB7;GPER1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.3391500405957169,-0.5350657828308016,0.9558823529411765,1.0,1.0,1/8,15.70%,LRRK2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.35581004525284576,-0.532949654766689,0.9726027397260274,1.0,1.0,2/6,25.63%,NBDY;CNOT1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.35260607811070505,-0.5328335229926701,0.9552238805970149,1.0,1.0,1/6,25.59%,KDR
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.33628859159037716,-0.531486153103492,0.8955223880597015,1.0,1.0,1/6,18.70%,MDM2
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.32188322081580206,-0.530725910908055,0.96,1.0,1.0,2/10,27.46%,ACSL4;FAR2
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.3560788135449017,-0.5302255034916462,0.9428571428571428,1.0,1.0,3/6,35.74%,PWP1;MACROH2A1;MTOR
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.2562218672985641,0.5296339944148662,0.9565217391304348,1.0,1.0,1/10,4.80%,ARSB
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.33782830721034746,-0.5274860246706798,0.9855072463768116,1.0,1.0,5/8,32.64%,MTMR2;FYN;INSR;SUPT6H;PRNP
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.28332797944105353,0.5261913627365642,1.0,1.0,1.0,8/8,71.70%,NSL1;LATS1;RB1;TOP2B;INO80;ZNF207;KLHL22;SMC1A
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.31254192672178316,-0.5261382924640202,0.9736842105263158,1.0,1.0,4/13,30.11%,RPS27A;MAP2K6;CYLD;TAB2
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.3226080677854602,0.525739921680479,1.0,0.998813759550389,1.0,1/5,5.20%,VPS35
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.27116259863523845,-0.5249825999796254,0.9891304347826086,1.0,1.0,10/45,29.64%,PDK1;DDX3X;PRKDC;STK24;HINT1;ARL6IP5;FHIT;ABL1;APAF1;CEBPB
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.33793546315620476,0.5240399841518533,0.9642857142857143,0.9980700351714408,1.0,5/5,66.23%,DERA;RPE;GPI;HK1;PGM2L1
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.29110355522898057,-0.5223279333636694,1.0,1.0,1.0,6/33,26.00%,RHOB;ROCK2;RHOBTB3;PAK1;GPM6B;ABL1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.28920223511801374,-0.5196929700860019,0.9875,1.0,1.0,5/19,26.77%,GRM7;GNAL;AKAP12;CHRM3;LPAR1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.2877525976308651,0.5194082230725352,0.896551724137931,0.9983746675363916,1.0,2/10,8.26%,RYBP;PCGF3
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.27616228240837704,0.519207503825038,0.9565217391304348,0.9970013633330405,1.0,2/11,9.18%,CDC42;SLC9A1
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.30199034417543036,0.5185293871205171,1.0,0.9957692508181055,1.0,1/7,4.97%,PLA2G4C
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.3452085031055476,-0.5164006665060731,0.9861111111111112,1.0,1.0,2/5,27.25%,EGFR;NRIP1
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.3214352890278483,-0.5161873434121415,1.0,1.0,1.0,3/10,26.03%,NAE1;APP;SIAH1
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.2889031636422033,0.5126974523329629,0.9285714285714286,0.9968571728494204,1.0,7/7,71.14%,PPP1R12A;PDGFRB;CALM1;MAGI2;ITGA1;MTOR;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.28462194939250385,-0.5096990779714142,0.987012987012987,1.0,1.0,2/17,14.16%,TGFBR1;NR4A2
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),0.2862877328195248,0.5086353623890271,0.9545454545454546,0.9966416649773633,1.0,6/6,71.40%,MSH2;MSH6;MSH3;SSBP1;CHTOP;POT1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.3469110307875445,-0.5080155015629529,0.9846153846153847,1.0,1.0,2/5,19.38%,CSGALNACT1;EXT1
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.3189252504408948,-0.5059034270562607,1.0,1.0,1.0,1/6,19.86%,SFRP4
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.29456509345108584,-0.505230178737054,1.0,1.0,1.0,2/13,17.97%,TP63;YWHAG
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.29456509345108584,-0.505230178737054,1.0,1.0,1.0,2/13,17.97%,TP63;YWHAG
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.3272789217565437,-0.5030714599119082,0.972972972972973,1.0,1.0,1/6,24.86%,SYNJ2
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.3272789217565437,-0.5030714599119082,0.972972972972973,1.0,1.0,1/6,24.86%,SYNJ2
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.3272789217565437,-0.5030714599119082,0.972972972972973,1.0,1.0,1/6,24.86%,SYNJ2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.29293183626766717,-0.5023970787901233,1.0,1.0,1.0,2/14,17.97%,TP63;YWHAG
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.30070430907715107,-0.5021246953134737,0.9861111111111112,1.0,1.0,7/17,37.87%,NF2;APOD;CLASP2;RASA1;CASK;BCAS3;NEXMIF
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.26789858745379724,-0.5014370930173236,0.9882352941176471,1.0,1.0,6/22,29.18%,SPOCK1;WASHC2C;MINK1;PIK3CB;NF1;GCNT2
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.2875933080691509,-0.5014195477970684,1.0,1.0,1.0,7/18,34.81%,CMKLR1;TMEM64;LPL;AAMDC;CEBPB;ZBTB16;NAPEPLD
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.3222866697183935,-0.5009092666344707,1.0,1.0,1.0,3/5,37.39%,ADAM9;EHD2;RIPOR2
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.2632694882327469,0.5002604805304125,0.9545454545454546,0.9978209284641796,1.0,3/13,13.28%,MORC3;TAF8;PML
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.2995815929745156,-0.498131010752876,0.9868421052631579,1.0,1.0,1/12,14.71%,CLU
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.260739832000526,0.498096999271872,1.0,0.997017765328124,1.0,3/11,17.08%,SLC27A1;ACACA;CPT1A
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),-0.3413162999605288,-0.49604661145823364,0.9857142857142858,1.0,1.0,3/5,30.94%,ROCK2;LYN;EPHA4
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.2590412671549276,-0.4942597636781904,1.0,1.0,1.0,9/29,39.43%,RAD21;RAB11A;SMC1A;KLHL22;EML4;CSNK2A2;TTN;PDS5A;CSNK2A1
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.27610022486347574,0.4931097213095872,1.0,0.9970755355810413,1.0,8/8,72.43%,NBL1;BMPR1B;BMPR1A;AIDA;GLI2;DSCAML1;ACVR1;PTCH1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.3278267079947216,-0.49152826602060457,1.0,1.0,1.0,2/5,27.30%,HSPA5;SEC62
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),-0.3001419152062106,-0.4905923356526504,1.0,1.0,1.0,1/7,21.09%,NLGN1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.2571691167407973,-0.4903742990230415,0.9885057471264368,1.0,1.0,8/30,29.03%,SMCHD1;RNF168;UIMC1;EYA2;EYA1;EGFR;BRCC3;SPRED1
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.281607817211572,-0.490063972419921,1.0,1.0,1.0,3/18,18.70%,GGA3;BTRC;MDM2
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.2740992205629925,0.4861361984029762,1.0,0.9973917347987106,1.0,1/10,4.56%,PPARD
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.2614412852279414,0.48464848618053713,0.96,0.9949406796840372,1.0,2/11,12.46%,DLC1;CORO1C
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.2614412852279414,0.48464848618053713,0.96,0.9949406796840372,1.0,2/11,12.46%,DLC1;CORO1C
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.26276956046315514,0.48374344835029576,1.0,0.9936593512446187,1.0,2/7,14.31%,MAP2K2;RNF13
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.2874678515835256,-0.4819830494213847,0.9871794871794872,1.0,1.0,1/7,23.02%,APOD
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),-0.32518936513339103,-0.48117454350886407,0.9722222222222222,1.0,1.0,2/5,36.32%,ABL1;ABCA1
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.2887953821513509,-0.4793994409021236,1.0,1.0,1.0,1/10,15.38%,UBE2L3
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.28610511388039683,-0.47902706623163976,1.0,1.0,1.0,4/11,29.82%,FLT1;ADAM17;SP1;COL4A3
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.31558832698386735,-0.4770172244647075,1.0,1.0,1.0,1/5,21.94%,LOXL3
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),-0.30665208504973895,-0.4752382487000105,0.9743589743589743,1.0,1.0,3/6,34.76%,SUPT16H;ARID1A;ARID2
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),-0.30665208504973895,-0.4752382487000105,0.9743589743589743,1.0,1.0,3/6,34.76%,SUPT16H;ARID1A;ARID2
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.2799054903109811,-0.4749646725646872,1.0,1.0,1.0,4/12,39.33%,DNM3;WASHC5;DNM1;PRKN
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.2679039016838045,-0.4739846844348772,1.0,1.0,1.0,1/21,9.96%,RPS27A
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.3035456580547924,-0.471161330716572,0.9861111111111112,1.0,1.0,2/5,39.40%,CEP120;NUMB
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),-0.2726186319506605,-0.47030072259305256,1.0,1.0,1.0,3/10,39.11%,UGCG;ADAM9;PIP5K1A
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.30338084847903257,-0.46473637256561434,1.0,1.0,1.0,1/5,20.55%,EIF2AK4
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.3101230107786323,-0.4646559999808513,0.9850746268656716,1.0,1.0,4/5,34.33%,SLC44A1;ALDH7A1;HNMT;DMGDH
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),-0.31255156400539985,-0.46250060156724965,0.9722222222222222,1.0,1.0,1/5,26.00%,ABL1
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.3182893942298541,-0.46141770203444804,1.0,0.9998753826439479,1.0,2/5,28.39%,GOLPH3;JAM2
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.3182893942298541,-0.46141770203444804,1.0,0.9998753826439479,1.0,2/5,28.39%,GOLPH3;JAM2
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.29877404902635574,-0.46106972744664354,0.9436619718309859,0.9995636490353557,1.0,2/6,36.40%,KDM2A;KDM2B
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.24254448457950756,-0.45625849284339637,0.9882352941176471,0.9996771864290933,1.0,7/28,30.86%,GOLGA2;SMC3;RAB11A;MAP9;CLASP2;SMC1A;KLHL22
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.2906903248373702,-0.4562306870261685,1.0,0.9993303322027233,1.0,2/8,23.07%,UBE2K;RIOK3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.28460925928236863,-0.45222243141603713,1.0,0.9994120151937587,1.0,2/7,24.91%,LYN;PIK3CB
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.2861052987664745,-0.45141797683840634,0.9873417721518988,0.999192878553769,1.0,2/7,23.56%,SUPT16H;ARID1A
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.2463016812621892,-0.43708330287159713,1.0,1.0,1.0,4/15,28.60%,SEMA3B;SEMA4D;FN1;RADIL
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.25148963013328607,-0.4332556051215816,0.9886363636363636,1.0,1.0,4/14,35.55%,ARHGAP28;ABL1;RASA1;PAK3
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.2460081589419983,-0.4322338912106559,0.9863013698630136,0.9997841262208528,1.0,9/18,39.06%,RPL35A;RPL5;RPL24;RPL3;RPL11;LAS1L;WDR12;RPL14;RPL23A
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.2905594971924701,0.43199530755852755,0.9583333333333334,0.999906236527211,1.0,1/7,7.11%,HLA-E
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.2431770586314737,-0.4261780245040438,1.0,0.9998619742039944,1.0,1/20,6.14%,SPOCK1
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.21409874949572516,0.42023597128495155,1.0,0.9991215622677208,1.0,1/11,8.60%,DLG5
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.24364849123336085,-0.4185490125856419,1.0,1.0,1.0,6/17,37.10%,RAB27A;EEA1;WASHC4;WASHC5;DNM1;USP8
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.23851172972140727,-0.4161573104513944,1.0,0.9998197731100777,1.0,1/15,13.12%,FYCO1
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),-0.2842537037325555,-0.40968231357713425,1.0,0.9997810460462309,1.0,3/5,39.04%,ZDHHC17;TMEM108;NTRK3
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.2380935034544106,-0.40752325490634494,1.0,0.9995447503665247,1.0,3/12,35.55%,ARHGAP28;RASA1;PAK3
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.24502660550862682,-0.36165430356680434,1.0,1.0,1.0,2/6,31.22%,NRP2;PLXNA2
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.19515572969568412,-0.34625527411569595,1.0,0.9999682657216904,1.0,10/26,41.55%,CLU;RPL5;RAD23B;UBE3A;RPL11;PTK2B;CSNK2A2;CSNK2A1;UFL1;NUB1
